"analysisId","targetId","outcomeId","comparatorId","targetName","comparatorName","nestingId","nestingName","outcomeName","type","targetEffectSize","oldOutcomeId","trueEffectSize","trueEffectSizeFirstExposure","mdrrTarget","mdrrComparator","stratum","logRr","seLogRr","ci95Lb","ci95Ub","method","comparative","nesting","firstExposureOnly","database","calLogRr","calSeLogRr","calCi95Lb","calCi95Ub","calP"
1,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",0.978532589211201,0.269600756131842,1.51538672783045,4.36006173527558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.746650050493451,NA,0.48959168012329,NA,0.342290781587017
1,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",3.00375546496558,0.130657377682188,15.611770115935,26.0545556399495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.63380235800251,NA,1.89263519382288,NA,0.000645074680199485
1,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.189509123260189,0.152528864556497,0.615567076089365,1.11928579759511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.341788935445242,NA,0.225135428858039,NA,0.681744882177214
1,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",3.53742432784128,0.116077263603697,27.4518084584387,43.2694377374094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.13108290335636,NA,2.610299548202,NA,4.87675763434894e-05
1,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.172583404853043,0.143150469915354,0.902119360343171,1.5811162606538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00438421529622268,NA,0.292492337952932,NA,0.982735601329206
1,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",4.63172964089321,0.101948906306197,84.4502387806698,125.938644504472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.15079431578237,NA,4.8793403802114,NA,7.15587929585817e-08
1,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.498337759101573,0.136736285819661,1.26678595385108,2.1651276899257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.299180054752215,NA,0.368363616385969,NA,0.680858149903085
1,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.2642627521916,0.127604292816219,2.77793643463882,4.58095732292139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01286065764376,NA,0.62295741597131,NA,0.18362019391683
1,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.20258203770928,0.0728147672083756,2.89045091289412,3.84525975683028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.955404828060426,NA,0.603112462225924,NA,0.205582940912562
1,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",0.0596666433122482,0.232496135294364,0.658481618966599,1.63812030951283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.109605071871613,NA,0.260586336523236,NA,0.911912996298998
1,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",0.456879930350383,0.320109272200471,0.799910754716419,2.80541134454289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260536717687512,NA,0.330407234538713,NA,0.732498652706012
1,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",1.56488729030667,0.143341362460485,3.60536674505367,6.32374321528097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29303161980685,NA,0.758266118568186,NA,0.0920400740499501
1,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",3.20587896584612,0.106325634695797,20.1061921862133,30.5027445820516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.82213497840279,NA,2.14526348036304,NA,0.000243354423349633
1,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",-0.0277120834073042,0.197997266797056,0.649063450399404,1.41045200405653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.191048011398564,NA,0.24857398388384,NA,0.829944391324135
1,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.350739002186794,0.170391695583419,1.00679847211376,1.96344118402555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.161641393662807,NA,0.328854230207876,NA,0.81573253324305
1,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.687491327489108,0.150401786032964,1.47224442235003,2.65475460249844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.475432421683668,NA,0.418479283379849,NA,0.524938381913308
1,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.25743127696302,0.125275763823192,2.746510891836,4.48798268418763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00649606511247,NA,0.620408590222791,NA,0.186146661262404
1,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",0.674821972008954,0.23606381147154,1.23029932135451,3.10374866448391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.463622886352553,NA,0.402437445414821,NA,0.544167886573998
1,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",1.06193406981721,0.212867965803259,1.90573570805312,4.38985073491056,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.824366947405302,NA,0.530504892379443,NA,0.286739543034465
1,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",1.27677229016386,0.201462301879235,2.42154443181716,5.33411637670216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02455742675019,NA,0.616060913817414,NA,0.186228867166486
1,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",2.0442008740936,0.175005797530385,5.52284322206238,10.9671333689153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73965362048296,NA,1.02908827108008,NA,0.0250125270941108
1,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",-2.32906282926475,0.789576117961386,0.0279217789442561,0.616765261505957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.33548746949511,0.94300958770099,0.0204249824718809,0.823273478814928,0.0296250804664193
1,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",-1.95773881087301,0.772630926775751,0.042392137255286,0.876222875439373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.98948085689797,0.981350758364558,0.0290292210918409,1.35984667271289,0.0616319762703001
1,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",-1.53807192582031,0.761036418201098,0.0666028555411363,1.31547802256567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.5984232959037,1.05664975429028,0.0424503496416388,2.67131482669845,0.131519433526249
1,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",-2.88998363792092,0.807226479674894,0.0152101571636714,0.360046465586481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.8581778903556,0.901412914429169,0.0120720021569224,0.413378068823059,0.00834067565520952
1,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",1.86767634596195,0.253106151132714,4.0350180667012,10.8826378357462,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57516295238442,NA,0.896709249474473,NA,0.0470671667551698
1,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",2.03608015331129,0.406293848308123,3.25535777894557,16.0056983545704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73205787939649,NA,0.935766785494063,NA,0.0407122494181293
1,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",-1.54138359594842,0.762227434535211,0.0661662202946536,1.31296957865688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.60150921371403,1.05686337065498,0.0422545842011314,2.66122317377252,0.131043207524691
1,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",2.52688252755369,0.337577346509036,6.27314354410014,23.5601440751456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.18943793775648,NA,1.33020873016537,NA,0.00776825891872746
1,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",0.571594426640035,0.805988664656274,0.483923854688624,11.3997314679697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.367429851371246,NA,0.227400569470199,NA,0.717573884022511
1,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",2.28517956603903,0.372103922315478,4.53722784695925,19.5101880190577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.96420328461049,NA,1.12135122178813,NA,0.0185361409589746
1,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",0.87791569270764,0.790811806826323,0.685887505121375,15.2241604383049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.652870062127173,NA,0.294079773144319,NA,0.52665611548591
1,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",2.90736768276293,0.302060336207325,9.97106073230146,32.5814051339191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.54398158416578,NA,1.71245989293643,NA,0.00172411278987803
1,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",1.32251898775386,0.772568176868582,1.12610256910506,23.2702151170338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06716461216575,NA,0.420952165616109,NA,0.301341805978982
1,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",1.56196954220354,0.763788125154236,1.46663761439013,29.2818209458496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29029220881782,NA,0.507576914102563,NA,0.210544443949121
1,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",2.12451537378065,0.249049804180736,5.26252745584686,13.9693928223876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81449587190707,NA,1.0613862709154,NA,0.0222241289045691
1,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",2.33862743769685,0.24283627853217,6.60663953213385,17.1153522512824,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.01403357174586,NA,1.22019249273275,NA,0.0110771031582859
1,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.98440052846504,0.235488743524227,12.8044347973004,32.2297678086681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.61576370203225,NA,1.83154949710821,NA,0.000969725420352855
1,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.0598446466543192,0.355253328248273,0.452056321468206,1.81960411030123,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.220966446284436,NA,0.221594373014657,NA,0.81138626513069
1,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",0.103634867778783,0.33401089280439,0.560006181734075,2.07402504239662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.06862916772817,NA,0.25365974821358,NA,0.954446505794267
1,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.590867457115961,0.28501029365461,1.0226517539664,3.12557677491928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385390778602351,NA,0.370660424988128,NA,0.61702220770492
1,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.29326756768008,0.238348615469228,2.29682937494219,5.84647574772841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03992107821369,NA,0.6149737016929,NA,0.184705944061461
1,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.0787926363854026,0.163096162567539,0.787519888170557,1.49250893895556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0917884074703941,NA,0.271895246933128,NA,0.928282601000495
1,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.43574282264744,0.151568464211849,1.15361512901829,2.08973667281568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.240851589154698,NA,0.351155117518403,NA,0.737323298981492
1,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",0.0100171427678724,0.14644251840001,0.760444476494252,1.35011793052383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.155841522113753,NA,0.260296953244705,NA,0.863095656984566
1,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.76762465850983,0.143826477691142,1.63462157991034,2.87255179112345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.550101963003435,NA,0.443028049812135,NA,0.463962752308106
1,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",0.390885556953374,0.136471052663991,1.13665987993306,1.94070387256899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.199056579229744,NA,0.341750393003783,NA,0.777340408648855
1,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.46078140414161,0.133209958688754,3.34416464317962,5.6372162571438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19603041404099,NA,0.709301928980555,NA,0.117933174244841
1,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",0.699507125003401,0.130723598946671,1.56650947270247,2.61503366220671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.486630455496197,NA,0.424113356457932,NA,0.513977854474262
1,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",0.356091768200992,0.443539246603974,0.657308064807774,3.73982726286204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.166599185553977,NA,0.281347726171627,NA,0.8295386391246
1,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",1.34890191835463,0.122339169286193,3.05216089007539,4.93035286087888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09172648795103,NA,0.65989042137194,NA,0.152013907030501
1,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",0.897348935414532,0.432389737278238,1.16125881484575,6.32456480455525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.670972143198626,NA,0.42022200249761,NA,0.425044408695591
1,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",1.23483736613667,0.426911592447777,1.64964528382353,8.79358938344893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.985461741714728,NA,0.535363224015135,NA,0.244726331862792
1,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",-0.0528929431112398,0.157796762863632,0.691722216964987,1.28400117407163,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.214483843125571,NA,0.247914309148611,NA,0.804966047498327
1,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",2.06986593275809,0.420740616554737,3.86009598613934,20.0848331504347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76354889849278,NA,0.949512204075149,NA,0.038581057107145
1,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.300355924471572,0.139472527849881,1.0242451061173,1.76946655933404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.114700815829902,NA,0.320442491063028,NA,0.861552782312822
1,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.525979945026797,0.130441203065264,1.30832007595461,2.18161199262269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.324937995741002,NA,0.376125061073343,NA,0.6563992899339
1,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.16257686631752,0.110569826733304,2.57865044435101,3.97765295217897,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.918126222526975,NA,0.58379746986925,NA,0.225746150575982
1,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.17185148298656,0.0977476596927227,0.694459154043597,1.01871482070376,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.325333741447925,NA,0.231552306963558,NA,0.694408920189188
1,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.212206572827857,0.0881377724099839,1.04020615863475,1.46948594472644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.032520995191507,NA,0.304784072352606,NA,0.944507628703546
1,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.553190900803308,0.0814239208683815,1.48324512588024,2.04093542578089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350302378789726,NA,0.387112688015879,NA,0.630466027501128
1,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",-0.0924379792569764,0.135102531683548,0.698094730420838,1.18553212466776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.251335226350971,NA,0.242754709693676,NA,0.767679947074511
1,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",2.0594836259856,0.127634909639108,6.11150080075447,10.0793827473341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75389503615079,NA,1.04934162733064,NA,0.0224619114522311
1,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",0.279552141352942,0.122026398175981,1.04110463718685,1.67970299952088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0953209623585512,NA,0.317242608445206,NA,0.880750141740408
1,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",-2.37074052295769,0.785570551059526,0.0270965321343794,0.589211810262198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.37432141283436,0.934491047822555,0.0198158840774284,0.772491833686535,0.0266272461400021
1,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-1.44243112089884,0.221884774734215,0.151158864444013,0.360720601124377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.50932946698766,0.725553878992355,0.0855440083841032,1.47019438364135,0.0615387622108417
1,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",0.579447486251642,0.113772596758564,1.42984608509061,2.2334493626932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.374761405298619,NA,0.391857147010249,NA,0.609764306135145
1,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",1.13212880005324,0.1023428188333,2.54498713589191,3.80114399715988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.889752951896733,NA,0.572791648479721,NA,0.239478904597705
1,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.552845419445994,0.165191177648087,0.416567553103363,0.795989630132796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.680355010144607,NA,0.172011271305578,NA,0.400434511624967
1,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.127674216234951,0.151376254661461,0.656544214684037,1.1884129672836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.284169480554077,NA,0.23547906682976,NA,0.736532617457236
1,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.134880646337573,0.145163371572477,0.864915497617734,1.5279187158182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0395156501119872,NA,0.284605754970749,NA,0.98134055374548
1,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.799766326823913,0.133567260395004,1.72393915951614,2.91009556569942,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.580052495615352,NA,0.454079998910589,NA,0.439939376564549
1,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-0.964824075053572,0.187678447721051,0.262269621163051,0.547333912462788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.06425435877589,0.882466826177083,0.12541463215446,3.9871489235096,0.185768196279326
1,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.766533002579154,0.17482839184975,0.328548750492099,0.651970902745341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.879474892842126,1.00141383910868,0.146305379086046,7.41430255439391,0.274680062643965
1,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.40318804957217,0.105862034382972,3.31686536802712,5.0228209600608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14231324058856,NA,0.686181681520404,NA,0.13319424983226
1,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",-0.0944890726812137,0.142122520335579,0.688794035686186,1.20237294407357,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.253246557675468,NA,0.241880794180221,NA,0.766122233480159
1,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",0.191093691345316,0.131253956917613,0.938481062170633,1.56990240465416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0128934044958415,NA,0.297348894683434,NA,0.965021664735489
1,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",0.551690412743361,0.123592221622306,1.36801031959932,2.22071667205358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.348895991282844,NA,0.383539156559276,NA,0.633879846700409
1,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",0.827008005059119,0.11902537671223,1.81913183711231,2.90063673855617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.605437326496605,NA,0.46415897499304,NA,0.419652474433636
1,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",-2.00587623774024,0.779215281742292,0.0396689287124785,0.841373778061752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.03435574134538,0.979231325140064,0.027554169277158,1.28007009699164,0.0569196850510582
1,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",-2.57988397562313,0.788819326327271,0.0217860045917687,0.479806411054999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.56918843535454,0.914129047115488,0.0163892264307513,0.589894798363624,0.016582632756818
1,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.0145168278347263,0.142285516911528,0.74404295085812,1.29964670372793,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.178717053927392,NA,0.25610519664411,NA,0.83999924926544
1,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.399984244930897,0.127385388576791,1.16248310555272,1.91534904135517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.207536731838742,NA,0.344746309613658,NA,0.768624342208222
1,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.674630494902017,0.11944411249134,1.55581600666111,2.48485047922912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.463451527752994,NA,0.41798549199923,NA,0.532541049265809
1,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",1.54258403762925,0.284147362055115,2.7241464978382,8.29781609513307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27223380680735,NA,0.714129734409035,NA,0.111571016768239
1,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",2.53207154382652,0.252027685741632,7.88898717173017,21.1872192080824,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.19428176761207,NA,1.37573171789833,NA,0.00583750381009784
1,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",3.245772579553,0.241754805192122,16.4890932491985,42.5364165770649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.85931323211635,NA,2.144317423732,NA,0.000322434714645221
1,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",1.42528445368511,0.112323847586035,3.35617216495518,5.21272358223054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16289993561091,NA,0.695552466033249,NA,0.126850527219234
1,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.482621175730827,0.195302249647907,1.10380755696366,2.37343048150156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.284527882338282,NA,0.357609351362835,NA,0.698648048181816
1,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.940721211595882,0.175765573691282,1.82150658124098,3.62789408792553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.711395713286475,NA,0.494393377778051,NA,0.351173404266936
1,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.214520158521361,0.210548625226576,0.816248509477825,1.86320667182373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0347047813819199,NA,0.294073860701516,NA,0.943760163363488
1,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",1.19197551269442,0.266393645755525,2.01635721954619,5.72897384203868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.945519487615261,NA,0.567633394737303,NA,0.231311795980152
1,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.45167964089188,0.160491576287937,3.13838579149189,5.88745612618241,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18754345123461,NA,0.700702216954113,NA,0.122641792994024
1,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",2.1306500626164,0.253419756993602,5.30701517348518,14.3308815299526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.8202175153085,NA,1.0640682331846,NA,0.0220067801042115
1,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",4.13921934748922,0.235489474971444,40.857769222008,102.842508218226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.69186045289211,NA,3.63276629967342,NA,3.39310836758502e-06
1,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",1.44954718444032,0.262368952823823,2.63268212717322,7.36302271304968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1855417683435,NA,0.676934214098146,NA,0.134582990598574
1,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",0.892075783157957,0.274387321230549,1.4676383201327,4.30265837645305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66606579628753,NA,0.460125651582828,NA,0.396131534428383
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",-1.20619015476878,0.477204596113371,0.104329809632728,0.677334180719581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.10263289076567,0.723454592548894,0.0837988782534729,1.42839899636833,0.145609341801273
1,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",-0.521454970624471,0.347445572403116,0.28490875480803,1.11223923096791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.346605246967,0.639822561914353,0.210853114481503,2.5895000543606,0.599010283392071
1,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",-0.181045953733369,0.301568010555959,0.446319831606994,1.45558139706362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0292240608551124,0.617855774826709,0.321034263567916,3.61735360858266,0.971396716230562
1,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",0.437536929762565,0.238508965940264,0.957701089797441,2.43931778022642,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.712237916168131,0.597397397926637,0.663457349361572,6.899604286793,0.247218417479835
1,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",0.632077533806418,0.622869393616541,0.607582566650164,6.98200382346493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.92702873530729,0.87621515465987,0.476668267945805,14.7872571513696,0.295842265698897
1,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",-0.381459698893833,0.406629478835948,0.318805173031076,1.56954090831959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.19203353447349,0.68379888511955,0.225918973555686,3.29650727653679,0.780203859829327
1,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",1.44870558971835,1.12414512865209,0.922170969835017,75.6065781641029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82869192676112,1.36558544340089,0.45200996965512,95.4827431464969,0.17950322853287
1,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",1.78802363853078,1.11988346991509,1.31165940544639,105.758225049051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.20336108804166,1.36528650568662,0.659013023149769,139.047107245193,0.10451303234052
1,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",2.03348616183297,1.11762252171584,1.68833106975193,134.927863348719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.47438347612973,1.36599355853323,0.864127518244499,182.830853055601,0.067748402109241
1,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",2.60090892821452,1.11370671443889,3.01400487878243,237.203831064172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.10089249090041,1.36922321193155,1.61186328853534,345.380668689045,0.0216155233236715
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",1.01222656149159,0.497347686345108,1.07294000043892,7.53809615325888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34679133062739,0.778898212671892,0.879282818309528,18.6263306487047,0.0846695375393051
1,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",1.12335724351915,0.483064183116087,1.24382191047213,8.26281747088243,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46948962605339,0.769964693465442,1.01220649510408,20.7042446274253,0.0562391461471227
1,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.53876233623167,0.452957534340646,2.03123141288195,11.9915606612215,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92813998164784,0.755703208020766,1.65015948082523,31.9181265792016,0.00975761979871626
1,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",-3.33700491963637,1.21618289244465,0.00585779875177685,0.688918673853097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.45531913251038,1.41684582934362,0.00203242281433634,0.524876071431931,0.0170704174477152
1,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",-1.00379506641366,NA,NA,1537.34939533181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.87884575102706,0.428962364044032,3.03036752048256,16.2840397967213,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.30365254606572,0.745637636084368,2.45441874783206,45.6377760220967,0.00155686243375934
1,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.569324337398098,0.545461079127898,0.168292867473849,1.42777684628887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.399456987487879,0.790271814255737,0.148904098773168,3.29813044206632,0.619066700058453
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.78474878303638,NA,NA,2.712891679309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",-1.04261994052408,NA,NA,8.48460996895846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.866264342032443,0.647349039572969,0.126949949134091,1.60576332346918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.727315860178463,0.875094003598694,0.090737346043043,2.8025205458051,0.41617615335733
1,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",-0.676856124335909,0.890252535480501,0.0724328411381595,2.37412829829325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.518187066357874,1.10796753618231,0.0709206375699728,5.45732709082198,0.641604475997571
1,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-0.210844495126359,0.300336432344608,0.439112741534967,1.42517996479912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00364972286199281,0.616499641596613,0.311438259130365,3.49062227489874,0.987789254293656
1,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",-0.0922664102021418,0.288033104062482,0.508690510282837,1.57326572478006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.127245758487025,0.611824817929796,0.358448615834487,3.94456726300161,0.848929450455276
1,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.52138251197427,0.237675732648821,1.05444792063235,2.67697943917847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.804819514601068,0.598959152423628,0.725872559498501,7.59504390247289,0.19029663089526
1,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.02137541130496,0.211147772618621,1.84464445079334,4.22057176759415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35687750954898,0.598867048402788,1.26401245636116,13.2210048740388,0.0238478649799755
1,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",-0.747795639767524,0.392560671643882,0.229206152136461,1.06788077842438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.59654087117618,0.666716241100232,0.155646488511088,2.12402250398419,0.389646024861427
1,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",0.331021106252579,0.607239267855024,0.40833591334592,4.41350458217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.594641274266461,0.857730177508676,0.353970852111831,10.2133920461816,0.497544754632372
1,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",-0.335242388681897,0.370414798080745,0.363379408158133,1.55222834140888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.141003522130735,0.659045505792647,0.249610920426095,3.30540503938933,0.830049830704372
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",-0.176713025979761,0.232732967755632,0.525621367243211,1.308815212504,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.034036033926501,0.580388473294579,0.347160509696253,3.37742291460316,0.963431241683024
1,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",0.244644639523596,0.205250882128994,0.851795411920271,1.90438622620171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.499267366542115,0.577457344379206,0.557061570220259,5.35757629481714,0.407469460847343
1,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",0.516343247605599,0.191890757155485,1.15115293460745,2.44235304660944,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.799259673964663,0.578385875439637,0.751530074827966,7.25424575762159,0.178737374852833
1,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",1.15516476659566,0.167419094606691,2.29972572989518,4.43292953224787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50459642734245,0.58511802094742,1.50624887776595,14.9280630653278,0.00986210023578406
1,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.735358013349872,0.219286955278004,1.36881196525713,3.23339365944457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04108133954512,0.595455624412959,0.926603288934733,9.56311393975592,0.0852479116718805
1,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",1.01857937758858,0.20915868137723,1.85851976541873,4.21929187127105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3537901195377,0.597942301439016,1.26238421270681,13.1561971866862,0.0239688057171792
1,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",1.20818891003921,0.203637387222931,2.27436649696777,5.0528146298983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56314561170549,0.600347150365277,1.55053092548635,16.3122276755841,0.00882950726730227
1,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",2.04088547032827,0.188008618202153,5.41270772887078,11.3104798126208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.48254803143955,0.615728999822551,3.78956270315877,42.3455762384757,2.55873126841299e-05
1,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",-0.205392770843005,0.358165856797157,0.425643724171967,1.73296142043558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.002360679402263,0.653310307079752,0.291513455658611,3.77447096446696,0.995508526051226
1,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",0.236082461752654,0.344032013042886,0.683076019082713,2.63117782018194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.489812244872358,0.653104477233114,0.47576948596552,6.15522116648341,0.469584000153203
1,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",-0.195224568538663,0.389848834496376,0.399348374414857,1.84090670711171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0135968126844684,0.675343942472778,0.282360484975579,3.98576355023818,0.99153694486745
1,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.720997940079165,0.320127809048521,1.15855515605207,4.06352826093109,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02519978902221,0.648653789564349,0.821673344181915,10.4464663985718,0.119277258938058
1,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",0.0329878726937826,0.373565748837524,0.520847339905302,2.25252663118359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.265573013087427,0.668550374070632,0.368519763308335,5.06527470944586,0.706088683468873
1,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.30372701796541,0.313954033917479,2.10398942676885,7.20310705332503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66863047126251,0.658217742727941,1.53904305418789,20.3143385527535,0.0105977708013455
1,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",0.631023452484997,0.352851183114052,0.992729909054573,3.95845807629613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.92588198184556,0.667188375053225,0.717119742069562,9.80426920492127,0.172625878137386
1,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.912502288481282,0.288892496277222,0.225883992982136,0.700965968171325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.778389285623999,0.594959032422391,0.149257180281547,1.53742991031407,0.217486127905435
1,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.590655239340861,0.267315432433295,0.326508666344224,0.931050698442384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.423019267813486,0.589337564395841,0.215595547312238,2.17235038734975,0.491965894047116
1,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",-0.0930837950946949,0.233666544961661,0.576967846790481,1.44193691005051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126373542818709,0.582750678563979,0.379125720667697,3.72271511543068,0.843270033633197
1,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.279825385718161,0.209767451470872,0.881959140557536,2.00704551980246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.538111978773379,0.580273533281058,0.576035008810719,5.60155149404626,0.373066870025016
1,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.522333844889364,0.471781617387056,0.217692508884652,1.38358538595547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.347573005370147,0.730750811975232,0.176270287473985,3.09180112241949,0.640642368129259
1,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",-0.0161596648510422,0.389065897416451,0.443646877770351,2.03884595566583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.211307723329498,0.678306077450379,0.342373360155478,4.8893409706157,0.768926571075446
1,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-0.55385983258489,1.24602052815849,0.0849979652676577,11.2366724759424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.38236678269641,1.46999638077872,0.0399858413485168,12.7184039402652,0.793145434471801
1,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.572708863194699,0.323922283555143,0.935127808664221,3.32902661628217,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.861494726514478,0.647702375882816,0.698399154459884,8.84614856342496,0.192578037217767
1,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.32342520521644,0.273604269805682,2.22761369442342,6.5106542473704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6903763633192,0.636252618287195,1.64222467751766,19.8879946768635,0.00731061136921935
1,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.510045241971075,0.609478348538318,0.20080917192259,2.18958276996828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.334005911826128,0.846479087186312,0.142430721937133,3.93235109406496,0.695573900781207
1,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.0723929117286631,0.57529436589989,0.34070210863553,3.24905995581465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.14922896120396,0.8236692490588,0.24194080524238,6.10838206806666,0.864871983480554
1,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.710233457088267,0.543124558259839,0.810874167022761,6.81664047769443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01336603009466,0.810034528892062,0.591804407552435,14.1639204004876,0.215976680497914
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.261192956950195,0.467837030934439,0.478065763406395,2.99181577869667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.517546063640922,0.741807676942165,0.411150398398605,7.53106496889964,0.49813545567989
1,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",0.131143768176694,0.331680971156087,0.625943598887711,2.2971529448068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373943121854979,0.643008711559988,0.431974360147055,5.37177712106524,0.578026861661401
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.522340495226244,0.324685273441226,0.940245930729752,3.35727312659903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.805881102426053,0.647067191940904,0.661282375048763,8.35518619228022,0.223445785176105
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",-0.757687859864566,0.978527271658626,0.0789924892876258,3.65960023976143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.66462932315405,1.36191398049741,0.0552670858693473,11.507821835175,0.623884458021193
1,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",0.771537889392826,0.332625986421515,1.16067731362963,4.27538276133873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.848232372973154,1.22189001159033,0.431501134248733,51.8956873699836,0.330611862076212
1,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",1.14749465813761,0.316759850245035,1.75496485925162,6.0746515524248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22017264240301,1.30509838247768,0.592924997686613,98.8105405154758,0.164104639926447
1,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",0.404277110426947,0.178817677548358,1.06483960188472,2.14636689143073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.48490653820688,1.1051147803378,0.344113318915538,26.184982936722,0.547702071273426
1,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",1.36928418522521,0.310567711113095,2.22281042273525,7.50954898347382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43958909087794,1.36197741038958,0.712702967953472,148.437323346008,0.101300226868176
1,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",0.81899844039516,0.172910475458585,1.63187508986193,3.21403232374511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.895189305643383,1.19154150768903,0.484022749682882,51.6832380055112,0.28117854462321
1,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",1.91363068788396,0.298018924415396,3.94547375776525,12.6895872413745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.9781116329635,1.53269672431187,1.11269620799427,452.526734875036,0.0245986449800214
1,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",1.10648915600133,0.167150117004161,2.20188097632046,4.23985216964113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1796134424896,1.25901807467836,0.612329031196284,85.180680739576,0.158770723780136
1,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",1.85597126065957,0.158895696516296,4.74145144343819,8.83925843308103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92106883821256,1.48129183515422,1.11982403254211,372.310749675096,0.0229687377231083
1,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",0.24505008437791,0.1443461737505,0.963904683306181,1.69734240762181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.327386352779167,1.06836347573302,0.305342923256208,20.1174595881348,0.673074981748455
1,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",1.11832318662954,0.46590521847463,1.39128834035135,8.64123124845309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19133861845179,1.35359996703924,0.522802732776852,105.368454663292,0.203056229814523
1,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.553521014497484,0.135253921808851,1.33798458183448,2.27356723996231,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.632544574608873,1.12803055391088,0.39422059472698,32.8172363875737,0.435881426869258
1,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",25.9509527194689,NA,0.133828057853981,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.817592579520645,0.129105624247779,1.76553690340173,2.9286442017073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.893798169565789,1.18440823794011,0.489632013708978,50.8405272107298,0.277678004535974
1,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.486254993797,0.118475558941629,3.52398991245965,5.60696459499261,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55529289897818,1.35556821052188,0.841693521535507,170.953300505445,0.0625340225666338
1,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",26.5698884609292,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",26.7039521583211,NA,0.251757884111255,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",1.50344495983176,0.463022834352571,2.05997375783055,12.6506601869637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57230144450507,1.45572811839376,0.71992391422251,216.53227648906,0.0947365435176096
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",25.9682339663631,NA,0.428071471301182,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",1.80746816993086,0.461549225158697,2.80207260054698,17.1089047681991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.87308370628583,1.55223591589016,0.924218900226082,405.794409545111,0.0471279119527173
1,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",2.42554035446223,0.459331192864991,5.22835507723105,31.64695393589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.48456771910974,1.82781023822311,1.52600793055072,1973.45206363741,0.00868145906954966
1,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",-0.618999539467214,1.09621259244623,0.062830197434562,4.61704518888719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.527403537588874,1.47425764188819,0.0522832854483321,16.9100008838532,0.719937027757762
1,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",-0.183771921750777,0.460728576078144,0.326067041668502,1.98450708232347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0968532023973544,1.09644195283693,0.175708271258147,12.9234471304344,0.948150617135383
1,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.574534404084524,0.143983737660655,1.33164210364843,2.3415631646102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.653334498474818,1.13369331518087,0.400079364777605,34.052511699967,0.422467095848319
1,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.17308286321082,0.190126941888758,2.23666199018214,4.71273532878985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24549135963056,1.28005757703708,0.641380798145649,96.8924469183876,0.13948380136234
1,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",0.62345994700598,0.369778328205364,0.912188692561019,3.88683810457865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701732940327492,1.20346645692357,0.372601945925358,41.6898304963963,0.424229483732365
1,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.83073935301779,0.131546226355424,1.76652487488261,2.95845153410665,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.906804502989217,1.18772154088739,0.494587506839649,52.0264219662478,0.27120449752091
1,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",0.918312724778895,0.347675393072371,1.29031880285697,5.04174281685322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.993441658071202,1.25988566828027,0.482394589850187,67.3341959798449,0.260122953097236
1,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.53433947622415,0.107061709451751,3.7594245000238,5.7198356729872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60286455061236,1.36870081580716,0.876698876374072,187.469639033216,0.0546625613017483
1,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",1.47650210774248,0.315311100521912,2.43160441724044,8.36911459194131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54565983608846,1.39395662700851,0.775476267356128,183.081547811284,0.079541369167973
1,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.50714051905294,0.178857412322862,3.19729242340842,6.44569526359118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57596159240018,1.37053105399406,0.842551170199066,181.464878589372,0.0622727844055273
1,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",-0.580831843463241,0.896945636136586,0.11776482797049,3.96258527463666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.489680684526254,1.31890281300949,0.0732251922707653,12.8814496485426,0.710295729514157
1,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.68546388654049,0.174066747109759,3.86023337205296,7.63739633473834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75238248761407,1.42533374896775,0.973311407633924,259.862963552007,0.0383694440353707
1,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.28696453255485,0.156839532790776,7.30230571874177,13.5040524436487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34745906529468,1.66175621307881,1.57603364561487,1063.02723339529,0.00558889431307247
1,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",31.9603616875246,NA,0.0701384440094829,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-1.22074307935797,0.143251270668878,0.222971819249019,0.390950148687955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.12274614694053,0.838274087992843,0.0899376913216576,2.40448531932038,0.204235694448128
1,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.807445008072409,0.131980522917251,0.345283247580547,0.579241350421825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.713849369382433,0.893102611180963,0.127860136375181,4.23794977124277,0.427048450459734
1,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.505316739438474,0.125132659521894,0.473951298685191,0.774033831770116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.414956783274768,0.937182349540336,0.164950101553565,6.49852376770185,0.656042216541034
1,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.249537893488905,0.114900774273162,1.03015992842785,1.61626320181836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.331828493049966,1.06503439886865,0.308898288775032,20.0878450717315,0.667707444670692
1,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",29.7796467824237,NA,0.140606716180172,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.493460840643567,0.158584737460154,1.20005651530568,2.23448192346182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.57313593934814,1.1193354421138,0.372767919666866,29.9915313673171,0.479862414983841
1,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.74733272164959,0.149014041942585,1.57908999792773,2.83197129896351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.824288980472368,1.17155569362036,0.459974192086333,45.414390924003,0.317041101584272
1,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",33.0297234845688,NA,9.23206104688142,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",32.7979928735099,NA,13.5646779044897,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",-0.847071806897792,1.16389699985446,0.0233672855009349,2.23887635445062,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.753075675575909,1.50653819537053,0.038010635004339,13.9521262867842,0.614901049372639
1,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",32.5134006630232,NA,17.9610292744652,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",32.519284117561,NA,34.8984425422109,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",0.88001060532618,0.976485299728917,0.317126173718286,14.5748359683166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.955565800435598,1.61323655019698,0.241003432014252,134.40087909991,0.440628222565747
1,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-1.07052183711628,0.435427291685724,0.132420882647851,0.729842658180372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.974126876155838,0.959948348103646,0.0839711759473674,3.6170063048851,0.321995868716407
1,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",29.9951150527949,NA,0.208316635261832,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",29.8299506393382,NA,0.276403642239272,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",29.6155008676313,NA,0.484412110022072,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",-1.05797193819221,NA,NA,36.1646856597015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.151990200479083,0.168373533061165,0.828021035085355,1.60206817075729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.23532185443033,1.05516443264397,0.280614198364438,17.5559699282752,0.754283004193408
1,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",1.55894364717167,0.183502709471659,3.35937276992149,6.89689757852575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62721255149455,1.38699547190434,0.877017300067649,201.480737829224,0.0546611422257368
1,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-0.344437561096445,0.445014702375523,0.269748592509152,1.54366689365567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.25580099586517,1.06420206414477,0.155390294882231,10.0722099405156,0.816324363962015
1,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",1.32678046930145,0.151072369140865,2.8289228132783,5.11454690059825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39754432907316,1.31437090137211,0.734830888836953,126.992035078687,0.0953486001966592
1,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",0.0952536354245986,0.226418008000154,0.70684263277281,1.71702829297103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.179189660325706,1.05744755717853,0.261458263015737,16.5045754249071,0.807077187750388
1,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",0.513449992842254,0.209191907990623,1.11561879193359,2.53305588197837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.592910540950129,1.13324066818495,0.371996333115616,31.6061116628251,0.471095406621085
1,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",-2.21703328418703,0.43194167609023,0.0485170032315226,0.263774501119233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.10836297774418,0.833378332483209,0.030896983003728,0.810330003190508,0.0285724665664985
1,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",0.760721910664282,0.201017620815648,1.45471452705313,3.1988273008285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.837535845093473,1.18391854675676,0.456951842592122,47.3562190738373,0.315416210978083
1,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.135880030474011,0.175256054560384,0.809294253203258,1.60865496853996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.21938377144538,1.05351828480821,0.276226819026171,17.1703292026923,0.768724877631814
1,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",-3.34975311104863,0.59363996475115,0.0106760040333002,0.109401490118821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.22896037778418,0.846884496242623,0.0091076667725672,0.251852294995302,0.00191381248153468
1,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",-3.2687692702891,0.566498924993014,0.012464828167127,0.114840695580303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.14884602628981,0.832915059814624,0.0101847876977586,0.266630083762363,0.00213744676890913
1,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",-2.72843105416149,0.487158696218848,0.0255733790102406,0.172634894281898,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.6142933904154,0.82064290976956,0.0184013251387766,0.459107218858527,0.00802475698034086
1,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",0.676859427471751,0.162891474284974,1.43980290539806,2.72652820186007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.75456849413967,1.15844155820019,0.432473686362686,40.5596475355268,0.359307313185885
1,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.15119443147873,0.137302230703833,2.42476581167086,4.15349355906961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2238425953196,1.26580546900964,0.640178544694648,91.456010392001,0.141727488545726
1,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",0.0854982833840716,0.180562520363631,0.767053228090452,1.55673859952389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.16954132632697,1.04543527739194,0.264442227949175,15.9251323510068,0.813433920125304
1,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",0.393368980560419,0.170471585389092,1.0667157495245,2.08094240568161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474115394221689,1.10140433730604,0.342047189812525,25.6519373131372,0.555296295469565
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.869705006163802,0.49274176458448,0.152838331670502,1.05457480002457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.635819473704866,0.576574066539108,0.216509205413426,2.07509429590549,0.293639114611169
1,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",-1.05723004973801,NA,NA,5.03986327378513,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",-0.0680829408214898,0.328446325695848,0.496826684794584,1.8003334576344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.110624272213283,0.610454854620321,0.380845444340956,4.16858818790047,0.891445345978318
1,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.379042130997035,0.302833455672078,0.825237770160444,2.70472868222037,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.182316744821403,0.675420230065031,0.4927634805088,6.95786500473654,0.659784144374073
1,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",0.847222175739914,0.285023958647675,1.37380758569966,4.19905513378917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.48905131280908,0.77349018377541,0.63887882936601,13.2498381491491,0.291304725866077
1,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.55932026228855,0.26872049991112,2.90750828551523,8.33665001299352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.955590995564214,NA,0.935246941808167,NA,0.0454729908514626
1,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",0.681778872180833,0.286952473634977,1.14438015543995,3.52435051654221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.380658926572795,0.73325731118449,0.584303188791578,10.3499384275426,0.401742608773739
1,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",0.464269169153097,0.79881918573833,0.443572892028639,10.159614860468,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.238155858226235,0.897300398079921,0.359977201656396,12.1294738832698,0.690760334836867
1,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",1.00058421411438,0.27279222814314,1.62644640823173,4.73851313595133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.58952854861268,0.814883539976048,0.696510503245847,16.9897865792876,0.206654340142448
1,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",1.30994805751215,0.262407822509587,2.2696650498919,6.34871244801479,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.792190167025666,0.939882226641692,0.822936875860767,32.766113179256,0.0935284471311974
1,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",0.802866731129982,0.785304173617994,0.646336798059625,14.0398714499026,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459988226777421,0.968800509002703,0.443574116819135,19.7813156566072,0.470779007713707
1,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",1.03183027098146,0.776487917743229,0.832761367639329,17.4749522411658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.609999469656669,1.04113278277299,0.509833587773805,30.1895129186468,0.345608887735626
1,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",1.63518015406335,0.761166690471108,1.58966587587119,31.41364812989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00528369807983,NA,0.726161580860781,NA,0.125384633573305
1,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",0.192162967901357,0.633716374239331,0.342408607898461,4.10568272565755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.059877121465735,0.766366237933662,0.356014349196449,7.1801208071293,0.872093873979168
1,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",0.925187740406262,0.406964806420296,1.14976096122072,5.66794596296826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.540123980047293,0.830506378357141,0.628195834953525,16.2911474490401,0.279310053957622
1,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.1989568934895,0.384537961587579,1.58768371448761,7.16807602333719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.719489719516037,0.921121664723983,0.736474750385061,27.2444614131728,0.151251666528106
1,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",-1.16097588961348,NA,NA,6.15720600192703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.54950905669735,0.361095744911096,2.37211303982132,9.7693550044191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.949163776513523,NA,0.896844358487005,NA,0.0581890985477172
1,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.06487174071509,0.32423974896774,4.30977902708657,15.3617874846908,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2868126433822,NA,1.19037945848623,NA,0.00952846429135779
1,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",0.303708066384893,0.54715734775006,0.449280676329364,3.83707331596759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.13295950207718,0.746111482298975,0.406491608500923,7.57240920698721,0.767812094839044
1,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.203294116698689,0.327446560054201,0.613812876053412,2.21555241506463,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0671728249214467,0.651568139137499,0.442391708152491,5.6890347870572,0.833585398894193
1,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",-1.00681865236727,NA,NA,93.0240485883204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.406301000310333,0.297347812241494,0.848065600454276,2.72041575190929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.200175820199696,0.67906035267646,0.501366070228243,7.18107363727195,0.633507082338412
1,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",0.247515015939607,0.51580531493944,0.456401584388525,3.44711445466586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0961431784167062,0.723769776743964,0.403040212297457,6.87854021510998,0.812208683770552
1,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",0.0299385491163402,0.792102600659407,0.162444963514502,3.62396640524498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0464035645052564,0.82199467150714,0.28070127571552,7.04061590195183,0.993347494684651
1,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-1.3121601080617,0.556318428046377,0.0789307090562073,0.698753848990628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.925692885888351,0.567881586913335,0.158143295237964,1.46492081612791,0.134559462852116
1,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",2.45306328202734,1.12463634160543,2.51362920901283,206.483614244051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54114064879298,NA,0.83709119726515,NA,0.0696103149108277
1,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",2.44548971132406,1.17020946212705,2.16592712584245,212.72182020461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5361873044346,NA,0.798065133618566,NA,0.0788191750284289
1,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",2.77510571771009,1.12035844383291,3.51482951883297,283.926505840299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75213035040949,NA,1.00926512941816,NA,0.039201002853174
1,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",3.035927574536,1.1178761962436,4.59680723982077,367.732639797941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92301195242214,NA,1.17120898059171,NA,0.0236851795055359
1,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",3.66149017857026,1.11354124048515,8.70846183154067,684.916292855964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.33285490978886,NA,1.66044947208022,NA,0.00610787497153385
1,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",1.98632169731632,0.600410936237181,2.11670249019879,22.2741557297372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23534270005829,NA,0.989759275343647,NA,0.0363833343228326
1,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",3.05908363178943,0.46326127104055,8.65454742352001,53.1987930920149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.93818233710417,NA,1.86349792125125,NA,0.000372509482273558
1,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",4.01510646673114,0.392296014560203,26.6188652214247,123.889780438238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.56453554826769,NA,3.06439998536124,NA,9.76867222575187e-07
1,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",1.8997430678793,1.18068206523168,0.357745884963551,36.6076152949969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17859662708934,NA,0.575123343499718,NA,0.176955521384605
1,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",30.8284100405608,NA,0.106756761052816,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",30.0404697357878,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",32.2104374538449,NA,4.04623395707624e-09,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",31.0565165038041,NA,0.593692451712681,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.84020485029226,0.249897718372328,3.96867620669993,10.5699349489683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13962530337611,NA,1.08796524957743,NA,0.0168467481569471
1,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",-0.545543178303578,1.20762447189379,0.0973957899042504,11.0765321497124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.423428943926751,1.0012625205217,0.126684290674745,6.41615976242856,0.676697372002913
1,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",-1.53832086132005,0.622674960004875,0.0694527950737232,0.797505160593264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.07387028311002,0.584461612134863,0.129789782967541,1.28300916470966,0.0951928003040837
1,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",1.474267772109,1.38488816628434,0.414557791528306,94.4545690035709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.899869104510113,NA,0.359539225767129,NA,0.356492072550925
1,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",-1.00398385415118,NA,NA,84.3757820497565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-2.31844139019505,1.1614492568063,0.0053740138524172,0.509980512541697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.58497306345308,0.859349704721538,0.0437671361476253,1.27088928935831,0.0834622593044339
1,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-1.17388540315314,0.477373613195732,0.112592831550968,0.731464163469756,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.835108430270617,0.543209574048641,0.183632838364049,1.5442300610731,0.156789229827722
1,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-1.01373037864371,0.449704522260275,0.141721498920059,0.826064775543926,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.73018303222946,0.545510074828796,0.206038490396126,1.74834201469209,0.210925517515837
1,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.886199909219425,0.427880503257041,0.17000753392697,0.909689657314783,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.646625024067989,0.548668089177813,0.225447732038814,1.93686842446822,0.265009917532156
1,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",3.32302010997681,1.12697511035143,5.95666991659283,493.82087075508,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.16450147242498,1.28141717793778,2.0126902557478,305.67892877051,0.0117727156624592
1,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.822885712407881,0.211256771641066,1.52322073069045,3.48663930608711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.468974788660531,0.393191529904012,0.762154954922285,3.55970289251904,0.223572408955772
1,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.114498160446715,0.205601160924061,0.752196882865008,1.68402130001127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.294778065704294,0.374797283014691,0.366909220436338,1.59446384938313,0.403034797670458
1,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.457801464695793,0.238370603925914,1.00115068001877,2.54860363694043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0753409335656597,0.40348464065162,0.503007640084743,2.44606548214828,0.876491146894523
1,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",0.00584486236720906,0.202838880847471,0.677056350563243,1.49947197341012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.411927256892261,0.370840339085075,0.3287371368648,1.40659317616087,0.246626788704963
1,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.665157197595955,0.0946723541482121,1.61897345728138,2.34644423073723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.298920789471895,0.332125091144283,0.724137408733071,2.66214535049945,0.363525172116887
1,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.286305835060789,0.107836634889158,1.07956225101469,1.6475139867329,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.109541067330464,0.327624117287939,0.48472522290684,1.75082979022903,0.696622288611716
1,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.33599565459002,0.0868994907274111,3.21783928721818,4.52378869544931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02216917952624,0.346998575527909,1.45468782782071,5.66893204258215,0.00116978666464638
1,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",0.274803927552691,0.186304715678447,0.917791064159596,1.90506390231535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.121939997481481,0.36619643672718,0.443869830298794,1.86496021414018,0.703001236947448
1,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.167854417221308,0.108110804495841,0.957916235915064,1.46344262885821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.237256580105295,0.324933772954119,0.428635238627298,1.53199070391854,0.428808575988082
1,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.668152599600792,0.170112317624611,1.40749061683505,2.74185979159052,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.302141632295103,0.365625825461768,0.68034475626911,2.85214483427416,0.408629997426484
1,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.436615647083106,0.278054487915872,0.909170488195181,2.70399664517142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.052521885586788,0.431729336579458,0.465125376205787,2.52666339982937,0.927976253593678
1,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.317273196714411,0.114286986523578,1.09992029015976,1.72156621854173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0761523108629386,0.330896886557821,0.498056835043201,1.82221150964423,0.77750679988504
1,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",1.61820643941779,0.346272589771051,2.70039218888807,10.4935483680058,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32648101664702,0.50699726483075,1.44355368542313,10.5328681632743,0.00588898368769973
1,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.897999433608416,0.175631538586029,1.75549808991136,3.49458842939611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.549956727889782,0.373882605451089,0.858634478631877,3.71798150584782,0.127474424968529
1,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.731789403613682,0.27626870369071,1.23420187657627,3.64507858887573,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.370761414712537,0.435965231022207,0.635027273175709,3.50736474817171,0.396114288198123
1,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",2.08926588549732,1.17395921803673,1.49970356204721,149.471096040581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83432097394594,1.31822320403999,0.490957545359345,86.137287217743,0.161490960120952
1,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.682631431593704,0.270991563738726,1.18534215907183,3.42910359626814,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.31776226056062,0.431125514993211,0.607840345011611,3.29411631553296,0.465794567911562
1,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.39796435600875,0.225227836265123,0.430332574759669,1.04047772144376,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.847300010718145,0.378024358216273,0.209373277360194,0.921448538120329,0.0243922664074336
1,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.537525677650334,0.0654822913289253,1.50645455652671,1.94730191173041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.161292741771978,0.32055374626393,0.64512739647499,2.26650756196245,0.629301762437535
1,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.055441704623854,0.38161941637203,0.505378711399843,2.25572948335537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.358444558764029,0.510114914952823,0.264020292405883,1.95010732388817,0.461908031264977
1,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",0.00984029766701719,0.299630989498883,0.565070485738183,1.82892267998856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.407604848631526,0.440850705911937,0.287839038865654,1.62052336904387,0.335397790197618
1,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.556688036395133,0.567569253802198,0.611396634301932,5.65658989121372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.181976068245932,0.688603453364224,0.320214023648682,4.76125007040762,0.805319415205204
1,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-0.405693259013959,0.97564874547802,0.0877863439457821,4.02137337168325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.855619487041662,1.0928353760289,0.0511692285621066,3.71069438115171,0.425907174706269
1,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.159122491992665,0.104532937889938,0.95619993237913,1.44047559507419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.246673054824526,0.323358829948068,0.425914884122447,1.51289883141891,0.409690168047485
1,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.523283663439123,0.194584183053392,1.16123034456141,2.48988385893295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.145954939699888,0.376464845880019,0.569326430632612,2.49032633764355,0.71695296717326
1,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.73533182169873,0.236717367479698,3.65850090967004,9.2531913750357,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4527171825499,0.42978714026645,1.90663669919593,10.2787168405345,0.000232984283472978
1,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",1.19826212571547,0.200939419399924,2.26830748987289,4.98633915584492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.873688574755235,0.395260025417507,1.13994720366617,5.36755650226844,0.0191475209826463
1,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",1.4296351459189,0.196150135869337,2.88875446337017,6.23214036402503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1231364106722,0.397851298093714,1.45733473564681,6.93206448849457,0.00230444189202483
1,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",2.08930506054994,0.187185178126325,5.69841592714059,11.8691268180716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83436814649875,0.409158237990173,2.91394521974279,14.4888404573532,3.7667908143029e-07
1,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",1.09497453323102,0.217427286935243,1.98340267178881,4.65114392230943,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.762328747910331,0.403034253042042,1.00383961050837,4.87294023377115,0.0476069561425391
1,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",1.07135697132333,0.217416105303312,1.93725293718302,4.54272217293282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.736865383356554,0.402498021628825,0.979524243981373,4.74492185002505,0.0556896996988314
1,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.441972233559609,0.0983737426825726,1.28518811561277,1.88989842921278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0582937416886918,0.327884859159584,0.573419116193566,2.07331057698181,0.889065795646546
1,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",1.05440629309295,0.264088879838488,1.75195236876651,4.93296482545695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.718577155259899,0.433533805217959,0.904954908551129,4.95080964220224,0.0864277854056906
1,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",-0.0772578176734905,0.205319384974885,0.619901223567451,1.38630518717446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.50152724657868,0.370780003502046,0.300491854798967,1.28543383381822,0.162714404895821
1,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.301330622557898,0.188870097787762,0.9381575082137,1.9670200921536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.093340138108834,0.368280891929239,0.454947595662872,1.92718719457152,0.764171699990659
1,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.653493469091751,0.100971499601407,1.58120718776579,2.34899976013699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.286345404608956,0.333994846542655,0.712433811531643,2.63838628145745,0.388564533579965
1,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",1.00822265637045,0.0959445418747653,2.27744418571714,3.31729448386644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.668795836111351,0.341220519736981,1.03148095547947,3.92966998613574,0.0368791280962078
1,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.70921212407477,0.0898055866066796,4.650095745656,6.61221860037564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42456430079051,0.357962579850034,2.13350295637857,8.67940291730548,5.94600781800395e-06
1,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.463276071797891,0.183375913790282,1.1164003548679,2.29086600424243,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0812543025489114,0.368524705079487,0.541877778672459,2.2976238843434,0.851078311465144
1,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.625669101660979,0.178184873097708,1.32826527815838,2.6707134767648,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.25633961586459,0.36912448568752,0.645295078765139,2.7425655520397,0.492978483473668
1,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.40496572032343,0.161981644250039,2.99849944589227,5.65798802613083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09651692356634,0.378848308849917,1.47272025454465,6.50238664651304,0.00163918600753019
1,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.802182862940505,0.0626863928213883,1.97451481309627,2.52451470551307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446643537365233,0.326687525027173,0.849004820114428,3.05537138408053,0.154534788487476
1,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",1.03789579639029,0.0605887703216835,2.51023859096152,3.18318230162167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.700785439293514,0.332401917069385,1.08372268044119,3.98841381647865,0.0235437228869013
1,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.336996974036642,0.202201318434162,0.947819079814398,2.09388871114759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0548863408691495,0.377205599787652,0.464651091537323,2.03836962497667,0.850412336983435
1,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",1.17534356499031,0.516606888933096,1.29548877147887,9.81537316236265,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.84897980800587,0.648386057267843,0.67717150464684,8.60029007931097,0.185793597652985
1,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.457221751018368,0.101656436764353,1.2967504157496,1.93159746873757,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0747348878297841,0.329419515021642,0.581218367448695,2.11419056008973,0.848490673067357
1,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",1.24151137138449,0.515476920616244,1.38754871406941,10.4664099178159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.920301014001363,0.648272325078295,0.727662219197196,9.23741879628247,0.150240174621277
1,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.686117193351712,0.0976770329305951,1.6438808795413,2.41077137674999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.321518762553877,0.33365570920357,0.738540511127936,2.7314347592935,0.32831916118152
1,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.84241656425017,0.488206360627472,2.71306666047138,18.3901164683758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56818652217629,0.632409566406618,1.43965893026183,17.1741642970516,0.0100820714899554
1,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.25388596966188,0.090724485021096,2.94227858556988,4.19887972089973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.933659576349756,0.345964132128396,1.33355686403182,5.17585314371651,0.0031887919646673
1,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.93442052952231,0.339140746836779,3.76775881704767,14.237618408909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66738343531731,0.507618738920482,2.03126145101899,14.8572193232247,0.000441809368436085
1,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",1.11592700015754,0.255596355782567,1.89302389941406,5.15565825128162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.78491810865599,0.428828914800226,0.976280214027769,5.2434140783237,0.0567470989617822
1,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",2.29392447425351,0.333944812926261,5.46483261637753,20.234176995694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.05497960998195,0.511089523074809,2.97924282161519,22.0895202169985,1.1971398531877e-05
1,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",1.31091749607992,0.25750829185858,2.29805213344934,6.30583768575809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.995148320372189,0.434267147520341,1.19316571664298,6.54633910797355,0.0156618933434321
1,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.8972468385513,0.2460040482048,4.24002252447027,11.1215729445795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62729528641996,0.439561836146313,2.22934678308823,12.4878897641268,4.94298140573456e-05
1,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",0.805904952796683,0.186034255268698,1.56952068082342,3.25441050349892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450665057293857,0.37763350774892,0.771427013298286,3.38984071580812,0.222418953893814
1,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",1.22104945655119,0.168476225034111,2.46267817571401,4.76674705767821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.898256648869438,0.377671815829494,1.20940908783179,5.31524016566238,0.0109248157772331
1,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.978672058101003,0.102827239001956,2.18264497305272,3.26615287637953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.636964282198397,0.342801219111785,0.995895488740192,3.81768084167653,0.0488827962076898
1,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.3301901503889,0.174249558260944,2.71989467255857,5.38511611613646,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01590578583606,0.383341745372018,1.34619209943865,6.04935690192181,0.00427895644689461
1,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.57276028552822,0.163229985841269,3.54109235606895,6.71460524765481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27743534427248,0.383655167982085,1.74985713112044,7.87296523681194,0.000244504565369552
1,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.598438728950419,0.62566059095805,0.585461720783987,6.80181829585951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.226988581113656,0.745523330871375,0.299667438918363,5.56955857382112,0.772931775709423
1,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.833701353523912,0.258186987539102,1.41522815812624,3.89372060518958,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.480633076970399,0.424861939042359,0.724731627116593,3.83233522112128,0.251213974583396
1,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.21525282623312,0.156593191301836,6.82982721628966,12.6181140660277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.97015948442905,0.397233685299619,3.41931438078216,16.2252308541566,9.48565504854867e-09
1,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.49911030298838,0.564685992736109,1.68771668401943,15.439126320568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19805197330894,0.698020143228653,0.872611114132251,13.462706763613,0.0803853001748676
1,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.50715055378093,0.240435310728811,2.88814145132343,7.41201474751154,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2066928992061,0.427020109324616,1.49698020704891,7.98318898254583,0.00244239413306161
1,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",1.07544408269091,0.160710215658376,2.15809904378009,4.05195804082836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.741270146358041,0.37017993632299,1.04818039745957,4.4733357899777,0.0340645050208138
1,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.2564899105539,0.537401443565704,3.86381214118974,31.7606863518834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.01463166113625,0.683876340826822,2.03917285757334,29.7637217056552,0.00211009876257125
1,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.35495979587263,0.156246243599484,2.88170360364597,5.31671519792036,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04265305222128,0.374780096966514,1.40620428521743,6.1104783664854,0.00253443345387833
1,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.237789723051201,0.365103668559471,0.631074012719596,2.6401822609306,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.161846709260724,0.498605458581593,0.328979232743992,2.32271516254871,0.720383732993158
1,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.829722256119163,0.18058351294186,1.62434389480889,3.2968858474894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.476343314525416,0.375070845657381,0.795570782756439,3.46099196154318,0.192286496815299
1,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",2.04225640732957,0.148352519803934,5.82757100584745,10.4242150317167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7836394879197,0.388822523414441,2.88160444634585,13.2302188903738,1.44947737974081e-07
1,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.58832931618905,0.166672356553213,3.57456561849488,6.87015931260375,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29422415796938,0.38577131663973,1.77227317124463,8.04023871693375,0.000218869975945716
1,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.686007779041149,0.107060113190269,1.61482164283273,2.45688047287909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.321400663747217,0.33700070133411,0.733636247570202,2.74910808415335,0.333914751778285
1,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.116083638914562,0.810686502572563,0.242858049920302,5.82730443604106,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.29304116551638,0.926420916084222,0.124707181970369,4.71013432218957,0.73896042966757
1,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.105000776768788,0.819140223881079,0.233407206874126,5.78923403818458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.304991769953758,0.934968029783928,0.121173558457172,4.73260568903289,0.731621918879411
1,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",1.07767160178753,0.689365355676799,0.885321073894988,13.2031790039004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.743673741470019,0.813622053376217,0.440696617405698,10.6967639444057,0.362010598380255
1,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.95938702485694,0.238607246529118,4.57192233886232,11.6494268203616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69429699522051,0.436232526118906,2.40031676812624,13.2712600088356,1.83754978890383e-05
1,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.58342739780687,0.0571606139548591,4.36114755383111,5.45646264465716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28893038903402,0.346528303786865,1.90379210512789,7.40543160779481,2.48865245856834e-05
1,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.479118902474222,0.191262651196386,1.11756504485475,2.36526027173774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0983375514726974,0.373516042775878,0.545888551801634,2.36036328455842,0.816071529931171
1,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.63387932684795,0.174618564637868,1.34806019608383,2.67288620112994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.265190595021958,0.367312549832261,0.653372936942983,2.7572437459699,0.474684950212023
1,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.876999884001466,0.168281301503169,1.74259389764381,3.37037943284772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.527314581819633,0.369423483368325,0.846687801966316,3.60272390594286,0.139571696692465
1,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.47602089759141,0.157536428376431,3.24675533645731,6.02060402929182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17312469079222,0.378427150188313,1.59191378654099,7.01705842227868,0.000684821641965917
1,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",1.28245756941445,0.573028655837475,1.33051911475933,12.5761257272489,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.964461766899139,0.702991810818826,0.683336023672846,10.7500316936911,0.165501761759086
1,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.47940555160491,0.272803063774624,0.960490174580824,2.79842520851787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0986559578153643,0.428603479226349,0.490175926541137,2.63031562187613,0.840054177273952
1,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",0.882788701129443,0.257270887784872,1.48934872909074,4.0829602569013,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.533557244053367,0.425204630120489,0.763794765732364,4.04432783565729,0.200618759507488
1,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.791998943051241,0.261523852673552,1.34685922809975,3.7544058697253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.435684578309863,0.426406367723072,0.690632095587384,3.67419560920028,0.302787575392669
1,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.76560410248438,0.332590078898445,1.15493194780028,4.25362080819025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.407233864453213,0.480287536915179,0.603913100038783,3.96841822632615,0.398236492747518
1,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.28679224769895,0.311930178208111,2.04107445560517,6.93249788264834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.969127824228294,0.473651713724509,1.07604559240587,6.88932721175645,0.0330857741756666
1,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.92682925575126,0.327258733626775,10.4534980880205,37.7040430244038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.73735043384142,0.52022927012601,5.81466437605919,44.6852886143714,3.3690503185883e-09
1,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.54971332572029,0.559952973567604,1.79788967929631,16.1446528048494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25260930236667,0.694254789736067,0.928635986918704,14.1171492577934,0.0655449141278075
1,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.13283489409227,0.254628851725935,1.92961723766622,5.23542705777047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.803147491293317,0.428508390394618,0.994956425697002,5.33701062645637,0.0507293689401535
1,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",2.08926588549732,1.17395921803673,1.49970356204721,149.471096040581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83432097394594,1.31822320403999,0.490957545359345,86.137287217743,0.161490960120952
1,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",2.61522887568466,1.14643129036428,2.76424225755046,247.322865107817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.40139465349981,1.29435853964941,0.910170350590889,145.426200234332,0.0603729219526692
1,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",1.02605202805175,0.16844702680349,2.0245560189977,3.91827160045258,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688017898302113,0.373004009771914,0.988094056516025,4.26384554689299,0.0524069131064256
1,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.87200467599284,0.202650694129032,4.45746555237711,9.86463822853927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60008422321987,0.412268652735236,2.28832981969108,11.5177075460156,1.6307546927724e-05
1,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",0.417192275268115,0.646828522862854,0.461743940707425,5.82859767569248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0315777525710664,0.764368584010069,0.237339309613489,4.74933835921531,0.981952071183825
1,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",0.990536423003038,0.59837724331563,0.928709886270089,9.69525719684072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.649728848977753,0.723575663524687,0.478370818131491,8.15797033108445,0.370767733934934
1,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.58233551031433,0.0967458174881241,4.04284338787652,5.90727645899673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28777108994852,0.356609887121186,1.86434954213119,7.54433757538613,4.95670912932254e-05
1,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.29647981846093,0.536613315921429,4.02955033575076,33.0208881734785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.05774549726419,0.683795535643311,2.12989263951688,31.0780200889535,0.00166537859469545
1,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.300530259326318,0.0778424828868692,0.634736441620524,0.861217241852256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.466646605616249,0.288518359353315,0.352402950520492,1.09197848430709,0.0917824995227151
1,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.355260306799178,0.0848259996630519,1.20705614580372,1.68319919690892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.20621876489602,0.284123089333416,0.696981878045291,2.12282166131724,0.519358067116394
1,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.0627401404809733,0.159862238241135,0.775336110592064,1.45090834673631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0939046899548334,0.318911095901848,0.482131664789096,1.68298749619113,0.725178070972521
1,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.246457449760795,0.108794819152222,0.630221660864775,0.965397037583304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.411178056983159,0.298358686153218,0.365404709350749,1.17679520037259,0.149394143954942
1,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.292029104547946,0.123256310956676,1.05063991475586,1.70327911078814,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.141332141067749,0.299152675113378,0.634208168355667,2.04885049353746,0.688255274480633
1,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.552008114163548,0.0378967081739785,1.61244586361354,1.8706847914689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.408080182372849,0.271254427264286,0.874830345104027,2.53342594055056,0.164260836906202
1,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.704126285826064,0.57988505038707,0.658983457502552,6.39841805333206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.564149918476231,0.652305419083858,0.484602255074035,6.24988734955015,0.40630854456792
1,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.212185799413492,0.0618697671252174,1.09475932060057,1.39523041149602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.059409901911307,0.279236664113963,0.607549543109492,1.81532779552303,0.887443517886872
1,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.327809823088652,0.116837212598669,1.10316073363489,1.74398532555699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.178045365529592,0.296107311977482,0.661868988872521,2.11283720131259,0.598565455669963
1,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",0.15505501975088,0.150298079724146,0.868718343374899,1.56583828250907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.000775690961022811,0.31314428595167,0.536096544078644,1.82953535506548,0.953669159090624
1,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.65785522129404,0.02571471507353,4.99103133361184,5.52035626697089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54270671084932,0.258819088026494,2.79003576207493,7.69527570520917,4.3068042644271e-08
1,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.871615891571904,0.35455770179867,1.21315585844368,4.86986279751073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73599513421484,0.450314092644648,0.855092615766824,4.9960785426725,0.116897105166892
1,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",-0.0299285042451246,0.0745944267807855,0.837842637738568,1.122411842289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.189004616472626,0.284894611365319,0.468588054992597,1.43151755846041,0.468553357039963
1,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.0617192074407183,0.0571450419525497,0.95052759473129,1.18918281669889,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0949529183151775,0.279689273024726,0.520111571852879,1.55682715451159,0.686622859101881
1,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.173543568272915,0.108453940351022,0.959801457886422,1.46829637997124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0197622270187857,0.29417774279214,0.567062350487407,1.79655249192145,0.998510972827624
1,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.358888752788732,0.0952469538263762,1.18737676557442,1.72479408692019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.209938641543313,0.287546232395134,0.6949055092911,2.14508916065344,0.515957436015521
1,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.45898743287552,0.0490625220708376,3.90893165880503,4.73786046976745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33865463689031,0.264252742401059,2.25069249192991,6.34133718644503,2.74859327109583e-06
1,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",1.0089412060698,0.313935821930214,1.49473947417139,5.11694579051242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.876888400049441,0.416467107753772,1.05211371872256,5.38341144070356,0.0434541682582697
1,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",1.03340447426845,0.311825613266861,1.53950250444934,5.22676875408724,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.901987250316655,0.414635090522858,1.08276309585218,5.50059288847772,0.0369364137866448
1,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.575947254645887,0.115085619972836,1.41962219867006,2.22892213148091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.432654773568364,0.293068908845131,0.859048649441305,2.70981207920554,0.169583019224988
1,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.78396917859048,0.26968527986559,3.5815655016663,10.3082739325676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67208305931758,0.377203137326942,2.51808091307698,11.0464178286677,2.41442780979113e-05
1,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.912564005491147,0.107380237590492,2.01972867692271,3.07678733850656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.778010873097811,0.286841114665257,1.22864959745396,3.78222396092618,0.0108816585099644
1,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.527349751095597,0.0803982928232025,1.44729475607694,1.98347755512102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.382758486225851,0.281087865086509,0.836652212093715,2.51808167629012,0.208217061599521
1,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.910088871089292,0.158009945620141,1.82936552115427,3.39857695789362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775483780769068,0.310557031914633,1.1698599847211,3.95209281768686,0.0184162442405606
1,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.52937159914482,0.144450401208906,3.49743544937625,6.16116041592222,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41087196027537,0.298191333718401,2.26367900235173,7.28545515485081,9.35890011917007e-06
1,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.721290285540677,0.0766576049767843,1.76995095178418,2.39036034163338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.581760363417601,0.278104065112762,1.02699686900299,3.05502197404033,0.050639110996843
1,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",-0.0622220734750197,0.180540713244676,0.655783536027396,1.33080240367095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.222130753715799,0.331405274866574,0.413812254861068,1.51701093305112,0.468762209535632
1,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.800272221573973,0.104903397201305,1.81382814192001,2.73642785722852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.662796983467906,0.286916782295878,1.09468219572651,3.3708239453507,0.0302657595328848
1,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.79020011237046,0.0893652044491722,5.03967917309878,7.15382793028399,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67848189919289,0.272111350224744,3.11394014694861,9.04801815239014,1.27648081025028e-08
1,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.40795424751194,0.0530179947546408,1.35512774061994,1.66816203734858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260273710016108,0.275347158389262,0.748506934365582,2.20266109174716,0.392905119209673
1,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.547964752304608,0.056709913580149,1.54765220706246,1.93293167666536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.403929086997612,0.274729232425924,0.865283062647808,2.54014258830801,0.173879429763284
1,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.705224761461271,0.0494812129079212,1.83728936845228,2.2305631930931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565285773052395,0.271691642014679,1.0229692665715,2.967503748142,0.0523820851532105
1,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.928375594593391,0.0518909191164912,2.28618324146356,2.80188494538255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.794249362837948,0.269968294632768,1.29073807193456,3.71905823069191,0.00597923615215073
1,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.63954673840706,0.0457995776844758,4.71290005204071,5.63972038068489,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52391644027809,0.26189330852524,2.72167197197631,7.59772827968995,8.40891148989751e-08
1,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",1.22607984442846,0.0335683842689744,3.19147024378052,3.64030456721064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09968449105893,0.263961003990083,1.77299430386387,4.98971072261593,0.00010764928618878
1,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.92000981080029,0.030493116755141,6.4270490203695,7.24307843947123,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.8116940825074,0.256846990167397,3.66593127720564,10.0332452480532,1.24981706295998e-10
1,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.44275605056664,0.0965738049059361,3.50942269831901,5.12440238012178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32201490319921,0.277851847550656,2.15523817108489,6.40488170586327,9.40985317095044e-06
1,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.42147652277351,0.062919777500213,1.34705486057966,1.72385251459502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.274147507069211,0.277397660703096,0.75592127250669,2.24243157939863,0.369851625237944
1,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.43073687121909,0.118948786465687,3.32328318068439,5.29744102812674,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30967321877542,0.286953829641324,2.09113854031848,6.44011898855892,1.99931334613082e-05
1,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.09071080589393,0.0537569513674918,2.67957042291436,3.3081193936771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.960813580391848,0.268768960218279,1.52843922987044,4.38330088786908,0.000851988323523534
1,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.0775417756824932,0.0996634651157335,0.888147280447678,1.31266039144082,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0787377448563997,0.291810679463242,0.516217708171367,1.62036293269951,0.740006961938994
1,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.740187946012188,0.0871763502977614,1.76768660544812,2.48779481822157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.601149779529519,0.281168722648695,1.0408484747336,3.13364655999357,0.0454884616224434
1,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",1.07123993121467,0.0821923580031634,2.4871073036706,3.43256718854407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.940814859150179,0.276427234851033,1.47584420604179,4.36145195207047,0.00145116322990885
1,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.75639782179651,0.0731813264514333,5.02476503691775,6.69421835924272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64379999636594,0.267284842819159,3.03631210719823,8.65711033591186,1.48559416409857e-08
1,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.428098704478579,0.0298335579358213,1.44727600940114,1.6268222523953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.280944165521525,0.271443471333501,0.770028407604866,2.23158251881546,0.347411743454641
1,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.127588780254759,0.169417590339844,0.812074195513753,1.57765754677303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0273725216663048,0.323501844749918,0.510712476419028,1.81512695638598,0.886663756248566
1,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",0.853478185688946,0.14135395096554,1.78136048148027,3.1002250131122,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717407462226412,0.302478997191526,1.12141477287794,3.67034975778241,0.0254960006677758
1,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.41308049998663,0.145824954726935,1.1341626350917,2.00876063187005,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.265534024869203,0.308593191733346,0.70499334653606,2.36338796883228,0.433795426450182
1,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.135256320257188,0.0887606667979761,0.961225613297733,1.3612308021614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0195218324408543,0.287529675821938,0.552346243691233,1.70491531676033,0.894295516662683
1,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.752720631528562,0.133552865056018,1.63452117455468,2.75899784165336,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.614028068617341,0.2996205986111,1.01687832077102,3.29112229351452,0.0541761895866531
1,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.126332171836719,0.0670928702889963,0.994204912398144,1.29328730380753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0286615821673253,0.281359785433837,0.553971145264597,1.66907138409834,0.86671256474787
1,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.552206722185,0.113266118327028,3.79260847653118,5.91238356097098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43431338864987,0.283437396762613,2.38531334320761,7.24552962734204,2.44381322229268e-06
1,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.681144311978293,0.196462257870213,1.34699163674078,2.90953009306836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.54054215700058,0.33470793657855,0.882033231661687,3.27561440477513,0.127920053748461
1,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",0.403691050771742,0.174106419825079,1.06495009008942,2.10731064556942,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.255898618744822,0.323749349645003,0.677783754086428,2.41125447701032,0.47254057770496
1,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.77158198498672,0.165534748677037,4.28213219237084,8.19345244115199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65938483021003,0.307554404462414,2.84994634287355,9.5152072233452,4.42637860461517e-07
1,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.200834664749769,0.218188616202508,0.794462738605326,1.86860930290439,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.047763501114139,0.352365152308638,0.520328692301075,2.07083405106372,0.936071742653309
1,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",-0.264478548471445,0.732494289029749,0.160899863025687,2.84155595741221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.429656723112701,0.801208405359581,0.13387581722457,3.09515068450716,0.575188315486058
1,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",-0.614864317881883,0.862334760229376,0.0786570902411776,2.31088979053813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.789152896723809,0.928538820925065,0.0727865600940229,2.77203398015294,0.383237090834415
1,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",0.00326525196588532,0.659401286657447,0.255874845525294,3.3930821859067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.154946647962203,0.730213377964437,0.202552463621022,3.54531671492615,0.811700955304603
1,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.60206733840808,0.446182912046549,2.16624871717933,12.4535017213079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48545414517287,0.525632283284814,1.56177690593991,12.2590556915484,0.00613207734140761
1,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.704126285826064,0.57988505038707,0.658983457502552,6.39841805333206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.564149918476231,0.652305419083858,0.484602255074035,6.24988734955015,0.40630854456792
1,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",0.811208356625837,0.562236062742015,0.768118784203059,6.95954415134368,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.67401807305874,0.635363177173178,0.559191143388119,6.74845751539403,0.306137784868131
1,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.62259539944349,0.510576137313293,1.9820288672699,14.6661582740791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50651639265258,0.584026725369195,1.42254557451549,14.0383184133249,0.0120688104031662
1,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.700480311102224,0.0932638871698421,1.67780959849244,2.41832911201003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.560409053227857,0.283595334746241,0.994522573522194,3.02279168073829,0.0646731776727964
1,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.36001733518468,0.0806837802367316,3.32942970772894,4.5680007529571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23712209022312,0.273234184276253,1.9977080646837,5.83024414493,2.50320521683986e-05
1,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.739997102150669,0.0285431006174232,1.98209938387309,2.21675291953431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.600970124750819,0.268157448969185,1.0675220898591,3.05413998793429,0.0366601508083764
1,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.98082863496385,0.027476843597249,2.52721675355912,2.81461602052145,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.848021573431342,0.265639879968035,1.37376883812502,3.89170410415646,0.00289886288771732
1,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.338268078763495,0.0676343049984221,1.22805714481729,1.60088238417823,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.188773221449002,0.279387558039943,0.69131612667646,2.06684033871486,0.552462186463499
1,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.08842919358266,0.0574280965421907,2.65452532008153,3.32470135953572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.958470458437516,0.269589851219677,1.52241056053831,4.38008342811449,0.000906310941523744
1,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.434001606093364,0.0517186799748034,1.39481531919851,1.7082945249487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.286999242214584,0.274826195652154,0.769582632194023,2.26006131573423,0.342146907472326
1,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.728314372721779,0.048208023391216,1.88493363882929,2.27701322384994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.588977174585382,0.271221638167062,1.04847700270489,3.03590000593875,0.0427834892052449
1,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.42872908649377,0.042122950855397,3.84398750894918,4.53411164079942,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30760901655893,0.263280984370344,2.18600844057669,6.13567284480565,4.26933072859768e-06
1,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.52469276056177,0.0604597505193235,1.50080975438183,1.9021839354214,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.380050819600744,0.275800506088236,0.843077629520248,2.4853708397298,0.203452674128583
1,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.814455293880718,0.0557292418079925,2.02450530181255,2.51879342931233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.6773599039086,0.271888721389382,1.1439405776406,3.3209907345682,0.0199128243516045
1,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.909339293237404,0.0744301877956084,2.14654603409369,2.873759289009,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.774701874607045,0.275657619891479,1.25173474275799,3.68801509070937,0.00852574809312927
1,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.741468243292842,0.163539009340492,1.52734962438468,2.89966466744869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.602469795354979,0.314983162293506,0.975391737614008,3.3527979330865,0.071607827923501
1,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.99984488108583,0.0718555398057425,2.36145244913203,3.12972585512632,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.867562037127849,0.274056472149417,1.37792413333426,4.03440868988862,0.00306685849348567
1,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.64924012468316,0.0633463273085574,4.59926948638329,5.89562484264099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53385909457311,0.265633579875172,2.72877600839247,7.73006799928976,1.00457185014293e-07
1,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",1.08144988668678,0.347791400455732,1.52147753994228,5.94766774159154,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.951285600407506,0.443468187739557,1.07501086008043,6.11469026662934,0.0390441835058988
1,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",1.51571723590702,0.325748058438237,2.47299698715926,8.86702815270217,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39685698403202,0.422835583676071,1.74830380603549,9.1717773981677,0.00150211798554942
1,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",2.14708347888844,0.307991803902709,4.84147277537292,16.1921191757286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.04465654947387,0.404735227324333,3.46376348098873,16.9266388944471,1.42895463149961e-06
1,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.850791507595826,0.0824082032173605,1.9930500347619,2.75302516440084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71463096783602,0.278591618970281,1.17194117737609,3.49285893200545,0.0162947471726032
1,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",1.08035204069338,0.0788656604800781,2.52596408200497,3.4410288563834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.950163936111153,0.275317507946206,1.49297171763216,4.39291657704439,0.00124893039429952
1,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.955471447247049,0.101988149319564,2.1311699419274,3.17865228264992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.822034659177519,0.284361819660352,1.29025043201026,3.93343929992124,0.00667920576634334
1,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.83209243296857,0.0708394965688228,5.44604347435791,7.18916549943543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72146394576195,0.265918443402291,3.29050722769881,9.33175284594769,2.73447258738608e-09
1,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.39937124234222,0.0431347161616666,3.72538746531712,4.41168121313076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27748670746474,0.263737632349787,2.11919780031227,5.95880610192479,7.19848992456948e-06
1,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.947041023732431,0.0351617247769389,2.40667669285857,2.76234030942462,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.813409451723424,0.266926913198388,1.32358217516997,3.76849645191639,0.00444941588025035
1,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.08865736461219,0.0805787792636588,2.53880547084352,3.48182539094076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.958685391583535,0.275761035059522,1.50444856272487,4.43438892528805,0.00114841385045988
1,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.501652145800178,0.139931701259871,1.25604133521613,2.17382256218507,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.356413142666876,0.30489365845499,0.777718272401374,2.56965138347476,0.279609478976867
1,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.152667493956746,0.0678787535780701,1.01922134667761,1.32991997974157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00164063610276879,0.281295394205884,0.569227622796446,1.71460511169675,0.941746302163802
1,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.738272478908807,0.132172147743218,1.61752235320186,2.7155672558277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.599204047385778,0.299104486031456,1.00291817491353,3.23938003987766,0.0599380244200152
1,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.473947241479887,0.0989441522613228,1.32218023720936,1.94864842861787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.328000829165524,0.28776083548723,0.781720089199854,2.41510605853809,0.295060954971327
1,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.332236097494907,0.0933089378912768,1.16088944936706,1.67355614976972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.182590815170575,0.287132816522821,0.676694040944731,2.08549016029873,0.577051364160114
1,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.413120984793485,0.0838397608634809,0.560368826987565,0.778400373019552,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.582172647722679,0.291415044651054,0.312147572845478,0.978285989425194,0.0380558966632378
1,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.590961388248585,0.215460884631938,0.358003004054825,0.833082373882128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.76462937607054,0.357045059390366,0.228654492195023,0.926860446457171,0.0269401318229152
1,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.48684579286776,0.0885157478559407,1.36809941031596,1.935562226568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.341244521657992,0.284035525472053,0.797947069412358,2.42950076008633,0.269109144580024
1,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.0446786318943082,0.0584038873385686,0.932156284737851,1.17196782840761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.112438142814602,0.280135104269799,0.51064342226161,1.53116011655935,0.642090845510736
1,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.759251086609362,0.32818106299437,1.12716831260658,4.08023545929798,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.62070693118301,0.429431960836484,0.793747495049134,4.27315516747205,0.167643619763164
1,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",1.10945954836061,0.180909814475418,2.13773110460391,4.34444699500533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.980037529733937,0.321823416778356,1.40424568668543,4.95811135660503,0.00394531818584867
1,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.5684543536128,0.0657465949193689,4.22311666011883,5.46462399457956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4509666068574,0.267004600817677,2.50484581024717,7.13395645083267,5.05221999870216e-07
1,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.17337202962919,0.0139456084835923,3.14584322992388,3.32260047715392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24512751707282,0.140260783152914,2.57394731753689,4.46046405423134,2.36325913053667e-08
1,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.396415061546271,0.0392925088227857,1.37645845425275,1.60566446419434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453942382680752,0.187480552095641,1.04492424781686,2.17897515195361,0.0465918822424322
1,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",2.44824618802466,0.20742021986877,7.87553600613513,17.7579547042434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.54331577663282,0.230281830416286,8.01660763597169,19.7707491982965,1.12810819922387e-16
1,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.276232930318136,0.0166530259926238,1.27583620846215,1.36189958077276,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.331521721982971,0.191753985949503,0.913433053195088,1.93695397042175,0.14282840792057
1,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.562478328791454,0.0156770922989563,1.70196028232924,1.80983153538599,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.623029956523443,0.173406812608859,1.2780172230894,2.52199952004348,0.00546058472032028
1,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.24001490771979,0.0142598230874631,3.36141640962329,3.55466176399265,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31299907589001,0.137129810458643,2.77473869852406,4.74976697753559,3.9020376160973e-09
1,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.428587495109718,0.0166206096185914,1.48591633968496,1.58594943120324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.486688078023892,0.181781614610304,1.09291366021435,2.22869909115081,0.0304781690415531
1,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.697830107383298,0.0157644360281621,1.948307894588,2.0725022697555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.760859570698257,0.165446580751491,1.49505699412298,2.8596607775578,0.000675971342696012
1,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.36445760896798,0.0143990136171903,3.80486745976441,4.02580243501035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43967616248615,0.13143716900375,3.19117812435986,5.34207632097024,1.05422805244587e-10
1,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.171335869065036,0.0203413709664445,1.14049755855774,1.23516100628447,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224744193134995,0.199332463462701,0.805911592133545,1.76048205952127,0.32558816747415
1,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.464790146479427,0.0191096744262973,1.53321206531334,1.65247385498004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.523553512269784,0.17976077489708,1.13964486944747,2.30565773028494,0.0199325340023461
1,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.16271284731634,0.0170853197803198,3.09349160333636,3.3077680094907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2342678562697,0.141136291819956,2.54131562356741,4.41905559392176,3.23013244524927e-08
1,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.1688503848004,0.01638047952952,1.14653619629436,1.22257060316174,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.222216749534705,0.19911783652878,0.804147701072005,1.75515163988404,0.330481108319958
1,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.485118342540272,0.0153325103450067,1.57631380469812,1.67395890437609,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.544253778265789,0.178103902405931,1.16794133100006,2.34760843160264,0.0153492381462519
1,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.684750761949278,0.0371519862381027,1.8444114076639,2.13356292354795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.747512996987933,0.169767339157803,1.46237509339558,2.84492763457289,0.000966422399834194
1,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.34096101192618,0.0336342549216731,3.58015207106236,4.08470346319307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4157722822396,0.136118063333285,3.08614961742979,5.26192662900248,3.16858500552549e-10
1,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.383504993439096,0.0203860817538052,1.409981761303,1.52728055837786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.44076690774762,0.185077152819718,1.035771148948,2.13963515998802,0.0506679787071164
1,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.680612092070787,0.0192689407889705,1.90199523322254,2.05122324046752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.743326429197359,0.166827969244552,1.46448901928907,2.81640151617109,0.000913460201165249
1,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.40779009360113,0.0175724740261122,3.94889898104263,4.23049764835042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48379747164084,0.129918179468208,3.34721178060371,5.5700141836457,2.91769946901246e-11
1,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",1.57680050096381,0.220870166217708,3.19717036478714,7.5993392270591,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65592900095757,0.256833154388021,3.10656928948692,8.50187272846507,1.72460973428072e-07
1,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",1.93641325584157,0.214062280964014,4.65127115221174,10.7644525035278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.02212151093341,0.24391411303977,4.61451814407746,12.0051197597273,8.71743183298121e-11
1,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.135616159695341,0.0346070743538769,1.07011527850441,1.22559154127408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.18835870721848,0.203935646825716,0.769166674814344,1.71080745539792,0.416292587892064
1,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",0.122569128774311,0.030557573126092,1.06465429074897,1.20013448626645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.175073604832069,0.204165419176072,0.758318800680431,1.68819909511331,0.449837599703115
1,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.443939737549203,0.0323693571578418,1.4631196619142,1.66106084134401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.502350135281586,0.183066489594599,1.10781373442766,2.27049056763161,0.0266706347413927
1,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.278031435892979,0.0303662008464853,0.713413151133117,0.803593888060235,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.232867271688223,0.235046509474655,0.4666394685656,1.17253380342258,0.285329819107238
1,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.15967223502149,0.0285209735795073,3.01618818363787,3.37297115849349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23116222235571,0.14322582094175,2.52301266166681,4.42331134885025,4.14458707092473e-08
1,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.0974970521331722,0.0211492407546583,1.05763373871785,1.14905238675505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.149544555195009,0.204670430241254,0.737778425102392,1.64572597243945,0.519063665781021
1,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.41899492868003,0.0196920458359021,1.4629138990049,1.5803110096075,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.47691343754256,0.182719947057118,1.07999872849089,2.21047824990564,0.0342290540566327
1,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.13208403158329,0.0175613794378402,2.99739481523102,3.21100142503716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20307480325769,0.142695493993438,2.45452001424403,4.29429452308602,7.15816287636827e-08
1,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0507236552946108,0.0181473213090966,1.01525702660935,1.09010933765639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.101911540170924,0.207772168175578,0.69796334535023,1.5759578431448,0.666267813275928
1,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.416272541428917,0.0625018565431796,1.34214315118154,1.71475545476106,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474150314982062,0.192880165975342,1.05563479022711,2.24839952338543,0.0422250750532064
1,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.0517898501685692,0.0226551664789556,0.908254243067346,0.992603176679919,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00248373965466342,0.215947133131148,0.616259696874789,1.43678846251703,0.969402378183757
1,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.658604735140315,0.0594506726627668,1.72042503489021,2.17192468956418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.720915818584861,0.177809551538138,1.40074145026977,2.81229911164328,0.00184889211844457
1,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",1.39628865238389,0.225178911070663,2.64392523320288,6.39137710928885,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47208537605073,0.264626887265241,2.53930612639215,7.16500817244736,4.25115128715583e-06
1,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.33799779122151,0.0534477880958724,3.43539828716702,4.23610556387858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41276542494284,0.142761845752983,3.03689972132141,5.31457644761087,6.91881902471714e-10
1,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",-0.116343149558816,0.0183792350932765,0.858649461963882,0.922794014014669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0682188856322962,0.220525417734588,0.570328081066614,1.35377941814619,0.738244094825991
1,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.357568832187899,0.188318969156348,0.990874518768087,2.07306755470241,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414364504468019,0.26890641060538,0.854844894290119,2.4528694009278,0.163395175786961
1,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",-0.336852109830752,0.064135505013883,0.629364865860966,0.809257953787302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.292747753142933,0.247157244926748,0.427900567243803,1.12746772559394,0.195617270138771
1,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.515142725658248,0.181813227521664,1.17652135926316,2.39949149939046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.57481338201383,0.256932640823928,1.03226633005128,2.82614657766174,0.0488004718322329
1,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.28443291776225,0.161004764114981,2.65685245475939,4.99415991355359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35820193551256,0.212899159611024,2.50383792460865,5.76828087913294,9.25059346789257e-07
1,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.509180936150823,0.0268484731163172,1.5787420594631,1.75395361043605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.568742618633211,0.17808082415416,1.19777308431582,2.40735364850493,0.011684097475921
1,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.774965067792353,0.0254370225210022,2.06518254985896,2.281720857652,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.8394068476762,0.162393486218809,1.62985746826091,3.08041194628624,0.00018605007485934
1,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.43771430448936,0.0232023806901933,4.02454995949738,4.40775175936337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51431748603335,0.129540226426272,3.45477864766149,5.74050246874725,1.27453053513263e-11
1,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",0.123993406896203,0.0291784210525697,1.06906141415227,1.19860501042695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.176524611239168,0.203848025056673,0.759933333433769,1.68968987494498,0.445569324191628
1,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.442064289275794,0.0597296584773711,1.3844085732072,1.74963813111493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.50041513989777,0.190379518079095,1.0898775873186,2.29868996994801,0.0313657653268413
1,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.0308877828171262,0.0428814541526766,0.948156831866909,1.12171285909415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0817084257562461,0.213092268104477,0.676383095096719,1.55941490030837,0.737533772066705
1,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.700472668732064,0.0568288399707658,1.8032163042019,2.25316718754405,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763549814073068,0.174600003011313,1.47248325510925,2.91937543109766,0.000935910925134432
1,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",-0.140013693033877,0.112151428183289,0.696921082895394,1.08170924192795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0923017953841355,0.250396357705498,0.524407329687122,1.3994077844479,0.692986692477887
1,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.45830047649499,0.0507511856558833,3.89513027479745,4.75248727364889,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53522657671015,0.13674119016501,3.4795694302349,5.94722173396231,1.76871836521033e-11
1,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.277082922615904,0.0229979853245035,0.724530355571062,0.792881759671763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.231901526976589,0.234054162889085,0.468028596390156,1.17145852833299,0.285309312646287
1,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.469048979705488,0.0215187641865539,1.5325183600495,1.66739807884525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.527885778604054,0.179787339868438,1.14468000696079,2.31608567128147,0.0190415919204174
1,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.741136638825006,0.0202216964041835,2.01691556920756,2.18329890428127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.804959008529211,0.163504818321102,1.57002487061477,2.98028391898728,0.000328544848910012
1,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.39801850542888,0.018585609688444,3.90278761043206,4.19773595223708,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47384291451533,0.130496070819317,3.309836522039,5.52030988288381,4.01985635742947e-11
1,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.547240944953533,0.0434723314686998,1.58762034922152,1.88258280689283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.607530476596523,0.179267735233665,1.24345524612013,2.51082303718603,0.00774466876912899
1,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.826305749302676,0.0412135856176687,2.10824917100265,2.47790169973563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.891716080678044,0.163027366867834,1.71717451441537,3.25351435139981,8.53513669238103e-05
1,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.53651808294372,0.0374068941312693,4.32196203092405,5.00452149857726,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61490994982822,0.12891402959399,3.83036345241852,6.34897514312325,8.1212269137867e-13
1,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.478188111974124,0.0424014569493645,1.48474442453016,1.75321861945543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.537212397173282,0.18314134921942,1.14807753066826,2.35370275401131,0.0185791470767913
1,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.712170769141424,0.0406334805205805,1.8828734006386,2.20798278423408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775489637192948,0.169079743667599,1.50679580792397,2.9234541081362,0.000638027531648487
1,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.36284804954216,0.0368347773524507,3.63685109102011,4.20177853488016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43805817625937,0.136033200556356,3.15726880773229,5.38139535444915,1.83055080277008e-10
1,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.282164091093821,0.0317002404588973,1.246162432634,1.41104622719012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.337601087668171,0.193384589046023,0.91621434197997,1.95530993520562,0.138540557183135
1,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.585210388376557,0.0298903447945196,1.69331703781589,1.9038103933853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.646162551193941,0.174012059548241,1.30717625173638,2.58566833189342,0.00419199285539882
1,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.26849168496055,0.0267939360672636,3.37435221814148,3.74804237345102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34198004195291,0.13778912575119,2.85403629990769,4.89815050447838,2.1426016409553e-09
1,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.117819988862563,0.100458018660922,0.923888051994351,1.36974395270441,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.170231982756151,0.227273828900658,0.721005541835625,1.75731764851318,0.500975783757715
1,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.407444872012343,0.093836518933981,1.25138152797994,1.80774562598613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.465162136806882,0.206485734370225,1.01833092565403,2.2877622238927,0.0569978426579559
1,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.07580806150028,0.0834651899410294,2.49497407900405,3.46064806123927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14575784793543,0.167891100361964,2.20373292645927,4.25576156527812,1.55279777195711e-06
1,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.257594192867376,0.020942927472889,1.24179042670177,1.3480363767739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.312592726671107,0.193458362810891,0.892717576737842,1.90571608513584,0.168339569688881
1,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.535703084631178,0.0197493723378338,1.64383463122954,1.77614950060712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.595764632962707,0.175457148681175,1.23779650707825,2.46234013689801,0.00800832553408447
1,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.0658468265035136,0.0644579042753659,0.941396649560304,1.21200938713613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117307068118912,0.216404557400396,0.697271734167975,1.62858281094882,0.630087976667139
1,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.24633736194219,0.0176561122517248,3.35958106055016,3.6003352642424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31943153871718,0.137247508811218,2.79228781728125,4.78201312873792,3.40943316807238e-09
1,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.113504986066219,0.0562565842120819,1.00315273270801,1.25065764775334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.165838313972612,0.21057423784429,0.741689984109375,1.69318591353777,0.484898139577168
1,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.425393444478157,0.0521825019098085,1.38168411512027,1.69529162660434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.483441924947408,0.189019017887057,1.07388359102604,2.25290960113883,0.0360856825193691
1,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.15787481225622,0.0459029604249187,2.91090974633778,3.48476969843587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22932763248051,0.147991163719486,2.49480711840465,4.45633251100767,6.50915683212509e-08
1,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.265549849425291,0.100980947140447,1.07027035473404,1.5900243388605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.320667067992529,0.218316515289485,0.857290969508177,2.01739508513789,0.197602992293693
1,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.539332981363549,0.0950670805458394,1.4247387589281,2.0681295046352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.599465068093839,0.199781092394378,1.18452243324752,2.59209693410851,0.014087080933787
1,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.2298137021541,0.0848345368243186,2.90282426215135,4.04802626445023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30258304187005,0.16219841100359,2.61381823526909,4.93631038011919,4.92950822869622e-08
1,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.402286455563681,0.0593543334085786,1.33132863861693,1.68008121012486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459908857465535,0.192671681320753,1.04070729073218,2.21479463074099,0.0480520500079389
1,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.64199857102125,0.0566641967568152,1.70127421561198,2.12441629217121,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.704005329277723,0.177762740893056,1.37681699056629,2.76375827235019,0.00229177913542334
1,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.33323381579415,0.0509206163890322,3.43571835693394,4.19473925081853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4079204420705,0.141990529649803,3.02657146157255,5.28051217862741,7.14304974984302e-10
1,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.385930787559009,0.0476622992716214,1.33995899270133,1.61522100258516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.443258598780894,0.190198038526893,1.02800490497401,2.16665076566528,0.0538249384382264
1,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.692023487711828,0.0448126964833401,1.83031060185,2.18179563285132,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.754965733495101,0.17131571199335,1.46902288737794,2.87525891705276,0.000926990531305706
1,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.38427537062112,0.0403190552069533,3.6897126496834,4.32147325124125,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45987615650368,0.136149545749734,3.2272026676042,5.50310306721343,1.08752517868005e-10
1,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.175124695528783,0.0267290705911163,1.13057610486558,1.25546166000496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.228597463673107,0.199871748738084,0.808270826918488,1.76937214499406,0.318644677976126
1,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.473941074711303,0.0249729795054376,1.52966195969976,1.68697848564281,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.532858791090441,0.179962613845703,1.15016588681975,2.32878498239493,0.0181212950141189
1,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.19721546449438,0.0220096286656155,3.17151633757555,3.4572932058105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26939969522976,0.14022383106545,2.63851503413433,4.5716929695351,1.38554044861889e-08
1,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.519884035885294,0.0280263061435943,1.59206187109597,1.77693692218739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.579639639733686,0.177606705824348,1.21234476835264,2.43211634743929,0.0102093550918978
1,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.780363941822393,0.026558497618566,2.07182415929764,2.29914393901691,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.844904582145133,0.162285906417305,1.63938782331566,3.09711786243637,0.00017017745436245
1,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.43072208140835,0.0242396440154828,3.98845604736478,4.38601846075066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50719430106244,0.130056988646443,3.42654856205889,5.70514005088408,1.62728015578023e-11
1,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.00695133545416343,0.203905833670858,0.674206175733341,1.49941774737081,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0573327002138316,0.29827393825633,0.557678655953755,1.79542180850466,0.865876887327335
1,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.347205166125286,0.0240396399875901,0.674075227616498,0.740684956900941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.303307454395054,0.240133109088688,0.429090860299206,1.09989850097765,0.16502129475205
1,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",-0.0225520580326232,0.0694955125091721,0.852899914447396,1.11997272378302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0272896265271518,0.224334585336292,0.625239857826984,1.50644939082488,0.927240944336143
1,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.177690865060137,0.0233950699357702,0.799628847044927,0.876428097903268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.130689554639585,0.225917673054172,0.528700105387687,1.28177660585023,0.539284230346065
1,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0179642456273266,0.0528734909751045,0.885330589316426,1.08922465737449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0319614683329183,0.219061004398928,0.634821651318178,1.49824163097413,0.909516049093864
1,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.238900118491377,0.0182532329981812,0.759789213630592,0.816145300035198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.193019426027487,0.230409368296976,0.490990882972565,1.21149896563017,0.370403392921577
1,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.17120999905537,0.0472813397063215,1.0816897676951,1.30195094193778,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224601758424366,0.204188321118556,0.798158762356767,1.77705190824502,0.334931048481592
1,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.14941312215291,0.0458051427726853,1.06142674474006,1.27019044888998,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.202405661763036,0.20533062643315,0.778291177796344,1.74059447149286,0.385666943960797
1,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",-0.289503128538368,0.0389625478978553,0.693438716243543,0.807863612862101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.244548838657626,0.237365033408818,0.45887242440273,1.16354430639788,0.26536499275216
1,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",0.0793110334841821,0.0234947006919161,1.03379923101583,1.13353166288219,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.131023084702957,0.206258786180466,0.721495107204423,1.6194553720136,0.574830946413528
1,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.238385144636554,0.110309405154724,0.6338175192437,0.976686783908727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.192471818829078,0.256728687119141,0.466442132551882,1.27600824785484,0.423975927475594
1,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.0659258251769085,0.0653321507845141,0.939605769768895,1.21385644928743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117387497437099,0.216680576135322,0.696950167539702,1.62959396788764,0.630217464611425
1,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",-0.104369244410001,0.0350894452055676,0.840931835831006,0.96493303296363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0560257798884332,0.221768528132681,0.576206030093873,1.3744129094341,0.781981210756929
1,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.81300145784379,0.0804332470929136,1.93294884873688,2.64941609096559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.647279570804471,0.64683052484072,0.482439824449841,6.08988978240617,0.342311889757482
1,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.269502488749622,0.168378850120158,0.555621053561911,1.07504679250897,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.499720371719278,0.718056053666399,0.130743611693452,2.18193254353408,0.464549854288827
1,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",1.12536743256986,0.0797055702244913,2.64528536965242,3.61545981430195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.978252518673381,0.63209494477249,0.694819931840938,8.27851906291371,0.149726147459269
1,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.00502170795235541,0.164742770645479,0.73676935648168,1.40536830811863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.208840041596995,0.7033836926237,0.180907461652589,2.85035563203939,0.755216452748494
1,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.81077132218612,0.0787574247292713,5.26003596328552,7.16251585622327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70449841725505,0.601086048590545,1.54175603128173,16.266960060704,0.0118090699386841
1,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.426347110537103,0.0990809298936596,1.2677456978755,1.86942405316704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.237591445375527,0.668320300750999,0.305087353297251,4.18962109932876,0.733238956703897
1,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.630710424409795,0.0986726117649113,1.55677231552242,2.29195274206155,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.454128784247668,0.658373199390048,0.387645617139155,5.11978171200587,0.508871998413458
1,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.792539264000059,0.0340376459736696,2.06773094171567,2.36286995558392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.625622771727127,0.643111309829303,0.475392770346909,5.91408077108755,0.355728251553094
1,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.45232758149111,0.0334745884693817,4.00430227348313,4.56577069652772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3247065920008,0.612321290927592,1.02633435658369,11.3163539496564,0.0491916261974074
1,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.673712183891991,0.12649163538238,1.54426130344316,2.53548204467162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.499692820566479,0.661734840350732,0.403335343068389,5.39766235460573,0.470074684036192
1,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.34563220189062,0.124042336489987,3.03907593780296,4.9421009066542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21167268452055,0.630197948631172,0.883655017859322,10.4504184544123,0.0772341500751512
1,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.425873353809471,0.0329849906817156,1.43584963820641,1.63404011105677,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.237091492750533,0.660845346013753,0.309440190962274,4.12669029970919,0.731018573789006
1,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.71970778885794,0.0325664702823214,1.9280391470087,2.19056985591655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.548447452784584,0.646519422036055,0.436637933324124,5.50501012728324,0.418820743393808
1,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.40945073396762,0.031923458517528,3.84774787103725,4.3606697872428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27927354083752,0.614178602998788,0.976570807413312,10.8463418238482,0.0575164783494727
1,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.686448318319252,0.0979187818021958,1.6482781577539,2.41951177458099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.513187423491006,0.655579914814731,0.413867702334244,5.40658215152649,0.454498288796416
1,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",2.57216859695132,0.0897374557860681,11.0379373448988,15.6912393197794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.51126302446253,0.570532993623431,3.70447800762785,34.6740163875136,0.000210731913172064
1,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.33761742771029,0.0961139605604031,3.17284409666138,4.6245921313028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20312911731837,0.625000627738951,0.885040394079813,10.2557184684639,0.0771142263290528
1,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",0.217442342017484,0.794127465935748,0.350613423821483,7.88412658933216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0162392536769579,1.08123723250103,0.108341612800724,7.5075269191522,0.992959666978563
1,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",3.07794791452586,0.0895663775281004,18.3108947776814,26.0128325039292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.04718000139177,0.550094084588445,6.62955056930498,57.2751130569042,6.8298003343654e-06
1,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",1.37971878253842,0.197228240669398,2.76149598677764,5.98282613395175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24777496331449,0.649622418278204,0.882351335255099,11.2605799166295,0.0766652594452938
1,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.8377103239093,0.308327838338542,3.63501244679848,12.1731834223815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73305280853826,0.678937099638912,1.3622514546756,19.5021231367193,0.0204287193050306
1,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",1.73033018009898,0.185925869967388,4.00161354205271,8.29384508057055,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61926661253105,0.63073668711627,1.33431928298743,15.8134942562536,0.0207885063228226
1,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.63985293856218,0.196298383437708,3.59002942985413,7.74955888530517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52337912132243,0.63812650080918,1.19335031782365,14.5584948653062,0.0304273449400516
1,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.31912325486673,0.194775688607846,7.10493824871602,15.2456884690503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.24314873332977,0.609577691980819,2.61605932967242,28.536094424139,0.00140394734938062
1,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.540200525289253,0.0343197909240881,1.60569928605091,1.83692037887574,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.35823493154183,0.655319537938866,0.353779926941726,4.61690769532822,0.599924461319337
1,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.278313632121648,0.10033318339547,1.09052191025028,1.61600208481605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0807362091231003,0.675767022388825,0.256366238404755,3.62483878259177,0.913043411319132
1,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.60050315793186,0.0962041488689105,4.12707004328328,6.01755515548543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48170378830445,0.613221663683927,1.20125735412329,13.2918830783755,0.0293175734825177
1,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.385778265038262,0.128026333335119,1.15413802246427,1.90638307595686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.194627136387555,0.675857474856923,0.287768778359029,4.07029160609968,0.783201762589264
1,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.00607886153024703,0.101617951896051,0.818416145540416,1.21890231927202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.220603996332693,0.690158026711328,0.18345565936189,2.74446861391686,0.737273684624858
1,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.490979521823491,0.0630011110013094,1.4471647596259,1.85255565546229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.306077610096428,0.660143311190737,0.332363097022171,4.42020903158352,0.656226422839163
1,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.771952760665449,0.0624229429770446,1.91879440609656,2.45074121470534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.603784861169509,0.646516009201495,0.461885530478999,5.82324693505752,0.374568505708516
1,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.523338768179143,0.045673627165331,1.54481623869348,1.84770123817124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.340367028672618,0.656931577677607,0.346320246273401,4.54820705008692,0.618989756950168
1,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.570020636802821,0.0455714644321964,1.61893817066975,1.93558061742781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.389832243232307,0.654649954234856,0.365798712784447,4.76124221448036,0.567986028545301
1,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.834847372530312,0.045139737292817,2.11178755929242,2.5205554453565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.670425154305193,0.641871574674077,0.498738658365065,6.174434423391,0.322492439675344
1,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.213391259370481,0.0589866146229582,0.720716025833574,0.9082035056266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.440249588038589,0.69508593306805,0.145301007805734,2.21607811242176,0.505937333290118
1,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.477034701885658,0.0564966905372756,1.44450942915493,1.80260479273335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.291301826524441,0.660152687708734,0.327405446491034,4.35443560902706,0.671883282170124
1,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.54043227717797,0.0444609424818299,4.28233905241242,5.09766738622343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41806351375733,0.609132136292934,1.13528003881115,12.3620766126651,0.0353785350984053
1,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",0.0899309697942028,0.0659159742488921,0.963472293839069,1.24754088765351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.118877971633594,0.680339309135024,0.207412385648251,2.98570177592286,0.851872399016097
1,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.15683267646665,0.0552409534066185,2.85823495030734,3.54928027100685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01159904834581,0.627669044804497,0.724973222926456,8.48921797990282,0.134642627576905
1,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.486705548641731,0.0429910951677121,1.49690465472101,1.77166788159017,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.301549892470452,0.658515575903055,0.331896949201969,4.38593518348576,0.660260602835151
1,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.239445934544115,0.0553430599330292,1.14172051897704,1.41832579776146,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0395525659764481,0.671761615395831,0.247797473981945,3.44910108192204,0.961051665836348
1,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.773199541190238,0.0425440088032393,1.99541491945041,2.35754649717306,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.605127979973353,0.644613773242595,0.464234498352828,5.80938137301436,0.372270788969852
1,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",1.44329345881096,0.186785285701693,2.99711180457348,6.23285166224487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31514661573036,0.643337381385601,0.956440035376626,11.9090547134347,0.0607820089490907
1,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.466427387391051,0.0645243070768211,1.40796023409805,1.81316266735845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.280061825163365,0.661510922232202,0.322826121061921,4.31645187829679,0.684490212142497
1,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.41946575113617,0.0417957975858418,3.81275777337069,4.49151143804563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28988514796571,0.614396724964064,0.986711806368342,10.9683476072782,0.0556887430450683
1,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",2.18347958617957,0.0901328421135148,7.47619948598409,10.6444520429694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.09942389916027,0.58684704188325,2.36502493963821,23.5985837642135,0.00196063465152329
1,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.23716243343948,0.0575783534447996,3.08431737963799,3.86527704591676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09671549907597,0.624187064551799,0.795749951591625,9.19167385592757,0.104753481716317
1,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.126900334740753,0.061143923460243,0.782468562508722,0.994394015136229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.348600890854829,0.690849304467639,0.160834599175223,2.41258969935495,0.597057305029194
1,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.4154114956999,0.0627089152461178,3.65031234366345,4.66751667182544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28558821726985,0.616603580529157,0.978177166343624,10.9679474109621,0.0571874311468586
1,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.666199577063346,0.175430071877394,0.367889700331802,0.731762795258507,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.920050836784491,0.740282762791883,0.0815755173568212,1.48531818080673,0.182014031100211
1,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.132867648373376,0.107899204774396,0.712359373577958,1.08739437616729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.354945804035448,0.697657365298808,0.157682865101154,2.42928548038258,0.594146605278204
1,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.646271208881016,0.15929005439031,1.41594689768079,2.64376498618927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470617093536371,0.671046840403709,0.384511359893283,5.33705142236316,0.501458397463499
1,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",2.39726112517675,0.0899325754594798,9.26379102667263,13.1792362649449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.32593464968557,0.577818104810854,3.02751190451375,29.1585003838694,0.000600425268357765
1,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",1.19234040906764,0.311894784814037,1.89044433141674,6.41999274623488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04922244175287,0.706532970274582,0.645231435884067,10.292465678415,0.162445689733798
1,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.001035307542206,0.03379991991555,0.937387888495147,1.07018885996186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.213088417565982,0.682159851875536,0.187794278723983,2.72265989582686,0.742876711224259
1,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.660020502123409,0.317034094072884,1.09680304583887,3.80056765622705,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.485190878364309,0.73151051080852,0.346591893721009,6.09739250151981,0.522813129602578
1,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.207545397371921,0.0508815479121774,1.11528154906506,1.3614616784646,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00575123593047863,0.672949838359835,0.238868694759578,3.34034341591825,0.998810819347642
1,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.722162942919787,0.0779613770963033,1.77299152844592,2.40673541971735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.55102940038163,0.6508112956971,0.434122494515302,5.56615695347263,0.419492448806905
1,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.95604098761756,0.185380190089554,5.02061872298948,10.3836262843223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85842557250193,0.621094453341503,1.73253320424801,19.771275192695,0.00792383395262074
1,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.389896887281347,0.0775921288033584,1.27222127159218,1.72447035252258,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.198969336126389,0.666856912510889,0.294190389357205,4.01686972663114,0.775548754041802
1,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",1.03532029053615,0.0772293077318438,2.42893360123618,3.28769146862142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.882841535798588,0.635926809479749,0.625985851003804,7.57126209195239,0.193720759346214
1,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",2.50723037585251,0.184488742091015,8.73160521398868,17.9956813905161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.44248486368011,0.598408201850385,3.27159258590112,34.1579017562574,0.000475614524384639
1,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.77049215599404,0.076092559996018,5.07751234321454,6.84212803584716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66181959911616,0.602465675728118,1.47252448326107,15.6207524599785,0.0140588415177046
1,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.61886871066122,0.0499805345689806,1.6857475168337,2.05059335137212,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.441592557795253,0.652647880407146,0.387060068423512,4.99859712435437,0.517093083744965
1,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.889990447991432,0.0977411187114543,2.02132119995117,2.96503697232109,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.728855715945457,0.645916763563022,0.525029639860808,6.60380914731698,0.286199299584626
1,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.884487627834081,0.0537842103659486,2.1825001403186,2.69473886491984,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.723022728045151,0.640273434415342,0.527741999206101,6.49269689651047,0.286143526955757
1,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",0.0287646790242987,0.130794206986127,0.802835406208479,1.34057457654374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.183683420605512,0.694006521332188,0.189042808718303,2.8710384261235,0.780482897060592
1,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.90450753054871,0.049452197918362,2.24562018373728,2.72598760934996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.744234779704222,0.638926453430287,0.540654552847496,6.61652916025097,0.271846567199554
1,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",1.0439392860169,0.198796047643286,1.96731757669628,4.2885006198484,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.891978892537048,0.66492288043043,0.596873837788943,8.08815205302642,0.206974236623809
1,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.59058096711135,0.0485636420688862,4.46753740090343,5.40434531863119,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47120191032233,0.607233928803328,1.20256696158684,12.9976902428563,0.029096444019529
1,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.553251530258734,0.058772631660159,1.55253299659949,1.95476947544046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.37206227220018,0.656662956663889,0.357840197824567,4.69455216717522,0.586716117473148
1,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.82851875233394,0.0748054154199094,5.3936946737981,7.2316155237266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72330290408901,0.59973296976773,1.57558419708137,16.5359395127222,0.0108467834826798
1,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",0.111405003535645,0.064329371114425,0.987295395423696,1.27046185902469,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0961251574969943,0.67908610662985,0.212790587279622,3.04811043032774,0.878439665100217
1,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.200222205788766,0.0464960749741034,1.11646967300684,1.33968283294815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00202124370457247,0.672953555053023,0.236989938704159,3.31411914662783,0.989582639058645
1,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.4299241200577,0.0613301788352092,3.71329713570124,4.72246109025015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30096598577427,0.615786845962873,0.995140238225176,11.1224820701912,0.0542101676875862
1,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.176341173817289,0.0350112129489798,1.11440777100699,1.27834279743709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0273261089393443,0.673355124839001,0.230788351781112,3.23247912072984,0.959460301836141
1,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.190349828271877,0.0573599783245439,1.08296742284555,1.3560171954276,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0124797661147389,0.674401663902587,0.233816287641184,3.28835150601441,0.977177516864935
1,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.810324192886281,0.0763540137640961,1.9421286558206,2.61977084685483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644442660540331,0.646393798779121,0.481464800755393,6.06718643076982,0.344072867957314
1,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",0.421021067963088,0.0818137194766621,1.30218581554503,1.79453894950932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.231948432307612,0.665908055948075,0.304782789950458,4.14604842204751,0.738555973743495
1,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.693562029663284,0.101277468593551,0.411184380026476,0.611577759463427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.949045963180939,0.725715779968458,0.0814989434841654,1.40156344688508,0.158413768256973
1,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.51126954275002,0.0443421580747171,4.15914459131944,4.94871274719038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38716200650169,0.610438181531524,1.09745808813561,12.011570312137,0.039594044997648
1,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",1.10926959056309,0.0756963312384729,2.62274910085106,3.52876237956658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.961195378240643,0.632278713504238,0.682653339990241,8.13941988388798,0.156688356300688
1,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.744471508574116,0.0638431731376906,1.86181262562386,2.39123790348441,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.574683091167559,0.647987266009786,0.447137914147884,5.66992113489771,0.398416133564531
1,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.279391461577216,0.0595531123958335,1.17873178965313,1.48866987051878,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.081878415755616,0.670200926752953,0.259476840218185,3.58963860251305,0.91099694322809
1,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",0.400370551238252,0.786148684270939,0.430758192342668,9.38805212582091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.210065029211989,1.06876060734312,0.135206796417261,8.9219519372348,0.849083211707988
1,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.828231799151771,0.0451143191528093,2.09798545932837,2.50383225623684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.663442031755571,0.642184737519942,0.494898217635715,6.13441522288411,0.327628265539368
1,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.59792505347814,0.0543278116812771,1.63724351967576,2.02582121285397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419399680808845,0.654057886509619,0.37738865372714,4.90070999672524,0.538935395562709
1,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.503488590876309,0.111682955002549,0.487828079593971,0.75578140447794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.747645635662045,0.717434907000465,0.101699696615366,1.69310174512701,0.266900373217655
1,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.83067761084304,0.102630735294101,1.88793138959048,2.82296236203587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.666009505725324,0.649567990524434,0.489066727355569,6.24014482857236,0.330796707527311
1,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.985242559186753,0.313533229725437,1.53102014338937,5.23288080748643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.829799436991468,0.715952458004844,0.506990763194993,8.39150236465387,0.270586147504899
1,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.54105921637039,0.0529270104296251,4.21648513021619,5.18864166819684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41872702672775,0.60987364779868,1.1343936363619,12.3883812414242,0.0354808665801367
1,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.33578652684536,0.761134491663868,1.17803929489119,23.2764896687967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20121513052657,1.01969497454457,0.407199764151886,22.1686572941861,0.254351106890209
1,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-1.25574159274519,0.11036655891188,0.229945536693539,0.35441602856198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.54471430161719,0.757816013314495,0.0416812864229456,0.81292304319538,0.0223672642875953
1,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.108245268415646,0.0438852814458387,1.0234196290875,1.21552579910397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0994755602287354,0.67738297619482,0.212777682178372,3.02764494116801,0.874172549310578
1,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.916122752042165,0.104438971713222,0.326979249222783,0.492399292332944,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.18487100625772,0.738187216935637,0.0625349310744968,1.12931441579084,0.0789142418419121
1,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",0.787085692011256,0.772166386560252,0.659798717184715,13.6128765645798,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.619814041938157,1.04510752281855,0.214746758146818,12.9157874344111,0.561886204296158
1,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",-0.0572118780498671,0.0954389062023233,0.786399860287983,1.14319131436286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.274783387892538,0.69173459209194,0.173081868988313,2.60532964254899,0.677388732364196
1,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.129010461903951,0.105936293784476,0.929410011030841,1.40784103496088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0774670657857521,0.684138650668657,0.214725503049775,3.13735295025573,0.90121602496214
1,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",0.258600205373858,0.0796475181494678,1.11155899402784,1.51888431662152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0598481552160242,0.673593167708775,0.252054495794192,3.53363376330016,0.937247999298487
1,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.0942690809584664,0.0466624027263295,1.00386694780669,1.2053533348879,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.11428369413733,0.678299120771893,0.209220525690781,2.98774002900958,0.856851907799222
2,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.28363357812331,0.514544852176245,0.494572545196026,3.71700160401569,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.390853437921927,NA,0.565268724841338,NA,0.410594476717344
2,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.05951690711889,0.357962106890297,1.5232567653677,6.19682042736196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1304394812396,NA,1.58671229117301,NA,0.000807281562583668
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.135771450582683,0.570420686421925,0.280984558214274,2.62886564304346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00892941315730371,NA,0.341424503174213,NA,0.994422961001575
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.302142843141526,0.381314256341007,0.675143176743857,3.00986106994819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.408495155353457,NA,0.737934559470794,NA,0.246500873061495
2,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",0.5894268780996,0.697310578068388,0.536599187421119,8.25569597067442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.682341116359412,NA,0.537717193563822,NA,0.295694399817574
2,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",1.83305845602076,0.344844483054247,3.35759264123447,12.9745503775373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.86780954359144,NA,3.34994571713259,NA,1.05968240892084e-08
2,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.399682072132101,0.851895728646939,0.132812960631454,3.74550495332097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.260493234023016,NA,0.156913023565071,NA,0.760280976476487
2,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.314094729437264,0.380031478225586,0.685310661003831,3.03986466645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419887898374006,NA,0.748180643541428,NA,0.232379455200524
2,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",1.24164869337618,0.654050931905696,1.15164701564818,14.9547002209231,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30404952681263,NA,1.08557121563413,NA,0.0346796696986979
2,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",-0.153381372490537,0.404289130752889,0.40471700281621,1.97430622198803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0257154713643317,0.385391361056175,0.45793120147223,2.07439605600122,0.973119872299776
2,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",0.421809913131417,0.742526328224325,0.39917396823917,7.33231854796652,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.522565924321169,NA,0.421189313235048,NA,0.449472703773919
2,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.00013035486359634,0.735702112228172,0.236435461737442,4.22838147276293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.120365597241412,NA,0.285325797639961,NA,0.849474396677483
2,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.947793715612731,1.24613519474629,0.019822165364162,2.62165474000456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.782962013120125,NA,0.0445529116555194,NA,0.516704968575374
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.00013035486359634,0.735702112228172,0.236435461737442,4.22838147276293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.120365597241412,NA,0.285325797639961,NA,0.849474396677483
2,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",0.405470918579753,0.667515736568723,0.428528866457783,5.86625493077832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.506991257281369,NA,0.477062628431349,NA,0.414040458285315
2,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.688939124373147,0.63160984918334,0.627386646618434,7.46087609424437,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.777197782362487,NA,0.668432924870246,NA,0.189506466268721
2,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.957883796934575,0.453114888866119,1.13505784586204,6.70505246341854,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03357929284744,NA,1.20566787675925,NA,0.0154167905435586
2,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",-0.445715590732348,0.393492283168683,0.286755094988495,1.34089144646197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.304373109344391,0.375081285442786,0.353623476928459,1.53844022937689,0.436838764112608
2,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.390776427640829,0.309717050246968,0.808800022575187,2.72335600298908,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.492979849641972,NA,0.91791511845793,NA,0.0867186691167498
2,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.66387729209291,0.41967576766023,2.49952898028674,12.9513636768648,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70652829430602,NA,2.51404821011028,NA,1.72588288491636e-05
2,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-0.552030926987542,0.408240170545917,0.248699810004238,1.23215340018364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.405714584262577,0.389139048244656,0.310858624070351,1.4290072664648,0.312554279954676
2,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",0.786101711056089,0.386789953239182,1.06529507603356,4.85224062762828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.869814451856132,NA,1.15857049685946,NA,0.0166792491497354
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",1.24571980470922,0.837014277612771,0.86724879357744,23.0716892685851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30793078088046,NA,0.77426761817143,NA,0.0978712513936257
2,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.88252231913389,0.79474729834431,1.85032173217933,41.70878159269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.91493888679069,NA,1.5374679818606,NA,0.0109416020727879
2,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.077340709235517,0.444536134471459,0.454724268692603,2.59733411905473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.194210784726538,NA,0.529246711925146,NA,0.625285893451833
2,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",1.24571980470922,0.837014277612771,0.86724879357744,23.0716892685851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30793078088046,NA,0.77426761817143,NA,0.0978712513936257
2,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",0.930341821040551,0.277833885210394,1.4940304727947,4.43960896083083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00730686557255,NA,1.62939876763889,NA,0.000117356646266366
2,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.0143235673144116,1.3270793347718,0.0464844501663179,8.44367781885903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.134143533699431,NA,0.095828262261311,NA,0.907568358842664
2,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",2.20499108180511,0.777590843881062,2.6824897864287,56.5341842101284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.22234315634203,NA,2.15871637324249,NA,0.00256638131576736
2,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",0.93753215165181,0.377051469867586,1.26911149875631,5.56407999313556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01417138608023,NA,1.36301402800558,NA,0.00427470595372508
2,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.284648024567481,0.177656133800207,0.942176872947441,1.89049176612663,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.334418918642928,0.363394464010128,0.733111240813772,3.04658806025402,0.264726901359339
2,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.577249078442495,0.354309214759579,0.901778936864504,3.61640605646081,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.643493605976055,0.501983209724997,0.768016196233827,5.49475261376348,0.143914631350307
2,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.456689040878539,0.476076061805923,0.258727040580373,1.67230380495774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.448585508710282,0.57358269926308,0.218350330596704,2.06834419304143,0.439469566330505
2,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",0.228458271847105,0.427965513582369,0.573373611869036,3.06907508033657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.27507044369174,0.55065620970059,0.478395810470289,4.14215359242162,0.575302959304053
2,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.871281467446122,0.333804639655159,1.26993170306118,4.69948658305016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.954044218143936,0.49987212324799,1.06208439196992,7.5360343974233,0.0250906690628273
2,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.165000639186919,0.196922493969778,0.57612124338961,1.24668102916482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.140502189735006,0.352614705034457,0.460582890844096,1.83484829840719,0.69829650342098
2,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-1.0685341174828,0.533129230058031,0.123182091650234,0.995745657074354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.09484741390932,0.614640947961036,0.104442752238512,1.16210388891656,0.0795259182057064
2,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.588516932425049,0.167917905212167,1.30431931576432,2.51911437366065,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.655371886335631,0.37521255895937,0.996023889969925,4.33543594176235,0.0289747534980318
2,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.30429298548705,0.1532127200641,2.7544549788801,5.02187022862221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41138678271706,0.414941150669035,2.0129353874554,10.2382782982103,1.71126836750693e-06
2,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",-0.149489231920706,0.260375997484741,0.514486406773795,1.4277060718536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.124117210869356,0.397364937443296,0.429095866311295,2.03718104549841,0.767881281623214
2,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.161822251135446,0.239726095810552,0.736070831338486,1.88377944376134,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.204688377371225,0.396230797636838,0.601934737493857,2.84507644407333,0.538267096868697
2,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.366897725690472,0.262289000699364,0.871688747930153,2.43715440332131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421279928473513,0.421815902139364,0.714931907248071,3.73564306762245,0.243164023362256
2,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.567494792442135,0.220007367692929,1.15418666192564,2.73411811908555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.633170776735869,0.403784295679083,0.920653412988035,4.48228842241056,0.0579101849284403
2,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.782911291885079,0.244039218854187,1.37775045782563,3.58611063137249,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.860697327573067,0.431019549296485,1.10342365542982,5.97738598897117,0.014849529716297
2,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.00292630041628894,0.185556762530466,0.698169289817581,1.44495108997538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0368602548354096,0.353552985897366,0.551083239030588,2.2034687555897,0.871900719637916
2,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",0.214545007154836,0.434726249814178,0.534374894992357,2.93714479040495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260373183217023,0.556182981283152,0.466182134509089,4.12480336527868,0.599270691743255
2,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.300477676830986,0.144332718050964,0.556806921892304,0.980431125438912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.283596828082387,0.315687435567532,0.427830995146,1.47468583757552,0.358176095613331
2,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.363781845993799,0.171064295554779,1.03378584752554,2.0213939760819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.41800043891462,0.364074244999772,0.797670915380314,3.32372340642583,0.161206428662418
2,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.679464665727513,0.395876676385973,0.936321850503524,4.41943584841167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.751439343774932,0.540868028779406,0.795534763791459,6.62879462834365,0.116034930914996
2,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.141420979500134,0.128753878417837,0.895478695657279,1.48335895579292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.183145375722725,0.330968188597841,0.668967187395598,2.44819542530549,0.487914446792197
2,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.20051033442421,0.151682945505249,2.48923839906888,4.5111992189788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30176918265352,0.406907819456893,1.82489913101575,8.99414722226978,9.42481040500582e-06
2,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.402948137415593,0.121537025135391,1.18100619880154,1.90176646007258,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.45937180943414,0.342834529332767,0.867552715127644,3.32612398640316,0.0920495864527435
2,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",1.20125980593035,0.278178889285536,1.97933594463638,5.88968558730024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30255747138292,0.478045308616271,1.58958279799814,10.354019132741,0.000643650156016512
2,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",1.00401322523569,0.466954084470332,1.11295829605178,6.94101472445002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09422883337492,0.616343125145954,0.978107418737743,10.9559739635401,0.0450082140343908
2,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.83758323715182,0.263363835148786,3.8690604856653,10.8631787303986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.97465846104523,0.511584138627048,3.0005997099913,22.2910476137084,1.05898125966616e-07
2,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",0.300033097348977,0.37161348033704,0.655383565332112,2.81275226138703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350673839044914,0.50451669419358,0.565715342831559,4.08779148619527,0.43287826333494
2,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.362089832406971,0.373073344660028,0.328511444387714,1.41798526251278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.348665469159727,0.482104330670336,0.289114978318792,1.91340318468616,0.473885638561558
2,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.0054815946490254,0.337090010008856,0.511623239839859,1.91784425966352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0279850817774318,0.463733879495208,0.440236344315957,2.71111463385469,0.922440736352793
2,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.34689838961638,0.310406018050559,2.15924332670747,7.29017156866743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45638791853372,0.509178175912305,1.75494860151424,12.9148955963178,0.000362222617985732
2,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.343858947415398,0.309624036004594,0.774202855998782,2.60591162696591,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.396963500077789,0.456052827060053,0.652164372443635,3.89711130754957,0.317804060971194
2,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",0.944090823378374,0.20626949036596,1.73435279643736,3.89306147734649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03092771920911,0.417417669295381,1.35078953276741,6.93746516115726,0.00162831535528236
2,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.859310966270676,0.280640368334359,1.38697390890827,4.1670750343153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.941391870269384,0.46005087598394,1.13308513605245,6.8778796727049,0.0137404587560841
2,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",1.79784713397374,0.427956207982106,2.68730141700658,14.3836911911843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.93268870384731,0.625909143089366,2.29833867585273,26.727828891578,0.000164099164708327
2,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-0.532547035702683,0.476830730223882,0.239578686643699,1.55312455738023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.528706467044952,0.572323182256865,0.201731834984372,1.9015125270426,0.360410806373876
2,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",1.98043872760892,0.38583897512181,3.52719110217585,16.0059867250087,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.12551456420784,0.605255674781813,2.92977531078317,31.4212489554682,7.64510194336181e-06
2,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.4655247138737,0.360111367162703,6.06007337044461,24.8618009580427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.63789892919927,0.623658643451931,4.86123932961584,56.0357775257308,5.68718022468236e-09
2,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.0182202305525,0.374781803254595,1.38314904126448,6.01033499381458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10923526775657,0.539543756436674,1.15396266212485,9.56561094458436,0.0164229390025575
2,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.09215284497002,0.108153295964196,2.41970497091869,3.69728493779706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18730143659585,0.382716213687196,1.6993046026814,7.61743044114947,1.24783127801349e-05
2,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.589906989010094,0.304907100361709,1.00946629761997,3.33554353024203,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.65681766724386,0.463874940376005,0.838831591803791,5.16864743015348,0.0997871525640906
2,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.814203158745512,0.293490950209558,1.29725684413625,4.09888628715476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.893749588718823,0.466793163620292,1.06461429710497,6.63532831647135,0.0226294451918297
2,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",-0.652510865275258,0.76776068838401,0.10577249076388,2.14491900316821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.655417878485044,0.857494396949893,0.101562905240118,2.92776505916608,0.450030279917522
2,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",0.230536509895276,0.605241152481926,0.399035994951245,4.27933690306857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.277276968140928,0.716115305486983,0.347100931022256,5.74874023496909,0.6709461436527
2,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",0.0203365560491993,0.610699274967672,0.31964170905211,3.50202929467432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0552665068192415,0.715526647316308,0.276807794566487,4.57396764255274,0.9198266259135
2,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",1.13626466721127,0.519794208728421,1.23477219120721,9.47296876350691,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23391476888037,0.669141036075388,1.01982685922025,14.0499316302899,0.0385483185452601
2,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.92945932865345,0.239149720057501,1.61285878644787,4.11837193811083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01548136767961,0.43630237480898,1.2812633939208,7.08599640873319,0.00377166758826593
2,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.283991842820422,0.199843077540423,0.50780172682991,1.11149533787704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.266182609940727,0.349151255824301,0.40788764678921,1.60301183258863,0.441767903464425
2,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.6530691914093,0.222081083403201,3.45544072576358,8.25229927111531,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.77977116954885,0.474133150743155,2.63218457334913,16.8842618459004,1.6829313027331e-07
2,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",0.0295342332817726,0.454644891697917,0.422505264540386,2.51085129037521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0649686663380833,0.567910100548689,0.372991745809564,3.45550184432018,0.883489951773747
2,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.00228811478333312,0.101781467829767,0.816048298259879,1.21615505257228,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0123199758780333,0.125607403402244,0.77646539080014,1.27044694730078,0.883717423546564
2,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",-1.75312461534629,NA,NA,1.61133501275205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.120134779860657,0.215091551500543,0.736395783522437,1.7111331865015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.111449177772267,0.230136394469413,0.716282171236502,1.76550539757824,0.648289125844438
2,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",-0.0186902040334291,0.15968036821351,0.715670400114819,1.33829978133464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0289022113134735,0.176762642016693,0.690804954539955,1.38126405772627,0.843207842942177
2,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.14504803429819,0.103598725592424,0.942365906903698,1.41444594821697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.13663071478503,0.128875199851112,0.895845960774356,1.48467322992416,0.314019868264434
2,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.395293495098678,0.142148144670305,1.12258313399874,1.95980090187481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.389582236848442,0.164868762943552,1.07612667536385,2.05369756342946,0.0183799032746713
2,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.0120276883770438,0.0802627931467847,0.864021920375355,1.1834894409377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00214784568222374,0.108639188967963,0.814452665671656,1.24684807660016,0.96962958656844
2,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.449048425386073,0.42065278465776,0.693373466994685,3.60651562104083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.443954221866976,0.433838843470066,0.670971994994258,3.67513232010395,0.311088520526001
2,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.0955618875818983,0.0896351041560886,0.922092420036841,1.31029634605931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0866199035669103,0.116996590672931,0.872064430627607,1.3795070684689,0.497443516443489
2,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",-0.0291037485118786,0.0746297602069158,0.838554137260778,1.12352060105348,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0394210136010537,0.103870802059261,0.788525506763816,1.18480184065117,0.668659829521831
2,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",-0.0398926731943051,0.0763814933672335,0.826642123990286,1.11519194102833,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0503331366845686,0.105020830898291,0.778190499088536,1.17455595442033,0.600459391732733
2,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.37798442519629,0.142526080506616,0.516212698954598,0.902538056445894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.392120378682445,0.158076096815673,0.497841637769218,0.925125073675893,0.01441255527952
2,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.55787145826644,0.36312714905311,2.41713475421481,10.0343591703024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56490196853564,0.384983920310608,2.27944001521945,10.3092241427501,3.21749539706935e-05
2,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",-0.00826278251313746,0.0470261794883787,0.904011364158173,1.08700465282526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0183330402414161,0.0860656703524767,0.833956972344947,1.16858984185691,0.782398631200372
2,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",-0.0331166433783966,0.132630270882834,0.744091161381857,1.25145814249858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.043496715013191,0.151988573963563,0.714649566973778,1.29669833235772,0.746211806696543
2,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.59504702395609,0.115228493475129,3.94747423402078,6.20132720441542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60248401975283,0.162409583786863,3.66090235281507,6.91950012981055,1.69192079277454e-30
2,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.650749910561765,0.408739918946702,0.873977424511206,4.3385071167441,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.647883208905378,0.423035990658683,0.841071181763556,4.41581152727969,0.126796603400847
2,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.852830563037359,0.409349785902292,1.07111049557005,5.32982087945023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.852144342230392,0.424810805681932,1.02914002788835,5.44093699562018,0.044408684502873
2,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",0.724366039344232,0.0397083032903859,1.90918357342848,2.23073112589196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.722280289027615,0.0968807973060748,1.71714139641344,2.51036127338027,7.74635322667323e-17
2,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.338405729510088,0.0691515728754748,1.22473112799528,1.60607050759905,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.332096498833322,0.10560949369622,1.14083977370156,1.72589583955137,0.00160063029686357
2,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.68778786631246,0.0850130122750571,1.68442781579206,2.35060047193977,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.685306219955351,0.122587626970727,1.57324567557614,2.54384181098197,3.21844631332813e-09
2,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.33680031553173,0.0744015323413028,3.29417780100323,4.4096938051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34140953234884,0.12911701494612,3.00426006774806,4.9836407695085,8.34830439352801e-36
2,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.49693127981503,0.0329986350417387,4.18950392033112,4.76803658739242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50329556279559,0.114631705444785,3.63792498506125,5.70168353569399,8.06064601640997e-73
2,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.196270445306158,0.0992435054672377,1.00115458193761,1.47724860770349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.188413358047779,0.125962675168657,0.949032721820937,1.55496433986297,0.147985645579709
2,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",0.757714369822459,0.39171178058517,1.01280381056698,4.70301832471046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.75597260564037,0.406783693120048,0.967921243747417,4.76814920012726,0.0630118293493956
2,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.369524593276274,0.0726598547222564,1.25471620568668,1.66817599813616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.363562253252473,0.108512740706562,1.17075383838856,1.79142246051105,0.000722621469160257
2,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.41554667985997,0.658522562790173,0.416913484588401,5.50955833206492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410070116567378,0.671933593311102,0.406843832523409,5.66669136970487,0.546839889659652
2,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.456334436614335,0.194727225106888,1.07882454230453,2.31448860390857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.451322959447627,0.213501890758414,1.04083656470154,2.40352596665377,0.0349652573798486
2,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.10103145577084,0.173237913295128,2.15420981658957,4.24823721311121,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10306655827971,0.201126819840921,2.05265899414574,4.5156027139559,9.17829867249112e-09
2,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.507675288745108,0.0933538575707179,1.38336933437101,1.99463777490971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.503222349234945,0.125770900914024,1.3021994138488,2.13201504681881,4.10100125067214e-05
2,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.785584750575807,0.0361810538275405,2.04396089509391,2.35541437039519,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.784167854651128,0.0968726769961616,1.82732617001607,2.67135999754708,2.74883318337506e-20
2,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.41417753176751,0.0774542579111031,3.53857762661565,4.79387929775177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41963438550813,0.132819655851144,3.22689865206772,5.43122653770715,2.14381105266983e-38
2,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.24220535155731,0.0802101778916349,2.96338318609885,4.0582413049455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24578229005607,0.130466431698336,2.72139567666689,4.53835167873477,6.63413006292343e-29
2,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.340508146652614,0.0677189696959838,1.23075833792866,1.60493618819025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.334220628797835,0.104688186080318,1.14534239758712,1.72646122376008,0.00134272159874088
2,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.861066902868655,0.409622775395924,1.07928975689382,5.37627075895739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.860471536229582,0.425131533773132,1.03713748672487,5.490116586509,0.0424894698873243
2,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.837511353986225,0.136415547861006,1.77187215592876,3.02459084441767,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.836665818494054,0.165498315104226,1.68394569864793,3.22160970830412,1.33500707503766e-07
2,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.38559524387848,0.0354368634995652,3.73014023945797,4.2860080833003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39074208941042,0.112146150466319,3.26397270236109,5.0659916617649,4.43302342233353e-61
2,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.313699152113388,0.101341236768476,1.12152035605408,1.66851761073218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.307125422387515,0.129213436446837,1.06230391259472,1.76287749695744,0.0183560651417145
2,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.12735355972307,0.15356195296221,2.29637278730505,4.19243882673326,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12967671981542,0.184365002410502,2.17873924890025,4.48816491262141,8.03658926766818e-11
2,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.221845270190058,0.207696992309525,0.829360995256059,1.87209381061707,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.214271582333337,0.223807863474323,0.804042175823666,1.93325894234426,0.351828554440501
2,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",-0.00562870158542379,0.127835397412812,0.772823493807798,1.27557997061879,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0156966435447391,0.147986954646466,0.74063413956037,1.32293094523044,0.882886360388762
2,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.54120036051605,0.112501287960125,3.75808154948208,5.84102062557004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5480536259018,0.159225201602391,3.48723010511253,6.50947674632431,1.77162457456135e-29
2,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.484498666760098,0.038010292025918,1.50697932107301,1.74910600734484,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.479785268869936,0.0909229395749147,1.36178841667126,1.94489933900375,2.65375710087629e-08
2,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.747117592626201,0.0884519519925255,1.77551686071655,2.5113409417045,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.745254302019899,0.12609229992728,1.65950387729247,2.7204339873896,3.00121096244124e-10
2,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.207778583619005,0.233924569873109,0.774777305828872,1.93825450012781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.200048363817095,0.248838975134599,0.754711536744514,2.00172875589832,0.435559736690685
2,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.337292536352199,0.276131732558705,0.408301075475901,1.20522473904105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.350984337277289,0.287046438454186,0.402939030386871,1.24138953464553,0.216711122127446
2,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.472406804837518,0.0929211555255253,1.33694324061533,1.92443050207012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.467568308901567,0.124886894487045,1.25855809451791,2.05343566998503,0.000134483994730865
2,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",1.08992992725291,0.191771978380036,2.05365382702659,4.35512321654528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09184356373806,0.217596478266793,1.96521574202325,4.61155242895075,1.85491472294037e-07
2,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.0870551757824387,0.117853622723883,0.865032016763864,1.37298740422653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0780030863747435,0.140229070226772,0.826087127021241,1.43137114007358,0.612219034772628
2,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.72574912369652,0.355011986335418,2.91357323842209,11.7165416493261,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73461521870455,0.378876861931246,2.73724598823797,12.0869010586029,2.46328873578405e-06
2,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.634210291504164,0.13551861283904,1.44720545826908,2.46171343922546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.631151332037889,0.161978904969709,1.37926292021975,2.60255819041758,6.64689845797254e-05
2,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.57955069744816,0.089128690866155,4.08425517669096,5.79223037263839,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58681778118557,0.144128693062831,3.73497560444457,6.57132431395049,5.09815534156155e-41
2,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.60012435277776,0.201463881585762,3.37669879270037,7.43815212619657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60762283354918,0.233524795667142,3.20139483025796,7.99636431135605,1.74919052840623e-13
2,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",-0.084503557569173,0.275757448263791,0.530553971769901,1.56379529120106,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0954367522315666,0.287866121650027,0.519795833795338,1.60656006849723,0.72454037367712
2,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.617654092457741,0.0647986531309532,1.63367369363101,2.10609881088939,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.61440300990757,0.107810480110561,1.50814978969112,2.3013431046292,1.33630292131503e-09
2,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",-1.75312461534629,NA,NA,1.61133501275205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.747578851879367,0.0663619961588892,1.85488607463562,2.40598052629342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.745748731461687,0.111308237368839,1.70907444940101,2.64394531519794,2.94093526695633e-13
2,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",-0.848547204494962,1.30275206607568,0.0209039350943693,3.45173293481748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.867830874120836,1.31967899110124,0.031757199235944,5.60360844646593,0.507526359056873
2,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.42484650494574,0.0587560712182258,3.70810276174822,4.66850983571667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43042025734839,0.122841150490163,3.32653508981675,5.38415138907266,2.23788162933136e-49
2,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.406875581563426,0.0423349806742294,1.38251131696187,1.63207418999393,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.40131694427225,0.0912839661407994,1.25773701152632,1.79883755874675,5.87020040796563e-06
2,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.465064455377124,0.146436245461946,1.19522621477436,2.12199143268901,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460164375367003,0.169453809062346,1.1447456484904,2.22427094528416,0.00638500277369441
2,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.41554667985997,0.658522562790173,0.416913484588401,5.50955833206492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410070116567378,0.671933593311102,0.406843832523409,5.66669136970487,0.546839889659652
2,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",0.41554667985997,0.658522562790173,0.416913484588401,5.50955833206492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410070116567378,0.671933593311102,0.406843832523409,5.66669136970487,0.546839889659652
2,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.38034790442876,0.123045419981792,3.13622919384551,5.08019866365077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38543768808923,0.163790026229669,2.93414058494603,5.57593323217624,3.00029611717011e-21
2,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.927481703297412,0.124971006650296,1.98195540746164,3.23478117012147,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.927619131230103,0.157334072210334,1.87489909365003,3.47395276636451,4.10773672856006e-10
2,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.431105597982457,0.198833985099787,1.04154986441964,2.2707831170234,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.42581817928473,0.217128890664242,1.00733915977976,2.35948168662709,0.0509384900571702
2,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.454888797934464,0.116330350386367,1.25456329493857,1.97940072350813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.449858493722315,0.143381068738784,1.19238998738766,2.0917544160109,0.00153497950536036
2,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.202332600328888,0.121422332586902,0.964472642743026,1.55238582019717,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.194540802056008,0.144589225086468,0.920654628152541,1.62272857477838,0.192377274510887
2,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.770298407680669,0.108181188501832,1.74924805155098,2.67312574126851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.768726476625439,0.141378361721664,1.64891536008298,2.86999620814925,1.02945760895514e-08
2,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.648305939945498,0.0629023239288979,1.69086718246942,2.16368784594773,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645389887177707,0.107249030647988,1.55753771249514,2.37148101248253,1.10496910355933e-10
2,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.48448722974947,0.161041262958464,3.24049828579938,6.09212687152699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49070179105394,0.1965364801545,3.05954197041385,6.61059766043789,1.42244470948285e-16
2,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",0.948303905711064,0.103963471675537,2.10910731237023,3.17019818113796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.948669006659183,0.141122510650979,1.97679788083507,3.4372384754913,3.66639729215681e-13
2,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.564489048980345,0.137803976780631,1.34321930060612,2.30539230331766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.560672763755842,0.163058099649087,1.28227899384154,2.42981461452361,0.000476834891940579
2,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.188938824914852,0.203229819171861,0.552905028474831,1.22639285353697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.201009182365411,0.216729053246286,0.537512040036024,1.25703799812574,0.343710647555706
2,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.131947991712811,0.0406655350051853,1.05361269159022,1.23569168898069,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.123380379775651,0.0851928001972761,0.963027693554812,1.34484199490449,0.175412798526762
2,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.449220870873967,0.217677488893411,1.02240517120535,2.39992608626233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.444130002582776,0.235097416640108,0.990545734970672,2.48945969919611,0.0600506490719858
2,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",-0.0983762259153727,0.112818449564686,0.725129811601675,1.12843938868684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.109456153742038,0.133908710448254,0.693018521617451,1.17141678779028,0.397853573057573
2,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.826385267726686,0.180703697058664,1.60864492806272,3.26656064617812,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.825417303762721,0.204356919021518,1.54294666941022,3.43754795145118,3.47252960112898e-05
2,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.538899032517751,0.105989918368027,1.3932552738182,2.11090291588357,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.534787355031057,0.136105558907561,1.3171722679202,2.24568636413785,5.7318850556518e-05
2,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.703214766832324,0.102187274024225,1.65507879304203,2.47048718063972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.700926545397045,0.135622806238172,1.55776455739643,2.65085823269217,6.05892304767984e-08
2,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.35391726390739,0.055563532487393,3.47537983705354,4.32109491949319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35871372013856,0.119413566908095,3.11571771260866,4.97563057758906,1.69077019052774e-46
2,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.515259101137477,0.0803900643050236,1.42993419001377,1.95962216901465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.510898972921925,0.116334719102416,1.33674391231083,2.1090981940091,5.73299891251414e-06
2,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.24324319291761,0.573115874323679,1.2017564289042,11.362939318851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24683323298261,0.590122807283224,1.10741368277198,11.1927492308959,0.0337682534656461
2,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.20715379628494,0.230827272698816,0.512988464202511,1.26785229327928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.219410068349765,0.243306891682725,0.500898573315161,1.30003845254601,0.357474479796465
2,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.839573314371097,0.0740445930343864,2.00354132494455,2.67825576438111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.838749318692067,0.117977564813678,1.85213309533624,2.94115262962384,5.88040535560531e-15
2,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.47956242958685,0.0661795360344878,3.86099560456584,5.00453295708444,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48573594414907,0.128094545988911,3.48106495527729,5.7514940860654,2.15909063969955e-48
2,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.3277893804188,0.0568706951905444,3.37717937034873,4.22056870837444,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33230074975042,0.119364319329486,3.0342687213976,4.84462566804222,4.68521323374802e-44
2,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.7981102503522,0.681220032159019,1.86753230537837,26.9761028311869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80776263051437,0.701950285825956,1.56611628421644,24.5372754605295,0.00932270432805684
2,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.735401994649379,0.0924047727738621,1.74180557533711,2.50212986568917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733408677213827,0.128771614150735,1.63129939017574,2.70243257491117,1.54587786849532e-09
2,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.24069150746882,0.154631803086233,0.938251000057339,1.72014356391495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.233291941305059,0.17445573317742,0.902787190838986,1.78887241472035,0.191620020182551
2,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.50010962079077,0.0949840389232234,3.72903980183632,5.41125674108056,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50650574444433,0.146039403685121,3.43181667395872,6.08333890112495,1.59574077077165e-34
2,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.188129449046165,0.110245336838273,0.666175492048235,1.02629131352101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.200189769347188,0.13076939506249,0.636650314730661,1.06297531661531,0.125572150683355
2,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.5494054593258,0.436941563240303,0.739726169407973,4.10130104734352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.545420641643505,0.450536141636836,0.719031453732557,4.20476769505069,0.229114159574839
2,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.441682045314561,0.243060903733331,0.967132912323635,2.50768969708663,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.436507969862504,0.259302353419319,0.937449717834801,2.59050902391494,0.0944393966697899
2,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.465249447150394,0.0894502227663752,1.33608799556777,1.89720996588963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460332823421822,0.122151792971481,1.25617438655855,2.0276898314335,0.000120851345098476
2,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.639015445452953,0.133634957072823,1.45845304216179,2.46259511747268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.636009512902731,0.160427286468908,1.39023196371417,2.60734906383322,4.85032052106674e-05
2,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.34192990761494,0.0822007464990409,3.26230827026783,4.50260450604241,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34659779114775,0.13401531009781,2.99112587449361,5.05804591303828,1.1015853048231e-32
2,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.768514646698492,0.227186478429079,1.38925068561864,3.38488237776725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.766913780902571,0.246910573252131,1.33850025342719,3.52338239275692,0.00166648329125651
2,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.254155239212843,0.182207317453599,0.901661866924203,1.84176409626214,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.246940886589075,0.20001447914619,0.87049323231668,1.90664862972378,0.227305093647189
2,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.399300163023455,0.174453757646671,1.06006395776128,2.10049999180256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.393670364824751,0.194132764256693,1.02030159915466,2.18383983890795,0.0437030788694035
2,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",-0.0316243876526648,1.08166882703531,0.116291381045697,8.07205063949104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.188918760275423,NA,0.0846063755301805,NA,0.858798659412009
2,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",-0.329431553154197,0.701615061255409,0.175683599551599,2.74892484705055,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.509301191764942,0.755770610314562,0.136866079544234,2.6480247925226,0.484720349897524
2,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-0.0155811891390721,1.64762596601278,0.0389736796087172,24.8710969509885,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.171660102459771,NA,0.0260986363842406,NA,0.914743894851454
2,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",0.585583743636188,0.375971865429827,0.885132381875319,3.8642382361374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.475114957438937,0.412257857277393,0.727801557024874,3.66304310266402,0.258557925032459
2,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.297034031074349,0.207184114011764,0.901327234446195,2.03045500074546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.16466447606604,0.223485984677526,0.761656762452068,1.8290371745731,0.5108531099627
2,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",35.3081181134025,NA,0.395843118073526,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",-0.148167777100023,0.50646944225528,0.323290282858132,2.35400723273658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.314286951952004,0.545358458161689,0.251012216134353,2.12870156968097,0.541822778578062
2,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",0.0328820067853639,0.486796299738802,0.405222900344159,2.73160251425291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.119515266456037,0.524727226968383,0.317909259904668,2.48656850607225,0.792710516010765
2,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.1169719402319,0.413266215841915,0.506498401434871,2.55931510798834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0290520977036071,0.445494643718714,0.40637777637409,2.32992212822489,0.915524248178146
2,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",-0.517990524412192,0.515493127733646,0.215018424355225,1.62200715908244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.712200242087163,0.554670792221459,0.165439001759731,1.45516141196611,0.187907236196449
2,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.294012934277336,0.226659242602387,0.866402858915108,2.10661547844787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.161414210237141,0.2444873612258,0.728647153158417,1.89991123438682,0.556742940578244
2,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.183414140368074,0.133376546118563,0.926487360081453,1.56278826864721,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0424288032668812,0.143765034602947,0.787488773954247,1.38353582784396,0.865412860099556
2,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",0.564375457957396,0.609171062663835,0.592275606515269,6.45027964448948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.45227526102298,NA,0.435072623373826,NA,0.507660085343191
2,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.140170934323832,0.597915159504266,0.374408771784627,3.90156303533533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00409573753130608,0.647678588150168,0.282275985289484,3.5750651411225,0.972465883801289
2,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.72336312965305,0.403201447832377,0.214362171263621,1.04126084225761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.933124272506119,0.433801905692497,0.168078938965659,0.920489843565921,0.0283161762383099
2,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.226569407172524,0.197963323680805,0.854317947011456,1.85623476877099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0888555129200363,0.213371823996194,0.719928111268971,1.66162869558108,0.739747527001972
2,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.692159535940597,0.180380140160852,1.41450093793167,2.86868555855587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.589758301932031,0.19795442743382,1.23243107710329,2.67769353004826,0.00322194013834833
2,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.38302469317425,0.308558704342529,0.81491058364846,2.73150027677409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.257176991416072,0.333592812782202,0.67469708829711,2.49469967246088,0.471417248545815
2,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.643993411429281,0.353236116540961,0.981665215616643,3.92024904316143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.537950568007627,0.38905070312012,0.813052933552024,3.73628450555302,0.17134931652019
2,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.269461103419964,0.367559749633126,0.646812220255149,2.73220365943541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.135000225173885,0.396802025179796,0.527263014300251,2.49772315804527,0.767531382496165
2,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.227560574214349,0.394218872961418,0.592970316420775,2.78068874828071,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0899217709514056,0.425458989852417,0.47647385605746,2.52546743915041,0.865538939217855
2,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",-0.145200518817399,0.330979823384857,0.454578305868036,1.66367993446454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.311133862197411,0.356215364811495,0.36457552725378,1.47302341041515,0.355197601630372
2,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",0.103168596467596,0.415747614205001,0.495772315874196,2.52960256831084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0439012128420857,0.448118844788947,0.398298517438325,2.30721249127567,0.889733534156102
2,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",-0.0245965179431653,0.174289212186401,0.694255136572014,1.37476856896352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.181360070553407,0.187610983766269,0.577595146055342,1.20507215821929,0.287429516389651
2,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",0.573524107441412,0.15367652025012,1.31965702418008,2.41035192205141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.462125814964975,0.167270627222109,1.14766357669402,2.210938339314,0.00723968710023916
2,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.19816245774234,0.141234221676109,2.53133685477787,4.40339370413417,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1341668260384,NA,2.28678004204157,NA,2.05882801653809e-13
2,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.70325692032358,0.302212376520948,3.16598179700182,10.3513190832051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67755918094484,NA,2.79907576604747,NA,3.32801343302982e-07
2,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.70344745639693,0.808380270533929,1.4888753790626,35.4035992228781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67774673029751,NA,0.973505119740014,NA,0.0563513407369433
2,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",0.298449788350806,0.304198553651393,0.753196677291009,2.48185812837812,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.166187545000067,0.328300206526105,0.621714207395506,2.25159396962601,0.650928904017712
2,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.35019952936454,0.166354567004001,2.8155138840435,5.40455824514113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29772724055535,NA,2.54513562735096,NA,8.6945540391716e-13
2,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.297170640604149,0.393968289544829,0.635949299609375,2.9793074694338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.164811378094839,0.425769126361419,0.513794989990381,2.7265944098666,0.729248886906576
2,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",-0.384420253570246,0.356855262523567,0.336738777675215,1.36396941321883,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.568475307623083,0.383968822947649,0.266882773057914,1.20223744609956,0.126544661284573
2,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",-0.0570606785214131,0.32684058082942,0.501086631683249,1.80437678177467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.216259054929524,0.351822534351259,0.404363652112097,1.60589031415101,0.505033200894259
2,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.320464593414787,0.161537221367848,1.00770181176427,1.89816299987923,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.189872570764202,0.174345180881097,0.859979766844506,1.70331122135932,0.322978679971024
2,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.174163492751518,1.45920577143239,0.0912619412638516,27.8257008371971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0324744153234155,NA,0.0476234251771459,NA,0.992697634162229
2,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",0.856943483038517,0.11768808168259,1.87828891899935,2.97930489307405,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.767043878576772,0.134642441615765,1.67572350058287,2.84065223318872,3.3170382264251e-09
2,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.24963719160429,0.378919378808417,1.75261784988858,7.7403527028722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18952722884821,NA,1.47707217025421,NA,0.00405937754882865
2,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.386845660600992,1.40185934974931,0.133564372371636,32.5252251418152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.261287403453006,NA,0.0675629201648931,NA,0.871903571651514
2,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.792847684680236,0.334378713590099,1.18108884178751,4.38056289929825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.698109782583021,NA,0.992946706373312,NA,0.0587325708823745
2,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.763308935001671,0.189761997869981,1.49304270795887,3.14140290926741,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.666303867665051,0.210070117125051,1.30428301794628,2.9716376728414,0.00149819744315734
2,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.60781250007208,0.331383135754718,2.736111303421,10.029549666724,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57486116524502,NA,2.38987382878815,NA,1.26219109483414e-05
2,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",1.07175535625986,0.332306940582408,1.58234604191853,5.82132473258237,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.998166993645571,NA,1.34594362222224,NA,0.00612000170645163
2,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.32139368135472,0.176514359060754,2.6848665101425,5.3631665926932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26671980556263,NA,2.42276101590424,NA,4.86470077173823e-11
2,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.26770133912096,0.569166194415831,1.32611787842018,12.3461746494683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20895152756168,NA,1.00878379710588,NA,0.0518036028122501
2,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",0.181383885861232,0.308265827407254,0.664073223001864,2.22335424949675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0402428365922373,0.33223041052858,0.543471901849879,1.99879001729109,0.946784040315655
2,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.49674325489247,0.394464896650063,2.19932927153704,10.3235368411476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45534701184133,NA,1.86319226126174,NA,0.000707383284426354
2,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",1.03958755612405,0.524005064114819,1.10982352532367,8.65609003281285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.963536390827713,NA,0.868110143447208,NA,0.0935340342488374
2,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.992770963411499,0.35330039431555,1.40412971477662,5.60876071067283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.913165721802851,NA,1.18295538572299,NA,0.0185311575972909
2,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.71884704181414,0.210060367244017,1.3747524573407,3.13207333511189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.618469700213237,0.23113940756868,1.1915163022668,2.94844091744972,0.00789416867665914
2,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",0.746455685182285,0.364273702756423,1.06965620431395,4.46051383171342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.648142017615187,NA,0.886913838299188,NA,0.107898235813573
2,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.47966473838671,0.337378876626274,2.37403981913867,8.90928475390091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43699200499441,NA,2.06096782795365,NA,9.2630905391449e-05
2,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",0.643377473857248,0.287186752301193,1.1056296552636,3.4081389475971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.537276102995307,0.314462189747086,0.933906592962894,3.20364838129794,0.0928927676408478
2,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.159740373098758,0.986325012030788,0.191909091413568,9.16681135406164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0169558394141762,NA,0.127094625063718,NA,0.999136003677401
2,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.733245043911545,0.426994347853865,0.946704970038627,5.04813723450892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.63394264159948,NA,0.766090708745999,NA,0.180044274612505
2,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.16457734944936,0.849488098265152,0.772238405101063,21.5735967448021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09800614201837,NA,0.499944109854262,NA,0.237358010445168
2,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",1.48051719609528,0.81733102826663,1.16175797201823,28.6116251420478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43790844078158,NA,0.751594367448965,NA,0.10638512558809
2,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.52466913480556,0.109588355113992,3.72499433802694,5.72386221605013,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48540808184385,NA,3.30581224155676,NA,1.48314295240328e-35
2,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.13623225391959,0.276997785152517,1.86033261800996,5.51001124510785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06751174272407,NA,1.62006668600431,NA,0.000429252203559365
2,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",-0.222114131839154,0.667867914587131,0.215373477305126,2.95238247755242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.393846365755023,0.719735984461907,0.164946227238537,2.77091464410603,0.566407244196102
2,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",0.906697204079136,0.326706496013949,1.34789967092279,4.85113895288701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820550618995042,NA,1.14053741075158,NA,0.0224271510051777
2,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.490657561156576,0.198274244097711,1.11584512921229,2.42742939725107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.372973354211672,0.214806079451492,0.95576843834526,2.21839673646142,0.0961922910996192
2,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.481673842562271,0.57085106139778,0.563077872366855,5.27699970309685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.363297372890012,NA,0.431532347764139,NA,0.574059779618158
2,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.55466531496366,0.332290449920699,2.58887746438842,9.52365781079193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51768222479761,NA,2.25533013099371,NA,2.73239744933227e-05
2,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.572239027275602,0.37311520887912,0.879905560374263,3.79864357077331,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460755165056037,0.408456617385946,0.721762312125005,3.57892013547036,0.270161587479983
2,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.06532605937869,0.522314629585094,1.143635974208,8.86090020852378,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.991210443661903,NA,0.895669969869888,NA,0.0833183317096471
2,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.55577858354608,0.333138274201218,2.586656182484,9.54716289184475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51887985334201,NA,2.25404277430859,NA,2.822169927773e-05
2,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.52915661962033,0.124167675816602,1.33496521289624,2.17196780462736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414397743782022,0.135074634837527,1.164283174795,1.97701560227241,0.00301172718628395
2,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.451059839701197,0.188216848112983,1.09252110048439,2.28481360774424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.330372422840173,0.203664779924615,0.935540171973171,2.07865297274547,0.123046442625542
2,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.995880645692901,0.527575573318497,1.05329084090204,8.33095122932809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.916514039088681,NA,0.822025057545678,NA,0.113455992730998
2,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.79269656727055,0.261495517908134,3.71510296656054,10.3547980153879,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.77375174703854,NA,3.30476538973808,NA,4.35904135679279e-10
2,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.660613617312444,0.369645171938482,0.968722203180387,4.12557356383815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.55584148800801,0.409103845956505,0.799574626844995,3.97483087031977,0.1763364445321
2,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.893426227446725,0.887153570981951,0.526677397093836,17.0544476364289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.806289317526028,NA,0.344942595352065,NA,0.40891347139471
2,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.89386969182172,0.485941274130491,2.8727594273037,19.3004388226098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.88261514709389,NA,2.35106321268249,NA,0.000361917960891347
2,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",0.501003964608022,0.446345754923905,0.716213416977915,4.12005338407088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.384076730683263,0.488880606552374,0.57287160485078,3.89340112368364,0.445952939227564
2,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",1.33958409863582,0.564302271920745,1.4414869227485,13.1668120479974,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28628625655356,NA,1.10109908609632,NA,0.036715982866472
2,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.15808721786466,0.405611504569209,1.52592949845565,7.48253480991407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.091025257495,NA,1.26558564617942,NA,0.0139439376112775
2,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",-0.0568370233450067,0.452608535012185,0.398543450304426,2.34962115232603,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.216031555372971,0.487432018400004,0.310235330467874,2.09651043088371,0.630609554354735
2,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",35.0612215530763,NA,2.6194549922946,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",1.0505436771763,0.349815811538076,1.50020959419749,5.91125175274808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.975323285733648,NA,1.26801184494947,NA,0.0109767157325316
2,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",0.516906199758179,0.928546570781657,0.32262605907184,12.2873998529794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.40121123471385,NA,0.210823046690014,NA,0.701348938042168
2,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.15936510884608,0.30545821397242,4.99843418216216,16.5518668514986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.16822682202867,NA,4.26725507935177,NA,6.03713782019158e-11
2,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",0.682795860566312,1.38105787756926,0.189653059781762,42.5673924212884,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.579683960597409,NA,0.0970589024409387,NA,0.705458802360295
2,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.963595698597774,0.202722500504543,1.78465465287773,3.95065948982396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.881790151790872,NA,1.57329519992945,NA,7.49402246055467e-05
2,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.0835548430943126,0.448660860116688,0.461757515142421,2.68049872738281,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.065001628479997,0.483657131408266,0.363833003460559,2.42259872797076,0.863290494605081
2,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.5119066235925,0.374013139019076,0.827016040394274,3.5829030376529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.395840389671991,0.407477041087989,0.675126925699805,3.33484460275381,0.347868227470743
2,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",0.596370539820076,0.903197391132785,0.37752790580404,13.018324277028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.486702611639781,NA,0.242248021859388,NA,0.629632157223807
2,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.765860339868518,0.290475785658431,1.2457060550201,3.88975680693302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.669048618842813,0.323735027917651,1.05807006262249,3.76393345979114,0.037254094825338
2,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",35.3081181134025,NA,0.395843118073526,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.09608345199526,0.268571799829569,1.8145593817191,5.19982402261382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02431791783141,NA,1.57951577469126,NA,0.000496936743184977
2,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.631480529869253,0.908211516756891,0.38249917716393,13.4515581840466,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.524475649276692,NA,0.2489276030499,NA,0.60429039249052
2,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.967108757492359,0.350554196453853,1.37825329879309,5.44645082250588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.885554802667905,NA,1.15744234578659,NA,0.0214440705055793
2,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.57087239727409,0.190090923481702,3.36780224268793,7.09509078200538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53511784824328,NA,3.0327851545745,NA,1.1904628115684e-13
2,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.37780592529925,0.820743399172245,1.03892833311307,25.9311445559766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32740702821042,NA,0.668143203118089,NA,0.138127819024492
2,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",35.4612195749933,NA,1.09931102720935,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.39313421510231,0.452157165635905,0.63323631329593,3.72665823387857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.268082390203822,0.491448280953194,0.503893452254087,3.45924869164218,0.607380324628653
2,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",1.90494807244989,0.791382831172465,1.91213386131812,42.5373927062638,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.89454151431867,NA,1.25320040488273,NA,0.0275303975932544
2,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",0.577412476897558,0.437489581722925,0.790535673198102,4.39243240228303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.466282820242968,0.48334050873118,0.633672767193101,4.21410562741556,0.340964880595071
2,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",-0.00955478393749514,1.08162943451089,0.118895578113119,8.25153964505184,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.165175572496343,NA,0.0866464590303044,NA,0.874846019727654
2,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.5485295378102,0.530886060901588,5.26310729706078,42.1720091945592,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.5869309478788,NA,4.17094742319547,NA,6.8719993324351e-06
2,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.54614190245782,0.317958656854372,2.62926188914974,9.14381951575931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5085144715302,NA,2.30204446057638,NA,1.31880749386491e-05
2,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.369426861151127,0.0647187780214792,1.27536281885395,1.64365702076155,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.343475043382155,0.191201586589505,1.05131790104605,2.22451956840971,0.00355191223032845
2,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.26251166703297,0.0698507150347588,3.08783599605975,4.06039513265817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21691798843103,NA,2.15346989286538,NA,5.5625225396414e-24
2,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",1.05256054052991,1.29117512912475,0.366896304100207,57.8953737472669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01160310971879,NA,0.231001450511109,NA,0.424683688835126
2,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.426638702260405,0.0850725834347023,1.2985073948871,1.8124759637108,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.399411224614423,0.207210868719464,1.08602521876733,2.44678794794365,0.00205674654264654
2,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.42608864426917,0.0748642437538504,3.60266794374974,4.8314040038317,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37694217225125,NA,2.43341197713145,NA,6.14687303533031e-29
2,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",0.0671226360340779,0.153651152789613,0.79249877248545,1.44735409745782,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0477967803508461,0.211303282089485,0.731169082636504,1.67394497748048,0.792178555724934
2,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.277253258280762,0.169196307310091,0.950366182592837,1.8447235410107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.253341995861208,0.241082055503794,0.864039289872094,2.22306584714124,0.189836972094555
2,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.119535100457717,0.0771210333742371,0.969349186619894,1.31150918198462,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0990477021228516,0.167721172490847,0.84073635018586,1.62251554635218,0.428363575306709
2,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.775251718051005,0.0528008265999706,1.95915020125884,2.40966141376016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.740375105872221,0.259058018720663,1.47895974141199,4.08298254144661,3.68688784536759e-11
2,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",0.170024988157269,0.248205461732614,0.732543440697082,1.93811314938658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.148477622088503,0.29665420934682,0.692076466919321,2.21400768245321,0.572282870256777
2,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.0331023414158268,0.0863165145508471,0.817062697780432,1.14604292502639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0502314206158545,0.158722870392031,0.728981813782697,1.35808514351261,0.697835699737532
2,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.117341614378394,0.264691766269605,0.52930302523625,1.49388255602057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.132597181304491,0.294235806897536,0.513734680889613,1.62797162346846,0.631506363931527
2,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",-0.00129966680034977,0.0928505399037215,0.832881407236651,1.1985391175289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0191259826820129,0.165029492715412,0.744389212113589,1.42149975228144,0.88488508311693
2,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",0.658228657442397,1.38105111632862,0.185050537726142,41.5332612991817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.625945739276757,NA,0.132357081068673,NA,0.644157214170566
2,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.4043137772132,0.0993953350656845,9.15922908383117,13.522900314482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.33364433862492,NA,4.82208715509958,NA,2.52095120515587e-63
2,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.00111966316653258,0.0461330046345354,0.914577626050192,1.09586622545407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.016743958180649,0.143776517169632,0.777715851165888,1.36642732214853,0.875282760094843
2,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.778864561925045,0.221219373829529,1.43127706746693,3.40665581501363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.743922993022015,0.353048091721815,1.25246206256274,4.99798261151355,0.00178494813738022
2,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",-0.0804519161183697,0.0712807011134,0.802460727951637,1.06113899162673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0965185917211868,0.146988114945086,0.71001207263498,1.26327747892421,0.42429126311142
2,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.422657532706018,0.102215001458194,1.25131455408335,1.86800326014924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.395532215357104,0.214934036588922,1.06538630471909,2.47406711654568,0.00502090870268005
2,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.05374347404828,0.213785426786307,1.91538717236448,4.42797892264895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01274744631731,0.445070337142533,1.60342970448095,9.17780953267134,1.21753282738594e-05
2,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.202763742590479,0.105875163135405,0.996434763286962,1.50900637720429,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.180472499893697,0.191270469529311,0.877658129875774,1.85756841422345,0.209152292146086
2,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.143463286036745,0.161660927005494,0.630984566097518,1.18913400237421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.158131728976495,0.203514484635947,0.596016833376726,1.32349471839505,0.395767664214321
2,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.463966110141157,0.0554599807132741,1.42702677550559,1.77356603953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.435926085136876,0.201481132076027,1.14463225339926,2.52155288064487,0.000117124203440352
2,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.685731903931926,0.0613686748565871,1.76185836504146,2.24101732612575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.652823970516991,0.241815334582115,1.36949609343392,3.53368611222567,1.83635024817594e-08
2,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.30472698210464,0.109996679742042,2.98561496946077,4.59507375569216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25822429393957,NA,2.17533151454072,NA,8.31878842470488e-18
2,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",0.193057156250489,0.270688701777055,0.718717161230846,2.07672645941661,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.171000218115681,0.318298151581728,0.68066392958331,2.3703064172714,0.546197089599173
2,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.418887445008022,0.423172359074641,0.68456246427011,3.59602756839733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.391847836517488,0.482218271303842,0.64301643854645,4.25747345733947,0.357659231168365
2,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",-0.0148520839457228,0.0907468863434422,0.825038645825581,1.17750313292723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0323450176113502,0.162703825221561,0.737259607454087,1.39510833989446,0.805798095061282
2,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",-0.122240291719711,0.18560341142094,0.61495436402436,1.27295985688727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.137384410398103,0.224363375951276,0.585089235521428,1.40986981254415,0.505470374147118
2,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.686861329523871,0.0977065762724465,1.64507124301755,2.4127964637226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.653927905961989,0.255668363378613,1.3363091718994,3.64047086882965,2.08960922490061e-06
2,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.4159914428082,0.08977485765204,3.46659038199214,4.92873561429719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36701858260011,NA,2.39778319743436,NA,5.99531036340816e-25
2,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.373420954598934,0.0791167387959857,1.24526085522939,1.69804391013829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.347410372654804,0.197449216323119,1.04336298850478,2.26242182725373,0.00581586097844992
2,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.644960138052046,0.0755150113236122,1.64599133534899,2.21301589399995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.61295106896423,0.2385467885976,1.31285192310248,3.34440245711326,7.31751568353722e-07
2,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.47767346083127,0.0893586967393051,3.69139161984427,5.23979918609262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42734564756758,NA,2.51271997204955,NA,3.72235856753583e-27
2,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.79953913570012,0.0427055796736609,2.04692270459197,2.41993418091244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.764124726414306,0.262670556491186,1.51441038677126,4.24047732943339,1.2931267669981e-12
2,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.177737380641467,0.144604448326398,0.630327194867949,1.11106918779957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.191685723350607,0.188086836592546,0.592818737688575,1.23914330113234,0.266320079072386
2,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.194202160427804,0.153841601126825,0.60883086829173,1.11274866017499,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.207792118407806,0.194412854317072,0.575739424252643,1.23365866186787,0.248151924675454
2,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.0252024041830084,0.147297663009456,0.731179401487494,1.3025186314766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0424826940072838,0.199807786944892,0.678690524120958,1.48533761310557,0.806479756966828
2,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.520964575166111,0.131864982231512,1.30482480956263,2.18796090877291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.491681599830855,0.245286423448235,1.12305362353352,2.93749311776532,0.00253208615571215
2,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.54478345731267,0.0710314290548347,1.50175248312668,1.98391235835602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.514977553738398,0.21933625119502,1.21213601327491,2.86384867057853,2.14914385449587e-05
2,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.428966940264719,0.0423863752564082,1.41369350579648,1.66922145813294,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401680281081384,0.192756569755577,1.11938111834709,2.3830181837181,0.000189638024418567
2,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.57496158014136,0.0631206932277591,4.27569636256594,5.47600352838834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52253763398816,NA,2.73126122377842,NA,8.68469871988631e-39
2,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.541929798031764,0.0596289317299085,1.53080657833095,1.93389458459298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.512179766361277,0.215029856682306,1.21813055091191,2.82983639094448,8.6958252575658e-06
2,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.252290456104073,0.243099246915003,0.804632593143969,2.08665441592371,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.228939350505761,0.298710391794621,0.753253465626179,2.42921878829422,0.375018525145747
2,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.8851157696542,0.217987006571899,1.60311055953318,3.76760381141362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.847852404452435,0.377567484567499,1.38011128582855,6.06298031774078,0.00031348087672059
2,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.32471119248982,0.128925666433892,1.07727293125474,1.7857028833698,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.299739132279828,0.218249333405475,0.950500537162023,2.23614883096376,0.0620573629145635
2,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.414126213284834,0.143031769627791,1.14704050692146,2.00944665327575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.387190530612594,0.237858838998925,1.01016134761531,2.56638831059661,0.0241002868718384
2,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.843704322331663,0.0680551213067308,2.03728883636913,2.66017283333177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.807328014017808,0.280528678799933,1.55063948478025,4.65675861918261,1.43478776851211e-11
2,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.25452684782624,0.112594435322502,2.82548896154329,4.39313682010841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20912667685955,NA,2.08816705939089,NA,3.49217178903004e-16
2,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",0.86140118589774,0.240553305746039,1.50179725756721,3.85593759918485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.824638938107889,0.389063036018835,1.31009793856532,6.0206845971241,0.00124557093859554
2,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.08916356976358,0.216038776425097,5.4172395475296,12.6346472156411,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.02542219611196,NA,3.62950360603136,NA,4.12259360027375e-18
2,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.0860795483429839,0.113756719311352,0.734346109469829,1.14699252712695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.102040031159309,0.171569307694607,0.672942738627085,1.31843350225361,0.492172210315003
2,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.378472987612854,0.125235567969239,1.14503487054193,1.87076885125392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.352321243942707,0.222262199963533,1.0004544287547,2.39098673276841,0.0255587997927703
2,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.598135430526328,0.120151764046389,1.44159710455874,2.30882297443075,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.567156175047894,0.250695971443226,1.21479755214868,3.24555896435093,0.000228356246300034
2,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.00257547993042365,0.135463717713856,0.769384711990041,1.30845081960552,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0153380165281714,0.193097926190873,0.707805601550902,1.50884455805443,0.924514035872599
2,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.587447218860878,0.159485004413892,1.32367287227262,2.47336626005871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.556703191768533,0.272892909877146,1.15082097658121,3.35414243715582,0.00261686671732241
2,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.0556871133629027,0.0601085479682498,0.939974677645132,1.189721011602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0366302390377264,0.154052506644139,0.807170502426797,1.47647040180209,0.753191494393951
2,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.750066752130508,0.0786753952497746,1.81757908435495,2.47417578527849,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.715748538504845,0.261202948029942,1.42799805767966,3.975578393568,1.21432621495177e-08
2,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.24780995698272,0.146035224713054,2.63718634705255,4.67467729712578,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20257283103851,NA,2.02295202898573,NA,4.74834110242997e-12
2,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.116239787789327,0.0646004451055944,0.990020881015464,1.27532346878723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0958515653673962,0.161820946185521,0.84743855787372,1.59805859198671,0.416923434899972
2,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.43735267441771,0.0728059364990879,3.6578730002642,4.8660175830763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38795693069626,NA,2.4562946045941,NA,6.45936539534113e-30
2,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.172926901056862,0.0474739374386169,1.08338806252869,1.30497990321748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.151303560119183,0.161654523151879,0.900242949981311,1.69652743894911,0.168269638178681
2,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.372872930661478,0.0762286133813783,1.25157959138473,1.68744761496162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.346863504300991,0.196152390940872,1.04533223903551,2.25519853324495,0.00524112483536998
2,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.31511374355342,0.0670633770432428,3.27214619500682,4.2559998029529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2683677853762,NA,2.24457594266904,NA,1.54327523127603e-26
2,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.637902342325702,0.0978261127965087,1.56603629146879,2.29795382941503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.606044586493871,0.246433506086287,1.2828562530621,3.37059953694946,1.11097614520315e-05
2,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.949734850534966,0.09376150700391,2.15720481589447,3.11538166832542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.911029709090023,0.321919103025175,1.66145939447051,5.86848239808596,1.578118723359e-11
2,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.719932076919087,0.0810775029728615,1.75545699493885,2.4122192889853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.686276172963336,0.255551832680557,1.3909314128009,3.78754624387302,6.64716166259079e-08
2,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",0.124005283142423,0.249880053469189,0.696964786951915,1.85612581466226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.10346788210862,0.294838823314337,0.661188773257637,2.10019680573936,0.695942132428813
2,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.802394249353844,0.0572681354283775,1.99572595896232,2.49801105980397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.766923330241955,0.266776306332318,1.50845403583532,4.29232787390374,1.71807657208983e-11
2,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",-0.097700799934864,0.113998439479837,0.725484824022701,1.13422607546442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.113409203725544,0.170912394876367,0.66573862240944,1.30096478642588,0.445940110570415
2,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.55213342812724,0.0530003137918186,4.26085507390772,5.24474841528122,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50020023899267,NA,2.69417768393778,NA,6.1724444224736e-41
2,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",-0.0876581831248262,0.0651690463323093,0.806280215051483,1.04095028538183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.10356657202377,0.143490967083433,0.709543200529405,1.245255039125,0.37812193980795
2,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",0.875537300535716,0.39306998765101,1.16398724262263,5.43390173622542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.8384668292289,0.543062375590185,1.04087064838548,8.74798090361223,0.0347792099479662
2,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.86930554859555,0.359431564388601,3.4110106224996,13.9566271480732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81039276416393,NA,2.62432889270214,NA,7.2194077099268e-07
2,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.24341707312162,0.229823017554636,2.25449567298072,5.55010015780495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19825389202457,NA,1.84375250162323,NA,1.08528532433209e-06
2,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.98710172745877,1.17788215573226,1.33703277753523,135.323203897956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92561503216775,NA,0.710681007540829,NA,0.0959030738338928
2,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.46866378019809,0.0398438160236632,4.01985796852575,4.69938410960701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41855538716019,NA,2.5414865228626,NA,2.17479962180904e-40
2,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.453959320794759,0.165411386134635,0.457983735741816,0.875884638379177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.461817662278337,0.191957130138091,0.443828674696669,0.941897769234634,0.0148747469597492
2,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.0308972890791049,0.0829353058635848,0.824328512542714,1.14101050403125,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0480650147529026,0.157059544741969,0.733021759870663,1.35673653675449,0.705554956700803
2,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.714601698915521,0.0406650628581071,1.88762067017082,2.21382380424795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.681047066325056,0.242701503246994,1.4154536150607,3.66497849059366,1.91231754712813e-10
2,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.44102675800774,0.0375267613903315,3.92762223034346,4.55004177342112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39152574351896,NA,2.49106702654964,NA,1.6861535308223e-39
2,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.309243854235775,0.104380940540729,1.11203342473858,1.67423445976945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.284611994293049,0.201968654977761,0.96430424775984,2.12836516120419,0.045855400609174
2,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.723426790093092,0.0971307824349,1.70835900744346,2.4999705097786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.689689924369174,0.262858112391771,1.37803272554262,3.86144624260214,5.21082137739622e-07
2,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.40219915779009,0.0565035077140955,3.6426607613433,4.5458015614952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35355121547663,NA,2.40704375681193,NA,9.85318181992684e-33
2,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.411760258829464,0.0830377288570893,1.28430745770154,1.7784132701324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.384855896377652,0.20426857280581,1.07428772026716,2.39258877195065,0.00270919395843144
2,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.5947926894298,0.087689925491429,4.16337007912433,5.87122354809645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5418929783014,NA,2.74453226189251,NA,6.69160725632425e-32
2,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",1.00290327586961,1.29219427530538,0.348171562307992,55.1605793362614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.963029106089583,NA,0.219648445730251,NA,0.447622041519703
2,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.587183300763195,0.0568254495947018,1.61050895440768,2.01234743554608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.55643765898239,0.221904613810054,1.26644803268452,3.02244546258032,1.00906759080365e-06
2,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.51940293242974,0.104365389866012,3.74178544935587,5.63314387549452,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46816763100976,NA,2.57227968912991,NA,6.2451226173702e-25
2,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.86839370774388,0.19873825104358,4.47280141415863,9.74792610973446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80949893004623,NA,3.12566094500965,NA,1.13163223295193e-16
2,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.482631473655888,0.119544017537392,1.28520674347781,2.05345457449162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.454190524365958,0.232582235593814,1.10158447221833,2.74136283857589,0.00308049071136609
2,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.560625555110088,0.0442862131176373,1.60675460708535,1.91136020543222,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.530451598749568,0.21401741258658,1.24683915601978,2.88505659023193,9.74556830982995e-07
2,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.273065333832001,0.0602195985563013,1.16823412266153,1.47927159409567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.249231944311003,0.177405345133044,0.972148473601934,1.94871355344225,0.0310124955392626
2,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.807035474200942,0.396580497085176,1.07755192602473,5.10009269755728,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.771476409438879,0.523750474188515,0.970970571450087,7.56554974381407,0.0540989735742485
2,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.26908515988059,0.052247516191281,3.21456975734983,3.94520148000064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22336249372863,NA,2.17934931041904,NA,6.03933277423776e-28
2,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",1.1445363221457,0.108409542850916,2.55054124581078,3.90111804026809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10155399630931,NA,1.92073487558178,NA,3.36394170772566e-14
2,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",1.06737559626315,0.129607156952788,2.26848688358609,3.770334625727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02608580106688,0.391064714988726,1.77567056543935,8.22455053482162,1.86465862962484e-10
2,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.42109802766785,0.0491522369828179,3.76499183148043,4.56500185385081,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37203483208125,NA,2.44702542501173,NA,1.55174858469433e-35
2,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.576014087040684,0.123131243748192,1.40208136628935,2.27191577437562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.545521118812824,0.248712232982024,1.18846841460412,3.15062066499619,0.000476073477893584
2,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.631525687880563,0.0729088625917389,1.63217347832718,2.17213387856643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.599811429219946,0.235101455326028,1.3006887302946,3.26896913840959,9.28556996872789e-07
2,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.32416313715597,0.0352382042048022,3.50976255076251,4.02965034060541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34376103034231,0.035828018114674,3.57347819286214,4.11230071058272,1.97021168778227e-307
2,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.567153262945429,0.0679511451206852,1.54443836237411,2.01581568321173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.574080392333228,0.0690885053095538,1.55064257599496,2.03295698184874,1.07863512782999e-16
2,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.40199761225648,0.0231959907598673,3.88341986881771,4.25307728447306,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42289829192465,0.0235842431782912,3.96170316388114,4.34542061826678,0
2,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.3192847929509,0.0651541939279925,3.29730731548285,4.25674982610829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33880103284832,0.0662447389978228,3.35001133779387,4.34331697194349,1.06617313055842e-90
2,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.295940618901693,0.0719074743956412,1.16804750986537,1.54837451382665,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.298328215441972,0.0731110552699301,1.16769670492067,1.55522969825634,4.74853023064596e-05
2,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.577477099319479,0.117755336432801,1.41749959468114,2.24900277638028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.584577028315412,0.119726314720727,1.4189508541879,2.26876650326225,1.0892467202166e-06
2,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.751064213735466,0.0328017429520702,1.98770144954993,2.26043978685514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.761069627045362,0.033350775591896,2.00511879429591,2.28515977670644,5.49580362119673e-115
2,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.309612365392554,0.124284940654126,1.06954420018435,1.74093198185409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.312228798475089,0.126365210873377,1.06668694966152,1.75049754802934,0.0137613329667391
2,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.368352407890876,0.0208722988783505,1.38746653329545,1.50575939803347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.371952024940518,0.0212216575502703,1.39146665792482,1.51217000624788,1.93499874230773e-68
2,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.415372249448512,0.0364997227152493,1.41053070039832,1.62749545223668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419758881440841,0.037110651809331,1.41484974821732,1.63639298862494,1.54278808053526e-29
2,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.12432015879258,0.108119062121101,2.49902085842064,3.81796643542451,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14057309808332,0.109928749359283,2.5221626006928,3.88075408905117,3.50175433418558e-25
2,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.35544516791062,0.0182562269086151,3.742531777451,4.02017495453861,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37556665692951,0.0185617980015657,3.81593683722107,4.10393845947287,0
2,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.0067850777152531,0.0292334103642114,0.937900877503621,1.05177777662863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00945935535551934,0.029721326524282,0.934527260039897,1.05000085381991,0.726389188241193
2,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.670638926758014,0.0250633507291184,1.8619323701958,2.05414845853515,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.67929818808735,0.0254828588522037,1.87639559992549,2.07351176290864,3.95052063897198e-156
2,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.40089200943044,0.0533229304168725,3.65960158713228,4.51035710841959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42177418361741,0.0542154448563771,3.72666549363981,4.6091087239206,2.1970200297675e-151
2,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.382209331575587,0.0506946496293915,1.32723235563721,1.61901058625001,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.386040885933185,0.0515431721403289,1.32978613012931,1.62753019345922,7.92904586968112e-14
2,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.51673228903392,0.11855423040048,3.63238207217733,5.78120821681069,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53955338745881,0.120538580504077,3.68143311915264,5.90503079078781,2.58746485443434e-37
2,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",0.0203811381395892,0.0379419333136109,0.947416284902248,1.09934323895785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0181564448271313,0.0385764897661826,0.944168076254076,1.09830269036102,0.655323377997578
2,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.0248483237578389,0.0823017742440206,0.872328910496899,1.20445633578298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0226984018166131,0.0836793083689196,0.868220140280872,1.20527394658211,0.794814914958479
2,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.0107204861834986,0.05532251063143,0.906856272354559,1.12647011384522,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00833409376192532,0.056248377091938,0.903110402932627,1.12589594687581,0.895366536993341
2,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.741585317330702,0.0725635115745804,1.82293467969705,2.42272127547454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.751432074806671,0.0737780731406091,1.83460593403962,2.44986872383041,2.63502720606941e-24
2,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.39215598408391,0.0229572310348585,3.84717737510974,4.20944336712656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41289193546007,0.0233414871143625,3.92412525477312,4.30010916484201,0
2,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.00750009586428475,0.029678240871299,0.936408650334637,1.05193703611135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0101866447681633,0.0301736835842596,0.933020384356124,1.05016829893282,0.712291628646084
2,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.46346350786882,0.0658871246607658,3.80361492192873,4.92450958266559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48539299819954,0.0669899374596395,3.87325459196445,5.03639658432282,8.46797540296592e-109
2,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",0.133731528875133,0.33220063559168,0.597220205738046,2.19621007806368,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.133404084285555,0.337766103428709,0.589420543030856,2.21533457265412,0.694915358686117
2,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.392104812940707,0.0279479642543988,1.40129960815636,1.5635425377995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.39610199629114,0.0284157547803826,1.4055211233671,1.57113117294866,5.77895821277125e-44
2,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.688184318030507,0.0346669861259665,1.85977653209541,2.13048238303986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.697137253514902,0.0352472390391275,1.87396017909904,2.15161897971118,7.72198351022262e-87
2,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",1.49821110387182,0.265001850531307,2.73422286845901,7.72634114017471,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52072219635621,0.269437427811305,2.69833398977498,7.7586616453088,1.6946969936216e-08
2,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.117947604710262,0.0619232980163498,0.996619971467759,1.27042198139799,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117355970152989,0.062959682200845,0.993975641795193,1.27220910397068,0.0644420114743376
2,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.910863596035701,0.127555159840162,1.94429785614644,3.2056277952434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.923543718363995,0.129690166723456,1.95297853781358,3.24700091313648,1.12781372308946e-12
2,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.680787921375085,0.0200417860540861,1.89947446568624,2.05472004722841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.68961705444532,0.0203772436769709,1.91492487238837,2.07415889180206,2.21624122893318e-250
2,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",-0.24029244039938,0.368399668585675,0.376763207831067,1.59673637406657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.24689108539925,0.374568689927051,0.374925905946652,1.62784235167406,0.508220875184131
2,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.502665485010544,0.0569843035814573,1.47906415567977,1.84925697991688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.508513223677399,0.0579381017576516,1.48431981591013,1.8627796663989,1.94088568692292e-18
2,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.691511600278357,0.0417178546878026,1.84055956387368,2.16755677172503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.70052022785723,0.0424161244081757,1.85407543061553,2.18945861183853,4.09634280424946e-61
2,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",0.0658510051195718,0.0378741288601316,0.99163138394916,1.15034284900044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0643873823107673,0.0385075257089762,0.988976282595264,1.15011483993426,0.0994079977820699
2,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.770873277393364,0.0542015414774099,1.94497536727896,2.40539817397092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.781210253888122,0.055108762030537,1.96049906351923,2.433234501162,1.64790953378194e-45
2,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.386125029906574,0.0210035636818893,1.41199278125943,1.53316539428529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.390022123455474,0.0213551194523637,1.41646857976483,1.54014626389024,3.59579325632676e-74
2,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.0403179574478792,0.0595002724616485,0.926492724231983,1.16986422602361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0384269648370379,0.0604960923528421,0.922984331447449,1.16999245974989,0.535444369189031
2,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.6051834746968,0.0725605139148412,1.59014447180431,2.11331300958673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.612747150382446,0.0737750253062717,1.5970381505351,2.13260351951656,1.10497991606892e-16
2,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.656985706547576,0.0200570907760533,1.85473873790148,2.00644840236257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66541644039525,0.0203928045679811,1.86908176946365,2.02462723653935,6.90305034571333e-233
2,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.0264952466698804,0.0482911493695451,0.934067642506489,1.12872808026236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0243728907632762,0.0490992415298845,0.930661681082222,1.12818035485174,0.633130352960904
2,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0101160752273083,0.0685505454360857,0.865335131234452,1.13210053561702,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0128510590208328,0.0696978882319109,0.861175914998924,1.13173767922245,0.843185262650232
2,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.31605568579622,0.0184919375618264,3.59633747497025,3.86670615843018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33551787718693,0.0188014539586058,3.66441133551704,3.94468084467774,0
2,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.0247534193561147,0.0308166860056252,0.918341844732372,1.03625537206384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0277294976885784,0.0313313822548558,0.914717710265919,1.0342504763489,0.36017799179282
2,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.428233808145459,0.0617666188711323,1.36005434562719,1.73263843878828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.432835716146017,0.0628004630128225,1.36308303337333,1.74354842591429,6.09865571694465e-12
2,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.719855726448208,0.0585589147242144,1.83255972559336,2.30541447136468,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.729338775841003,0.0595390686009345,1.84530457599873,2.33038433815387,2.04552770863757e-34
2,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.390704132427018,0.0210722364566514,1.41828052975848,1.54040734687924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394677870575241,0.0214249416658901,1.42288394119813,1.54754527901852,1.98155638540716e-75
2,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",0.0128013808170241,0.0400021941598403,0.936464413044424,1.0954464115166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.010449818216308,0.040671333665754,0.933080575386577,1.09435481342069,0.815058378867507
2,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",-0.0124137530961939,0.0230912611090389,0.943943250966722,1.03337159557952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0151743010001479,0.023474260318563,0.940645244671156,1.03130831079939,0.492227223351178
2,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",-0.0943870784222052,0.0791220187790379,0.778923711019705,1.06216623907259,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0985326646735037,0.0804463294496938,0.773983589283672,1.06092292018955,0.216285201593287
2,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.45294967554118,0.0298212084106165,4.03432886674233,4.5346003267321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47470318628688,0.0303203531294433,4.11762436308045,4.63728926976482,0
2,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.569735477765217,0.221351866433654,1.1544005886362,2.74907532759682,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.576705828250636,0.22505683417959,1.14522661997206,2.76712567148177,0.0105176630237723
2,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.00518630339918457,0.133726515039673,0.765184908337005,1.29247701308262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00783893049666454,0.135964813697687,0.760084952136012,1.29517678999185,0.948538808519269
2,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.20626841408267,0.201205203723659,2.28219915035757,5.02210627966587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22389299594006,0.204572958440318,2.27717892930793,5.07765035813327,2.25762471962234e-09
2,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.107221349462166,0.0827175199689809,0.946609984988473,1.30915070053402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.106450179833161,0.0841020116042819,0.943285126109758,1.31165165205133,0.209627079911406
2,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.705477213281215,0.131937865934694,1.56861244209655,2.63103778811496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.714719596737069,0.134146230132783,1.5711342598486,2.65817919821515,1.03236341224055e-07
2,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.40702238307834,0.0348271922427799,1.4033745970049,1.60865728665143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.411269255707906,0.0354101266714298,1.40757263128385,1.61716049210455,4.74037226249105e-31
2,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.673690028983269,0.0479658259405505,1.78621242780789,2.15570970453166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.68240036089973,0.0487686736448116,1.79825278228473,2.17708147044828,2.26567508514976e-44
2,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",0.00531997811544315,0.0444759121359797,0.921364100266206,1.09684994202459,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00284319247540198,0.0452200744187344,0.917790624260271,1.09578767432729,0.966367129231626
2,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.34171003767013,0.0316550616904272,3.59667076878723,4.07183677132994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36160162930768,0.0321849012814107,3.66387152459907,4.15653949806137,0
2,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.3383036540353,0.0301649670345109,3.59483665324048,4.04605790738549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35813822992828,0.0306698655544348,3.66206207793933,4.12988706608582,0
2,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.476808882615825,0.076311855955307,1.3880792747094,1.87209467930679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.482223835926988,0.0775891569742061,1.39117940845693,1.8856937478523,5.53885816838753e-10
2,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.296108048367547,0.143067064168367,1.01722329859522,1.78227251746511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.298498447410574,0.145461707890904,1.01348890416625,1.79247645121245,0.0407920165069785
2,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.00806251503647352,0.0289220419372066,0.937271910688195,1.04979034741883,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0107579573120941,0.0294046884009319,0.933893766425542,1.0479875151666,0.690727254490216
2,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.30287101999972,0.0607720158238872,3.27094767384211,4.15080244587473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32211252763371,0.0617892123886031,3.32346494463623,4.2342963303981,1.96585099291472e-101
2,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.692870992298901,0.0264850524026014,1.89853190727383,2.10623165395961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701902372108492,0.0269283568411124,1.91386309553155,2.12693288455618,2.22136728103698e-149
2,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.37526845711512,0.0241380832428822,3.77407975675235,4.14862157124784,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3957217465755,0.0245421043210152,3.84825618219334,4.23686406017586,0
2,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.355894499016616,0.0761253285266028,1.23020733334448,1.65796098209434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.359285598231056,0.0773995074660537,1.23070275428543,1.66693372392637,3.65907582734723e-06
2,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.37888511286383,0.0380992673687802,3.68675193570932,4.28059586181628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39939893758461,0.0387369694979645,3.75645567232676,4.37244348475433,2.14887902289422e-285
2,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.46969407749023,0.0494190674655891,3.95018192352862,4.79455461731141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49172785453794,0.0502462393962213,4.02790759916864,4.90477232055919,1.88893765031517e-193
2,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.383106368579513,0.0272420711838786,1.39065680911875,1.54737990516086,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.386952936745462,0.0276980465347918,1.39468106667524,1.55463394130216,3.79623980869012e-44
2,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.422259391652088,0.0544548300162756,1.37141923207402,1.69775221670236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.426761300344983,0.0553662900901795,1.37471352754813,1.70792167208422,1.45934062251025e-14
2,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.667014046295786,0.0521156207055675,1.76003492510032,2.15895246011467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.6756126363033,0.0529879273033755,1.7713787659656,2.18030999325675,3.89448845239632e-37
2,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.414252317950698,0.0262072618396007,1.43756743287967,1.59310187587607,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.418620204061431,0.0266459166443095,1.44252516853174,1.60134714564506,2.23039010728777e-55
2,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0140852897857614,0.0229968140588123,0.969487558264081,1.06094308680042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0117552171080908,0.0233780847487388,0.966515602443435,1.05927273230351,0.643578972559919
2,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.679814949325697,0.0386414664061749,1.83007449194119,2.12937484562542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688627799294151,0.0392882438146979,1.84342316029881,2.15035155384026,1.34156194377069e-68
2,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.45293827953215,0.0699044171292037,3.73452913258028,4.91180760435628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47469159953247,0.0710744710100614,3.80147137650882,5.0228374491306,1.66188418161171e-95
2,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.41931866564294,0.0267876241559226,1.44323151772878,1.60302146815355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423771351864785,0.0272359930131646,1.44829903203065,1.61147984828694,2.35532133542734e-54
2,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.376902905528864,0.0408572641244648,1.34579371897358,1.57955237037632,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.38064564125168,0.0415411293568225,1.34881512764529,1.58734809444577,6.21300568370212e-20
2,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.761979303858028,0.0766690548921618,1.8458171049184,2.49293125108808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.772167414078104,0.0779523346749879,1.85778263640059,2.52174515219015,4.43678140652561e-23
2,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",0.824518549740906,0.289863907314988,1.31609727515385,4.09971059638922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.835753436497905,0.294715623471788,1.2944959982044,4.10984553136915,0.00461684333328214
2,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.37864571840945,0.0184800412383006,3.82871361876549,4.11636012273946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39915553616727,0.0187893585154809,3.90527838523835,4.20377109479781,0
2,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.675783106266916,0.0258191288038696,1.86878173873555,2.06782197445471,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.684528470517824,0.026251287072753,1.88339668373778,2.08752686626734,1.73164483377063e-149
2,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.513309367185315,0.0803738902328056,1.42845220097394,1.95746709971679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519335262346895,0.0817191812180894,1.43213825449519,1.97289481692559,2.2436818709015e-10
2,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.398720747194193,0.0442781169053234,1.36633229886005,1.62530749343993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.402828668042816,0.0450192400655227,1.36970115211596,1.63405516598821,4.37240166970334e-19
2,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.35644707652255,0.022825421753787,3.71315049039044,4.06069732660067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37658533539816,0.023207471621335,3.78520303268896,4.14569789171642,0
2,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.469581233069992,0.0346667015549304,1.49444936476449,1.71197691625819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474875210026974,0.0352469497048404,1.5004911052759,1.72281221093188,3.23956352072189e-41
2,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.575202446495059,0.221507387271095,1.16058996632507,2.76550005464114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.582264302613864,0.225214958110944,1.1512532089535,2.78341198896124,0.00984537522041217
2,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.673802030829113,0.0197736486571868,1.88723455546853,2.03933512947375,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.682514234632772,0.0201046182203097,1.90238793890529,2.05837855216443,6.32015674457336e-252
2,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.188376337313342,0.239320976470609,0.757169521210221,1.93470116300233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.188963532635303,0.243321469618104,0.749815941150091,1.94619292841315,0.439679245405869
2,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.40415747186249,0.0265303952717613,1.4222307118433,1.57810348684884,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.408356391398918,0.0269744586549413,1.42687597830985,1.58601623382781,1.5259931775185e-51
2,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.683440523637391,0.0252764964032466,1.88514425605379,2.08149501260889,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.692314056946188,0.025699572139565,1.90017088411221,2.10156917683355,2.06433584217128e-159
2,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.0543354808300181,0.0889714940222396,0.886793775963015,1.2568631182186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0526791122797987,0.0904606714432668,0.882831867031156,1.25857333861554,0.567328547397876
2,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0241922496308361,0.022844527383606,0.933338178307085,1.02077405952104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0271495350475069,0.023223286722356,0.929905103133852,1.01853047070636,0.226362551289908
2,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.3293353661105,0.0473657718365092,3.44621944646073,4.14933562630798,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34901983160243,0.048158575888572,3.50654336977968,4.23510832331221,1.99978429496667e-172
2,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.699505982992448,0.0255205711394954,1.91476017691671,2.11621937159895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.708648418514626,0.0259477321769236,1.93052463574107,2.13721811917379,8.50930490725629e-164
2,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.36106618001586,0.0435360689498674,3.58378295899316,4.25067243024706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38128175303257,0.0442647717775861,3.64925995347455,4.34071513201698,1.7650435152375e-213
2,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.00157259587113419,0.0296608428850226,0.942010018828445,1.05815729969816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00415989068864772,0.0301559840390048,0.938692991839907,1.05647984398319,0.865675645704705
2,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.35575625768892,0.0235176154624517,3.70560145476704,4.06345233115272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37588295370069,0.0239112512063776,3.77733132836591,4.14850548335933,0
2,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.692962142343019,0.0329194789238353,1.87508442741184,2.13335460453313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701995048493106,0.0334704822177879,1.88965469023727,2.15458038613462,2.05889287261397e-97
2,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.673871789188153,0.262883268876642,1.18094146848883,3.30949448210242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481286160560723,0.44167344838291,0.783699318221301,4.42645150607683,0.308948595316865
2,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.255963296848739,0.288855007017024,0.732511286874231,2.27280395456047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0160302065675601,0.423426679548055,0.48830373002972,2.56763287684824,0.975428308183629
2,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.807246865189823,0.256053803943649,1.37057498161892,3.73946597602876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.629735227543587,0.452784819419961,0.906142760338848,5.34587622372035,0.178544897328544
2,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-0.964910058389954,0.591318721293773,0.10683179837637,1.08483416834433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.3430110900797,0.684679854946963,0.0708908804828222,1.0379859349313,0.0751920919199307
2,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.302263337104711,0.246230518640437,0.838819895910928,2.20217748354494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0675927816995873,0.389919001497424,0.550679661753134,2.53920841449886,0.885003202035183
2,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.28091026830782,0.459834091660107,0.297421078125688,1.80382632391856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.581584458553768,0.56299426365066,0.197779632295997,1.79731722799631,0.356568889202884
2,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.964065735778902,0.217389867203535,1.73467727848486,4.06727812390708,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.80430386327705,0.446649855724088,1.11870978972659,6.44310978642807,0.0694382234602116
2,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.35692583353145,0.207014172987691,2.62986250753798,5.92044854055199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24162532066513,0.515038246165109,1.6585009803732,12.4887344858436,0.00445782227071731
2,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",0.92222383603428,0.827192294086468,0.449183290079532,11.4984236642349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.757726041894184,1.06168157600144,0.340711505516274,21.8673819826152,0.44578106717244
2,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.649138055256748,0.229408727632582,1.23243463151327,3.02907495041051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453729333162366,0.41217539676157,0.804331321658929,4.04691095469547,0.314262126037171
2,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-0.104577143081611,0.800918058667119,0.198256221455322,4.57838383784707,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.385297776479498,0.944901651695892,0.116835295509115,4.74435905923223,0.689116854791818
2,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.31403329577728,0.435684412803753,1.54946426982663,8.54854210400724,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19390161305723,0.695018826578216,1.12469316129472,17.14889929118,0.0506180491402418
2,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",-0.133226540237473,0.320874098193107,0.461590454930213,1.62373022419048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.417166339976993,0.427481377182274,0.305658202277235,1.63298302561443,0.416488088580933
2,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.65204896971397,0.390503122918072,2.42271027164743,11.1968330396338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57017037578941,0.743474610645926,1.70835010674715,31.4970841683754,0.00600479878109221
2,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.48980466178874,0.315483499707177,6.61669919704628,22.7888009564557,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.50273703940091,NA,4.21242600985172,NA,9.53179677289751e-07
2,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.383807051046514,0.278801527040009,0.853858677596305,2.54693919332534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.158346178967489,0.425325816977808,0.567322521158103,3.00542578267668,0.744619390112379
2,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.504964169679544,0.272802106426508,0.977310005130972,2.84741974861186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.293210679338507,0.431649818299614,0.649211313660541,3.52555961322161,0.541729780945908
2,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.22187206400545,0.239962522899291,2.1569100056762,5.52516134445983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09129001684932,0.507947579186961,1.3976235485877,10.2357986924513,0.0169691520072358
2,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.55678346811324,0.228907928354985,3.08426102370024,7.5656228794554,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46410884260587,0.581531101129829,1.95589769079997,19.113775264499,0.00113721006316553
2,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.901411802519032,0.355294466189742,1.254739370576,5.05135535014518,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.734585731573451,0.550634670421919,0.847971201744267,7.34147401067427,0.175809333143047
2,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.59378888823382,0.399026097615965,2.23815323491069,10.6953026195733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50531798495508,0.731772599624861,1.58981966003314,27.997534947562,0.0092970807558151
2,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",0.30952215243564,0.392580161694271,0.633825191667417,2.95324294646421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0756740855767653,0.526966622452736,0.426563469024405,3.36583842540903,0.896217043761172
2,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",30.0685910274345,NA,3.11967057053662,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",-0.195859944244381,0.408349830561738,0.364633882711784,1.80731159072733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0374185358234571,0.342361638991466,0.530673634634235,2.03079002756111,0.838246404762012
2,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",29.9723472448762,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",30.8782079990254,NA,1.90439093682659,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",29.9723472448762,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",-0.0132353525842911,1.64788550334315,0.039045346021666,24.9421934288542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.190529324642453,1.38157015905662,0.0806774027925051,18.1443415151461,0.871771097991028
2,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",0.378256874238788,0.457893274520153,0.602867495029936,3.62861417111521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518750512552488,0.383899383539702,0.791608792239541,3.56502109983697,0.151038795073752
2,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",-0.541753600159593,0.97678120387819,0.0764760265273725,3.51884916630952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.252577668928153,0.81892976539478,0.156037410948455,3.86702781445219,0.788102878583478
2,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.266636217503385,0.378502744768527,0.627609374904867,2.76728356080338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.425168433831423,0.317341496961739,0.821336173032309,2.84947003430277,0.14926178981345
2,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",0.799000273893075,0.341720298616962,1.16763201611886,4.45709289491973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.871493428189643,0.286496607332471,1.36338918580179,4.19133673235759,0.00160350375294009
2,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.55010557974046,0.312053777128248,2.65447283848239,9.02027128493664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50121788582729,0.261626200224554,2.68702525646594,7.49315988295559,4.56749815169369e-09
2,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",-0.448318377253984,0.57338462276838,0.195832825125256,1.8536052066841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.174248149673856,0.480722496201397,0.327442396500398,2.15535281691332,0.76805967156873
2,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.52189512499887,0.923632125742288,0.711175070198912,26.5687245249699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47756752192615,0.774366498412821,0.960628492388476,19.9912237808129,0.0511720264221832
2,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",0.254498664769395,0.468500462931585,0.518665665577185,3.25434906339392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414993342193044,0.392791707692495,0.701262551052329,3.27017099900294,0.254617817475884
2,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",1.13110703386504,0.480825469712881,1.29853770721584,8.55092956190714,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14993461856449,0.403120374580346,1.43308743866193,6.9589875451631,0.00335557577877485
2,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",-2,NA,NA,0.79916316010998,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.824014398293732,0.741922169072513,0.0917634859787758,1.68159146351919,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.489222820066252,0.622029341879983,0.181156861575535,2.07491093595893,0.462764568459127
2,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-0.929845093046365,0.690235877950534,0.0876053066221965,1.31096199920166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.577950095900538,0.578696915983879,0.180469986675084,1.74413622437335,0.345878542146177
2,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",31.7388073933645,NA,0.588265589461196,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",0.937525722651928,0.411230533851454,1.18454697606955,5.93789369804024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.987633174501626,0.344772894553471,1.36600875609309,5.27710727759073,0.00308849362754496
2,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-0.680318138824938,1.38119168464254,0.0235457405560427,5.28758474836882,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.368747332441058,1.15797930787901,0.0714792996854658,6.69156709084338,0.771509809043971
2,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",0.249782596824671,1.34163370299899,0.0581164628169259,11.1763638133506,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.411040846768696,1.12481683997628,0.166365522747746,13.6758707931791,0.693361926489694
2,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-0.162106200805112,0.62379783614382,0.244934707127596,2.82491698825041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0657173888894274,0.522988394415887,0.383151374179008,2.97651067411059,0.851078875463233
2,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.78503981723539,0.835743897841747,1.15659596545942,30.6164381326039,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69818534227385,0.700679979079113,1.38386044664547,21.5740686092315,0.0135125884594863
2,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.3801967297961,0.702200492462018,2.9662640759176,46.5198277259482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.19715922664665,0.588718113218921,2.83854811825966,28.5319722949503,0.000152317644406036
2,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-0.162106200805112,0.62379783614382,0.244934707127596,2.82491698825041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0657173888894274,0.522988394415887,0.383151374179008,2.97651067411059,0.851078875463233
2,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",0.0185047016297314,0.59314261796226,0.318537385391615,3.25782862175384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.217139408502347,0.497287952009436,0.468822058163177,3.29300645080799,0.615707401719303
2,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",0.0631087798121209,0.398109545471613,0.488183247972478,2.32447988021284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.254534188444459,0.33377739216459,0.670541445051903,2.4811286785912,0.38985300790728
2,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",-0.377948449925758,0.703200890876644,0.148763626996349,2.34222237446575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.249209055373393,0.645651950715538,0.219800777985739,2.76178011878346,0.710778966159792
3,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",1.25276296849537,0.847943204841861,0.845802191258419,23.486047505497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24760830956224,0.778326290498827,0.757376889512763,16.0080019371789,0.106176042111253
3,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.405465108108165,0.66751496853421,0.428527074234255,5.86621273543376,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469874951991141,0.612731577007872,0.48137936157305,5.31622795054488,0.433632219827555
3,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",0.916290731874153,0.887143248607077,0.538867977559545,17.4484872636249,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.938757208852447,0.814317173053694,0.518249270734178,12.6134755116617,0.244036304660537
3,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",0.405465108108164,0.975645765854495,0.248615924408062,11.3886253375164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469877755783182,0.89561085220198,0.27647689900004,9.25442688801023,0.592162080805668
3,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",0.405465108108164,0.975645765854495,0.248615924408062,11.3886253375164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469877755783182,0.89561085220198,0.27647689900004,9.25442688801023,0.592162080805668
3,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.28247467873077,0.596186343660095,1.2559391681991,12.9992434187131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27488031405633,0.547239467837666,1.22421762328355,10.4587741829605,0.0188897754110151
3,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.779824116807357,0.555663136030517,0.754608992625809,6.66322708081373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.813488359993647,0.510045780237355,0.830121586004858,6.12978465539955,0.106458756699161
3,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.405465108108162,0.667514968534216,0.428527074234252,5.86621273543386,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469874951991138,0.612731577007877,0.481379361573043,5.31622795054492,0.433632219827562
3,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-1.66362576052919,1.20696618070363,0.00996935859716426,1.13086345354125,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.4293221629802,1.156262698183,0.0225863730716951,2.1002533372182,0.200104258002626
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",-0.401851238881105,0.761121653859349,0.136444169485085,2.69581965171491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.271149246178858,0.698875218945022,0.193707915631145,2.99857349421163,0.708406937350205
3,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.870453575654532,0.476063995546921,0.936526480542787,6.05303070623597,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.896669877215698,0.436980594613538,1.04103299868428,5.77273483399646,0.0380231580459092
3,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",1.24119934408252,0.676680771262169,0.98946038459458,14.0404764174277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23699408833115,0.62112355734657,1.01980119307243,11.6390672303636,0.0447035564095132
3,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.377948449925759,0.703200890876641,0.14876362699635,2.34222237446575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.249209055373393,0.645651950715536,0.21980077798574,2.76178011878345,0.710778966159791
3,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",1.24119934408252,0.676680771262169,0.98946038459458,14.0404764174277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23699408833115,0.62112355734657,1.01980119307243,11.6390672303636,0.0447035564095132
3,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.106693271972596,0.696818976023091,0.220293595361084,3.3827402150365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.000226002373564829,0.639696832457227,0.285307289209752,3.50214988743792,0.98797662782334
3,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.71111131324643,0.614199699943358,1.82597986223406,20.2820312947724,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66832225331303,0.563774830449443,1.75651803405921,16.0112273551764,0.00291347447611293
3,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.22406375597513,0.423956703698753,1.50835818284998,7.94785041197188,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22126521994103,0.389155163707009,1.58172866832623,7.27161602296652,0.00155801236730641
3,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",-0.776510943038977,1.25486602232017,0.0229243987677764,3.1375145161433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.615064477700505,1.15613420346266,0.0556062346163383,5.16808828600001,0.59929963611353
3,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",0.0441279169249357,1.24266326054204,0.0527887478255866,6.88739721394274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.138211139566449,1.14115305454036,0.122526206506415,10.7381995383866,0.896709224372117
3,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",1.83855840879494,0.348692947216933,3.25108465302498,12.7539358294166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.78530337416742,0.320063153583545,3.18353504870865,11.1631339509431,2.03758882763109e-08
3,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-1.02661570739973,0.860775154253895,0.0525288008882436,1.53385309255282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.844631203387586,0.791786660598691,0.0907368831785306,2.02173352112687,0.290733559066324
3,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",-1.02661570739973,0.860775154253893,0.0525288008882441,1.53385309255282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.844631203387587,0.791786660598689,0.090736883178531,2.02173352112686,0.290733559066322
3,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.718691309041752,0.536539647481719,0.728331166521286,5.96671983797294,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.757375036227599,0.492493163193558,0.812292159207645,5.59930522695681,0.119253270686392
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",0,0.735701046765198,0.236466777868103,4.22892386412851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0977060064264919,0.675375194208579,0.293416540894865,4.14233680868809,0.873435978971136
3,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",0.627269988599009,0.458435550602424,0.753009979815309,4.54195501298651,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.673457235690075,0.420802082485668,0.859591425524704,4.47369980597632,0.104393327114485
3,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",-0.35130455023933,0.623259095520959,0.187897333884189,2.16251349191088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.224752814514246,0.572217867611314,0.26013948934047,2.45104761051098,0.707197663531693
3,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.1945108645303,0.463868398769419,1.3909339463899,8.57032912082519,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19413895982399,0.425788350279196,1.43274988534042,7.60385425525345,0.00468773430797922
3,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.62629417471739,0.617942241449888,1.67012175461272,18.8249968482118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59046932888771,0.567209758454153,1.61405356949157,14.9120581325852,0.00478090021933549
3,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",0.458660690457645,0.460263004795983,0.635860825577649,3.86291568960108,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518695806828616,0.422483511351308,0.733911779710941,3.84486496959652,0.210883796433313
3,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.295061313549095,0.256874079994023,0.810428681195673,2.21828850626907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.280000173413103,0.350728703396061,0.688205544293615,2.72144645687156,0.456265685456159
3,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",-0.243637362969958,0.141681663594404,0.591693786145429,1.03108937068755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.324195493804062,0.234307294563358,0.468589726596349,1.17402737700567,0.167031483809927
3,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.384637863158773,0.226104211362881,0.944977822468637,2.29267303720581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.380468152026082,0.325445554960877,0.800815668544233,2.86795332513732,0.260283394252624
3,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.549306144334055,0.814875228989623,0.371344507083911,9.05780796851765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565157933645784,0.945995271619306,0.287515219290061,11.7253579230587,0.560612539223351
3,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.410238748857075,0.0400410347852843,1.39347146167914,1.63028697938989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409182129762882,0.207749124265974,1.03814371661907,2.34385224246949,0.0507346832331534
3,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",2.03431743626165,0.522952482472202,3.02518225547011,23.4978141505255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.23075368716449,0.673788621426481,2.70976886877943,38.0182461131601,0.000347154277619045
3,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.971491719794917,0.171520881530592,1.89588195250575,3.71371840932887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03867493985953,0.304677912046395,1.63088467958444,5.38403495543524,0.000191459859122911
3,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.307731335872744,0.105233061428453,1.10618096930588,1.67099546477448,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.294197177078744,0.230512536262286,0.883454595548906,2.18076810831463,0.228553021009717
3,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.65455209888874,0.162498083419017,0.375198509432576,0.709411693968779,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.785073598924969,0.239394171163607,0.291222587909687,0.744338413941021,0.00239413843240902
3,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.361545119780786,0.0816977919566324,1.22311469773965,1.68480544787262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.354562845999412,0.22049714482783,0.957903502975094,2.2735095422677,0.119460790145345
3,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.19038067945249,0.0344338206585811,3.07451274712429,3.51881585845345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28418146587345,0.251408270876937,2.32686969064025,6.23404996702066,1.4882412740893e-10
3,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.621248164113483,0.0769117678420122,1.60144858417654,2.16494980120573,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645844179246539,0.231156591437385,1.26154075184238,3.12192869049799,0.00317943795777008
3,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.115177512976427,0.110899789664089,0.901747767188558,1.39277582469631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0782345186803224,0.225813713229878,0.716167292111936,1.73556324773595,0.805115622732631
3,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.594477186350449,0.126696901319392,1.41553134194483,2.32599451126566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.61582007619975,0.256472774575916,1.16440766629681,3.18218261774737,0.0132348395915866
3,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.54324798352512,0.0855824061388315,3.96415911042224,5.544301380667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67994533994177,0.28934341776019,3.24385095824725,10.0841667705633,1.52572183555509e-14
3,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",1.25663451589447,0.571974640042251,1.23727732900879,11.6465809030732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35849049588359,0.697237701146131,1.05127575781342,16.1694878446634,0.0459935861010229
3,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.158311013257807,0.138907421569477,0.891794217995338,1.537237872283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126621836369583,0.246411338398386,0.722439858556229,1.89798651264295,0.672064005968826
3,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",0.748773413795116,0.0498803310319208,1.91825420809564,2.33250503066873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.78886818834461,0.228433034937165,1.4672485281478,3.59243390241679,0.000136822333619875
3,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",-0.0165745591856596,0.0905519094850758,0.822949222771149,1.17362375022231,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0695267896968484,0.208419450380384,0.637922060708588,1.44404769232033,0.676600624506905
3,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.23629803981815,0.0683869360480659,3.01398888284749,3.94061292143692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33569176990177,0.263069128190322,2.39763492795569,6.72407815112152,2.61285327450868e-10
3,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.950814691996934,0.0946991071911112,2.15182212443263,3.11905060384701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01547214814668,0.256799478476479,1.74908901845185,4.78617019390807,6.5708031043444e-06
3,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",0.944675420128761,0.175947664302848,1.83137488046103,3.65015326075782,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00858627036049,0.306644038244214,1.57545822314433,5.24129553542401,0.00035219657999673
3,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.421321034989084,0.142628756304419,1.15280910750512,2.01636445886877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421610938805379,0.259530864075941,0.949989927725962,2.62751464132305,0.11078610179823
3,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",-0.085474026503329,0.134898565893084,0.703111087483904,1.19309680137335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.146803723880067,0.234561770096072,0.560462823618658,1.4056121153987,0.492798396679998
3,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.01425175032919,0.203817553873913,1.86356730472974,4.14309331626482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08663675256771,0.331177790969662,1.6263093277972,5.95663853093724,0.000373591862033688
3,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.713661490950899,0.134635432712023,1.57065856425749,2.66247514932528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.749496501030369,0.267106152497614,1.30675040239578,3.72318812625029,0.00299664930028523
3,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.38700792600707,0.0456695052259167,3.66246480977217,4.38047662478804,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50471419600476,0.266585747314318,2.83222125322687,8.05310898328559,1.18704146656543e-13
3,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.724241558067494,0.114467555556246,1.65098157882133,2.58590250838278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.761363228338588,0.255286311024239,1.35360164604639,3.68206183535053,0.00142958018376675
3,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.0350221528596409,0.0887011955694187,0.869794866698202,1.23146487600929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0116862751775402,0.209540101884896,0.674959690605598,1.53461540400379,0.878625537155418
3,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",-0.0110382689301828,0.315171298033411,0.529830439457838,1.82257536582878,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0633379500823415,0.399599092290736,0.441529580619072,2.1146501759517,0.833180041131976
3,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.558753585421358,0.0783130520881975,1.50020670554072,2.03925475621749,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.575750508376456,0.228574402955676,1.18062816936591,2.89227051476256,0.00903608391802168
3,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",0.749542048547876,0.225113636669919,1.36571266399967,3.30060449223774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.789745973672086,0.33764037076819,1.18596547089057,4.45524974616298,0.015691105236056
3,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.180907628264578,0.137944893452079,0.913800808437004,1.5692399296273,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.151965849616649,0.246590012520023,0.740990054546495,1.94808533656478,0.598300193007056
3,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.21044259225895,0.0878880091713552,2.82774218023942,3.99080610712985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30666581568437,0.268854136134573,2.30123359279113,6.60174608041804,3.14884979604259e-09
3,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.0558439155516889,0.135964283008152,0.808854615666183,1.37827691818038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0116957578544014,0.240439029543895,0.650548859158455,1.6695678209332,0.968113193102326
3,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.19988274226145,0.424386470762407,1.51822665088692,8.01333775793263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29485488756224,0.542407886486338,1.33207502807542,11.1667179512682,0.0131915189818144
3,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.25791408004102,0.111809353293485,1.03886396006524,1.61028693110852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.238327986015207,0.232299823632219,0.831821352819754,2.06774986537555,0.346691264443543
3,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.544588981574851,0.126433353400959,1.34683881297997,2.21083409920005,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.559865842590005,0.254027158102505,1.1052342737436,2.99165123324147,0.0247187608004822
3,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.396271796746993,0.124472635306902,1.1646050893334,1.89706094022589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.393514209577568,0.246211296538133,0.947640040122541,2.48767861937883,0.118707288887131
3,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.0698786464748042,0.273688300240268,0.621673380632034,1.81756553443351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0274381784025696,0.360562101896286,0.522498698723449,2.14737181377325,0.98702269566438
3,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.54315702336111,0.109240541878854,3.79069025630235,5.81687504476352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67984750146862,0.299479563683819,3.17991891763911,10.2861056312682,4.26317179735334e-13
3,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.247762045421647,0.0838591989154511,1.08680518739405,1.50978067350372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.226945194989382,0.216288868754154,0.848448939094157,1.98078139750955,0.339229443539419
3,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.843351705085554,0.0861262353182018,1.9649838464276,2.75410537839745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.894955573602092,0.246941169115576,1.57668207254353,4.15085476494453,5.28921535878655e-05
3,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.21645710666669,0.0691578446740465,2.95038163753251,3.86912467875461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3134384876394,0.262082727111361,2.34809129697767,6.55972181820937,5.51936967558666e-10
3,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",1.39269919761164,0.569661059257404,1.42732736854317,13.3142387010723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51109796134227,0.69876194514028,1.22617187834414,18.9725560122894,0.0256480187257707
3,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",0.549306144334055,0.814875228989623,0.371344507083911,9.05780796851765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565157933645784,0.945995271619306,0.287515219290061,11.7253579230587,0.560612539223351
3,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.138398662444961,0.25704918972436,0.522656096658349,1.43158571004853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.206162379346311,0.339292954723624,0.429928351458609,1.62558415996765,0.511802312883193
3,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.393596813215401,0.49097656087893,0.57592049646243,3.94641313137934,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.390517303323738,0.590740115475845,0.481551712430596,4.87888663958966,0.527228475619332
3,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.990602887397352,0.155483686387481,1.99055818430978,3.66159902851116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06010760607966,0.294353611593818,1.70102148244626,5.39284943584798,6.61508467055307e-05
3,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.52867411297894,0.141274357199497,3.51274675096719,6.11156932584578,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66360463794842,0.315448304812491,3.03102605874176,10.4378208338758,5.01534003091496e-11
3,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.0170905592362755,0.187455441789686,0.702699413789418,1.46519124149258,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0317918701353595,0.279921299671709,0.576197753596593,1.7262768451078,0.851926380041591
3,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",0.645162591607755,0.112941138554858,1.5289916387953,2.38054531740681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.672669196811714,0.250537111466355,1.24820423888142,3.33273517271245,0.00483545620961867
3,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.821387966637529,0.12186646495763,1.79409880126443,2.89275865799847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.870321208194036,0.264454243429402,1.48576289791756,4.18945210003852,0.000336185127203007
3,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.159917562197107,0.121464638848812,0.669931852244441,1.07848076339021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.230298569551821,0.222325469315262,0.527525534291053,1.26104635503606,0.286851155537306
3,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.439136563685535,0.093403482935102,1.29215490433141,1.86348095213934,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.441591732352649,0.229975685878695,1.02721602148891,2.53030632974378,0.0560292099132847
3,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.558292641242393,0.173957115751858,1.24249737908157,2.45720059647041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.575242135494931,0.288304422545124,1.04981029474441,3.25028292278861,0.0437780409856057
3,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",0.922476578647092,0.456916677849877,1.06618607055207,6.39277422883897,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.983700364255597,0.56738841593986,0.922626964020958,8.53001771945993,0.0789648057519138
3,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",0.945093578073578,0.0891966087565064,2.16233644581568,3.06741015049764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00904893923498,0.253933872380974,1.74742818783751,4.72821422388158,5.68384693900742e-06
3,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",-0.0559853941670725,0.162696810098385,0.685388271636004,1.29691711093182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.11372794018909,0.257001784109339,0.554634327569081,1.51889368342677,0.610817077511906
3,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.49529312437595,0.167773130905151,1.18295877975079,2.28342687256969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.504577936104234,0.281016505205526,0.991027775989861,2.98187334338753,0.073332097504828
3,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.690840080169878,0.121860083635289,1.57399990551397,2.53781338982772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.723899602738967,0.258018229675766,1.29595763691194,3.56321342383073,0.00300537092332483
3,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",1.05347359623456,0.59129733622513,0.964182415234056,9.79006593506349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13062917473188,0.712434258929312,0.807918992837015,13.1891892237721,0.108369879732871
3,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.48459691537502,0.107664240729572,3.58538059470172,5.46793318777639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61416667628863,0.294915562366558,2.99869723495466,9.52791299757703,2.77511719267768e-12
3,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.559336043128707,0.103065591231122,1.42992915649657,2.14177429612361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.576406927606935,0.240842535816817,1.15336674692037,2.96468463311169,0.0137423591070713
3,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.530047158052489,0.336424181455428,0.295426234836606,1.10453281836699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.64542777770064,0.41128205972786,0.239488784755537,1.20075119663759,0.115661106412998
3,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",-2,NA,NA,1.15366687395321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.454443299063576,0.0526887749657376,1.42107723676876,1.74708975083859,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.458782006214294,0.213568292679575,1.0794392563789,2.49331717586255,0.0305081293419161
3,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.50262767287099,0.706880558017146,1.3089393039622,20.9081281021093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63439149692764,0.84867714327285,1.03979633934031,28.9560202872329,0.0481061631517588
3,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.654379815762846,0.182501213783611,1.34882058827435,2.75832106428596,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.683008818534501,0.298869640976909,1.14757369709981,3.7032001443574,0.018788793338903
3,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.52039906592683,0.15681724403668,3.38527845260027,6.25980143307648,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65432247023128,0.324320047252906,2.95060414716477,10.5204519687233,4.14924078760749e-10
3,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.46334293351849,0.243032509816997,2.72662693938817,7.069114500153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59033018764144,0.384172868757251,2.45765164701963,11.0799398452991,2.66657607248604e-06
3,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.523087778356249,0.103406443427157,1.37761834445726,2.06618101002806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.535751291440594,0.239301026467762,1.10997837626228,2.83596798826454,0.0225245273740228
3,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.132346777813445,0.237076096684322,0.716535375502805,1.81483319862436,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0975019065263904,0.327594944860035,0.598358528449187,2.16102668975883,0.817243958218319
3,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.14574903747948,0.101018944057977,0.948567690388892,1.40942928182832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.112509669512286,0.221098273539191,0.748384152125996,1.78042205523719,0.684610680501864
3,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.64427255146696,0.0380726792485983,1.76786194125045,2.05240655495976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.6716845697856,0.219692423934436,1.32455336662637,3.13382341681056,0.00102077307762734
3,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.179620397895964,0.0422826645177798,1.10150317159269,1.30007345386755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.150523808865748,0.196925121900265,0.815484940581412,1.76466340986775,0.516872441177471
3,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.393596813215401,0.490976560878929,0.57592049646243,3.94641313137933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.390517303323738,0.590740115475845,0.481551712430597,4.87888663958965,0.527228475619331
3,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.259285643183265,0.256723232231877,0.780544652629822,2.13522760586999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.239874648208042,0.349552519796697,0.662269327329929,2.60683732083935,0.528953596083971
3,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.47718027376465,0.143663566130414,3.32406457021385,5.83771313263473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60584684374672,0.313683166942813,2.8660076859716,9.80149995608291,3.04709548132005e-10
3,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.0703689897583748,0.121874952869177,0.732309017731115,1.18079546914351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.129861967905438,0.225854037222809,0.579963011555941,1.40570732010213,0.522448741336142
3,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.164125396937447,0.206909781176525,0.784248606878244,1.76480857784097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.13314511024683,0.301381296160497,0.653046021486088,2.12821861112728,0.711716518105239
3,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.471706039553273,0.190133238980057,1.10543265768853,2.329247851819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.478122822438895,0.297789460493092,0.933569497986941,2.99988323170932,0.112629940923545
3,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.0900690495045836,0.0567355950270951,0.979035741277802,1.22288438293608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0500835330772029,0.19737835411074,0.735870349450201,1.59521352597421,0.888429043308226
3,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.549306144334055,0.814875228989623,0.371344507083911,9.05780796851765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565157933645784,0.945995271619306,0.287515219290061,11.7253579230587,0.560612539223351
3,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.42501169085063,0.117689726228262,3.31288778332242,5.2548712346897,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54733725940498,0.296085529873876,2.79315211584327,8.91561914330781,7.05926487567565e-11
3,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.446790903537736,0.247527381067779,0.962946162744058,2.540933999161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450176364554293,0.346763741756157,0.82447939466916,3.21004758613518,0.205098895274159
3,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.933620506065739,0.222949272749249,1.65430677097312,3.96429146398984,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.996199715414844,0.343229566198009,1.44819922466152,5.56087820843248,0.00204230946800466
3,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.58929221153378,0.200626016856071,3.34322440640401,7.34026736150683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7315932152825,0.358086359909682,2.99103529438888,12.1738756707307,8.1613603702241e-09
3,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.414581789022816,0.286757850313168,0.866424774525001,2.6662956947895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414022690009229,0.382541142769699,0.741032785393496,3.31953035968982,0.295523482513295
3,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.394857375104901,0.106914907663395,1.20309715058302,1.82941808056173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.391920144184687,0.235365653447959,0.966417212997841,2.43137457808242,0.103418350900262
3,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",-2,NA,NA,1.15366687395321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",-21.0257808475093,NA,NA,0.896947602987581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.2446040703817,0.733079041794377,0.933579189907286,16.525217558361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34499570829088,0.870256383719991,0.740145661549279,22.4307787395923,0.117132175187331
3,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.356761948971414,0.196420713665502,0.972788661383824,2.10090168359601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.349203214684561,0.298816660929593,0.817278864836316,2.63679686627007,0.263533215509034
3,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.36951029249766,0.102460791223854,3.22549450776221,4.81976511470309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48508503017625,0.28515251912259,2.67668425665401,8.18543328616104,7.56422377946941e-11
3,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.748760511057389,0.166247302679573,1.52808901321337,2.93203111250184,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.788863082624533,0.290573422552153,1.2992061780664,4.05836560342915,0.00427262958539397
3,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.579474686129289,0.274390974141947,1.05087519976622,3.08088284706701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.59900830609105,0.375864408827013,0.906176855910314,3.95444642074456,0.112056674050577
3,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.173325039112433,0.227658831930102,0.534455576781075,1.30460401636271,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.245333477346174,0.310515236228209,0.437155105798031,1.47658227793749,0.404633322300546
3,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.609872936810381,0.162669972232194,1.34083337367111,2.53690774257073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.633087826201649,0.281905018177162,1.12752603958559,3.40441545553505,0.021393064430585
3,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.50401383772135,0.0768393811654998,3.87691843403566,5.23960157115191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63593475849281,0.283475360114146,3.13596045539577,9.52708205120217,2.36208913812984e-14
3,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.589562878076873,0.0462995463487464,1.6470482254705,1.97481676779806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.634996420151271,0.0516405176509972,1.70696722229193,2.08996088641561,1.42839997772196e-30
3,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.617850165365099,0.102020965226699,1.51983712031208,2.26713746354534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66579313958666,0.111941764042439,1.56452285615961,2.42634144596835,6.65534752284019e-09
3,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.552389550040824,0.0945752811677472,1.44418571113799,2.0923209053043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.594508246904324,0.103632995723799,1.48031267586436,2.22217670086095,2.69066630272029e-08
3,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.36718098414293,0.0486031455029594,1.31253598412695,1.58801047798073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.392827707700632,0.0533628308821718,1.33453620429933,1.64503600623239,1.55655104866164e-11
3,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",0.0531865823792507,0.0919658223283001,0.880037560082347,1.26201381205498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0508891714573207,0.100211226687099,0.864659848197471,1.28069346638424,0.696087993603038
3,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",0.220413206019243,0.163427765594748,0.903527733719009,1.71459447636696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.233008220271902,0.178106184471311,0.89061068338843,1.79017883651365,0.215145849334229
3,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",-0.0045737566506442,0.0695318219820254,0.86820123730058,1.14022770392255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0120016960548576,0.0757807097888677,0.851742597613841,1.14635117931503,0.769126828493273
3,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.274103764982646,0.11073354802596,1.05837807204534,1.63363100467612,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.291462228020405,0.120759708202401,1.05657605102856,1.69622110458161,0.0217818590704121
3,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.606071977892224,0.0896336234662154,1.5386053298876,2.18635051820735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.652967027928176,0.0984477110914206,1.58581662570052,2.33265576574959,1.18406708380647e-10
3,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.00901169428708293,0.0383443407818105,0.919124938459539,1.06819877108124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0168643118426459,0.041850165068587,0.905912296918791,1.0674118135176,0.548301674330304
3,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.429167231752148,0.286604633516214,0.879295814189132,2.70427976438719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460318989360102,0.312670134308095,0.85949367071004,2.92774524686919,0.150802289645639
3,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.0292959673837022,0.0526150911541848,0.875666358662189,1.07624403861318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0389442075638002,0.0573659732671353,0.859583626850822,1.0763366895346,0.411112123122335
3,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.53761183352366,0.086827577794631,3.93404179263768,5.52910077626297,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66739087833041,NA,4.26494449245631,NA,8.30481394713084e-66
3,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.784515254287411,0.0977865254849052,1.81130166251029,2.65743633339954,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.847313416252311,0.108295537255655,1.89179755149569,2.89225989733098,1.19371085382821e-14
3,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.052543027700529,0.0401411086673043,0.876850894266933,1.02627109353972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0642477289480724,0.0437977373603424,0.860688189863615,1.02189728896046,0.118015290165022
3,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.3478877036915,0.0892325683021945,3.23870260268236,4.59495084650173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46079509932891,0.123725217313502,3.51114846140071,5.70268502399043,2.44779770201318e-48
3,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.101806734503924,0.0619727660949933,0.980228878807883,1.24977007494974,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.103835982557054,0.0675927023265682,0.971872475113953,1.26671614961183,0.187392516807995
3,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.20803695610442,0.083394193693242,2.84687219094595,3.94764874428706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30849668912434,0.104398864507982,3.06949877567066,4.6216431957836,3.21262827854742e-44
3,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.0755885173529163,0.116008982288944,0.858324953959415,1.35252651686506,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0752842719546243,0.126398026023705,0.841693788079949,1.38144790332821,0.615238511540372
3,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.204611313312006,0.0774668445323169,1.05397071024074,1.42793466653741,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.21578689621866,0.0845083305704811,1.05161484823076,1.46461660046958,0.0182096138427124
3,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.671196537357073,0.100847098346932,1.60717084170629,2.38640668014688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.723885951607866,0.110888395150005,1.66203188086348,2.56694223848696,1.71372535400156e-10
3,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.499403808817263,0.0818932406810121,1.40376735569203,1.93513133085935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.536808229065756,0.0897229865345164,1.43564501193643,2.04075916488571,8.85438556311901e-09
3,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.681415844453656,0.0535080514271387,1.78026173174093,2.19571580660606,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.735016120186004,0.0599088843392812,1.85712099025025,2.34870930456813,7.60103110030551e-32
3,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.692509660068139,0.0434999236265478,1.83566804265516,2.17695048735673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.74710226083856,0.0494026889412706,1.91891382546712,2.32894247740541,2.17619576535064e-46
3,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.681123256668448,0.144846392866055,1.49013574463212,2.62913434653109,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.734677455213871,0.158806618631508,1.52993990107083,2.85119715462162,5.33399408424442e-06
3,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.717698755628718,0.0778517827457299,1.76073325515162,2.3890689399291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.774525718280373,0.0862663947522831,1.83526829696309,2.57371076584596,1.9120482973891e-18
3,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",0.060408257599343,0.0560847477528824,0.951441979076297,1.1853897208528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0587548985114835,0.0611788176070211,0.940750527640181,1.19570894586952,0.457637137107575
3,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.26292533228177,0.0412919080451184,3.26229098395134,3.83546626769371,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36828604624627,0.0700146040178967,3.49941596963222,4.60456541708837,4.78394216431581e-167
3,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.34661884221892,0.0697237781192846,3.35761510678552,4.41294876528058,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45940674675132,0.104523524165708,3.63275343419751,5.47239064932975,6.44277931948498e-76
3,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.474579984474803,0.0759764289958656,1.38522632627107,1.86579207452014,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.509775823367849,0.0832437811798959,1.41510542915037,1.96111592880032,4.69701315977544e-09
3,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.491271833952835,0.173173933183637,1.16373894725304,2.29439087935617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.527931803128337,0.18905471275136,1.17144904105444,2.45793688966851,0.00641406333547687
3,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.39382905228991,0.142065109785147,3.0654786129385,5.34995799126737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51082795212714,0.190805242069117,3.32086707118763,7.01582786325243,7.00549287180393e-22
3,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.0559277012696592,0.0410318360216772,0.872364871587055,1.02459184139815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.067933551777842,0.044763908469065,0.85589674674398,1.02006440120026,0.107351971939479
3,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.19909687105588,0.0231304739620981,3.17052808913759,3.47143466094068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29874488503587,0.0512166726788763,3.36612039430172,4.11453789697792,0
3,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.972604175301715,0.153880395149063,1.96245672221022,3.58729050259795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05211118213943,0.171667071396072,2.06002390029871,4.03755834555764,6.88968041693882e-10
3,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",-1.06123540413796,0.681243622332775,0.077649343050733,1.12173179779392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.16268745130024,0.741865629718021,0.0730435289825497,1.3382464038986,0.113764978205268
3,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.366064397898918,0.0470368365466133,1.3150219902019,1.58127961035255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.391613718643169,0.0516673954221728,1.3373509098185,1.63758597781565,4.66836316664013e-12
3,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",0.0259494504910527,0.0312852664458855,0.965165509254052,1.09109339789729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0212286887219732,0.0342065822350107,0.955288137596204,1.09236499849663,0.795814070940646
3,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.27677891140427,0.0233436526144374,3.42519215789934,3.75340343640943,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38332492506297,0.0600042508956905,3.62724572422116,4.58910927712263,0
3,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.327940106977025,0.0636087310206183,1.22536421747967,1.57236328400366,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350089427241365,0.0695636100707804,1.23867473787874,1.62698138856138,2.59175339775049e-06
3,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.0624825788574,0.13344746632658,2.23524695043487,3.7714372792364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14998907373954,0.15145629506093,2.37072068698123,4.29259636585578,8.25486185868613e-15
3,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.562758059071917,0.0601633445163234,1.56059063466978,1.97565569052374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.605800353642972,0.0663987149163293,1.61043758205741,2.08920604677487,4.02833775398796e-18
3,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.3097691085542,0.0298992559009456,3.49532742722469,3.92996289841226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41927186618803,0.0680560780230489,3.71747315225498,4.8540776342391,3.41961354952531e-296
3,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.3425777169591,0.0954990567745241,1.16802583494538,1.69836228810197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.366028608293981,0.104244866416736,1.17591633252586,1.76947000339069,0.000803157013993021
3,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",0.981975579959691,0.252744423719127,1.64899832545284,4.4411260699668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06231631539444,0.281368521651532,1.68640711934491,5.08118569365925,0.000139190175740748
3,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",-0.0124200942073895,0.0537501544025823,0.888665251733634,1.09709093758899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0205300094977648,0.058606043715312,0.87340506819987,1.09897248071099,0.610364063942803
3,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.350130104002968,0.0271581541653831,1.34568920851827,1.49685211443005,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.374254459524179,0.0302452362891302,1.37065301096395,1.54318185464999,3.24065422746091e-24
3,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.608235972590037,0.0255890307837749,1.74740910635317,1.93177899555462,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.655325602806978,0.0300769628660751,1.81734080307406,2.04474658683258,2.34303956845182e-78
3,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.00148696784701206,0.0389829098131031,0.924915536621508,1.07762262442695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00862911342255263,0.0425462683424815,0.912120676536962,1.07766356329642,0.676019573115474
3,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.601380056687248,0.0329117008610868,1.71077873862189,1.94635845216334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.647857717699016,0.0375605855753943,1.77750738242623,2.05946620591778,3.98708631372139e-54
3,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.41026401793791,0.0385653951998382,3.80033050533042,4.420538889325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52871064957188,0.0913074009163336,4.04803028807508,5.79009586721441,6.64954615299853e-233
3,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.339268079158992,0.046638252644144,1.28130458122286,1.53832991001959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.362433741361035,0.0511862198064239,1.30006596442781,1.58893074040597,1.2566975834156e-10
3,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.229958709143447,0.296579809896529,0.704069436206766,2.25171735770638,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243385065194691,0.323209835000232,0.677310600634865,2.40448068904195,0.472641299395428
3,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",-0.0105860415940212,0.0513433115353183,0.894538767427598,1.09397193019514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0185330390893175,0.0559887862775715,0.879653010174574,1.09553656110617,0.619087444067703
3,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.0153017295738889,0.107380780961779,0.821894337854738,1.2520491031656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00963352825615745,0.116983170746132,0.802873950148432,1.26998876236414,0.990897821686257
3,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.624115576244332,0.0333535869360309,1.74863652717976,1.99287837889538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.672616079551229,0.0382039133461421,1.819953023551,2.11396911579689,3.89478090335056e-57
3,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",-0.40089476641605,0.522607403237206,0.228759014030641,1.77446187295071,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.443588007797477,0.569163964668193,0.210341930756927,1.95826898751275,0.424717669261725
3,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.804933849911815,0.159775213116248,1.63891700452451,3.0659055895516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.869518566303956,0.175905049421224,1.69568616309361,3.37914459150872,9.50453909257431e-07
3,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.4019805885303,0.0283695074724496,1.41395206177603,1.58026900700854,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.430717721791136,0.0317050090407671,1.44624666838418,1.63763486853241,5.19963274256695e-30
3,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.140566345341796,0.0828912306697016,0.977940441044675,1.35340162292868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.14604351604223,0.0903725702806284,0.969524372424296,1.38168573450991,0.144212304171087
3,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.28615733708231,0.0310913818480796,3.40573881390228,3.84717022858433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39353314063216,0.0656055681295789,3.62916687038365,4.69347014139687,8.24570714316681e-270
3,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.693110319521142,0.0267526399805363,1.89788774105949,2.10772670192988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.747750060963187,0.0322078423573789,1.98593775822303,2.25318246770152,4.15619707288602e-96
3,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.294477991149562,0.0998090323080268,1.10383716994208,1.63237606714128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.313649244578855,0.108886371685986,1.10573322070383,1.69441135425613,0.00618082427718869
3,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.29205582151493,0.0475248132410023,3.31900777089995,3.99866165435271,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3999861002382,0.0781858921313186,3.56804729752971,4.84768628273905,4.60127840797084e-138
3,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.41819235358721,0.0635045839911324,3.65053612329475,4.68238424777431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53734594046731,0.112040707764598,3.94078038479634,6.1139330611008,1.15508914535021e-99
3,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.377559327885809,0.0355365934245492,1.36056617784178,1.56392987919458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.404122694749059,0.0392964004358383,1.38742474774276,1.61848153961568,2.03461566436934e-19
3,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.360040595052897,0.0347206436917398,1.33908078980291,1.53431775526183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385045266056123,0.038372453371749,1.36364312184702,1.58498847740508,2.51421617623874e-18
3,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",0.0127967295712099,0.104707364138103,0.824216806017686,1.24249773453067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00690565002618567,0.114071252377126,0.805269151813215,1.25932062027929,0.97188057605931
3,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.24234608358261,0.0790729914982073,2.97081282535772,4.05032054506344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34587237466963,0.102455138898639,3.20857623160181,4.79437838485171,1.75524384014937e-51
3,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.027186097406137,0.0305301673949875,0.916560357781205,1.03308420314818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0366346916329869,0.0333576185994816,0.903068209767375,1.02922106704173,0.22054117420536
3,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.602948619454092,0.034712304432458,1.70747523461201,1.95635987817486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.649561727868895,0.0394597064395553,1.77392883532156,2.07067776135265,2.88832174517916e-50
3,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.600225008435511,0.0488067255719274,1.65655462930371,2.00583166369497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.646604607481263,0.0543761161957316,1.71774763861703,2.12583438900673,4.94472104540941e-29
3,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.34831289170695,0.0240231501587871,3.67435565346985,4.0371815126272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46127205196076,0.0710202492777791,3.87798095796651,5.12283966846304,0
3,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.20599981983887,0.043771634030945,3.06724451986904,3.64137464658841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30629299009906,0.066683413480345,3.29308645732254,4.27686145422215,2.80803570268199e-138
3,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.497014629627001,0.0719609501008347,1.42791997661385,1.89326066949986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.534206672102023,0.0789441776991045,1.4624589653112,1.9928678500491,1.00221339959154e-10
3,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.708327076784109,0.0688314947108402,1.77528401667121,2.32512760357205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.764320330381326,0.0765014761936467,1.85157446114254,2.49906487881954,2.84153568197674e-22
3,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0438933590112316,0.0293808288532108,0.986332881550754,1.10672959930337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0407692516448548,0.0321532389377299,0.978072785523425,1.10945310057012,0.430853825149492
3,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.363993845647674,0.0517762329759784,1.30021404278706,1.59279128616622,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.38935436673875,0.0567899502132656,1.32100064993757,1.65037416974722,2.62487494272379e-10
3,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.26250829918818,0.0292686483559066,3.33791021772523,3.74370559293858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36782596951577,0.0615911774254179,3.55492936434132,4.52568149622646,1.36969710319249e-283
3,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.468984080252604,0.153002925782406,1.18462695296453,2.15801402421752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.503706505829617,0.167028184776776,1.19362178331026,2.29729111683679,0.00332807284399032
3,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.435665210025691,0.280870263623754,0.896342789981192,2.69543295049928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.467394899657476,0.306425254824289,0.876255415535261,2.91266149569394,0.136488548401321
3,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.619207084710487,0.0336851188856124,1.7389108175775,1.98437140209416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.667270852314348,0.0385095661248664,1.80912204709188,2.10390763894961,1.99557920121943e-55
3,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",0.160618776465652,0.448024215329798,0.484169725979156,2.80359603746738,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.167879085108539,0.488327676029229,0.454588199253336,3.08282378078904,0.747981046275954
3,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.370945432319153,0.0358529969422481,1.35077778206077,1.55460536195442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.396920327702041,0.0396198758484932,1.37657862658636,1.6078666273036,1.56785946044238e-18
3,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.737659952970351,0.0714352595481593,1.81890349437082,2.40669615224817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.796262987712715,0.0795069965646437,1.90088632581593,2.59602638951781,1.47907666762929e-22
3,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.25593879417886,0.0299159777821423,3.31187022596479,3.72393733078171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3606252252781,0.0612431647023733,3.52955829221591,4.48725666674662,5.25619187509929e-272
3,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",0.954467370172504,0.36975443802952,1.29181328078809,5.50390389051384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03236651808037,0.41374907263193,1.27522706831508,6.45587660489524,0.0112948554976
3,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.63091224150791,0.0260664168622329,1.78581110710121,1.97793068630135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.680018830915242,0.0307869707036714,1.8603862272535,2.09901213631901,2.43373854899228e-82
3,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.350272570610072,0.0276513855446868,1.34457076954605,1.49850249272335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.374409298783372,0.0307716263702368,1.36945197395092,1.54501435205096,1.10601043556083e-23
3,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.319582916334173,0.0370190244723115,1.2802143068382,1.48014402991568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.340979953870929,0.0407463604953152,1.29876736557202,1.52369519270602,2.42798346436443e-13
3,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.640811904547193,0.0338324242943808,1.77641807181258,2.02834397429178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.690793636580297,0.038846211143487,1.85116483445412,2.1556438101534,5.91594717191174e-59
3,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.388539391096403,0.0351641586633034,1.37662047729378,1.58007534907988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.416079707610434,0.0389256220801318,1.40516229630277,1.63679235286835,7.78083691304204e-21
3,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.31626734690075,0.0293962816314737,3.52148177906091,3.95157078734264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42634720596218,0.0686984486688196,3.74269239725412,4.89932879495043,1.69505016109608e-306
3,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.26782269353133,0.0391126855644443,3.29220759305651,3.83771543509404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37358754601473,0.0689216012663201,3.52742935250942,4.62158208624953,6.5392155734635e-184
3,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.610493954472147,0.0440747552645252,1.68905360196865,2.00759650745176,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.657792288928576,0.0493930513105264,1.75419294606608,2.12894402668048,1.88628497310875e-35
3,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.451647751275701,0.1053182725709,1.27844475249824,1.9318620767004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.484803026045533,0.1150810937512,1.29668363152956,2.03586247638307,4.72073477574933e-05
3,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",0.0255278358111733,0.039257005472047,0.949714489156171,1.10770549742135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0207929804762495,0.0428569419504661,0.938788549766161,1.11052304235762,0.836009128781777
3,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.405577475137943,0.0569256614279821,1.3417972619214,1.67724815581852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.434635692680022,0.062445138199936,1.36705601260901,1.74619646763794,8.05544692887744e-11
3,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.30498972725022,0.0620933536345149,3.26778126643197,4.16831849728517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41408339144127,0.0921846416689428,3.52949779568989,5.06580342747393,5.31802100776174e-88
3,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.23759112879513,0.0528387686963507,3.11017990771801,3.8259421088699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34067511705651,0.077142324115966,3.34924242848859,4.53183318128277,1.81751637421977e-105
3,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",-0.394877963685058,0.352398584983649,0.330265884752015,1.31458342974402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.366868188949356,0.388536474991478,0.323556474803116,1.48386977678488,0.308798266335444
3,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",0.849262005954376,0.454043195662363,0.962321957357141,5.70538469674502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0048381655551,0.500598232199164,1.02395916617697,7.28622559353586,0.051149053754276
3,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.0302303825881956,0.26919884200878,0.568619087694415,1.63345198769985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.035189599018449,0.296806477369662,0.578940682516607,1.85318310384101,0.982232748535098
3,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-0.223443042361948,0.639086201453074,0.208838187085484,2.55736216860764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.177860802900653,0.704613985624243,0.210373032712317,3.33063538401204,0.769563537375538
3,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.52318975733856,0.470261771324578,0.658825477896615,4.16241594607055,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645324336806897,0.518481810217573,0.690127962364829,5.26738009595868,0.23421057020731
3,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.403306250927056,0.240502211968726,0.935359594543484,2.40110036280975,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.513164554850491,0.265167349589501,0.993448934382119,2.80910040667166,0.0676160165484777
3,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.372084647250395,0.314657806364269,0.7664269772335,2.63114755270345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.478734995290653,0.346932020678302,0.817722448291142,3.18584075022331,0.194413862524284
3,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.536541092879349,0.235743426989836,1.0803983681365,2.72216381833228,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.660054452197314,0.259912360890823,1.16257061467935,3.22028972884369,0.0151147571551211
3,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.34081128353279,0.20031313530943,2.6087255025337,5.72060661040579,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54674223549039,0.220866151732894,3.04616386639955,7.24029865233197,6.22430496819994e-12
3,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.11693328571178,0.417820197071887,1.35121135360059,6.95059012212485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29995044952554,0.46066847434764,1.48744856963905,9.05076713009814,0.00578120014364135
3,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",0.173817827074551,0.554404505010445,0.385031407185593,3.38310982972667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260134323743208,0.611250164288342,0.39145229082471,4.29806525868217,0.704789799146714
3,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",0.29922005510462,0.528228757513645,0.465870459263797,3.6942258246662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.398393041112026,0.582391019125715,0.475651497320775,4.66394195396942,0.52540351242283
3,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.453885651735557,0.327105119646728,0.830893919788877,2.99509323522111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.568920055180182,0.360654240741133,0.871148443357008,3.58155032178405,0.134047861040453
3,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",1.01040420385415,0.289067245724031,1.57908506768842,4.90359392174178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1825162176248,0.31871282848618,1.74688451415143,6.09315039507891,0.000293792433644348
3,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",0.757451723596976,0.558212870426219,0.739720381808613,6.59737087153775,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.903601484502447,0.615452332867783,0.738855575895514,8.24721860162154,0.155079102350245
3,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",-0.099900140431264,0.324377330132065,0.473862598287233,1.68994822535238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0416515629404173,0.357639936037618,0.47587388376657,1.93347785409286,0.844376612346622
3,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",2.07832502693068,0.69293633437064,2.40168325351407,36.3222450560931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35990365352214,0.763986757471673,2.36911813936286,47.3369347083943,0.00227640686046786
3,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.703640411595203,0.265110621230265,1.19084342097193,3.36650916783534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.84427729088094,0.292302516108702,1.31179517151388,4.12555834664037,0.00525810171303138
3,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.41481737730608,0.43805569054824,5.14451170740237,28.6478160587194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.73089562689866,0.482979696572932,5.95528533302563,39.5483801998602,2.20270573886339e-08
3,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.208903298994681,0.259021810961339,0.484793444330443,1.3381853431549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.161827102989713,0.285587045264105,0.485998157330813,1.48874011184634,0.504993245194114
3,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.20584006098539,0.612422368812048,0.220477809663409,2.43194985920965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.158453073405178,0.675216794349559,0.227217557455527,3.20577502872986,0.781813110064923
3,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.307516566693664,0.224999780016252,0.877028166705677,2.11862387151689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.407561085981149,0.248078138854599,0.924333338895907,2.44431744168232,0.126576292739473
3,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.12799677252817,0.194550655890507,2.13045220935261,4.56746716073524,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3121287131418,0.214515501293743,2.43930091805956,5.65532060809398,2.17511694628275e-09
3,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",0.401075364022856,0.890488430738139,0.262369711814748,8.60763714828426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.510687831465457,0.981790697448081,0.243270100223551,11.4154292731968,0.623370116126035
3,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",1.43145975710158,0.486048558171805,1.72680656371866,11.6063124089441,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64671681539,0.535888630478457,1.81556784085155,14.8357989744052,0.0025308660011916
3,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",-0.0230795803298801,0.356029402558281,0.469580273111369,1.89589987462753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0430609622633819,0.392536175696699,0.483693294767846,2.2533303385998,0.9705461105979
3,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.538110228176568,0.283724985333884,0.985715952778795,2.99754751491493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661780257091129,0.31280878643787,1.04987960458429,3.57821261515511,0.0429425300771581
3,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",0.724682462165029,0.265064091198242,1.23785397175722,3.49876957619981,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.867475981878757,0.292251159104191,1.34271784377828,4.2219592352071,0.00409621315855511
3,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.174879338018381,0.186826382530512,0.57882324402557,1.20392594341816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.124312897483261,0.205981935002194,0.589766678798837,1.32234419676429,0.457994112417255
3,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",-0.023079580329881,0.356029402558275,0.469580273111396,1.8958998746276,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0430609622633809,0.392536175696692,0.483693294767851,2.25333033859977,0.970546110597902
3,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",0.819601580249253,0.829804321336752,0.471249499608935,12.1874357682567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.972122746711301,0.914884675800641,0.43998541264659,15.8833012812164,0.302372048057419
3,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",0.904015581870799,0.270074227791163,1.44141992134224,4.15494920618382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06516775771371,0.297774066748073,1.61863424868263,5.20092050449395,0.000498769298038189
3,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",0.0193451084935766,0.561895512668624,0.314560748422061,2.84627713814071,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0898251120442907,0.619510212063339,0.324849869458779,3.68416263560563,0.921219046179565
3,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.220654549528042,0.166366034456158,0.898441415376813,1.72469305235874,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.311761180211877,0.183441603133178,0.953369133625853,1.95682792975605,0.122572743796963
3,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.37533145811839,0.270766534916881,2.36742479928691,6.8427390345122,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58484613247932,0.298535450368893,2.71749165299549,8.75781750022298,1.85623178592198e-07
3,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.722550716601643,0.54477343174412,0.154249780562566,1.30511423468269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.728136868010588,0.600630602795864,0.148770652595112,1.56686889834391,0.20772844171926
3,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.402795258897124,0.482948492102114,0.248694247112418,1.65134852425118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.375599420673304,0.53246757875952,0.241903957852334,1.95037186545981,0.447837746479823
3,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.38192706878573,0.295479545745996,0.806396790317487,2.56787619430936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.489587800605599,0.325773678374258,0.861621225832687,3.08968713623319,0.157020019401304
3,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.532210202568416,0.319740683534055,0.913828263158309,3.20031047061726,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.655273500275658,0.352535058229431,0.964952968034038,3.84293392645743,0.0754364221058775
3,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.492062167897869,0.155021420216892,1.20729659618907,2.21678166346505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.610976333929178,0.170930830807497,1.31783281333797,2.57545218297431,0.000654805337935757
3,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",1.52269428975812,0.753984981649184,1.18160641669724,22.7017428839557,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74730220183034,0.83129435376287,1.12524735083677,29.2715737745675,0.0386801104377272
3,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.36720611290684,0.212096505819821,2.59461479892865,5.95863299305273,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57589878848498,0.233858266534966,3.05724981517527,7.64631106968909,3.66693805182941e-11
3,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.0591489629876408,0.434923832312537,0.445590114606895,2.45104464558093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.133713621840386,0.479522638616115,0.446583163237938,2.92579009676759,0.826424336845476
3,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",-0.0113077878650713,0.244075467906968,0.611004286296248,1.59059307303734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0559967578334176,0.269108901381616,0.624125416081817,1.79227106265656,0.918685469914263
3,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.668583073955639,0.374653698828218,0.946280905044406,4.10990411495409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.805623822565705,0.413074366559455,0.996025595929595,5.02909194400257,0.0599411312453457
3,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.893631960144141,0.244024601789368,1.50884317725523,3.92710342102825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05372852533326,0.269055971454805,1.69287022834519,4.86032581638546,0.00013868260894295
3,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.22026385940634,0.133124795363609,2.61838509061757,4.41230557440663,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4138633735672,0.146792316997398,3.08377744514092,5.48255151644466,3.78416305087126e-21
3,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",1.23321957246709,0.504819670915564,1.35444688549575,9.79870188091726,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42815397617955,0.556584113050694,1.40112132478284,12.4167019057627,0.0119150515352694
3,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.880908191854078,0.286691102868418,1.3754421768173,4.23161507743543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.591468336252946,NA,0.961978703794648,NA,0.0609832002591839
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.731575646479811,0.300913668278951,1.14764035421346,3.73320783363819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.424683749200371,NA,0.790470136553045,NA,0.197468402938978
3,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.370702541732638,0.331028372561455,0.747112305194681,2.73482544902352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0216373391628854,0.391760697122387,0.495035200966337,2.29916797608066,0.935128466009794
3,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.66314603019973,0.24514165509119,3.31546465896061,8.66711009289428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46511548522936,NA,2.27368639968617,NA,7.36047927060274e-08
3,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",1.25341782163837,0.271603274676077,2.07839752626066,6.02707880423796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00752028006417,NA,1.48528530524031,NA,0.000810395695742991
3,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.35374715255573,0.607102040105546,1.19577910718432,12.9176450823856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11956330384442,NA,0.810583910847895,NA,0.0961879693949171
3,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.834695801716432,0.290990467210363,1.31129257396264,4.1028219587808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.539855434468359,NA,0.905598658084772,NA,0.0915795066414061
3,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.92075212961423,0.54594398617101,2.42048749756789,20.5740395718886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75282314075185,NA,1.71880187996317,NA,0.00387007080026759
3,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.581216895696473,0.308961043741824,0.97767424916493,3.28224058289002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.256753125879645,NA,0.657007943542758,NA,0.442148743305697
3,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-0.581185753098666,1.21581934431469,0.0284801332205964,3.34469576865109,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.04148786017876,NA,0.0246514094569314,NA,0.446801522574505
3,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.41718345042959,0.243488357202818,2.58329646537847,6.70949109055968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19041293529196,NA,1.84178190244631,NA,1.04076893753397e-05
3,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",-1.2,NA,NA,31.1858564173389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.96105714209963,0.448473631387606,8.59647143273862,49.865837627467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.91470211558113,NA,3.99966323666677,NA,5.3464473592235e-09
3,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.561698614044911,0.311880501448464,0.940613524496687,3.1941664751577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.234953770237188,NA,0.638783577988582,NA,0.484681535224846
3,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.508635122111468,0.310030328504497,0.89501777622575,3.01736778443095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.175689205844614,NA,0.604522925224293,NA,0.594859543156215
3,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",-0.220734604114001,0.399797329931196,0.349333403472993,1.67438885091642,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.638918726900007,0.448114168414918,0.220009120669822,1.27441721292472,0.157965058866179
3,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-0.371074287651209,0.617995429171594,0.1847634671295,2.08301994957777,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.806823994896182,0.694169612760246,0.115369215034427,1.75326042125541,0.247396461828574
3,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.179810011842958,0.567905808482,0.254384372617403,2.35664968326245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.593208713840103,0.641255720083859,0.159396039726237,1.9685807953423,0.356565686278183
3,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.55479778935694,0.244460714316477,2.95072873899801,7.69307490654627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34412362609148,NA,2.08139159883537,NA,7.27330129994852e-07
3,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",1.16237569701427,1.2116389782385,0.293670929910496,33.9280496204788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.905813965840777,NA,0.174389236190215,NA,0.499277005695469
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.569636053792034,0.440409496355163,0.73412536775143,4.12595718785952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243790724640245,NA,0.48658780935072,NA,0.608035152183657
3,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.88111326987492,0.53984850679124,2.35454753545899,19.5410198957127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70855242098495,NA,1.6692945652119,NA,0.00440292678654862
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",0.433260747200261,0.462580887136297,0.605225430840425,3.71036212640939,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0915247255152515,NA,0.398070854961999,NA,0.846579949740119
3,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.04028110137451,0.23648734343986,1.7857831989533,4.51258625341052,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.944525743890509,0.24995762666985,1.57557331936231,4.19727334209863,0.00019034912338261
3,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.62163433773004,0.637306106136266,1.60864122316136,19.561901864195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.558993718523,0.673605160798847,1.26966312926846,17.8006562157594,0.0216266728099218
3,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.251985204152838,0.966863749862576,0.167395077170989,7.40857213520764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.111333859882343,1.0219344348811,0.150826779099168,8.28367006630382,0.922423375406561
3,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.72598853193099,0.21024255886536,3.7492210808567,8.54788422638214,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66929095267842,0.222217496509005,3.43409373889709,8.20570495987292,8.73113876197129e-14
3,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",0.0919665996953919,1.39401571777665,0.0480689669864135,11.3511914770079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0577991558196134,1.47341737459542,0.0525678895342759,16.9461414700837,0.962315895311551
3,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.725384028720003,0.325980335434329,1.07583043658202,3.86094625316469,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.611695004281946,0.344549482237575,0.938368005408993,3.62189031169852,0.0816718703017139
3,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.623438268824518,0.16758752793677,1.34041828763375,2.58548408727213,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.503940708067721,0.177132774876443,1.16972285985029,2.34225599958275,0.00546447961356949
3,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",1.0012389984553,0.290209924358539,1.5321514316723,4.77920833058551,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.903260953877627,0.306739811154743,1.3526462848368,4.5017258690745,0.00365845813095889
3,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",0.762028647808719,0.281337913906911,1.23205052277923,3.71175284686973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.650426371787818,0.297362412293265,1.0699453123151,3.43235554773004,0.0317464346427834
3,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.249209044724373,0.204247627988805,0.853801579053869,1.90137923190298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.108399163616359,0.215884876597771,0.729982153736548,1.70151320172329,0.654592754317345
3,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.0919665996953921,1.39401571777665,0.0480689669864134,11.3511914770079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0577991558196131,1.47341737459542,0.0525678895342759,16.9461414700837,0.962315895311551
3,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",0.426528608617179,0.478452064217385,0.578191169344181,3.77215669754949,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.295818493754928,0.505704049168387,0.498902471180062,3.62182772758194,0.574389377095559
3,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.10989808754322,0.384476286126006,0.513365547314387,2.31718300917021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0388499584172611,0.406375821568201,0.43373133681746,2.13322298113396,0.900785339503887
3,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",-0.611861747927963,0.396621752994287,0.237645744578815,1.12496792076219,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.801715752526391,0.419216489204927,0.197232493756657,1.02012622168341,0.0523043469519371
3,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.192985558750956,0.191556762032373,0.828354366836323,1.75518536473887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0489735821980541,0.202471544969414,0.706189373770494,1.56174225689691,0.854387680059234
3,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",0.529503721446805,0.286954019969336,0.960436896430166,2.95787791648313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.404658129339377,0.303300395754136,0.827120874758094,2.71586708369033,0.195238763485021
3,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",-0.266882692826059,0.520697162664454,0.261508228908277,2.01336176220066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.437088298806567,0.550357649469794,0.219638041524638,1.89949486403491,0.414693157911626
3,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.0919665996953921,1.39401571777665,0.0480689669864134,11.3511914770079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0577991558196131,1.47341737459542,0.0525678895342759,16.9461414700837,0.962315895311551
3,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",0.716805673713825,0.148149902038159,1.53257332565288,2.73925279151057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.602624432662436,0.156588046783142,1.34409039840626,2.48315856507479,0.000161271849036419
3,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",-0.0603931602588348,0.678927217513472,0.233794940996241,3.34690125935022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.218837560732825,0.717598885420955,0.196850906264916,3.27929114192923,0.74788893431114
3,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",-0.296041656142688,0.559924394566163,0.229834156833183,2.06362884323991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.467907834049899,0.591818648111692,0.196350246561432,1.99776934200744,0.417598053648175
3,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.609068147141504,0.331703040871156,0.946164589285214,3.47263366282987,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.488754366038463,0.350597898531714,0.82003512587867,3.24109230820917,0.173714018858748
3,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",-17.7078276453376,NA,NA,29.1289785441406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.62469441386201,0.253074305699934,3.09582845746718,8.34855604833877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56222774413485,0.267488723329096,2.82345052164926,8.05663724503131,6.78429419098938e-09
3,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",-0.245025420656974,0.571790128233886,0.23853180339229,2.24369371145026,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.41398593617798,0.604360185134344,0.202196713363694,2.1609202360893,0.481089045705027
3,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.159087988697286,0.125416616136336,0.914400059917743,1.49501613646356,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0131454002590936,0.132554210948371,0.781418164059264,1.31384520382846,0.992000077156709
3,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.46264030146858,0.0869480305496129,3.64227468709666,5.12145417518496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39094156465501,0.0919003103711575,3.35623653100797,4.8117597189626,6.62907350508889e-51
3,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.0197168183628847,0.397897462237738,0.45011536787591,2.14143900443909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.1341670432055,0.420561290815067,0.383486704587514,1.99395407402605,0.728509659688226
3,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.54905060907079,0.850808143497431,0.315514669977776,8.86008658805346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.425319067739092,0.899269276266131,0.262574651529739,8.91603139904796,0.645644143905005
3,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.0928725804763894,0.750293797049765,0.221880095237144,4.20165916058024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0568422876801433,0.793030035226418,0.199656816577189,4.4703437712329,0.931008043299407
3,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.089742973610142,0.356769248848902,0.537911658432392,2.17809103489558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0601535721423689,0.3770908259305,0.449672485360607,1.97177293285268,0.848647279051546
3,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",0.682921477023781,0.550920279104984,0.675130047954377,5.85161603132574,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.566814572251744,0.582299721022152,0.563001424200616,5.51846555037156,0.340531249256818
3,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",1.17690999682714,0.489062931899045,1.27780365696683,8.69053216773901,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08893936913273,0.516918576375422,1.07874382203864,8.18317994747353,0.037183914156791
3,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",0.800162432317889,0.104216522456516,1.81317512822579,2.72808741788617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.690722900157169,0.110152369050835,1.60773800297074,2.47593369728763,7.11828848983364e-10
3,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.752924605629729,0.413846989644662,0.935566488139969,4.73815266272011,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.640804539455428,0.437419864398007,0.80531252509524,4.47331396758256,0.150446295809052
3,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.0713055171837037,0.174048916784093,0.760720598069318,1.50496565497723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0796549692522824,0.183966958686834,0.643898432656993,1.32435155628194,0.619097248650413
3,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.478377684436082,0.432041446905075,0.682091108399677,3.70980498850621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350620626687366,0.456650279491297,0.580190221550154,3.47514756076472,0.458125982872912
3,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.33730036331208,0.137999007211916,2.90775100043612,4.99444401886448,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25846443758125,0.14586162525313,2.64474784459921,4.68489166843222,1.26389900876101e-17
3,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.117566812130268,0.38398385339341,0.512752977398623,2.30995483240525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0307444908415151,0.405855350119696,0.437707505813025,2.14839134767661,0.916488698565877
3,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.59639933797566,0.348376840717035,2.51716561297,9.86255865528543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53232127576136,0.368219803755812,2.24930864148949,9.52593430590986,3.63795068086255e-05
3,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.143766986480869,0.288854538400927,0.649279656769134,2.01455279559255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00305526175536663,0.305308595758633,0.548018874979008,1.81365138775777,0.961168623086859
3,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.442228505392562,0.158380155546319,1.13977284583356,2.12053366543533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.312410737552417,0.167408450214527,0.984404450291267,1.89744952016813,0.0725474978070775
3,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.499434051323538,0.341018143827982,0.837556726508803,3.18833958661483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.372876073835191,0.360443306360466,0.716352643133158,2.94270457792492,0.316480449266286
3,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.329155177597544,0.309983915899356,0.74961921695822,2.52672679904164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.19289886810629,0.327641415999743,0.638093741052862,2.3049538937243,0.580476412843899
3,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.618278108924546,0.178879370102678,1.30377772683344,2.62862327631451,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.498487037003836,0.189067763327956,1.13646325292699,2.38465162327208,0.0100510590725419
3,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",0.659258841237209,0.733894468270143,0.480122101656663,8.5258150321822,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.54180433332652,0.775695166089903,0.37586285987578,7.8627643299982,0.494453224089306
3,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.5398704508865,0.111854241354302,1.37594336022359,2.13315082057183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.41561058186961,0.118225102457442,1.20188798227143,1.91042842799247,0.000636612812017812
3,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.861981100236872,0.43814597835921,0.167244692592588,0.931651334649194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.06609086184501,0.46310411486373,0.138934465851437,0.853492816526666,0.0199354147472284
3,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",0.616640997186579,1.08748127376803,0.208219653052148,14.7860848950418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.496759213017992,1.14942185534277,0.172722598339962,15.6361013507676,0.673096560672807
3,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",1.09037815187614,0.338979019564659,1.54987689229235,5.85296776681667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.997477525580337,0.358286535155042,1.34346156071645,5.4723434725771,0.00594048804662618
3,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.25644253335191,0.145330077771804,2.64259338410939,4.67133180472078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1730014575354,0.153609868401811,2.39151538472532,4.3669587852133,4.04850575593095e-14
3,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",0.844683305397769,0.348987793572677,1.18499053102585,4.65406856264046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73778913151424,0.368865290340397,1.01493746347647,4.30920040785482,0.0490532567293219
3,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.495825158399213,0.367729912754015,0.80074803472207,3.38470185865852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.369061709869641,0.388676225186773,0.675209560832229,3.0982908793949,0.358023206496594
3,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",0.389368777570601,0.45856490919828,0.596108231424816,3.59738927559186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.256542171368469,0.484684240309466,0.499862108672698,3.34178237049401,0.613615493458109
3,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.154078518391175,0.186569478595211,0.804706754905585,1.67206864555245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00785070921336187,0.197200307094837,0.684776010704171,1.48341596607711,0.983955375951002
3,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.959072527588843,0.304309939454379,1.43559824722419,4.73250519718448,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.85869305860107,0.321642860088576,1.25644391245167,4.43311404764861,0.00846392881026169
3,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",0.646154952684571,0.323871364369889,0.997433616620515,3.55012472754962,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.527953417211296,0.342320310982688,0.866766643526185,3.31641861091382,0.13161266278527
3,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",1.11017004722228,0.282244990772932,1.73632524293274,5.2495952798171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01839813517916,0.298321291719977,1.54295295636167,4.96839107174114,0.000740415111826008
3,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",0.666544139560837,0.32056834020009,1.02650543381978,3.60659838952604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.549503853748847,0.338829233587514,0.891729206503636,3.36555679789664,0.112532644506252
3,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.43128969915258,0.250074473652758,2.56960855550705,6.8484852600286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35780746557102,0.264318758721944,2.31578921737849,6.52643621874806,3.53708744298471e-07
3,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.797898101884991,0.436027950415207,0.928044448681635,5.12700930692311,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688339600539994,0.46086406794288,0.806590317071397,4.91167266437644,0.142117566536974
3,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",1.15845432714719,0.394721569725962,1.46257194944397,6.87214727953913,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06943252097971,0.417203917073535,1.28624523682495,6.60044194633767,0.0112443538166801
3,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",1.81202447226142,0.222939286479389,3.98963453059937,9.56017062629535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76022721443061,0.235637381465263,3.66338218849762,9.22639481619446,1.17181950203035e-13
3,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",1.87122378750038,0.690820509624724,1.81070580700706,27.1583175577907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82279895730572,0.730167568649512,1.47948874372346,25.8911408775036,0.0131297901859406
3,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.0645108676039,0.664813216287722,0.861466586876994,11.6685934512971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.970138002699319,0.702679511461232,0.665584621456276,10.4579617236352,0.172626677872735
3,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",-17.7078276453376,NA,NA,29.1289785441406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",1.497866136777,1.64902416695517,0.176548113841051,113.283566529667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42817613898664,1.7429479336791,0.136977252460931,127.013063898096,0.416434003165369
3,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",0.804718956217051,1.72242406020865,0.0764460383650228,65.4056129910286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.695549513179896,1.82053024584258,0.0565500571760916,71.0737708643487,0.7072376058233
3,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.39744591211708,0.485890064956445,1.57188150234842,10.558459284043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32203624831565,0.513565034360745,1.37089922123863,10.263612081634,0.0107344657494282
3,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",-0.228420133378735,0.348483920527952,0.39155429461489,1.53480107107211,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.396436778566732,0.368339869497212,0.326808569895948,1.3847021521337,0.267700199911822
3,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.565698613076346,0.164884343334233,1.27151721104238,2.4267322296833,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.442912663174103,0.174275625084139,1.10665141730977,2.19128167358392,0.0133736186744939
3,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.677522413906228,0.855715609591806,0.352146936136647,10.0808420245815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.561108179856167,0.904456334074122,0.297721345656927,10.3171377225942,0.543639559525552
3,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.4042656342064,0.132634877750451,3.14705735722685,5.29300962274298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32924359482177,0.140189331088805,2.87047509635444,4.97293214407681,5.58794006185656e-21
3,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.44244363076272,0.360347346773978,2.10331782050583,8.63696852172476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36959682225807,0.380872026855994,1.86470087268074,8.29863929466834,0.000363953029843565
3,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.560879539905218,0.260907160958081,1.04892523722948,2.91684727876412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43782075921013,0.27577054775895,0.902410843871604,2.65997121578073,0.122394955387962
3,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.743878534447683,0.316013423615761,1.13638185717618,3.92199033525634,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.631242803022459,0.334015065652553,0.976853629291615,3.61791011668917,0.0636671397793225
3,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",0.987994238100858,0.311921968572715,1.46317583268326,4.9695085403681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.889262078448433,0.329688435354299,1.27517752070253,4.64336964687747,0.0077805618514053
3,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",1.16505780288022,0.539008418692445,1.09714356993646,9.07555217280341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07641211774975,0.569709692855475,0.960596846093799,8.96224260366059,0.061669140122388
3,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",1.00871598539624,0.741709438312694,0.669928923368096,12.266401205577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.911165314518135,0.783955341610618,0.535068940066623,11.5615945390851,0.251300960966753
3,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.54070520200332,0.262069149235205,2.8090730786921,7.84712130354223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47345486632669,0.276996692845562,2.53590331042952,7.510912722462,1.31491454143455e-07
3,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",0.249572597269038,0.985492031884063,0.160964394533186,7.66362943920159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.108783839929536,1.04162367506827,0.144747651383092,8.58766085924414,0.925829921018551
3,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.869000466420205,0.17047068746966,1.70534562262422,3.32676585428969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763487951388228,0.180181361628885,1.50733221294869,3.05457143870699,3.02200053458484e-05
3,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.43266366440446,0.147093940489272,3.1454215155415,5.598762324192,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35925918280385,0.155471935087386,2.87065374465331,5.280277093559,4.44450622473913e-18
3,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",0.301527181375856,0.377897415234532,0.625701448881551,2.75233242586229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.163697415151366,0.399422431066832,0.538397294357533,2.57680080906081,0.703757488919928
3,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.0928725804763889,0.750293797049765,0.221880095237144,4.20165916058024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0568422876801439,0.793030035226418,0.199656816577189,4.47034377123289,0.931008043299407
3,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.62223903080552,0.259040123845368,3.0894602085083,8.52851293197148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55963253070417,0.273794329025476,2.78154280848948,8.13568376164887,1.57477580142582e-08
3,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.15690803170023,0.624084153671412,2.84001780854077,32.7916940061793,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.12475492416978,0.659630195043531,2.29768720219689,30.4963164306708,0.00135901104027428
3,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.44863488756385,0.350784471440534,2.19312663602052,8.67441661040612,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37614070320014,0.370764508842116,1.91449687718152,8.18927219589236,0.000233449047149841
3,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.259804631676259,0.445638883214309,0.53446007490754,3.06600090298099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.119598575601004,0.471021949464672,0.447719221327141,2.83710206793777,0.819003494902461
3,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.3155271994752,0.244802131805511,2.31645009471235,6.0474857405842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23545159257348,0.258746096846937,2.07159105017466,5.7120786673127,2.25503933315465e-06
3,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.53492509249268,0.355993641380287,2.37185316145174,9.57486088450417,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46734568901468,0.376270389727786,2.0748077726442,9.06863117006396,0.00010959122365722
3,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.6540772460199,0.413963911110506,6.62712003102625,33.5782668824488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.65024123863281,0.437542067029278,6.00549194957392,33.3750215261946,1.6385097208882e-09
3,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.89205800776294,0.295298276500317,3.78722481535467,12.051407829774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.84481945967311,0.312117628372652,3.4317844807384,11.6646045433002,4.28497095951482e-09
3,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.456306305652252,0.176304743596875,1.11337884365705,2.2222079874021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.327290686059781,0.186352576525128,0.962746081667989,1.99875222947173,0.0904642299261519
3,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.42724894562551,0.26735274240123,2.46909787642961,7.04174736241337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35353659978402,0.2825810331675,2.22484330954937,6.73544436333152,2.05333106419876e-06
3,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",0.732819824063056,0.450506211609988,0.856318279707377,5.00700909234705,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.619554769591457,0.476166829827242,0.730725856422633,4.72478831650482,0.201843013683892
3,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",0.124533850443536,0.456233497909777,0.453928250918442,2.71444175687359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0233795035960315,0.482219806527804,0.37964770294037,2.51369894861947,0.94182078175863
3,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.35801466555944,0.173795886963111,1.01403494576274,2.00411932741825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223401196239242,0.183700626254518,0.872269403076475,1.79218629513291,0.249388905984792
3,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.31615965006624,0.698255582614228,1.01772423510954,15.71602009607,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23612022542252,0.738026662300274,0.810270774338569,14.6234229906785,0.0971379723060498
3,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",0.465992625890269,0.776112591485057,0.353479139405717,7.40662335264554,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.337530375907396,0.820319606067902,0.280755639557951,6.99589234750888,0.691324287787412
3,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.470300011672242,0.359203848903065,0.788898608557901,3.22500900102292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.619833390141475,0.717232575597712,0.566791313756788,9.42848981622945,0.309438830452692
3,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.365748772588927,0.41493834246635,0.612884659329218,3.11724592492182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.46685654085314,0.771744718373863,0.430160600428606,8.8603569878536,0.530063284679878
3,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.44518587894808,1.18253098113066,0.417891999321513,43.0733300212128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.04636095028311,NA,0.252026434413527,NA,0.257152745188831
3,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",0.693147180559945,1.64774137711557,0.0791534762044055,50.5347357034632,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.945935199113196,NA,0.0226812426388344,NA,0.721228802405048
3,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",1.05183782620054,0.490372515011806,1.17177657178517,8.01044224715271,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47078837005464,1.00865147777204,0.915865497642443,47.7488688216965,0.0535528646619664
3,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.3617967819637,0.433960494469418,1.78435913531475,9.77817833788325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92433502124337,1.05271758821684,1.57901559417011,97.844426129101,0.00378391388760881
3,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",1.13843797450877,1.43303073454143,0.135263668784416,37.2200633635761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59750567011314,NA,0.0798875191186471,NA,0.470901884442581
3,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",-0.105162639973566,0.583445997577158,0.270613204713865,2.66446028610378,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.222187908460394,0.951710353854076,0.143040627387195,5.96559890124323,0.71842794685344
3,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",0.695526592676071,0.468516473010818,0.807805834033378,5.06886675440183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.949443317852863,0.895075591830137,0.593665060697032,19.8299189904373,0.207676515801924
3,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",2.29755992506729,2.18336611458735,0.137826583606954,718.293941626837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.29358650039103,NA,0.051007713054228,NA,0.31532225509256
3,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",0.150381580116623,0.551011877355785,0.379903088471322,3.29395107939293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.151763528322242,0.929916278143503,0.224388260569319,8.59196450115603,0.934655982735623
3,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-0.779972104216812,1.32417878638206,0.0218800402326157,3.92947173454977,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.20960218584343,2.01000008153481,0.00666101081394353,17.5942387618797,0.503832028212569
3,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",2.90485944173274,1.74358898692157,0.900420757646456,837.021803727715,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.18222947461623,NA,0.428183761319932,NA,0.108343176479927
3,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",3.06601374313719,1.66414882724037,1.29698004170848,883.050199253286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.41803150083633,NA,0.673961046430564,NA,0.0752114018030099
3,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-0.556477610280076,0.526853972876862,0.186331853676897,1.46961959510752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.882566245970925,0.840450460526619,0.0875582313236252,2.36092634412662,0.209147660853536
3,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.693147180559946,0.479809473178373,0.815276052688254,5.34729093624693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.945959381034559,0.909653615516118,0.575457561091813,20.352156024457,0.220437474089249
3,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",-1.42977854651657,NA,NA,1.48939073690389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.64867014591458,1.08230198963478,0.693303081812513,48.243341210073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34410642208401,NA,0.44535786579432,NA,0.15384102432092
3,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-1.70787123354268,1.16939231678402,0.00980633073358854,0.96002739424353,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.56735228214346,1.74053539967324,0.00267446767229855,2.45657591262177,0.121035209416137
3,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",-0.612912326126494,0.70525654987395,0.117760891804932,1.86909774339836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.965149713435596,1.09403105242077,0.0492452051246068,3.5879451156813,0.308566027003603
3,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",0.346573590279973,1.66184183487206,0.0544443307178753,36.7347706111732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.438831557805082,2.87299366988882,0.01314033822277,1022.35054938866,0.884520123705414
3,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.169040198269275,0.887019820617612,0.117934348397597,3.81685438936129,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.315652899454781,1.3913030953849,0.056170950594226,13.1241279978026,0.757187676817562
3,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",39.1458771200005,NA,3.0183412158427,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",3.77285631825203,1.38479470292478,2.01141737868115,458.121816899407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",5.45230783245215,NA,3.89318568880992,NA,0.00808459715137252
3,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.60422630938255,0.895017571549783,2.94311009776988,98.2849870976881,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.74232171189475,NA,2.77526792807917,NA,0.00523594658865047
3,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",2.29755992506729,2.18336611458735,0.137826583606954,718.293941626837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.29358650039103,NA,0.051007713054228,NA,0.31532225509256
3,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.403198248598006,0.491218692414283,0.238030627864549,1.63261980390223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.658282272281945,0.799791392293371,0.120030798233217,2.75968827882044,0.300676665620173
3,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-0.556477610280076,0.526853972876862,0.186331853676897,1.46961959510752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.882566245970925,0.840450460526619,0.0875582313236252,2.36092634412662,0.209147660853536
3,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",0.440495928345731,0.505498531025315,0.593276864997729,4.30347884724051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.576252278677357,0.902771464565586,0.379982654814217,13.0811130910021,0.507146443965127
3,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.500737231189429,0.107563394648452,1.33820721751924,2.04004441552856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453566336972267,0.219712214277765,1.12102224997821,2.65248529090238,0.00324646476017488
3,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.0593355885252301,0.0692285950584649,0.926448489449555,1.21527972216983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0296246812151276,0.142622621898811,0.7640864869837,1.33642229099029,0.787625569972803
3,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.41067053886429,0.109585037996297,3.32111298249938,5.10318787445823,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44969192266888,NA,2.55316062809814,NA,8.36663706872511e-21
3,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",2.55849590851394,1.61197990320839,0.831125876130607,461.218125367119,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.70627481521782,NA,0.470027892108086,NA,0.12621848199196
3,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.495625440522478,0.0970711493410042,1.35889193548228,1.98810421248344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.44796967922632,0.212028658946852,1.13016948102434,2.59478763004916,0.00206053297908006
3,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.470741007703453,0.236144097250557,1.01415145835297,2.55926501248861,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.420734445517262,0.327744016067774,0.880636381948839,3.18235810272468,0.13111238851356
3,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.529047916688384,0.21517365410846,0.382620612288863,0.889366271638242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.673750959219415,0.248995575203628,0.317941665881626,0.843797591002302,0.00788105962956038
3,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.495451582645602,0.146539486808287,1.2351358072067,2.19373410429024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.447790901356956,0.248269096873577,1.05493407976454,2.79176847778774,0.0179752286294376
3,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.635644018020237,0.0871177603256192,1.59388385577459,2.24267434924013,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.601249664209365,0.231666656963821,1.30492208346096,3.23574741343098,1.17457928600833e-05
3,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.298803244271673,0.320195877595339,0.723371378229376,2.53783727121918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.232503334441233,0.398028251704671,0.622955503808107,2.96525161668339,0.529279932079133
3,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.3305949240234,0.130985410663998,2.94386196639961,4.91934645906408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36203925804961,NA,2.34132363679734,NA,4.7114195836012e-15
3,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",0.411570719186511,0.208108505988347,1.00733276196888,2.27749547017669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.355974586823327,0.292977796174654,0.872647494086922,2.75172576570508,0.155070331171264
3,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",0.668293821920216,0.335047819836928,1.0323742890353,3.83904871114917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.636976020240175,0.466883032843739,0.8939214870193,5.57342925096565,0.0951377599836783
3,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.16137530298387,0.0965558027171815,2.65064569610923,3.87015694651853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17677405045001,NA,2.08228382172725,NA,3.38344109415602e-16
3,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.0765889387632563,0.149843395881655,0.80492708836427,1.44827289466399,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0107677306028575,0.208207722981895,0.686518765528756,1.55276553559751,0.939943019414917
3,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",2.32319562124973,1.73701785041818,0.465283312884422,421.523728292349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.44864349826915,NA,0.278201019951765,NA,0.199098824030676
3,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.755315231984535,0.0632893850611282,1.88147848609956,2.41125588816959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.732259721637287,0.249164656017722,1.48774794096584,3.9510091669259,1.11165088368525e-09
3,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.42932043958285,0.162188887814702,3.06762815557107,5.7931340558687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47010657981303,NA,2.47308579717821,NA,4.48572925284045e-13
3,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",0.0839945884358592,0.374871987355162,0.522768792975018,2.27244239259226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00265529193328907,0.442672325032206,0.441867537732877,2.50552551214984,0.988141320350069
3,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.506543618737426,0.08148708355935,1.41577846951484,1.94858415191255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459916629459207,0.204561948802914,1.16223931013344,2.59144772960572,0.000553930989244854
3,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.173082181066028,0.117490004890778,0.944759405879769,1.49739566441627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0948751440764642,0.187785725969214,0.799861745089311,1.66994406947136,0.571765587715875
3,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.711755767958074,0.0604674614795365,1.81105520196953,2.29547031636431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.684572801233554,0.236618954932956,1.43281903169781,3.62253158395742,7.51684288640403e-09
3,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.792077621370489,0.0776804057540617,1.89863747761337,2.57445563282964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.772506097222987,0.265962456387393,1.52110116146677,4.31452912063278,2.78711381129679e-09
3,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",0.263709388743286,0.323427437664282,0.69554481714441,2.47132001746449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.194084943072504,0.398597730817077,0.596126991098991,2.84388999393523,0.60400387162187
3,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.604230774420248,0.152536644703503,1.36252465494216,2.47755454381045,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.566864496786062,0.270850467976055,1.16359579857882,3.36433177293031,0.00358004898422249
3,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.699211155471553,0.120519205835328,1.59317882764966,2.5552699887185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.670842372163759,0.266246606090255,1.33348641528826,3.78658438552278,4.75446903197752e-05
3,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.0519615281830697,0.123055102597802,0.745385096138093,1.20745260085737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.151473048464094,0.175514493839713,0.630155596359508,1.25384604261469,0.350940093222509
3,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",0.0542423684468433,0.341957624561316,0.538248490792216,2.05651810018377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.035229563218655,0.40492768533237,0.458312910761208,2.24136317784792,0.920023345486236
3,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.304653640562324,0.113080432783928,1.08739872424846,1.6939371664903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.238898980029309,0.197578200862473,0.918317981868411,1.99228207445507,0.135364880513131
3,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.26917461368412,0.129007775222104,7.57295504122007,12.5570786159721,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.38953329946961,NA,4.95017278366909,NA,6.03815845776055e-44
3,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.719944739770979,0.294547921531636,1.1740717741069,3.72506570931569,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.693537091902671,0.433500012566119,1.02044654668019,5.58189958684676,0.0405522262984156
3,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.100705143045411,0.105717105230715,0.899092788600359,1.36074779907215,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0156503131813779,0.172107567347508,0.757261388991914,1.48676479038133,0.936663983980914
3,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",0.120707052306332,0.133829058520163,0.868216047132612,1.46709693866297,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0375618689012726,0.197122849850685,0.738578186643136,1.59948077681908,0.847147457097625
3,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.00013806886162,0.282273956053586,1.59798395879577,4.83188366441933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00029857966108,NA,1.38855594415999,NA,0.00209890200751562
3,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.703030085681899,0.141683792700125,1.53629043235765,2.6771718626255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.675023017047982,0.282460369629092,1.30130544259277,3.93768209836034,0.000247373213669426
3,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.560987805431265,0.182882666191808,1.23087698895374,2.52089448456834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519510449818598,0.28957757097149,1.06189461520298,3.30414554281189,0.0205130855537676
3,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",0.313903261725743,0.212671097332203,0.904442093799276,2.08176977712508,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.249052514065227,0.287314240571113,0.782191917862517,2.41233697843968,0.330886496570255
3,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",2.32319562124973,1.73701785041818,0.465283312884421,421.523728292357,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.44864349826915,NA,0.278201019951763,NA,0.199098824030677
3,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.243106587599878,0.195818079105249,0.870568911938701,1.87570465694401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.171514856949788,0.264514578544845,0.750028212782976,2.11537825092338,0.475821664999095
3,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.18111061396596,0.194957306285545,0.567871442555521,1.21939932175326,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.292867797308728,0.238415620900135,0.480939681859198,1.22453189244682,0.206368892190239
3,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.43106816160983,0.084994788539926,3.55092852353759,4.95492768852302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47200336160631,NA,2.64072097635828,NA,1.19966217868616e-27
3,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.124491632546555,0.088666188706445,0.952007389105003,1.34767729774426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0416706610340735,0.161463093400572,0.794897742129168,1.49687843581775,0.782015842491222
3,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.311643360631692,0.200680737664527,0.491039380230323,1.07834028523415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.435758457417098,0.239572606990329,0.413675334107026,1.05805628644334,0.0675313217500775
3,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",1.96106744588474,0.284122208989366,4.22357170142565,12.8638331040333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.05221615443032,NA,3.39880581169067,NA,3.27942699511346e-10
3,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.47172822998701,0.106478581334749,3.5512664380781,5.39079382839685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51653261729319,NA,2.69357741859797,NA,2.36614549689405e-23
3,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.0528347534785479,0.125974741504014,0.740347433235949,1.21309653931059,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.152430764479798,0.178053441122136,0.626424785312832,1.25888964286549,0.355450392449011
3,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",0.112927498005372,0.136644303501283,0.856723437996164,1.46374131890221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0290388934017563,0.198984323028967,0.72923840914234,1.59082006698812,0.886857169909711
3,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.23968781079661,0.0977349239500481,2.86121233729804,4.19695512075542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2625050721599,NA,2.22662930689292,NA,3.3936653951734e-18
3,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",0.254753558080749,0.32378285313612,0.686391692590941,2.44219842661255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.184280710412134,0.398267252216656,0.590024116017936,2.81113150417827,0.623106529837888
3,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.8411272163243,0.0842739442105503,1.96907555101263,2.73987407178595,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.826202499177981,0.284984982588493,1.58154193855115,4.8332585375049,8.85849020014974e-10
3,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.762597088120738,0.0922439954796164,1.79251765163064,2.573356193455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.740231231588147,0.264848945930738,1.46085758680783,4.12560403682122,1.53668953327889e-07
3,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.529511042849334,0.136474672679859,1.30295925108176,2.2246707141144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.48506440342995,0.245397120558516,1.10764254024339,2.8984408531619,0.00695880298030406
3,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",0.358524449769171,0.525035266929533,0.524345417964266,4.10619089955346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.297889068689962,0.638304150179688,0.433678521044845,5.29442582933846,0.613725374349391
3,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.753748812677136,0.223168845802983,1.38524680000678,3.32238905560465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73054702101358,0.366856169012572,1.20288047142936,5.06710085639072,0.00571729557312498
3,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",-0.0402274523581455,0.581414491387396,0.304248108071204,2.97186933619492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.138652010492296,0.66826211405829,0.249355095382656,3.42349527371314,0.825148085150392
3,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.31542754218496,0.443933596593615,1.66899719666681,9.51063538598169,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34545203283868,NA,1.41646367938832,NA,0.00678762627808981
3,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.835916345617106,0.115850485883186,1.84395518863515,2.9038527318685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820497986339354,0.301349356095191,1.52464207490045,4.96805018857519,3.27765778551433e-07
3,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.20617142134345,0.207775383206889,2.25226706502341,5.08554310607164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22582475059417,NA,1.91120101534784,NA,7.85753355869319e-07
3,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.435288584895312,0.148894103953887,1.15734825526509,2.07463568327224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.381927271510718,0.241930946737604,0.990001796038961,2.55564174167722,0.0463878763089907
3,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.222572043438304,0.095019038564839,1.03742150637707,1.50562199814058,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.149045044307838,0.175516858879565,0.86852072604818,1.72814679013782,0.307647048659343
3,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.157187298292158,0.192786889682543,0.583224022614994,1.24175637992675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.266679198620547,0.237196875989628,0.495441808277181,1.25544400122392,0.244953606500923
3,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.433513565644734,0.0636779553618772,1.36219528701558,1.74841659976605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.379981164992764,0.183808836637978,1.10364287581224,2.26853401198567,0.00168712948067511
3,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.19820867561996,0.0706375429665849,1.06177749962406,1.40051282132988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.12236708524251,0.157175020278346,0.874234404109739,1.61883704123423,0.339848816498577
3,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.240787908253716,0.17047369609554,0.911252377611099,1.77768014121732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.168991860213071,0.240183671376872,0.783657084976903,2.00916446224041,0.432187512151602
3,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.43049753746081,0.129035392696988,3.26692959030366,5.41763853267973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47140275661317,NA,2.55566738006823,NA,1.20976862405913e-17
3,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.40908472027428,0.0553595736738078,3.67530391297477,4.56601744099521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44796476476679,NA,2.63166229869678,NA,2.62234601644798e-36
3,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.56143424415139,0.0940038070981437,3.97736978044164,5.74947700080747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61473165625673,NA,2.92393005638048,NA,6.18200565077237e-30
3,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.476821886042327,0.125801860524527,1.26143029878438,2.06551681055757,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.427385278961983,0.229190747250554,1.06832847191623,2.623492568902,0.012020675013128
3,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.749601127804299,0.129776055094695,1.64653062112187,2.73842574167095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.72600597980255,0.285101581150135,1.38243698351157,4.22671685215221,2.75708482104473e-05
3,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.49114165248322,0.266166150664712,2.70871371293468,7.68927127194837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53779427577629,NA,2.29034295059569,NA,5.93945352614408e-07
3,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.594976803328682,0.107260741740406,1.47187547508585,2.24115599631236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.556733379233391,0.235705868084077,1.22760717940698,3.09261470780302,0.000289742247272391
3,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",-0.207806953827199,0.17333058939972,0.57703817405404,1.13836903863697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.322081198755568,0.215395490285317,0.48784832833008,1.13494487644225,0.126803609403933
3,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.43404883305194,0.11907896291399,3.3392141194081,5.32555239820833,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47528830076697,NA,2.58487801770371,NA,1.55246488598719e-19
3,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.77616391048352,0.192510450994885,1.50086143970973,3.19205955693087,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.755092437478121,0.343737321991049,1.29439264675059,4.98018544840343,0.00121096641032065
3,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.864574029644887,0.102684162379397,1.94589627078113,2.91024479204563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.851870233265156,0.303464920557483,1.58781020364388,5.21696839683335,1.19183176181757e-08
3,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",2.32319562124973,1.73701785041818,0.465283312884422,421.523728292346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.44864349826915,NA,0.278201019951767,NA,0.199098824030675
3,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.579210269031903,0.0852540760984547,1.51162657544835,2.11145252415092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.539469071650031,0.219476622961865,1.23995756995357,2.93119360606879,7.17049497886499e-05
3,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.09045960764311,0.151919664014339,2.2245640277625,4.03527758583849,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09914744766295,NA,1.84816164611103,NA,1.32377312072121e-08
3,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.466962126703822,0.123781722710353,1.25385041952403,2.03691129483542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.41659140366958,0.226239092591727,1.06112091913565,2.57581700433215,0.0133624466713795
3,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",0.910950669258624,0.321315264480702,1.35804978478101,4.78546108595532,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.902642090406032,NA,1.18100675609061,NA,0.0137779686853977
3,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.290240208572855,0.173168928714653,0.954301628275089,1.88143398060877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223128820407611,0.247215793591085,0.820513106687057,2.16245188343333,0.303120995964366
3,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.33286926584969,0.13804317252376,2.91260566494302,5.00364872329495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36455018467247,NA,2.33019600465983,NA,3.80228150020409e-14
3,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.301819008008407,0.0904260240870443,1.13331842657518,1.61544989526053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.235803382064778,0.18118057777872,0.944526548957104,1.92157148081729,0.0946769068525408
3,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.885624223839297,0.286213852851586,1.40735434711324,4.32170188357323,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.874920683761984,NA,1.22830919045751,NA,0.00792490191891195
3,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.466296665691374,0.168376434796297,1.15024994121651,2.22554705995624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.415863566877679,0.262809880670341,0.989263153813211,2.77153383983596,0.0480364774631922
3,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.667275554348867,0.179351331605435,1.37900754288489,2.78544701804217,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.635852108764746,0.305746628262819,1.18738580989604,3.93636949991514,0.00392293617958506
3,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.170103051674757,0.157487006362862,0.87142065424505,1.61560137825518,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.091611753915268,0.222250968995669,0.745752481007577,1.78219590913267,0.656828884428841
3,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.242881249157712,0.539619967696401,0.450005579466237,3.73137241837931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.171291117588864,0.641925718686679,0.370903105718648,4.59279218225784,0.779445556875455
3,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.47844013933674,0.078271472003472,3.77077768608361,5.12484251235038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5239178561099,NA,2.75639237949176,NA,1.08832305403566e-31
3,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",-0.0355463945984704,0.0978300539017807,0.796438057548965,1.16868693820611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.13351972977057,0.155363189327045,0.667843290581378,1.22790661854495,0.343676159367851
3,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",1.0866621160778,0.141477808331116,2.25945921842275,3.93420299445177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09498116311886,NA,1.86456716504612,NA,2.46653192606925e-09
3,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.36517916941865,0.0718572485226403,3.40800426121678,4.51679240758752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39991309428766,NA,2.51837720697823,NA,7.43362250134759e-29
3,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.576214053631012,0.0655332452171375,1.5658586041211,2.02449422354871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.536191679059877,0.209066119718323,1.25968563668741,2.85875531401505,1.08185381961171e-05
3,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.348914789473752,0.11390791816168,1.13483267084307,1.77357280821874,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.287360773257964,0.203335301267807,0.958261152332951,2.12638806881153,0.0730241998983209
3,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",1.25570960663025,0.17931963880337,2.49508873124386,5.03918498532785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2800574826086,NA,2.0777387863133,NA,5.75431460377581e-09
3,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.29465194582675,0.0769478184567105,3.14516027612746,4.2524477434614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32271181774163,NA,2.36682690549024,NA,1.33558411691592e-24
3,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.4288636477936,0.0584208162855767,3.72687416196583,4.68598082343473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46961734406083,NA,2.67145336672615,NA,2.93836362105995e-36
3,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.0701376930672636,0.167653098584041,0.670485844257088,1.29360821730884,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.171384598964175,0.216200009464486,0.570247123414626,1.33083025820346,0.399733754137315
3,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",0.173315972931856,0.253696395844336,0.724182916822035,1.9576804465166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0951385609474478,0.317698154580822,0.623302405699052,2.1654547948707,0.755869205834408
3,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.565466936504413,0.108268376866291,1.42602378829362,2.17993321787807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.524428024812302,0.23098981516711,1.19196673536679,2.94782643984456,0.000689519331751157
4,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.437007962872015,0.0902323405926594,1.29700488059178,1.84736803793018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419919183012312,0.147602792366425,1.15622386774797,2.06215535123897,0.00321485695400892
4,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",-0.0655510029045129,0.0652653376040105,0.82377452938937,1.0639378806715,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.07554945102164,0.12107680708621,0.739476794579003,1.18862833816695,0.496017663198762
4,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.96963200673478,0.329468818997669,3.88034101905271,14.1175270667362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.93094969746379,0.373673949117902,3.43140186846251,14.8461986624037,1.93908149756712e-08
4,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.542100734070287,0.0856226034525727,1.4538639217379,2.03370494142291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.523528836783141,0.147689577008851,1.28333404330017,2.28963843513009,0.000164808343197993
4,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.428271362184195,0.628320104919399,0.456477752576979,5.35887592660128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.411307292292198,0.632974914915608,0.443191646557019,5.29870833752972,0.522774200815776
4,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",0.799366408603809,0.0365153338481527,2.07090310709054,2.38959112572019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.777148615222742,0.134713013745116,1.70037568510815,2.88323961496143,1.12180469366835e-11
4,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.50566127527066,0.0914179361723849,3.77057821708879,5.39557993486315,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47349889662752,0.181869911146712,3.1366867464202,6.39863072315761,1.39486649473062e-25
4,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.53142190917414,0.032749044072069,4.33837573864407,4.93263791066888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49889919590418,0.162014905698899,3.346172259439,6.31484899685191,2.11886279874108e-40
4,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",-0.0256381998941753,0.183706415887028,0.677307952313772,1.39164525808354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0362112341667939,0.209123067416713,0.647446037688547,1.46965478428391,0.827912621781912
4,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.523696015245468,0.176904942790783,1.19764923761678,2.39603502908964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.505373391475902,0.21249584489193,1.10983859526925,2.55278010050931,0.0154256893932347
4,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.639426030152162,0.0552291787590553,1.70103021939012,2.11219666930416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.619478517822038,0.135712317161925,1.44732154012604,2.46378095186693,3.89427808602477e-07
4,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.70122723991949,0.305755214773667,3.06443929991795,10.1594370721553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66631058969406,0.346437851300299,2.76459585186048,10.7500013640141,2.23580918945278e-07
4,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",-0.0739869872827251,0.0668487589255178,0.81430229539951,1.05825223051898,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.08386644066518,0.121720689733377,0.732390809808411,1.18021346161555,0.457790993359594
4,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.534096638011438,0.384430819117873,0.816397273598507,3.68432352116547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.515640112751092,0.39931016665692,0.77782377106703,3.72107198512239,0.198816915239904
4,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.49953981278981,0.069869929524246,1.43676885135884,1.88944253416201,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481569437830823,0.138106512647015,1.25347837416076,2.15392114136155,0.000211271084081869
4,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.0142162402914933,0.111843528321941,0.814063941631093,1.26200561214974,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00309270249467749,0.152303748441561,0.752881228068588,1.36775666653672,0.966517873993843
4,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.102603755181016,0.0779349655695013,0.95047839985143,1.29008693677983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0902246502824066,0.132082501105257,0.855102781665622,1.43507955329707,0.540615753774744
4,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",1.12615045982218,0.34984797808714,1.59587952547656,6.28901138031192,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0993608633226,0.37487009887206,1.47149822999747,6.39646101601102,0.00255011289552275
4,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.601571580558695,0.0939622564319663,1.51885645035225,2.19522158966439,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.582162308546341,0.154165906135891,1.34435036770599,2.46016924344275,5.29307973916206e-05
4,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.785739588327713,0.0896976044172538,1.84183723391137,2.61789803343199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763733191912832,0.156875549714173,1.60617420102048,2.97069500397432,5.69814200677077e-08
4,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",0.4691034713489,0.617277504306942,0.490069994415644,5.50951336902909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.451563441315352,0.622537351105865,0.471079622290431,5.40634586931254,0.47441575790193
4,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",1.02830492497223,0.356215808903713,1.399481767775,5.65444699631586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00289785155202,0.379233226335218,1.32332678439157,5.85160386083059,0.00682417837066272
4,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.54563622376086,0.0287176569982725,4.43442338095537,4.96279325569864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51291389367393,0.161873225094762,3.39504250862542,6.40351888069952,6.65206356354085e-42
4,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.503964682285227,0.0331010914432922,1.55145841459431,1.76641010074006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.485933422845009,0.124089183431455,1.29406803765994,2.10478102337952,2.1144509664855e-05
4,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.319410422702715,0.156327098892772,1.01353187385076,1.87054924748966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.303982210972664,0.192032945566653,0.942971966591989,2.00177960940874,0.116767788496959
4,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.111914522607393,0.0860775311799396,0.944283279482834,1.3232471107803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0994099295374512,0.137157264676034,0.854494186225821,1.46287110918047,0.510925040799815
4,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.19765633544914,0.15948660119154,2.43546679964611,4.55085183094575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.169809222226,0.214436154301248,2.16339997005212,5.01410691698049,1.07632578381447e-09
4,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.324461367455766,0.121389992573661,0.568883533340521,0.915541555071077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.330780971002849,0.153331995377462,0.537015953789493,0.979535206823882,0.0341206933337739
4,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.878099479757732,0.106566077177252,1.95215535313989,2.96437262940844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.854790285243098,0.169509778595295,1.71785468455638,3.33856928708164,1.78064727429171e-08
4,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.854293289928754,0.120551561394003,1.85689878538253,2.97862329950118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.831302463582119,0.177826499830218,1.65049443925433,3.31395378493926,2.820986831414e-07
4,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.335480019225236,0.0593751852089889,1.24482928035853,1.57105103665047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.31981915943808,0.128512190661292,1.08511395168057,1.79578730644064,0.0110564255743486
4,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.268651442865435,0.105615833293411,1.06347401560106,1.60889463542174,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.253941226312217,0.153343234027104,0.967223511575019,1.76432602310583,0.10192866945183
4,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.39107330495609,0.107818633113462,3.26025277226584,4.97510265917171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36052386471173,0.186459285323846,2.7721350578461,5.7576233110245,3.54799027759045e-19
4,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.26542602569269,0.199977830087421,0.876262326662382,1.9190090176238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.250759007690876,0.227440095149642,0.833859375368026,2.03370303151144,0.282412797100678
4,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.0152551890673,0.0901050347313985,2.31541749582531,3.29628231052968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.990015570579217,0.164121656437829,1.99030827621156,3.78722897610157,1.87317004588601e-12
4,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.48680681694783,0.0561510793865746,3.96338836600691,4.93922034562217,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45493067629591,0.166386228200292,3.17285926842352,6.09126141007414,4.38045102494527e-33
4,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.1786683393327,0.0659467997048965,2.85685704327047,3.699615107629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15109380459462,0.158163253725974,2.37007155361627,4.40574207886239,8.44981952269016e-20
4,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.799654530567097,0.0318456322541215,2.09041101104321,2.36834947199087,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.777481321085318,0.133559502090509,1.70470569498361,2.8775410020498,6.13689175441111e-12
4,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.0154640400664228,0.0996111587244358,0.834799287954535,1.23356038549237,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00432982877551543,0.143778714076723,0.766509424473814,1.34674950817805,0.971330256011931
4,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.440265221518053,0.0783825282346935,1.33158593517821,1.81053888779659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423131630725833,0.140900895464324,1.17530752997142,2.04183967303502,0.001746328556068
4,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.479199138933223,0.100652615905586,1.32616266157121,1.96765122402147,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.461516310070956,0.155108659616101,1.18814736288865,2.18236691614055,0.00197132932849379
4,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.7216541280406,0.151596165892615,1.52899076072078,2.77001832284368,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.700577750480047,0.196684962632665,1.3938848665609,3.01345000334772,0.00017174408297369
4,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.69917371130704,0.079349028291744,4.68779862613138,6.39812879283263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66428063808812,0.184008709380454,3.79122220395708,7.79895175920081,1.07003165806361e-35
4,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.35661989129272,0.0476805087121454,3.53766970166048,4.26470236779263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32656149539172,0.158474887664524,2.82920658878348,5.26565981952206,2.2078704448864e-29
4,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.620067137490251,0.0566389562754663,1.66377939773501,2.07739018880771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.600393224515544,0.135681423699231,1.41980475455478,2.41664634938098,1.01137094867099e-06
4,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.168719539202738,0.101850704275598,0.969685241539295,1.445512125604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.155416717110752,0.148586776767076,0.884049572375237,1.58281882116513,0.320585405238215
4,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.808064995340307,0.058450395738671,2.00103798495074,2.51629449145074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.785742375232758,0.142384584097612,1.68956207001498,2.95236539761011,1.78150922461406e-10
4,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.33015480037831,0.0485971499550587,3.43901309459437,4.16069391329996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30046967964221,0.157700718864375,2.75957001666122,5.12049101155766,3.95646505444123e-28
4,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",-0.197474326847723,0.782174317909753,0.170083776561803,3.64954617940911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.205613646051921,0.779739691870988,0.178641916806528,3.79677296139794,0.782273332947201
4,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.952758305598988,0.361784279267441,1.28493724869544,5.30621194079912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.928384443523758,0.383293136501562,1.2176120795897,5.47051693171429,0.0136192213219227
4,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.55982069452919,0.511322654432774,1.82542694237832,13.5469560324762,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52689572231349,0.532554952911063,1.66755520160479,13.4494156318595,0.00323831723327736
4,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.11654678166176,0.0944509563411881,0.933090741518968,1.35119328980028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.103965912493174,0.142545742657111,0.84942778820037,1.48524047767177,0.505953609082847
4,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.821314722345726,0.0830266650431419,1.93269638133781,2.6761378734491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.798806494770475,0.154302854655452,1.6724847262702,3.06230057804157,4.83485525306774e-09
4,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.5287186976402,0.0702559162340737,4.02212179711693,5.2973553457657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49622266494863,0.1732701867333,3.26436837763487,6.4383541630623,2.27135141541906e-31
4,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",-0.158700174535002,0.245293637940896,0.52604547601679,1.3759794135633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.167384644902259,0.262300762681389,0.511268363677013,1.42952102819691,0.50356557090603
4,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.759966347058522,0.373304820434849,1.0482374846086,4.52871472600275,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73832358730362,0.391470706208278,0.988904891947444,4.58770478644112,0.0572758641273669
4,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",1.04085263855931,0.15953053443517,2.0723323731977,3.87297492871798,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01523053567764,0.210322225248507,1.86511933201146,4.25363116243168,1.26226012121208e-07
4,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",-0.610523701184086,0.879429119815306,0.0895174347491228,2.81222766489038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.612843656022346,0.873603698357851,0.0987058386577228,3.03087813902398,0.47620756103852
4,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.22478958220062,0.0607142759768714,3.02229564115938,3.8343973479851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19660871585261,0.15780353160786,2.48352157211905,4.61012982802406,4.03115810748265e-22
4,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.428271362184195,0.628320104919399,0.456477752576979,5.35887592660128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.411307292292198,0.632974914915608,0.443191646557019,5.29870833752972,0.522774200815776
4,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.84138514951184,0.0938979439677112,1.93106431153692,2.79028707407409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.818593645728924,0.160895667323651,1.68435776914172,3.16478072401936,1.10993073104302e-08
4,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.04242150374587,0.134060193650018,0.801859364736413,1.35619673044838,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0309054197270986,0.169450009678676,0.748668095282271,1.45466016265871,0.900135907112969
4,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.824220721065684,0.0804650857654744,1.94802728994367,2.67041677185936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.80167148408176,0.153053579986671,1.68143815760112,3.0636544936938,2.83509987082293e-09
4,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.828578490889843,0.0646146179982393,2.01775805640916,2.59937666040542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.805967334166162,0.145637084941031,1.71347903126637,3.03257686164901,1.67899635437676e-10
4,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.42362524617899,0.0642681717621643,1.34661425938753,1.73242141243195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.406724183296048,0.133245593301941,1.17350118956748,1.97843252658039,0.00142141542174647
4,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.0572206305554504,0.110446384539389,0.852575284747303,1.31448914685234,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0454904930110681,0.152164191258782,0.785909086251365,1.42697741237185,0.814004531628601
4,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.43940505545785,0.127792028872617,3.29147384893421,5.43180228320503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40817773833578,0.200097328744725,2.83268446719702,6.20646786614223,2.76969223398939e-17
4,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.59111939565862,0.12003597917534,1.42818380882531,2.28630268641791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.571864816596258,0.170732767774926,1.28797577206675,2.51514880459263,0.000428261222354886
4,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.413782067205658,0.219960554938211,0.983695635870115,2.32981948069471,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.397045299051726,0.247058671410991,0.929837270364219,2.44906546717422,0.109189696274518
4,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.687742969201488,0.382285666884107,0.943060185837346,4.22030374609679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.667119001992836,0.399020514183778,0.906805054922045,4.3331895517749,0.0933095798007232
4,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.263545062406977,0.0962375890160379,0.635306067168117,0.926441863435681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.270749422601062,0.135912162523214,0.59025073880794,1.00557351041957,0.0501948798152745
4,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.303363412253972,0.0608058787086839,1.20208246167299,1.52563406216428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.288156451928693,0.128280957270002,1.05152011142899,1.73861523548179,0.0232723905676054
4,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.69375843643185,0.181258841044485,3.838088104937,7.81071066480906,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6589427123697,0.244965002923015,3.34658295455744,8.74240198097271,2.46069914353775e-15
4,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.375653469253979,0.123884987609076,1.13998915010721,1.85269062205545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.359445728662439,0.168480767356964,1.04424931822105,2.0212795343403,0.0312958762218343
4,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.444591410039625,0.130075987254543,1.20899923130769,2.01311130126558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.42739776399618,0.174474659788733,1.10522018271161,2.19015578126018,0.0124113301164118
4,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.282821345543634,0.182444399168788,0.930687406747328,1.90282016731023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.26790900933515,0.212806971253784,0.873063941275811,2.01061675032968,0.217217983301573
4,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.0802309609637031,0.0700389570093812,0.9441947911869,1.24249925448873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0681748683727912,0.127131604055826,0.84447721667248,1.39000759188141,0.645599918236854
4,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.57941248127307,0.0821779373893985,4.13560940908734,5.70741548205067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54620842208145,0.180365940771483,3.38685096314002,6.86833738584712,2.69786114556917e-30
4,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.53182534686653,0.562377226899537,1.62860978482508,14.764194795771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49929516162557,0.580750728022183,1.47572820702165,14.3773289787842,0.00833740912863472
4,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.188818403757486,0.138648660656585,0.919655198742686,1.58365631915409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.175233933680608,0.175708236395921,0.855198361288653,1.70291552157736,0.340141460974637
4,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.45267905843598,0.0731421953015123,3.70698070498866,4.93784922192271,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42125675011917,0.17144413869174,3.03616675538606,5.94555842991783,8.36052701227114e-28
4,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.225928305023615,0.23548681285881,0.496418535101015,1.24951497594236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.233664361562046,0.252618759151443,0.487446261276597,1.31215668982726,0.341534490724893
4,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.341884541096861,0.166887280915603,1.01313695930866,1.94884626394197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.326139147144438,0.200975153093036,0.947514264729364,2.0831784674309,0.106890523953677
4,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.389909700536045,0.189178221195707,1.01590519814011,2.13260670424268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373486764117389,0.220267358031594,0.956965479893887,2.26923828537386,0.0906640444138992
4,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",-0.822415442436672,0.990337364334085,0.0524181798621548,2.54352096896892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.821747082035331,0.982065107877847,0.0647119936918711,3.03987307554638,0.397372889362909
4,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.127498673678608,0.0881117868788392,0.739650285166824,1.04478807487853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.136623478642391,0.133176201228986,0.679119915305619,1.14463241983035,0.289342791266987
4,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.468135036030163,0.0382579509564382,1.48180429559167,1.72155659024119,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450608897234856,0.124424119163869,1.24797885096768,2.03248444282167,0.000103518202131214
4,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.034802587709528,0.0415787934946902,0.954392091565848,1.12333864145825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0233889452011187,0.113031584953909,0.829868314405888,1.29251175628272,0.90398076318216
4,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.657768797775827,0.11390744998268,1.54285567584956,2.41124698129063,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.637557574603625,0.168240859978072,1.38298305908917,2.67442620834114,5.21574462968314e-05
4,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.21780912383447,0.131792595345257,2.61848994674593,4.38949978333202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18970097457378,0.195658053781188,2.29003378196349,4.93095187149109,2.43546478343477e-12
4,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.139341147361265,0.0349822457188676,1.0734213354319,1.23118724105699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126453666398708,0.113724986259008,0.919339202300842,1.43575899970956,0.299075680801779
4,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.333580603320712,0.0769574582680661,1.1997502542113,1.62219651889765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.317951746292519,0.13729457929819,1.06459357276502,1.82353689823176,0.0188370674143007
4,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.702388327102242,0.116744151689214,1.60736859026647,2.54016005120568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.681557797265463,0.171279014694373,1.43718768549123,2.81254455177023,1.92766857792772e-05
4,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.64878257085502,0.0996341290731357,4.28702613928616,6.33539329148116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61460216224841,0.191516927955388,3.55196760519596,7.52502601200764,2.42792117291881e-28
4,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.50034914636955,0.0509459448091612,4.05906454787446,4.95628750758496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46826302763823,0.165289501337473,3.22300319409654,6.16098417315412,6.64249801953185e-35
4,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.122982008364178,0.194678754299011,0.604381628715462,1.29638192406733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.132170234127034,0.217317011170593,0.578493524000051,1.35599988317636,0.519132854245866
4,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.483052644912186,0.147854289756381,1.21512627285127,2.16934692368699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.465316004764024,0.188639398571649,1.11688365548135,2.33963564776885,0.0117648291987251
4,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.071835045175559,0.16879724274759,0.667802033729313,1.29422172106235,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0817447759555253,0.195756834328128,0.634854657081106,1.36751263840179,0.644643870155114
4,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.769243747351837,0.199775758011795,1.46549324058561,3.20687983423346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.747473663314152,0.236081243243393,1.35295245171232,3.41340618534239,0.000998390295443678
4,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.571827759390133,0.0719666823107171,1.5379565861085,2.03920261005377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.552838084258556,0.141220425697246,1.33869416109543,2.32860302730436,2.36737351285876e-05
4,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.38520277064111,0.0651394750012869,3.52471503799768,4.55006556459834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3564251047375,0.554438898405048,2.1741304726973,19.1057501924875,3.57264000568545e-12
4,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.154538320034554,0.0689949698928048,0.749379940869396,0.982108146676302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.127040060707144,0.209637199637065,0.626849146271724,1.42577191081991,0.518512082040556
4,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.180795187906132,0.114717099123969,0.66913665551048,1.04908231258035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.152336187276429,0.226397198005524,0.590563838711649,1.4344523933839,0.47997658247306
4,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.395996834246413,0.11778110210479,0.535244163266021,0.849303378782456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.35967220673133,0.210637983684805,0.48847020004154,1.11539534463991,0.0973935626728152
4,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.408304891148487,0.0542414203170757,1.35409046647693,1.6748983001053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.415232306204429,0.272405106174744,1.00860266160562,2.93402225289536,0.0304589496467916
4,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.0493624310578116,0.0485397879378881,0.955973423970309,1.15632550211555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0694127362349479,0.22525758310823,0.751983836771008,1.81839283151452,0.714649452921801
4,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.455661541783023,0.0491870567463555,1.43361763502292,1.73847933173895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460858314389226,0.278462383089322,1.05028047055826,3.12867542200989,0.015620279497726
4,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.47967027820473,0.081421259777515,3.75691404771623,5.1694348123003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4474367263658,NA,2.3230513476645,NA,5.4839265249472e-13
4,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",-0.0252168909670328,0.0733966348377931,0.845833942986982,1.12780954779041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00242186222962991,0.223994681978606,0.697216220891565,1.67763207327731,0.991230290241869
4,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",-0.0183757765658131,0.0376329995924489,0.912358234343941,1.05738204298966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00415413614388991,0.215633773198438,0.713696549140311,1.66191649327981,0.981284290187107
4,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.39413785077665,0.0845712603182505,1.26012663899254,1.75545041682276,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401602278203927,0.278433031554646,0.981665484508576,2.92394213525076,0.0465746359081871
4,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.50166597367367,0.0786963224786088,3.86007708254313,5.25495304188105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46862850958208,NA,2.36453555140304,NA,1.90384327100136e-13
4,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.4519019558658,0.0504734633146013,3.8740095706821,4.72157474332945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42068805463503,NA,2.29654582087855,NA,1.02345909111259e-13
4,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.191412264111158,0.113167928248677,0.663033637232824,1.03322044693398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.162565184334375,0.224692902798546,0.586069420830615,1.41405712084189,0.449329865347286
4,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.637820095349615,0.124954119171101,0.4139715619753,0.675604892876408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.592655827312251,0.198464004754974,0.391675021465782,0.852690864588906,0.00722269365511079
4,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.263986873621766,0.10430992254875,1.06470001137252,1.60252492397021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.276176079038182,0.268276089766331,0.869262219328755,2.4880829064288,0.18868037189085
4,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.700927028910159,0.0528452319982739,1.81981565524024,2.2386762034619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.697157136146189,0.320794920498942,1.27838258401683,4.49555285584214,0.000273387009228575
4,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.370567031701305,0.0700906281356762,1.26476921436795,1.66469159808421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378872759063922,0.270822302474736,0.970787939792135,2.80655201771396,0.0539219405130319
4,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.749701347842874,0.0847056116830763,1.79846856910228,2.50672069821938,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.744134298557481,0.337734820906694,1.31080124793485,4.92603675198253,0.000228043009375553
4,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.074566483144814,0.182888112135496,0.760218752207108,1.55699731862158,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0936836125113115,0.289142101344246,0.682555710915423,2.1201886754093,0.712845271546556
4,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.482322849267934,0.20324605650047,0.41720061908013,0.925447226242779,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.442841164310392,0.261877376590064,0.405035953330827,1.1306141840836,0.100190821070852
4,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.0197531464465845,0.119663041326769,0.778676553281174,1.24472046130018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00281655674406909,0.243746702031423,0.674879658470301,1.75461353889696,0.988680196277486
4,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.782097611519594,0.0571862227610656,1.95732707948719,2.44916140331137,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775376758612482,0.337686943982655,1.36188653652466,5.11705661699427,5.74221696792489e-05
4,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.49904739581626,0.0548734605377312,4.02763074018524,4.99420534889985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46610863823726,NA,2.37730805743182,NA,2.33391468144803e-14
4,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",0.75574600973227,0.20888669274691,1.44313494888625,3.27277609792866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.749971716209067,0.39544767254436,1.1855320508916,5.58630492743636,0.00602923355711045
4,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.546890900706423,0.0632925276593914,1.52876908164118,1.95925645036091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.548751508913058,0.295815986645907,1.12461679278371,3.5859366487199,0.00477335245290171
4,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.23875959936821,0.0601033806547747,3.07273085473676,3.88906052546008,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21533729358579,0.47031839104991,1.94618502539478,12.2985980295762,3.41860723786929e-10
4,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.112265836874434,0.0853933271981948,0.948744640066526,1.32593794483288,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.130028196504756,0.243045313799483,0.776338684160475,2.01285420631537,0.51944877378119
4,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.743003803858014,0.0822047769941191,1.79477109539355,2.47716384503508,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.737678947927468,0.335716730916832,1.30547740910837,4.86737222763167,0.000241354096418902
4,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",0.25642871534379,0.859264715979617,0.308820153012589,8.96438578711943,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.268908846518323,0.923282217583743,0.254983829414383,9.51286067305904,0.750983937658354
4,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.26543937322509,0.115686907120422,1.04405973556793,1.64312686030808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.277582171960366,0.273247327062465,0.862341740408841,2.51684517750091,0.197829355843293
4,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.31046853453898,0.798147700610896,1.03744496608468,23.6992267744863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28441786293578,NA,0.769529386942556,NA,0.104284502408787
4,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.168165778843401,0.111495437334018,0.954620193550249,1.47788551856785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.183862585171345,0.259845370931431,0.797451376270496,2.20833915797544,0.38888944505969
4,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.379966238016884,0.139570484624637,1.12002979099863,1.93568550597398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.387926987612757,0.299007487992572,0.929267450641513,3.00035052779417,0.0893461784941927
4,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.12414372331443,0.350785343171979,0.595329947904763,2.35470106946813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.14146467924047,0.422178538536792,0.557392554722282,2.91661570791883,0.712900283171664
4,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.019916874930538,0.0513895904234494,0.92314835387296,1.12916471092645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0410428402787648,0.222629283215468,0.732836178984779,1.75392767373491,0.829006914080826
4,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.0856191196589138,0.0388440071698748,1.01003275600173,1.17615244614237,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.104346984687255,0.227501357329383,0.777831031070116,1.8975108939686,0.578927457704139
4,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.0513726502878739,0.0661388874146581,0.835343611362602,1.08258050371352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0276444600373204,0.218990396130891,0.685078352689601,1.6164049474176,0.888604724945992
4,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.446665735216446,0.0586303335988924,1.395308202029,1.75583057792023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.452190388602925,0.279042026025821,1.03875560391112,3.10138288637543,0.0191806091147508
4,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",0.210409538248597,0.202560505455563,0.845052806024753,1.86949142666221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224566189158706,0.3155765236649,0.749432542108761,2.58208773714582,0.402786262643217
4,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.671010540770144,0.0681972126889033,1.714811262872,2.24034794230605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.668345894569864,0.318441377864344,1.24048615570403,4.32222634626128,0.00065025719657083
4,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",-0.0649280986448433,0.090845773097192,0.786540519470171,1.12299345515854,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0407043614408716,0.226353847420751,0.665908244923559,1.61718565600258,0.843213819495685
4,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.00404434751596432,0.0611708373191103,0.891580601770359,1.13317773597467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0257486543175276,0.22339114488897,0.719699891158316,1.72763984425423,0.893273749782094
4,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.44083172188455,0.0909963562332651,9.65523255181819,13.7935234064785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.3734697087192,NA,4.67006577652513,NA,3.76733799125858e-31
4,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.73200307807666,0.317380345824371,3.20206224038042,11.1106393226516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69054369544808,NA,2.34335901874166,NA,2.21505298781755e-06
4,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.788548139492282,0.196880726583195,1.52425060564997,3.297818370018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.781574726988337,0.394587358421548,1.23458788139179,5.79787364634347,0.00314992986162661
4,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",-0.0562540656841495,0.0569653009326354,0.846310425994107,1.05805341984932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0323475918070106,0.215882632007826,0.685725504599495,1.59834144837641,0.867815032399911
4,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.19784633334293,0.193869464721218,2.30966288924559,4.93847172340445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17590882815569,0.504168168819774,1.7319199869462,12.4975611620498,7.5708170490024e-06
4,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.164185148186,0.198565393431854,6.03473236486992,13.14305583563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.10692909487289,NA,3.64010718883086,NA,2.31516631964998e-15
4,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",0.316786199470621,0.880808563860649,0.306779799827616,9.68987059888581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.327059234800831,0.953320938554104,0.259503917276077,10.8913176890095,0.706253556108926
4,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.517130962453543,0.10710827887951,1.36558766626666,2.07807419870022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.520070795368081,0.30450959994432,1.06995624360575,3.52991380036279,0.0139355947902592
4,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.4498934037318,0.0998003005120068,3.52344465514854,5.21036075208078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41874721396926,NA,2.25337160043436,NA,9.54456466542826e-12
4,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",0.213708912364197,0.21597769374609,0.827052796163464,1.92847639209355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.227748306045426,0.324973327987542,0.738652404299458,2.64043640746606,0.412542731443095
4,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.708411509696457,0.135346114704241,1.56910426657971,2.66726058140358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.704366747955054,0.348190988772269,1.22484363233869,4.79559018532244,0.00183314206336022
4,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.686499990847674,0.0666481381606023,1.74645869938229,2.26788127860143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.683268750721201,0.320941923248249,1.25688594941936,4.42250560537976,0.000474658460135682
4,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",-0.040530608585687,0.0718227565728082,0.835499397206293,1.1071779381541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0171986680263644,0.221893008147907,0.688971385314778,1.64419198531356,0.93162025327602
4,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.29638811195004,0.0499605032993315,1.22063486688026,1.48469992379086,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.307407582734344,0.255861757118854,0.92188073648506,2.51335934081533,0.10705931947558
4,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.465797689742602,0.0464669432329915,1.45580281057704,1.74665857797432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470624266854381,0.279516412874047,1.05996929186231,3.17061045658645,0.0132452466199069
4,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.710142358043419,0.0348271842734313,1.90102801859979,2.17910633785365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.706036495801633,0.319801371906034,1.29453838775801,4.53467092056499,0.000168911206923547
4,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.783571299968898,0.0453262770524924,2.00497180986397,2.39481442110934,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.776780425963218,0.335932989027551,1.36874863823249,5.10760210709447,4.25562940529006e-05
4,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.64721461788231,0.0952945214996063,1.59189647227068,2.31283423832789,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645395461335694,0.321838295720679,1.19936152325616,4.23495324609967,0.00174980647923122
4,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.728016018738206,0.0479781818959038,1.88697756040249,2.27742949334564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.723256002900595,0.325165756876357,1.30845881811219,4.68083407342127,0.000145213724240345
4,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.706256355140064,0.170359761457717,1.46838288141411,2.86325677169541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.702291107198745,0.364668182560136,1.18465527983063,4.94770997104466,0.00447050245622697
4,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.319237424698735,0.108223013893548,1.11773387530816,1.70835296681523,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.329410022017974,0.276897116208113,0.907507152611872,2.68683230832752,0.120162754022368
4,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.270003244832254,0.0652036640410071,1.15424535707148,1.49039386849054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.281985278338946,0.255945155332759,0.895918570658933,2.44337632321068,0.148057462411931
4,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",0.886639759022392,0.330311634696569,1.3352353580783,4.873953378737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.876090120482885,0.506820535615329,1.13457863746335,8.27270325392085,0.0172409703932128
4,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.41871234863083,0.0636287183851378,3.6548385353711,4.69018444366096,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3887096996112,NA,2.23140524434464,NA,9.64109814562533e-13
4,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.124376018826742,0.0893687261139623,0.743051078166801,1.05477605924537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0979793746406476,0.21999567530377,0.633836338244622,1.50140704924565,0.631678434988632
4,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.304076865426875,0.126159694256537,0.578105694976168,0.947942294216147,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.27111178330632,0.222277711175306,0.524494805669823,1.25356671772617,0.220688331920884
4,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.745454830491979,0.0362537607588458,1.96399042288481,2.26390333838933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.740057778702212,0.326907164069419,1.33103575554451,4.79421478769992,8.23649404200962e-05
4,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.31719068847801,0.046219447588176,3.4133032081085,4.09127808095498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29090387523831,0.506228524490097,2.07492597947165,15.094113485191,1.08982658329595e-11
4,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.4160816572955,0.0358013371634852,1.41392778454017,1.6269549799988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.422728142676106,0.270317015600788,1.02131875435058,2.94679435037896,0.0244080705193506
4,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.738728703685727,0.104532037137887,1.71349050192548,2.58129335903399,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733571785726663,0.341833994157429,1.28415779656042,4.9040810543765,0.00048743112737804
4,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",0.073073373494892,0.145872478639465,0.813335686786201,1.44079962291485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0922440196366842,0.266752918561367,0.71155665616105,2.02455918584552,0.69020084748659
4,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.32541055882851,0.128867481948727,2.94811255774641,4.88571871429599,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29881385528267,0.534229995113038,2.01492318615999,16.3581161276856,5.34288482429563e-09
4,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.475942451705828,0.0372276133805167,1.49703101040203,1.73223656063543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.480399756293326,0.279609891707123,1.07174323797688,3.2070039490075,0.0106489064074214
4,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.41248525816511,0.0333031472919919,3.84877570737001,4.38548857035307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38271662311258,0.572600562232154,2.23675967224169,21.1065032243516,1.6407130038807e-13
4,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.96769716924536,0.188734675450557,5.04270431910172,10.5673477129164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.91762251802192,NA,3.16578936518187,NA,1.37642208176182e-13
4,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.606817941750425,0.0485485665391884,1.66964868613626,2.01964170223871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.6064886540032,0.302925835068162,1.18711668590365,3.89220123373504,0.00145383813047328
4,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",1.22968338657126,0.0937653168073594,2.85946790883976,4.12963427401955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20658746651987,0.474461344690524,1.90694881550393,12.2479525131187,4.40130574284968e-09
4,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.94145066968054,0.108091372274055,2.08511107629557,3.18525554982005,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.92888807719937,0.387215269196805,1.5078870065179,6.8796329566161,1.18048714226552e-05
4,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.552404119265571,0.33689330814838,0.942169807263228,3.52904657728461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.554063472854069,0.455464026547028,0.837710850959742,4.99433311132972,0.137741838691277
4,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.519891463138005,0.082055846538189,1.43627228317698,1.98120267666598,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.522762001505312,0.296444833815643,1.08982872608029,3.4835885228977,0.0092514959626733
4,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.41406948208284,0.043318750357196,3.78154817868536,4.48141963020072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38424063623424,NA,2.23518656551624,NA,2.67756704782775e-13
4,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.27724283645127,0.204393509169831,2.45459644042596,5.4694069850035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25240438091773,0.546164152685548,1.82822773271346,15.5532743151918,3.49789595439186e-06
4,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.175997911741517,0.190490876596843,0.582250415657461,1.22857610266298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.147693100311052,0.272846940978464,0.542381007689499,1.58051982631965,0.571264317245506
4,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",-0.10720593937231,0.927387913128425,0.178200562785255,6.75611629965916,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0814402729942594,0.960172489855945,0.158773426790482,6.84507842788674,0.929113508376113
4,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.399953371715532,0.0684975564249448,1.30661302696225,1.70906049387334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.40718498333356,0.274577498168329,0.995249932578055,2.9199387204264,0.0378105702460229
4,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.858543240735309,0.0801228433943391,2.02287931480918,2.76930856812378,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.849004237924816,0.359348228495179,1.43337065382728,5.86292099532867,2.21989888185664e-05
4,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.58373957242353,0.0771252327173204,4.20249261515521,5.68597823784509,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54770163744268,NA,2.51713631108218,NA,7.63390437274269e-15
4,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.594440669710562,0.060783225822755,1.61080164809756,2.04418226703033,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5945631890014,0.303202647053767,1.16996791904936,3.84014015757868,0.00214666659995841
4,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.27841954198629,0.100158571482289,2.96595849794918,4.39213146554008,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25354156482587,0.498553672640628,1.97427348863286,13.9362723425225,1.79458460833357e-09
4,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.48296895204371,0.0458788863162565,4.03154256083227,4.82586986681546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45061980954069,NA,2.35359408169922,NA,2.21257452877377e-14
4,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.331227452739925,0.0626727481472137,1.23313053337686,1.57653396357195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.340971668755716,0.263450772231653,0.94341401697082,2.64973066831241,0.0791492046106236
4,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",-0.100745594727606,0.052510853043454,0.816404322104205,1.00299769168463,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0752142103632363,0.210179961656904,0.662036975102108,1.50901397261555,0.695622970471912
4,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.616976332975993,0.105126149866141,1.51496361154346,2.28754308973255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.616267235558783,0.319974970175909,1.16275506757244,4.07581644968627,0.00343041964816441
4,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.42943742155435,0.0348112082965209,3.90325343084049,4.47393282062223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39904846024206,NA,2.26512864124286,NA,9.17796574973179e-14
4,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.56878919420939,0.0926812630295864,4.0225988464116,5.78478993585015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53329698145933,NA,2.4742948117243,NA,7.80365422332811e-14
4,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.406801756567601,0.0870571192805638,1.27031232486706,1.78696818440333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.413809572452633,0.281027116817425,0.990457549482509,2.98028157364903,0.0412820515927515
4,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.25103790136799,0.0577470958690282,3.12522801805073,3.91913788583862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22716721137281,0.475283164605131,1.96609401940831,12.6685762140891,1.99786367326304e-10
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",-0.181045953733369,0.301568010555959,0.446319831606994,1.45558139706362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0694991425222902,0.366352500089104,0.570604794426797,2.3989160124239,0.833557819910204
4,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",-0.335242388681897,0.370414798080745,0.363379408158133,1.55222834140888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0909194640347401,0.424246337264037,0.425872937852302,2.24656152919135,0.806304928234548
4,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",0.244644639523596,0.205250882128994,0.851795411920271,1.90438622620171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.51227920958468,NA,1.03015547526367,NA,0.0171847802112007
4,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.20586821248634,0.41061136810373,0.533217113796063,2.66642971303322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.471942852334974,NA,0.682991741710865,NA,0.272807133487272
4,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.06993782170731,0.314468257293826,1.66342119474116,5.7062916214408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37070160978982,NA,1.84122326909938,NA,2.920288171759e-05
4,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",-3.33700491963637,1.21618289244465,0.00585779875177685,0.688918673853097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.2131622035763,1.26574905676767,0.00337102330589998,0.481478452440376,0.0109948452081767
4,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.337170439323615,0.68493536550249,0.196480163019914,2.87975002044469,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0929001613053287,0.806326544332411,0.225254061092737,5.3133133300455,0.89228164290399
4,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.0564827174842406,0.631008950325884,0.292586842310603,3.47125386661528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.199075907229009,NA,0.336134231101805,NA,0.765830897926274
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.866773733946871,0.52162412739226,0.912346968509842,7.04976366085736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15938207325349,NA,1.06957271705235,NA,0.0331509601848801
4,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.288592343429633,0.727851753151987,0.161372313595966,2.79850506040882,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0423695524154302,NA,0.217113458691794,NA,0.951605009439659
4,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",0.419634487025235,0.574730452955359,0.524669722299861,4.9923945404203,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.694296409067691,NA,0.614508879276306,NA,0.247920948416903
4,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",0.240096755945949,0.607927555171817,0.429058251259422,4.65001126065273,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.507555600247681,NA,0.478296559894156,NA,0.425454943517142
4,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",2.03348616183297,1.11762252171584,1.68833106975193,134.927863348719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.37295001004844,NA,1.08395522603148,NA,0.04153305533543
4,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.222880678610834,0.656928529617828,0.238241231352955,3.12877318929178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0259958008582743,NA,0.268444048295146,NA,0.973846175766011
4,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",0.877626969979655,0.562694620561039,0.840084800350597,7.62528685219832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17067056415081,NA,0.999921367629833,NA,0.0461461665068768
4,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.778895242406332,0.345378398993139,1.10372210061438,4.27398497667006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06797912744175,NA,1.34933875969769,NA,0.00304790596898098
4,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",0.437536929762565,0.238508965940264,0.957701089797441,2.43931778022642,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.712931111201739,NA,1.16971136782202,NA,0.00424684098472847
4,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.54094201769121,0.51041067757526,1.82483170438475,13.4942120537486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.86059429405232,NA,2.06547051984474,NA,0.000468966324731757
4,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",-0.205392770843005,0.358165856797157,0.425643724171967,1.73296142043558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0441758457942854,0.424770224700375,0.49836375945855,2.63436892542208,0.913235692764049
4,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.411699174373123,0.320686861755547,0.849022589843054,2.9844035563955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.686037610505312,NA,0.992256510867312,NA,0.0407597388938197
4,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-0.573107442023407,1.48278923666931,0.0473814360487556,15.8457643240843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.338307973869109,NA,0.0346926051687399,NA,0.824571050784375
4,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.637420457686178,0.642823492000455,0.160836116056058,1.99861100214509,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.405191785543784,0.702655423146469,0.179676040759643,2.82288333730175,0.540955639318316
4,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.35849595051359,0.293445896605564,2.21935757582914,7.01116971760888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67084463989585,NA,2.40416909858907,NA,4.69858911244383e-08
4,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",1.44870558971835,1.12414512865209,0.922170969835017,75.6065781641029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76469060928034,NA,0.587670399064078,NA,0.132030543272825
4,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",1.78802363853078,1.11988346991509,1.31165940544639,105.758225049051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.11762614071897,NA,0.840179273295576,NA,0.0695441644944006
4,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",-0.242779371441816,0.61121464517323,0.222533512396164,2.44303180621927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00530950965463623,0.730875076059279,0.288507977330077,5.06292869929448,0.997860938153373
4,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.324141560510317,0.494062252173461,0.255897545598248,1.77484006323092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0793526087477469,0.563843369354887,0.336128085340005,3.06473899275886,0.871807414016607
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",-0.168656193223773,0.331924735297867,0.463208655154854,1.70155644179135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0823937452316209,0.400763275094471,0.544715643796602,2.62077950900035,0.819452660264333
4,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",-0.381459698893833,0.406629478835948,0.318805173031076,1.56954090831959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.13894738177303,0.459705161357492,0.37776131526994,2.28992346508062,0.736103539459524
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.221233467838576,0.32462552380831,0.69551106379728,2.48283315711996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487928085854328,NA,0.81719754810319,NA,0.151452304146022
4,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",0.516343247605599,0.191890757155485,1.15115293460745,2.44235304660944,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.794882209855432,NA,1.34659152861718,NA,7.35480409629465e-05
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",-1.04261994052408,NA,NA,8.48460996895846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",0.632077533806418,0.622869393616541,0.607582566650164,6.98200382346493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.915262987480325,NA,0.693813864282404,NA,0.159371559420698
4,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",-0.676856124335909,0.890252535480501,0.0724328411381595,2.37412829829325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.44623711711602,0.999784961513678,0.104206993290907,5.24727553349978,0.62714624223875
4,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.960323667280899,0.559209834249519,1.00015220596908,8.95502174933569,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2566873114921,NA,1.09284293237984,NA,0.0312118592336331
4,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",2.60090892821452,1.11370671443889,3.01400487878243,237.203831064172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.96312388565593,NA,1.92176534129748,NA,0.0106241156684092
4,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",-0.249245714945954,0.365489252761415,0.377438344342039,1.58145212975633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00144281926757178,0.427528962437986,0.469672486056041,2.50969961853363,0.989461135172026
4,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.767112691057666,0.310555505085865,1.16887055183986,3.94872662135484,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05573914385554,NA,1.41325347904265,NA,0.00112536722301642
4,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",0.331021106252579,0.607239267855024,0.40833591334592,4.41350458217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.602126724338372,NA,0.525904557037395,NA,0.343317631057518
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",-0.195224568538663,0.389848834496376,0.399348374414857,1.84090670711171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0547490010108983,0.46161258872329,0.472965123721564,2.88854949130167,0.899585071027
4,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",0.0329878726937826,0.373565748837524,0.520847339905302,2.25252663118359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.292123479846891,0.497448635074541,0.616214869295758,4.33102075896038,0.45773189966416
4,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",0.822918050603418,0.305544347066781,1.25901629518003,4.17052751327573,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11376599967843,NA,1.49890596650216,NA,0.000477248628773135
4,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.142282032772934,0.342280105611944,0.591942104282087,2.26452927911556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405806711061799,NA,0.730696545159152,NA,0.258572207325245
4,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",1.93494600436871,0.249156085878422,4.29195992738735,11.3977663027138,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.27043921087621,NA,3.78628719267984,NA,2.19254212199946e-18
4,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",-0.521454970624471,0.347445572403116,0.28490875480803,1.11223923096791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.284580200504703,0.386764727098262,0.36821236250436,1.67697979752493,0.425247393402419
4,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",-0.747795639767524,0.392560671643882,0.229206152136461,1.06788077842438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.520007671787373,0.42478003635706,0.2662443770977,1.40743157341575,0.19974131026161
4,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",1.15516476659566,0.167419094606691,2.29972572989518,4.43292953224787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45933260444969,NA,2.33416301849133,NA,6.29185478003778e-17
4,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",-1.00379506641366,NA,NA,1537.34939533181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",-1.20619015476878,0.477204596113371,0.104329809632728,0.677334180719581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.99680549927756,0.503688907332843,0.139397271458505,1.00400487943599,0.0438600885840517
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",0.236082461752654,0.344032013042886,0.683076019082713,2.63117782018194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.503371507232437,NA,0.799745614267256,NA,0.162513298512355
4,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",-0.176713025979761,0.232732967755632,0.525621367243211,1.308815212504,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0740019363175512,0.295671620635555,0.652969410626344,2.0808708005644,0.771119943348658
4,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",0.98994272750108,0.270047710495805,1.59449951768405,4.59572938791616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28749365093039,NA,1.82829119044928,NA,4.85701411054988e-06
4,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",0.631023452484997,0.352851183114052,0.992729909054573,3.95845807629613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.914170201892885,NA,1.15802747255159,NA,0.0130999222378042
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.40708745763162,NA,NA,10.774258202635,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-0.374564567281762,0.379496405247869,0.322998945666749,1.42973963339037,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.131782951308527,0.43073935214661,0.40167857962284,2.17355520556446,0.731640269749705
4,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",0.668195703545385,0.300151575001515,1.09267369497036,3.54380205523289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.95283253304556,NA,1.31183404028572,NA,0.00236190012528772
4,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.80908572932719,0.479544809468983,2.57044850720847,16.8417599116126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.13953699190923,NA,2.72048489835166,NA,1.8506670623587e-05
4,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",0.80180708120292,0.577144787602673,0.750994435672157,7.21389450454035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09180665776328,NA,0.901340501120747,NA,0.069869194366708
4,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",-1.95773881087301,0.772630926775751,0.042392137255286,0.876222875439373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.00276709668468,0.890736310469786,0.0310870889843093,1.02087436970871,0.0333947022760734
4,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",2.53207154382652,0.252027685741632,7.88898717173017,21.1872192080824,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.18191777697364,NA,1.54323937230032,NA,0.000576868412245249
4,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",2.0442008740936,0.175005797530385,5.52284322206238,10.9671333689153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72722146589633,NA,1.17990692356241,NA,0.00463535741592101
4,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",-1.53807192582031,0.761036418201098,0.0666028555411363,1.31547802256567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.61162057528457,0.969170068746274,0.0460431809503733,2.05628560888937,0.0847723574083959
4,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",-2.88998363792092,0.807226479674894,0.0152101571636714,0.360046465586481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.87164457507614,0.831992504586016,0.0125926099321855,0.328475028195129,0.00290103434998424
4,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",-2.00587623774024,0.779215281742292,0.0396689287124785,0.841373778061752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.04764867092875,0.889767035254088,0.0294444466102184,0.963264474053806,0.0304357826623658
4,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",1.27677229016386,0.201462301879235,2.42154443181716,5.33411637670216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01192824542846,NA,0.726135380116887,NA,0.0986435371061116
4,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",0.551690412743361,0.123592221622306,1.36801031959932,2.22071667205358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.336122568120909,NA,0.462012350295693,NA,0.559588586080495
4,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",0.0596666433122482,0.232496135294364,0.658481618966599,1.63812030951283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.122464617691149,NA,0.314588102377555,NA,0.867427913935004
4,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-0.611612973125318,0.465155166662483,0.22389468975225,1.38651759338083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.748123937027309,NA,0.154657246262844,NA,0.320077700547369
4,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",2.52688252755369,0.337577346509036,6.27314354410014,23.5601440751456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.17708092626398,NA,1.49275977458887,NA,0.00109886482338216
4,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",0.639032310313042,0.364594545173571,0.955609069741166,3.98994713951653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.417524481433161,NA,0.433986930667615,NA,0.525540098439266
4,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",3.20587896584612,0.106325634695797,20.1061921862133,30.5027445820516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.80994803381582,NA,2.3217753627331,NA,2.67918529921845e-06
4,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",0.827008005059119,0.11902537671223,1.81913183711231,2.90063673855617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.592729245721874,NA,0.55540561653392,NA,0.313039057049158
4,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",-1.54138359594842,0.762227434535211,0.0661662202946536,1.31296957865688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.61470718469035,0.969404026458876,0.0458188266847413,2.04814344722637,0.0844569836621719
4,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",3.245772579553,0.241754805192122,16.4890932491985,42.5364165770649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.84709784771866,NA,2.31850992662431,NA,6.54302719765721e-06
4,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",2.28517956603903,0.372103922315478,4.53722784695925,19.5101880190577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.95180312012794,NA,1.27132706176305,NA,0.00420796004496654
4,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",2.90736768276293,0.302060336207325,9.97106073230146,32.5814051339191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.53170809826652,NA,1.88660400639347,NA,0.000105715152619225
4,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.283700167147755,0.237270496986423,0.839284122394649,2.12735042107617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0863621357879151,NA,0.367339589166868,NA,0.870589873162489
4,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.826236574949576,0.199153338323877,1.5511456355674,3.3860380417818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.591980069420917,NA,0.541273677768781,NA,0.327856326384178
4,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",-2.57988397562313,0.788819326327271,0.0217860045917687,0.479806411054999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.58262586095751,0.836533134687533,0.0172479691478607,0.457988483092467,0.0066378526059381
4,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.0151235249407148,0.175066094730089,0.698754558415017,1.38789852456205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.192175654090582,NA,0.30726071545694,NA,0.776028690451638
4,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.037433590165165,0.235816978561512,0.651537534932792,1.64208257470515,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.143186843178789,NA,0.309068869657806,NA,0.84197950048104
4,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.627007880429455,0.179978193175561,1.31305623794048,2.65875768848419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.406321014183304,NA,0.477214901720042,NA,0.492913218331063
4,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.0240439518923463,0.416012096142333,0.444268112613965,2.26916156714382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.200486120243458,NA,0.256751317779944,NA,0.795803742989469
4,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",0.674821972008954,0.23606381147154,1.23029932135451,3.10374866448391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450858368018918,NA,0.481073700677949,NA,0.460216042080607
4,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.4084469079209,0.131489809603153,3.17467015024036,5.31553847811656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13465476881322,NA,0.805425624520411,NA,0.0576135283636451
4,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.295224289597718,0.397357716787931,0.331758074983908,1.57501431680343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.453238382739042,NA,0.212996119365235,NA,0.533083839328074
4,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",4.63172964089321,0.101948906306197,84.4502387806698,125.938644504472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.13888485952143,NA,4.82473826460448,NA,4.90593184383751e-12
4,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.449744395404156,0.329883297716609,0.815942190272541,2.97340271849965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.241096010501928,NA,0.389450431553881,NA,0.699679760535363
4,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-0.216279157577258,0.426009161047799,0.360627768500198,1.9155719772572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.379657353544924,NA,0.219771099043312,NA,0.611673841286419
4,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",0.430144785406942,0.629194792698284,0.460685927069434,5.42685356233927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.222835810505784,NA,0.287967309769596,NA,0.773941365242424
4,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",-2.37074052295769,0.785570551059526,0.0270965321343794,0.589211810262198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.38769927498383,0.85204362438755,0.020965645170914,0.59160240020873,0.0119196343895384
4,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.747093578847984,0.148345497486204,1.5828874863273,2.83135208702273,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518245753654013,NA,0.522692608825032,NA,0.38023522602249
4,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",0.571594426640035,0.805988664656274,0.483923854688624,11.3997314679697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.35466594345143,NA,0.257070369999697,NA,0.698013587447246
4,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.431746876561229,0.242900136509036,0.957033576685422,2.47993967679036,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224355579352207,NA,0.405899989750818,NA,0.704318565837324
4,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.57455569545647,0.300388729111763,7.48998052510669,24.3143905373885,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.2215143795893,NA,1.55712846766272,NA,0.000652837788682775
4,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",0.191093691345316,0.131253956917613,0.938481062170633,1.56990240465416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.21695702547251e-05,NA,0.360706296508055,NA,0.977708250609164
4,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",0.0100171427678724,0.14644251840001,0.760444476494252,1.35011793052383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.168745149955984,NA,0.31642501666585,NA,0.80328501928479
4,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",0.836550619743198,0.374546404288641,1.13841269032354,4.94229521208412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.601621042752863,NA,0.494474482971179,NA,0.36932774750476
4,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",0.87791569270764,0.790811806826323,0.685887505121375,15.2241604383049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.640176364067117,NA,0.334068233688328,NA,0.487599597855291
4,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.416289352017204,0.157474236085722,1.1157413132635,2.06846482434252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.209923173577727,NA,0.417188832222578,NA,0.710844213346937
4,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",1.76819123038403,0.332512121196272,3.13935845710946,11.5587419556752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46992024415214,NA,0.93968542299953,NA,0.0264734945200172
4,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",1.44954718444032,0.262368952823823,2.63268212717322,7.36302271304968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1729608753866,NA,0.792299677760273,NA,0.0639846442168446
4,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",2.1306500626164,0.253419756993602,5.30701517348518,14.3308815299526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80776337696951,NA,1.21501331613844,NA,0.00431168632142971
4,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.776170294096985,0.170226910579406,1.55585447096254,3.03224151998099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.545357620820144,NA,0.529143084299348,NA,0.360462442724293
4,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",1.54258403762925,0.284147362055115,2.7241464978382,8.29781609513307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25967482124205,NA,0.832885288457242,NA,0.0496651283923911
4,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.494811927864277,0.153328834166874,1.21977523369511,2.22488358435886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.283109339504978,NA,0.440664191840639,NA,0.623379961091186
4,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.206466480860596,0.111180053051267,0.988466165854163,1.52839311953541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0143604317492621,NA,0.366681660373626,NA,0.958635489187065
4,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.31800190528347,0.13676392023646,2.87633947881322,4.91662926769886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05035639813336,NA,0.759709756380061,NA,0.0789673137324579
4,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.10774185740884,0.280926407359282,1.75527867596243,5.27953969792757,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.854382397911527,NA,0.628752453111966,NA,0.179534946260035
4,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",1.42528445368511,0.112323847586035,3.35617216495518,5.21272358223054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15034816743616,NA,0.817184008649393,NA,0.0529648002635849
4,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",0.456879930350383,0.320109272200471,0.799910754716419,2.80541134454289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.24774511010128,NA,0.394076620601404,NA,0.690512824515409
4,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",1.56488729030667,0.143341362460485,3.60536674505367,6.32374321528097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28046320976563,NA,0.88608346736346,NA,0.0331017113879925
4,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.957141102874481,0.214398231676934,1.72495882208357,3.99733865651389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71400402800999,NA,0.58673067146496,NA,0.243504941995765
4,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",0.279552141352942,0.122026398175981,1.04110463718685,1.67970299952088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0824790564287271,NA,0.384372339979172,NA,0.869464286480472
4,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.56336430643665,0.190903408852895,3.31520197907097,7.00655516056054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27904335578578,NA,0.874113357824908,NA,0.0366229010385507
4,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",0.699507125003401,0.130723598946671,1.56650947270247,2.61503366220671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473893421127996,NA,0.508987263839314,NA,0.418283468744511
4,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",-0.198716422857784,0.291912892446262,0.461095127489969,1.44791791622386,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.363288226017351,NA,0.251047970230659,NA,0.596015270764815
4,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.308669563618381,0.219984688449965,0.884269499380471,2.09453324493456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.109623232506953,NA,0.377172795513768,NA,0.840422115583355
4,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.0537456388786269,0.249657588806297,0.585508968307391,1.55794241565935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.22816996103801,NA,0.28716115811798,NA,0.740541614587829
4,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.244194689566654,0.199810118105321,0.859470822275193,1.88099871732415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.049523801522424,NA,0.364222802802094,NA,0.915007499322219
4,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",2.03691457701055,0.49703918431271,3.22323499175782,22.6179380701877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72040841318198,NA,1.01317025074605,NA,0.0210951868970644
4,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.110049090082,0.211215104105556,2.00351587813714,4.58528182398606,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.856530109022982,NA,0.64949866740383,NA,0.162786364869074
4,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.106127510984941,0.240559294845121,0.700188572916836,1.79781046788626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0791608757943057,NA,0.323610909070449,NA,0.921903445321796
4,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.14126488647347,0.18005316702175,2.21340786336635,4.48316285966827,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.885624584060144,NA,0.67016605853422,NA,0.14369662735325
4,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",0.978532589211201,0.269600756131842,1.51538672783045,4.36006173527558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733950077622955,NA,0.580353308914804,NA,0.244350630362282
4,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.159918317763654,0.175091944026173,0.605520946719273,1.20283549986148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.327136026527002,NA,0.277325148931342,NA,0.614564869497857
4,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",1.06193406981721,0.212867965803259,1.90573570805312,4.38985073491056,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.811682326506166,NA,0.628985364408415,NA,0.18581169519239
4,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.246601152987127,0.124102494545825,0.612118914842393,0.995653602401268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.407893497599355,NA,0.266229323599518,NA,0.518214353171936
4,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.508109356880417,0.102784079992851,1.35944974872102,2.0339632127208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.295503545335311,NA,0.451024032650661,NA,0.603598768447485
4,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",4.13921934748922,0.235489474971444,40.857769222008,102.842508218226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.67984345305707,NA,3.72079717247835,NA,5.29643442229123e-09
4,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",-2.32906282926475,0.789576117961386,0.0279217789442561,0.616765261505957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.34885452504695,0.859973929301445,0.0216213256734628,0.629367901950857,0.0136736385480027
4,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",1.32251898775386,0.772568176868582,1.12610256910506,23.2702151170338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05456127887441,NA,0.479632648212947,NA,0.251027122011012
4,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",2.0594836259856,0.127634909639108,6.11150080075447,10.0793827473341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74145482528521,NA,1.20263040546613,NA,0.0037020919707292
4,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",0.892075783157957,0.274387321230549,1.4676383201327,4.30265837645305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.653366469064322,NA,0.546373714142048,NA,0.300001220963332
4,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",0.390885556953374,0.136471052663991,1.13665987993306,1.94070387256899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.186246033621291,NA,0.412911352241009,NA,0.73805477987994
4,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",0.579447486251642,0.113772596758564,1.42984608509061,2.2334493626932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.361993328457315,NA,0.47187285064607,NA,0.530038560405363
4,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",1.34890191835463,0.122339169286193,3.05216089007539,4.93035286087888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07915654148756,NA,0.777216765975718,NA,0.0699705008171461
4,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.0727713056970031,0.262973035932585,0.642543822369298,1.80131166111759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.110250223210337,NA,0.311742556609588,NA,0.88451642077579
4,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",1.17306786827062,0.548653240719531,1.19104786380426,10.2319447148621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.915270404693871,NA,0.542869488699978,NA,0.234318861318355
4,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.469703623508623,0.267471057778194,0.371192989348134,1.05911548916891,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.61586084426491,NA,0.209337436705061,NA,0.352507358764005
4,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",1.0882601377807,0.545948401999129,1.10376579700301,9.38212417833585,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.836225676430667,NA,0.512421689456081,NA,0.275384675533101
4,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.6724937425218,0.215501288200919,1.29805908666243,3.02109595798335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.448740321990531,NA,0.484919559230941,NA,0.457743969842258
4,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",3.00375546496558,0.130657377682188,15.611770115935,26.0545556399495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.6215457169339,NA,2.0716835203345,NA,1.35374079969112e-05
4,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",-0.0924379792569764,0.135102531683548,0.698094730420838,1.18553212466776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.264247018137378,NA,0.295707482680058,NA,0.683790998902762
4,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.110692727668441,0.162979040449567,0.814273472625864,1.54250403254685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0749066391580672,NA,0.337292925053933,NA,0.924647784069599
4,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",-0.0539609189252043,0.376150776164592,0.443175206533946,1.93613527725579,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.228370811368927,NA,0.26057057117372,NA,0.759176302351604
4,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",2.03608015331129,0.406293848308123,3.25535777894557,16.0056983545704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71962722130078,NA,1.07054334923246,NA,0.0136976192874281
4,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.518504696171001,0.224366459150086,1.09052190516156,2.62782564230857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.305210993290757,NA,0.434938010768076,NA,0.609013095941941
4,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",1.56196954220354,0.763788125154236,1.46663761439013,29.2818209458496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27773784026092,NA,0.578062770183933,NA,0.162604459027357
4,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",1.13212880005324,0.1023428188333,2.54498713589191,3.80114399715988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.8771017890656,NA,0.679595704882516,NA,0.137273797580544
4,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.45771809803683,0.142935587291775,3.25049744260846,5.69224800622829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18057736113819,NA,0.828644524647936,NA,0.0491763220855271
4,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.16197754563508,0.0897839493034899,2.68416532432765,3.81643380434547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.904925546098161,NA,0.694236443833836,NA,0.124362415989744
4,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",1.19197551269442,0.266393645755525,2.01635721954619,5.72897384203868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.932892802525107,NA,0.669310631934124,NA,0.140139451307659
4,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",3.53742432784128,0.116077263603697,27.4518084584387,43.2694377374094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.11894805713292,NA,2.77127111025982,NA,2.06218433175343e-07
4,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",1.49583008883994,0.360075358271928,2.2658371074002,9.29441555983683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21612555513728,NA,0.777335423662904,NA,0.070725809659536
4,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.132010348051102,0.31818088769252,0.613249962828199,2.13456633535426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0111804775995131,0.342426431932454,0.519997789777434,1.99044101555621,0.906725171633836
4,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.258464584783336,0.823421041720408,0.268576073785807,6.77425972705721,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.115921171256009,0.856534825031466,0.221237887516492,6.35370479368788,0.913761177865819
4,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.231734441004287,0.177799777346126,0.889436357714819,1.7856723255735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0890823377632912,0.215033883858825,0.739127927876997,1.71709356213368,0.725440518056807
4,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-1.13035063100162,1.51072060120327,0.0152958588941338,5.70728135538425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.27999958862008,1.5325807841494,0.0141765032449867,5.76287737760441,0.389634867620543
4,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.04880296549866,0.206868648102796,1.9164920350597,4.31202076605843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.910306219831855,0.292478866119899,1.52731430294273,4.80668147066879,2.12301673098614e-05
4,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.181012142137118,0.30893765311286,0.659793176552909,2.21484956609807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0380725306300338,0.334844320252271,0.555315675554542,2.06338342355875,0.969737133996254
4,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",-0.37422106158097,0.383093192463627,0.32791826071728,1.47212482030918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.520001355853542,0.396502588984252,0.277724116788097,1.31407703501285,0.155972487477806
4,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.460140709406198,0.285941726823315,0.906156752062253,2.7796582823198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.318629153013944,0.322725438746188,0.761839873809743,2.6994325626446,0.309076436761506
4,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.371501765948633,0.425144762729765,0.636389047413677,3.36891809729612,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.229547125490391,0.454616876081843,0.537702364210818,3.1950901694731,0.634340538769248
4,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.424152151465094,0.140170595341618,1.16310394399889,2.0148623540423,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.282456700245953,0.193550010281836,0.942591267111616,2.0129062423712,0.0690311345371558
4,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.216450681378904,0.315498071898785,0.668853313314466,2.30375225933564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0736923355544837,0.342240422100207,0.568007702348336,2.17262801768777,0.881179003651667
4,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.158515430956268,0.64128277563354,0.319259618672226,3.94335400992133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0154612958288085,0.666193391867703,0.285975783792225,3.89456490011808,0.98659282303192
4,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.73119504930009,0.600201980601603,1.93319940336569,20.3264884092693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59619938568642,NA,1.47027010371397,NA,0.00926018256402159
4,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.297392370802357,0.109891874712635,1.08546557166385,1.66992251395768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.155049879099577,0.164136147813651,0.874075653935846,1.66331654863995,0.243736921951694
4,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",1.30198093822612,1.51984405630173,0.263353415135141,101.841823522446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16477630386991,NA,0.160387366869678,NA,0.456110468278892
4,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",0.756712646099597,0.464773862578729,0.895955377384519,5.54011574946508,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.616719459077114,0.510931254289905,0.729693538239864,5.40693868471427,0.206271116152804
4,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.105584166812885,0.167366868674485,0.800595578242771,1.5429045541144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0377162475431916,0.201078060324508,0.666234054123744,1.46535462067785,0.703466102155063
4,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.79839505275097,0.187913660490627,4.21438177884415,8.80316153707165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66373004276785,0.421258375799457,3.06288860637567,15.9691853428043,4.34313061280946e-18
4,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",1.30198093822612,1.51984405630173,0.263353415135141,101.841823522446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16477630386991,NA,0.160387366869678,NA,0.456110468278892
4,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",0.55677021047163,0.710410359481306,0.485588212593583,7.86453273623665,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.415753019762577,0.751981768826324,0.372082841545005,7.09276755530909,0.5854583812321
4,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.185086935497056,0.36662182034752,0.59628320855397,2.50952021385277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0421521273128998,0.391197166367372,0.499907802256283,2.31667535397315,0.965635164381899
4,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.02202037592736,0.19479251181457,5.20790219372103,11.1757889767276,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.8884995079222,NA,3.67585823945685,NA,1.8830913469337e-21
4,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",-0.582947647146434,1.22189979052827,0.0581427978865844,6.99297380313923,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.729801622187306,1.2454556772338,0.0434047567336772,5.72538789491382,0.538138126162537
4,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.656596696260806,0.14492563862952,1.45351295631496,2.56531536184024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.51609184444131,0.212024883414702,1.16319280341613,2.67056727270297,0.000772547176030758
4,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",0.758119082298417,0.286125306509485,1.23431428598138,3.78901531315684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.618102535834745,0.338156985545412,1.01670412639334,3.8271376445139,0.0395963433472757
4,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",0.663330512027837,0.285001099776364,1.12493419166018,3.43806330418337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.522854212111062,0.331625221800957,0.929627582980956,3.41089854919371,0.0830134417781403
4,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.0544786629806536,0.161482761550401,0.769584148185518,1.44932193527014,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0891079459407406,0.194126569022853,0.640538143320498,1.37096594460268,0.47708906186625
4,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",-0.373872473384565,1.15509079827714,0.0832389033190262,7.70471342363671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.519655129524888,1.18127815133433,0.0610820048491107,6.26505450882032,0.638187117463281
4,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.872352840707789,0.256607270618565,1.44990269857688,3.96449493808145,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.732973616562092,0.319200489841643,1.19396364921376,4.17252554113088,0.00614703771103497
4,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",-0.554190147238749,0.299039603839743,0.320184350847794,1.0339178811188,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.700889718751269,0.3109520891381,0.273059297257004,0.923895314220557,0.015548227396931
4,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.305483183797115,0.235579331810751,0.85947471252458,2.16413368518455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.163182478266903,0.269653666780547,0.717765677684837,2.06557953386684,0.563187760535698
4,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.438182589383354,0.29771957650407,0.868775411413932,2.79091266635532,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.296558650391912,0.332947550717711,0.729788977309273,2.69158585609597,0.366436548146581
4,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.587315695665879,0.254317391787551,1.09846770607029,2.97672014318765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446454888125751,0.299405372570173,0.912105744797903,2.94953681643063,0.100236160479782
4,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.4468721414432,0.132393388614212,3.28787558593739,5.52461844119223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31040649358221,0.296982400052874,2.40287843826806,7.69689487299124,4.921411259918e-22
4,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",0.219248043492617,1.09426317302716,0.154410386919634,11.2603921240919,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0765039133369326,1.13991856723049,0.124921878554719,10.8953050331725,0.963586843818841
4,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.00169801396526372,0.300834204397937,0.56322711220411,1.83157467710464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.142159118691627,0.322305221266947,0.472425595742941,1.67119382724969,0.577461576008113
4,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.37294976590139,0.2248728466496,2.55669437808265,6.17309619580599,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23612102104993,0.346822758916298,2.00261528662421,7.79883374496966,8.66917542474607e-08
4,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.27756773030049,0.129708030219156,2.78780414191105,4.63529746758812,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14023623405163,0.267276649328263,2.07895271007605,5.92730401855803,1.29219443328082e-17
4,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.2541517922227,0.422455029332079,1.60454219917677,8.4050420253908,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11670497306319,0.510446908069723,1.28447893857058,9.49977631470627,0.0102290248486375
4,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.39007823516889,0.22017967368292,2.62692594013036,6.22705046196987,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25334037091572,0.345857326531124,2.04789401439703,7.94503942833132,2.9479357984531e-08
4,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.0646532254032819,0.151535190749572,0.793162610614424,1.43660115073603,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0788813195083719,0.185982462865108,0.657690461226865,1.36344825974504,0.489865815473478
4,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.971253543988789,0.367013792329542,1.30680676638442,5.5082898787012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.832357484167711,0.42891262481694,1.08035703800185,5.80429506274936,0.0288815146917129
4,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",0.365763438895974,0.292160692809369,0.81333221996418,2.55648496120524,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.22376905732385,0.32486110918895,0.686881922255084,2.454294315337,0.501279187849477
4,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.365209046990573,0.299212852982424,0.803938740880458,2.59778880995451,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223211790237293,0.331551772442599,0.677635359415372,2.48559759694792,0.512612053125967
4,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.961063237691765,0.252499527487747,1.59869212863393,4.30150875903218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.822122642339065,0.322576881054383,1.3078600373569,4.63145178977478,0.00171424270624764
4,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.95837110998347,0.314849672367487,3.89453835443339,13.3800285229407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82451256516475,NA,2.97583896674777,NA,1.32872941901629e-08
4,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.572277045415814,0.160159108395972,1.29632374671153,2.42867183944445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.431318856453057,0.217918545765518,1.0512043134862,2.46986001429616,0.0118642679434828
4,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",0.726300712533353,0.274990780823128,1.21162002876601,3.5605049826464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.586139465438636,0.326004899973837,1.0055994484134,3.60924841451333,0.0428103880669509
4,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",0.995059943481234,0.2355208553116,1.71689950663689,4.32211488762127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.85629160241792,0.310937280240449,1.38865950579514,4.69825253702973,0.000454662529191135
4,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.908047403481248,0.15081082973658,1.84811232227639,3.33786820537702,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.768817535559706,0.236835036364291,1.45473382987742,3.6810543974922,9.65426616636569e-07
4,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",0.596885108659847,0.241366450100325,1.13924905149121,2.93441588704407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.456073405902749,0.288208837258948,0.941629761966426,2.91425661424702,0.0764688293973215
4,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.93604361367162,0.338049607483486,0.201164839148595,0.756917888958024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.08470016080736,0.345983205561867,0.172936671592673,0.671258770485162,0.00107645351543002
4,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.711612461767272,0.217724338436069,1.33832991836737,3.14208386431404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.571387746521081,0.274211864614148,1.09383109949082,3.20456726200473,0.0127434514277184
4,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",0.717725483511364,0.132193313227077,1.58565761824725,2.66229221913328,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.577531071538039,0.207568409926945,1.25263899205217,2.8261227947023,3.34332781561669e-05
4,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",2.38143948761137,1.36396511186149,1.14385518838765,240.098508737795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.24976736046679,NA,0.642713312340007,NA,0.104835313715603
4,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.44673737788669,0.118998945244154,3.37546855401834,5.38168455385007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31026655796974,0.289941153297927,2.43435502501043,7.58543742481327,6.97725761078156e-27
4,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.54588412119128,0.231372904461962,3.0122483902533,7.46071976577084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40993503040939,0.382732114316545,2.31995961205334,10.4002734232992,2.68684465581538e-09
4,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.439705053363117,0.28032205682498,0.89886167481121,2.69720526239057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.298088996784727,0.316586954185783,0.754495815746885,2.60984937734376,0.33471891167216
4,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",-0.0559542357633636,0.278438773880771,0.549028879372412,1.63534812495756,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.200106222417766,0.299298485376093,0.465515645328882,1.50473820187719,0.418538026740229
4,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.44614300130543,0.227501886488416,2.73448690684765,6.67076685126549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30968656761655,0.360839097488638,2.13204706959619,8.77183354199635,1.99440117258343e-08
4,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",0.956406607863547,0.0931757408848074,2.1691052112358,3.12538329540422,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.817433757314824,0.20677641718542,1.62563212569571,3.65627694535305,2.97268305623346e-17
4,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.0519864123201233,0.330944257887343,0.494205761677568,1.80845759729982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.19611819755441,0.350471308715815,0.423090276338231,1.67138492962718,0.503733816116768
4,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.61471541602932,0.0802242622487329,4.29883130688675,5.88741208089481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47911136645819,0.310268563735018,2.89205075865353,9.75906187514498,1.42597572999371e-72
4,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.699575933921366,0.726078421419617,0.52987044585619,9.12531452867845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.559289290764384,0.776458840734422,0.416226055690213,8.73323588145777,0.465182264047343
4,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",2.44139022542705,1.25273510773427,1.71976866226206,233.415743337238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.31003037574194,NA,0.847815363796019,NA,0.0697223412484328
4,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.371351789605052,0.156014921578743,1.06877240440087,1.97008750180141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.229385929385661,0.203179809148932,0.875197940498853,1.94088686619889,0.195274352148229
4,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",0.24162264708221,0.418962869873447,0.557913935010547,2.88277595964032,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0990085070817172,0.444468983976405,0.478351747120837,2.73157251777963,0.862932113879543
4,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.6706143331468,0.430943772470829,2.32417404900568,12.5866065325567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5352958360365,0.60274680901248,1.88617210935258,20.0308485203445,0.000494345731699713
4,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",0.526391619384451,0.340479430249736,0.885975910338033,3.36554302173863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385189731508153,0.37752694732121,0.73513424091931,3.22901224558649,0.294263275901976
4,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",1.53160741294815,0.410510477313961,2.16975578045825,10.8458890552693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39557848463553,0.543431280959433,1.713006097664,14.4177668700276,0.000904733724266121
4,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",1.01863059728618,0.357083774841484,1.38357136182441,5.60921497095553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.879976556194406,0.423206288262874,1.15159059424901,6.05014523914222,0.0173812390281775
4,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.963487976411579,0.268254946884064,1.55969690299277,4.46393908238031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.824557125729564,0.336637117978185,1.27657956357036,4.77683187650984,0.00307038009794562
4,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.36007313750882,0.122712900678937,3.06919852070521,4.9651434577134,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22316135234322,0.2764627768161,2.25056154872164,6.65184282977801,2.90483359070362e-22
4,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.67594621851895,0.234041682658853,3.42726572548419,8.57790161417805,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54064802095728,0.415742621581357,2.5964518609377,13.2477400341492,1.21419496317219e-10
4,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.67507539066891,0.0999216618328721,1.61530782343401,2.3898037705335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.534663255830147,0.183509151023672,1.25393284127406,2.57442842564581,4.15316947775707e-07
4,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.27133886994897,0.620982686859762,3.20127528784388,36.5162241979435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.13911145100978,NA,2.38236132795351,NA,0.000711695801997675
4,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.28211331014411,0.686862018114758,1.0299093840467,15.2095034191486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14483367571674,0.797997070088918,0.802015526328709,18.3102996237796,0.105199393969897
4,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.23352221955255,0.299919596008088,1.95295857545247,6.3281545528191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09595646046716,0.391465710205165,1.5627405492713,7.24968796537511,0.000387599794418812
4,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.09822799272443,0.661675465061027,2.48560398948087,33.2560214211691,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.96508126809248,NA,1.87307340209671,NA,0.00355426273008337
4,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.43584856562872,0.295617503589442,2.41228314210255,7.68578855516138,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29931129810937,0.416004935192685,1.90232533151423,9.71612015032203,1.83196248223251e-05
4,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.680883833570594,0.278721055899959,1.15758033903629,3.45180876904347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5405000492283,0.326801437507264,0.956175186389649,3.44258954142376,0.0664318363446573
4,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.563185552227429,0.14232056260305,1.33056246742169,2.32446083818507,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.422203645165866,0.20368012633795,1.07031985126798,2.37825958697424,0.00564617244538554
4,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",1.13867192650178,0.489751030890095,1.20395993845462,8.21042621705427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00063240046453,0.565436850560786,1.01338612859879,9.29771853499173,0.0477785596175939
4,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.463417872699183,0.828961371981806,0.332558241928588,8.57223589762742,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.321922998922354,0.871271048034621,0.268744230911214,8.17699385509525,0.722729754541393
4,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.613975551450537,0.386154481418159,0.870102196525834,3.95330977246205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473260357297997,0.425825725680002,0.73554428354763,3.9042341357927,0.249497871002873
4,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.00247676021113007,0.358273929770195,0.504462700221499,2.0547344574789,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.141350455631462,0.378492719683085,0.423847020269443,1.86877195741102,0.641496720854463
4,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.14015184632448,0.649975735641111,0.982839761669494,12.5603984435402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00210974075673,0.734803859844437,0.748015066187889,13.3303853565885,0.135257506092385
4,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",1.0893730002454,0.374818057368604,1.43846809844844,6.25160676559062,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.951051102540225,0.446405052723868,1.19420806239176,6.8713384192452,0.0140986083285561
4,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",1.0231353003948,0.269311893534115,1.6606080077756,4.77248450040048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.884505646902408,0.342681937482717,1.34849092295587,5.16690903210488,0.00152195879316654
4,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.283580784677272,0.150817780456303,0.988788883192003,1.78589626913643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.141165968330344,0.194635582589743,0.811821500386566,1.74104006624995,0.448573215417999
4,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",0.200212519920093,0.770523560749282,0.297980201498711,6.10842291211261,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0573711543289838,0.79980104514927,0.23150572446238,5.32286561897996,0.967989756560444
4,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",0.182977058442253,0.908127790624642,0.208164052003821,7.31821706079207,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0400473962384861,0.941838479538302,0.173681109953798,6.9685323484523,0.987976422211232
4,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.82474364104808,0.718096487557518,0.604022869912089,10.0819156416696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.68509734635573,0.776818965360591,0.479011760859874,10.0648007271295,0.361367159367615
4,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.278556065345503,0.602306947991042,0.398545924122012,4.22520299781002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.136116309779099,0.629977545691651,0.347929997983711,4.11119042047095,0.856045915872178
4,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.50817164393026,0.238615274631836,2.8495853782643,7.26107719113784,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37202770918498,0.380902220871573,2.21924543728083,9.87766861793521,2.01114281279171e-08
4,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.72364097454041,0.254715024984943,3.45614024805833,9.38034911808199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58859524349391,0.446442613147354,2.63220193764015,15.1476229766271,1.04548583501723e-09
4,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.24454433697928,0.324356164294304,1.86355223576523,6.64548230321717,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10706867694636,0.415028104131536,1.51483696234263,7.70745537460029,0.000916310710346236
4,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",0.0743026970540402,0.342715929752686,0.559712294268011,2.14489236359388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0691932789074304,0.36487431019574,0.468843897552507,1.9597082434034,0.781653166528511
4,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",0.80130196026069,0.341762042915535,1.1625397553924,4.43838089600391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66154310321986,0.392994205246201,0.959154614602658,4.47634105781865,0.0644188495238334
4,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.72637580108997,0.375004312828469,7.70746225698307,33.5212269420589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.59645831666506,NA,5.33693797983622,NA,9.17962214450413e-12
4,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",0.62345994700598,0.369778328205364,0.912188692561019,3.88683810457865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661954938911539,1.52223919256548,0.372963004320682,145.589634001445,0.45017983393207
4,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",0.760721910664282,0.201017620815648,1.45471452705313,3.1988273008285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.804289576288962,1.58269518789304,0.461506927911771,228.330221292427,0.330379365126507
4,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.192343161255337,0.247991650984533,0.74096522672553,1.95875256953193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.214865403721652,1.22804312053162,0.281307108846411,34.6581283662014,0.77977536119956
4,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.617799138083962,0.220812167687419,1.20035974144875,2.85248084748133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.656074884674944,1.45257071543365,0.406665959425594,120.808833213202,0.426544811251832
4,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.487412451556637,0.216985036985362,1.05330297195494,2.46575150144671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.520856443239486,1.36377359622588,0.365684223350584,76.7005721263964,0.523016606492303
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.61063601512679,0.205919643859098,1.22135718957978,2.7377950283593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.648644036107482,1.44243883272713,0.406995590003885,116.198901997343,0.429446040309161
4,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-0.975119739374173,0.283459813106302,0.216534516314359,0.657794131917049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.995755189734842,0.90987894526316,0.100994759331899,3.57502895253403,0.271191053241578
4,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",25.9509527194689,NA,0.133828057853981,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",30.4965453119712,NA,0.183057296570572,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.37284517604363,0.167815230835327,2.83671222096699,5.47651708172792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4390569756304,NA,0.767930044607864,NA,0.0833600823729484
4,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",1.55894364717167,0.183502709471659,3.35937276992149,6.89689757852575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6320087456099,NA,0.886812124658895,NA,0.0510249523332939
4,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",-0.183771921750777,0.460728576078144,0.326067041668502,1.98450708232347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.175130977075193,1.19109928604162,0.172149671451765,18.350051987571,0.877659837944997
4,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",30.6733490362003,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",32.7979928735099,NA,13.5646779044897,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",30.4383374002577,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",31.9603616875246,NA,0.0701384440094829,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.49375797190159,0.17447701807844,3.17287286206527,6.28757073990152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5644602099447,NA,0.844277285661534,NA,0.0606118874209351
4,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.872308658043223,0.207283776514514,1.59258413342896,3.58907823759866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.920007531357018,NA,0.504406439123385,NA,0.268457490345605
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.66444200274697,0.314102265002186,2.85247433739345,9.77125644280327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74143399639271,NA,0.91083615363997,NA,0.0470133761004282
4,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",0.404277110426947,0.178817677548358,1.06483960188472,2.14636689143073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.434685142877304,1.30690004569315,0.347012532791859,58.2392577874441,0.586182323317126
4,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",1.36928418522521,0.310567711113095,2.22281042273525,7.50954898347382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43534803700487,NA,0.7186915465471,NA,0.0999608238274731
4,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",0.81899844039516,0.172910475458585,1.63187508986193,3.21403232374511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.864722978795442,1.66073655158054,0.48937482101727,328.764299735301,0.292705249601046
4,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",1.91363068788396,0.298018924415396,3.94547375776525,12.6895872413745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.99981689453125,NA,1.12148763690943,NA,0.0219285426040951
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",-0.757687859864566,0.978527271658626,0.0789924892876258,3.65960023976143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.770271909496644,1.45137965311381,0.049451885887671,14.622312442523,0.570990749818607
4,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",0.0763144575391741,0.598445505203005,0.309749158277814,3.23448848976993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0945716076986244,1.36766588165077,0.185911602799482,39.5936111178014,0.905916080804947
4,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.876867312447073,0.170403353506453,1.72278436213854,3.35989817544294,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.924734459743068,NA,0.513524785475548,NA,0.26115243293221
4,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",0.513449992842254,0.209191907990623,1.11561879193359,2.53305588197837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.547856943216021,1.37726938443686,0.375013864557626,82.9306320125331,0.501737291199138
4,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",-2.21703328418703,0.43194167609023,0.0485170032315226,0.263774501119233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.28359003305711,0.79474871923838,0.0284335836189654,0.640935418879282,0.0166775227838389
4,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",1.11832318662954,0.46590521847463,1.39128834035135,8.64123124845309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1751178439295,NA,0.523006120040722,NA,0.209989393475792
4,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",-3.34975311104863,0.59363996475115,0.0106760040333002,0.109401490118821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.45817582057509,0.811591168153347,0.00767123326660852,0.184722798134449,0.000894030889650647
4,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",30.1830461773761,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",-0.0492129025798204,0.25834100774821,0.564041638081362,1.55278631233977,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0355948185517627,1.14090777893735,0.228043726577711,19.9665510832449,0.992887166737325
4,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",-2.72843105416149,0.487158696218848,0.0255733790102406,0.172634894281898,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.81390039084303,0.778665928987173,0.0163705817852175,0.346471402957938,0.00410952569730601
4,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",0.676859427471751,0.162891474284974,1.43980290539806,2.72652820186007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71731490232199,1.48422437577334,0.437095195968753,147.002320904435,0.378501017312137
4,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",1.32678046930145,0.151072369140865,2.8289228132783,5.11454690059825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39128870604117,NA,0.743778028053348,NA,0.0925942346772645
4,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.436544748557522,0.253966384550705,0.391123915278326,1.05844313052351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.437256947793177,1.02347573099099,0.164357800242588,9.08152041111654,0.637895243055787
4,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",0.324418679979507,4.16583062146275,0.000293591763740286,3627.9957988295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.351855236658632,NA,0.000296062511148506,NA,0.931215120342012
4,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",-3.2687692702891,0.566498924993014,0.012464828167127,0.114840695580303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.37420468909024,0.794910875646362,0.00866715744141753,0.195494891759782,0.000990208387236109
4,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",0.393368980560419,0.170471585389092,1.0667157495245,2.08094240568161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423367786862112,1.29921050949969,0.345001004371189,56.1824068870474,0.594574035357825
4,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",1.14749465813761,0.316759850245035,1.75496485925162,6.0746515524248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2053470206083,NA,0.597411558292076,NA,0.166719740126286
4,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-0.510317047476576,0.658276060738918,0.156381800085047,2.06460704738406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.513754391407909,1.23401470692319,0.101609002552331,12.8151187205514,0.650935853136188
4,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.53064779162859,0.255304815845742,7.65349949486048,20.8205292227329,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.6396574614119,NA,1.85656556481119,NA,0.00217755832713264
4,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",26.5698884609292,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",1.50344495983176,0.463022834352571,2.05997375783055,12.6506601869637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57448516531147,NA,0.722234928677683,NA,0.0944474021118467
4,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",25.9682339663631,NA,0.428071471301182,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",0.918312724778895,0.347675393072371,1.29031880285697,5.04174281685322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.967713854020884,NA,0.484769126120062,NA,0.27083504791048
4,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",1.85597126065957,0.158895696516296,4.74145144343819,8.83925843308103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.94004963040934,NA,1.13111010435366,NA,0.0199133271127287
4,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",1.47650210774248,0.315311100521912,2.43160441724044,8.36911459194131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54653672415287,NA,0.781968938272707,NA,0.0773145708766683
4,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.5916451699413,0.182025427049852,1.26417978847912,2.58041460570187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.628944324626021,1.42171171536919,0.404646626994095,106.512931291506,0.439872814941769
4,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.19855803089024,0.156147848418949,2.44841033349604,4.51555132398853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25832421426696,NA,0.669825802274711,NA,0.127885386156672
4,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",33.0297234845688,NA,9.23206104688142,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",0.992872177910709,1.32603476098393,0.125165995392755,22.6428988915765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04503126995552,NA,0.146283716290734,NA,0.504031905222594
4,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",32.5134006630232,NA,17.9610292744652,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",32.519284117561,NA,34.8984425422109,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",1.80746816993086,0.461549225158697,2.80207260054698,17.1089047681991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.88975375817987,NA,0.928067119718922,NA,0.0451725045998483
4,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",-3.30311276107318,3.28658085995154,5.80655707207377e-05,22.8562037466408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.40984421159942,3.65684786454742,4.12485484237929e-05,69.3166812134975,0.334938758730992
4,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",0.771537889392826,0.332625986421515,1.16067731362963,4.27538276133873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.815509933870591,1.66334774819458,0.433447973985728,294.188246488629,0.347659002012061
4,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.216374113061708,0.200529362162849,0.835305190430899,1.83327233642654,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.239823511630998,1.22392804854651,0.294036643796666,35.6467831651741,0.754195971443723
4,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",-0.580831843463241,0.896945636136586,0.11776482797049,3.96258527463666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.586875080605747,1.4151439035244,0.0668371956405265,17.146029576894,0.653668353721601
4,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",1.10648915600133,0.167150117004161,2.20188097632046,4.23985216964113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16285030995307,NA,0.619624722408586,NA,0.159809240928681
4,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",26.7039521583211,NA,0.251757884111255,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",0.0854982833840716,0.180562520363631,0.767053228090452,1.55673859952389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.104098837295049,1.16635915114672,0.265861432755211,25.7198694399556,0.876655633318104
4,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",2.42554035446223,0.459331192864991,5.22835507723105,31.64695393589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.53067978542598,NA,1.53018902120347,NA,0.00745624587368976
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.18087669573811,0.36880529088163,1.56356324808483,6.63698321298975,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23997621353032,NA,0.593770240795511,NA,0.164973268900167
4,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",0.0952536354245986,0.226418008000154,0.70684263277281,1.71702829297103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.114229107599209,1.18256638842893,0.262301283776626,27.0399002849699,0.869071438966104
4,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.325458129959493,0.240832288988303,0.449601766682463,1.15563754015601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.322060552964279,1.04950760981778,0.18220151384941,11.1490272062057,0.734009717414165
4,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",-1.05797193819221,NA,NA,36.1646856597015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.393505856783388,0.200165093604733,0.998566432671149,2.18846011568697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.42352408200284,1.30681698528828,0.340862964343824,57.1885500580786,0.597459988838815
4,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.69407279527999,0.31897516646676,2.89430456722991,10.105749709816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.772161662666,NA,0.930321051225554,NA,0.0437515997219905
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",0.616321977683513,0.416408003172817,0.8034780387599,4.11025040332337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409236935509214,NA,0.788720786883704,NA,0.0600267494975404
4,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.170182735555404,0.341785651196762,0.580413455356148,2.21612584873374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.15184423190376,NA,0.669595939314575,NA,0.324194519955757
4,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",2.77510571771009,1.12035844383291,3.51482951883297,283.926505840299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65470278073072,NA,1.27684187280362,NA,0.00864355879938729
4,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",2.45306328202734,1.12463634160543,2.51362920901283,206.483614244051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46890693195212,NA,1.08544164001158,NA,0.0198326496070736
4,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.33199991274742,0.346442220542081,1.92646475672886,7.49109619244623,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.822132834792388,NA,1.13761348051902,NA,1.51727179821876e-05
4,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",-0.200224472942745,0.695451479188973,0.209997906312446,3.20740431736638,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.061851732253853,NA,0.4079480886701,NA,0.961641727284876
4,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",0.591108805079847,0.406335058558281,0.807037477714528,3.96862223290219,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394690557612432,NA,0.784594603793818,NA,0.0621581052634361
4,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",0.303661037359314,0.895835046530047,0.236918539769433,7.93727441448089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.228872481708074,NA,0.437807994310703,NA,0.599486324635278
4,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",-0.189026555228208,0.497368169001965,0.305236543607239,2.14465595687674,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0553903944284368,NA,0.495232415608328,NA,0.964320148288002
4,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.28239715945777,0.732720358920196,0.818024220732898,14.4594429912157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.793505931251816,NA,0.853676204214375,NA,0.0479515588585847
4,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",-1.16097588961348,NA,NA,6.15720600192703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",0.726470586784036,0.969660350416275,0.392348813968416,17.5559816184176,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.472789487547817,NA,0.510918828517797,NA,0.356947987085768
4,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",0.633746929784268,0.31969214836137,1.03717440604788,3.63158899523275,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419279655708068,NA,0.844156098602424,NA,0.0122788768658295
4,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",4.01510646673114,0.392296014560203,26.6188652214247,123.889780438238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.37009582247029,NA,3.11241109005367,NA,1.56664067988662e-26
4,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.51480527401901,0.294691881672591,2.63551469067993,8.36661548968084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.927598599154039,NA,1.25805250313274,NA,1.15537894302e-08
4,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",0.0299385491163402,0.792102600659407,0.162444963514502,3.62396640524498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0709358188415293,NA,0.419313507951856,NA,0.803866247739851
4,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.39487509118155,0.512397744173734,4.0856203082216,30.4484721044096,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4353370317775,NA,1.64308498154543,NA,5.75306207431073e-07
4,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",0.876909691175666,0.937142644748541,0.493922416983322,19.4559870348128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.559580823247655,NA,0.572436460522879,NA,0.265412220167119
4,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",3.035927574536,1.1178761962436,4.59680723982077,367.732639797941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80517851970369,NA,1.44958165631874,NA,0.00417023723331701
4,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",0.303708066384893,0.54715734775006,0.449280676329364,3.83707331596759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.228882500499206,NA,0.611079271138415,NA,0.389860510437051
4,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",1.6885078027309,0.854883293678558,1.32525514546757,37.8142470125027,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02779594607609,NA,0.940835684249961,NA,0.0299903220301817
4,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",-0.231180261984113,0.376103837631544,0.385926226621515,1.68571684710543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0797266843949364,NA,0.536115934938595,NA,0.864038988505418
4,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.142418603286435,0.344035152510061,0.601984551776928,2.31884570558633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.135826639025442,NA,0.659694282401888,NA,0.368797605630972
4,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",3.05908363178943,0.46326127104055,8.65454742352001,53.1987930920149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81853612809026,NA,2.17782593697741,NA,3.32287167566109e-12
4,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",-0.889157344544372,0.700342320245476,0.10747872213397,1.67335244187467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.459317434332762,0.506479513248737,0.278096624088489,2.02501387570279,0.302322996578355
4,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-0.686780133380815,1.30175738742759,0.0243423888155583,4.00386097495023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.342559731822566,NA,0.161724443296415,NA,0.689553081595286
4,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",30.0404697357878,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-0.452124875583719,0.492007717205058,0.225978084213566,1.55475434359691,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.207182330543042,0.454402440456918,0.433614006358227,2.57442010979207,0.561939791062451
4,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",32.2104374538449,NA,4.04623395707624e-09,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",3.66149017857026,1.11354124048515,8.70846183154067,684.916292855964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.16605589802359,NA,1.93375074511254,NA,0.000586201935050849
4,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.46279138059578,0.663140938718421,1.15683796315664,15.5670282283586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.897561450166842,NA,0.986408724173073,NA,0.0139968356185396
4,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",30.8284100405608,NA,0.106756761052816,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-1.12630448779101,0.644473643869946,0.0823875005983135,1.03042229833602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.596134260373347,0.450171875840045,0.25850156812108,1.50951409579833,0.13652681916928
4,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.722567853842473,0.332519533606936,1.07751537838623,3.96739788504925,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470525968217259,NA,0.873059385772954,NA,0.00748307630820188
4,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",-0.545543178303578,1.20762447189379,0.0973957899042504,11.0765321497124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.2610760600656,NA,0.194598785957879,NA,0.753790770107097
4,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",1.2860980868053,1.36260487122336,0.165480557879327,34.5501322985755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.795660540335456,NA,0.460708064206694,NA,0.286311420426983
4,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",3.2243780802729,1.3897410774663,2.35997400933038,548.033011622644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.91390112844687,NA,1.25523764015903,NA,0.014681821251437
4,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",0.554277817720212,1.38072074836986,0.191112076065898,42.8382177261318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373442565849163,NA,0.29995885678455,NA,0.601509494183295
4,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",-1.00681865236727,NA,NA,93.0240485883204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",-1.00398385415118,NA,NA,84.3757820497565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",-1.05723004973801,NA,NA,5.03986327378513,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.875925348253323,0.663183285917454,0.113312336857328,1.52504433362657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.451683471445814,0.485379517252669,0.291233394252485,1.95232789743581,0.284931583792114
4,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",1.24025027599159,0.882852434822968,0.80343757097985,25.5813138866352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.769200160027961,NA,0.730570889921424,NA,0.110997035925418
4,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",31.0565165038041,NA,0.593692451712681,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",-1.53832086132005,0.622674960004875,0.0694527950737232,0.797505160593264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.83383754055915,0.412067801582958,0.210193495567659,1.05712116943758,0.0276188610110905
4,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",1.98632169731632,0.600410936237181,2.11670249019879,22.2741557297372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19961669151835,NA,1.31284805676748,NA,0.000335745062091039
4,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.326268129547347,0.460390232652373,0.278219902060092,1.69105583161157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.134546684751732,NA,0.47639957705162,NA,0.729024878670096
4,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-0.441548905784282,0.487628593564621,0.231282850159976,1.56416964436445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.201083114277975,0.454455944800326,0.437781294404756,2.59970700315516,0.573106398649046
4,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",1.80031604165391,0.228197177851048,3.94304919856198,9.64530079199642,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85031416500834,0.23714200186983,4.00288661554328,10.1410883070167,4.53494830794441e-15
4,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0175612706817927,0.0600000688178652,0.873361652664607,1.10493930206187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0165317770405416,0.0648500521476019,0.866608011047557,1.11743849473016,0.776461068371988
4,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.397830481402507,0.0184961987457203,1.43559371745935,1.54354585167495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410049475429344,0.0298023152051885,1.42226958896652,1.59851780287376,1.2696807984098e-37
4,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.371929940909381,0.0445659054586003,1.32927049851425,1.58300578234852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.383472942422694,0.0511255756029197,1.32826669551298,1.62301158994092,3.51410085029306e-13
4,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.0594416294847274,0.0261267987582301,0.895411447890332,0.991975590017478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0595398150668402,0.0334163692648979,0.88288449591137,1.00644957437229,0.0942517070254404
4,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.611876701128592,0.0633494042753942,1.62909019581603,2.08829260888299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.629862961946075,0.0695469198870643,1.63928180611701,2.15303212486599,2.71603727867501e-19
4,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.360076865755885,0.206777500822716,0.957552683952442,2.15368078595167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.371266313094555,0.213595051054487,0.954323815812562,2.20455346708262,0.0845738168558183
4,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.468617601888238,0.0668185034113622,1.40187755080095,1.82163812732736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.482745066413673,0.0725355922956987,1.40666594470626,1.86928615581963,5.32046025351112e-11
4,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",0.0125574847670135,0.0330267708483301,0.949030948432836,1.08020268356786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.014399529091513,0.0395566004675381,0.939285145397161,1.09682851565268,0.777410834385477
4,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.677449125742855,0.035498298243267,1.83660691548881,2.11080749579116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.697212966965734,0.0442389944678044,1.84271697391279,2.19165018779447,5.54931194120775e-55
4,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.435938706841316,0.0316370598392988,1.45349392787432,1.64540286857617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.44918513609619,0.0399489813863084,1.44993308513699,1.69573205196265,2.84931818800171e-27
4,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.50547559596538,0.0550209849470914,4.04845178613936,5.02292699633861,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54754963663375,0.0651766185170895,4.14141747907132,5.3469471150851,3.99775969506386e-137
4,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.043586460635124,0.0254778173076967,0.910650116418496,1.00629441485116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0432404501811536,0.0329446324115789,0.898213774994238,1.02203261459993,0.211398282048582
4,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",-0.00448152696586117,0.0490003124757727,0.90427047106404,1.09576300155206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0030993209338223,0.0542342975557815,0.896805036160256,1.10924294192686,0.922304202710317
4,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.697163047288205,0.0297998196321829,1.89428410656333,2.12900372046952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717470504689323,0.039663642179678,1.89732744425058,2.21649009850404,4.79997109449638e-72
4,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.704127223019071,0.022687860324949,1.93422263018096,2.11412345074385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.724605864438916,0.0343728318785025,1.93088090034456,2.20938754661182,4.57777835313052e-97
4,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.850206894718124,0.10407878343068,1.90952485549539,2.87150355259373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.874603970646645,0.110129954376984,1.93399344051643,2.97810887615918,2.06047883333148e-15
4,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.13709492563346,0.174860624884161,2.22868229476196,4.42314758426293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16922909489636,0.181939777407949,2.25605494015177,4.60346144422533,1.2485999768167e-10
4,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.122927840851819,0.0732013090318443,0.979437215902035,1.30495259818633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.127743795718766,0.078082656504633,0.975527248232536,1.32485259263027,0.114345273931192
4,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",-0.00693372371613503,0.0783440857959489,0.851388294060072,1.15744639905299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00561756324906447,0.0829748833553181,0.845546487754209,1.17056136911125,0.924292292133326
4,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.735220366653793,0.0631446070895838,1.84376619624875,2.36158413358826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.756528934407973,0.0697029212985355,1.86019884085444,2.44467897667046,2.68681974589597e-27
4,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.146587194323367,0.0540307873316433,1.04144145821566,1.28711408070931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.152051774246915,0.0594158329440407,1.03678586968251,1.30869597579138,0.0142698194229111
4,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.518119546454922,0.0492292282934389,1.52425935493936,1.84870177974293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.533584894506585,0.0559031024423154,1.52910295898314,1.90373433551267,6.54030113164343e-21
4,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.40786644468152,0.0580209651891559,3.65061521154263,4.58290789733617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44731495751966,0.0674046389819461,3.72983200668107,4.85779447805524,4.26069851362085e-110
4,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.3158023372471,0.0149918194381784,3.6199222493991,3.83902873058819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3527408027316,0.0342486630693756,3.6208463277526,4.14109432649168,0
4,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.60874012304958,0.103414953676311,1.50149562845251,2.25204989596141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.626641406053179,0.109013798631324,1.51236429200928,2.31868547820778,1.09419708639059e-08
4,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0267005630732766,0.0202032309412525,0.987168368276698,1.06852644148358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0289267650448284,0.0291261592136888,0.972721258560694,1.09036743088801,0.419849887929781
4,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.700328788552988,0.0659346018126267,1.77090152045651,2.2931986658947,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.720697456312386,0.0722757031808144,1.78565359642319,2.37049799857764,3.16014240798916e-23
4,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.29634306345923,0.0186838612558258,3.52465453279029,3.79248628879408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33276582033199,0.0359566226418795,3.53732922296513,4.0727537038169,0
4,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.34248345238453,0.0192137615101901,3.68729992283085,3.97574051212125,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38014949443942,0.0366215196942843,3.70426215991278,4.27608474239654,0
4,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.291926791234519,0.0625143699732882,1.18440455615295,1.51329893260531,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.301296581220781,0.0679435099316523,1.1837728401027,1.54502536073762,1.51248660426612e-05
4,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.267888062609888,0.12258812438185,1.02653277964119,1.6598438103887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.276607440459632,0.127828083640279,1.02699693067161,1.69505607452723,0.0327804448476872
4,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.571678002135956,0.0578947444374466,1.5813870956318,1.9842591067848,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.588582132538186,0.0642184215745119,1.58947454070832,2.04446281110407,1.29312387495077e-19
4,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",1.21659184411607,0.242852989528333,2.13380018340536,5.52824684889366,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25089641583418,0.25122868830507,2.13722289706379,5.72192699872512,6.35823377735699e-07
4,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.16872310260387,0.0915924271589514,2.69362223825091,3.85712683004112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20171152316624,0.0985198159754066,2.74454468228892,4.03822715116383,8.38833739115124e-35
4,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.42758666764826,0.09195601933825,3.48722784579589,5.00065087610948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46754692129772,0.0996367621212761,3.57311232186126,5.2804216127196,1.01362304186941e-50
4,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.0176251695976279,0.0519723581642384,0.919153512650042,1.12684959824726,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0196265298186793,0.0571521175553867,0.912172549818883,1.14122937064278,0.771220464534935
4,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.398461347187275,0.0184744806824217,1.43658064677721,1.54447550316815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410697324831768,0.0297915896607272,1.42322156775797,1.5995205006235,9.10544686124342e-38
4,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.671978836476322,0.0174301322457532,1.89240042519921,2.02621790098893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.691583592525321,0.0307625902020341,1.88140825000861,2.12252772876317,2.03349303479876e-108
4,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.31564582485157,0.0553623181601111,3.34619153946724,4.15718908276992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35257008211705,0.0645857569446679,3.41135076823264,4.39417520838251,4.06995749284562e-104
4,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.33270456007661,0.015746092407102,3.67714944741678,3.91126712101497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37010178477827,0.0347474733117697,3.68069909044066,4.21778579346701,0
4,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.408494017886082,0.053775202998273,1.35409626279488,1.67184731106751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421006148610157,0.0598455762924237,1.35571821600909,1.71415750803266,5.9138620122569e-12
4,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.710455711380896,0.050285701834009,1.84428026700919,2.24612257868187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.731097998741518,0.0575229638269237,1.85726404197853,2.32702431750919,1.08669466719731e-36
4,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.35434218686413,0.0357604749670705,1.32877441612962,1.5287272275414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36539051436154,0.0431537954365874,1.32499693576304,1.56920624723996,4.71058207913401e-16
4,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",0.48806943717194,0.263950302502102,0.987644527940649,2.77939627740474,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.502716776752076,0.272145171289241,0.970437143835009,2.82012390895682,0.0661123160256409
4,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",0.00261850478073235,0.0204556736898062,0.963185913647543,1.04359964942636,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00419555219639654,0.0292122144433338,0.948778745453293,1.06388800183084,0.956812999379295
4,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.334510514645452,0.0181316263658349,1.34846264183707,1.44779227768473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.345023546503614,0.0292169347675931,1.33422606317086,1.49612686019016,1.97873552095114e-27
4,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.683925646987146,0.0274244433242371,1.87798784985471,2.09112616014191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.703832809856488,0.0377408009974489,1.87878996183117,2.17835314600096,4.14613885299947e-76
4,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",-0.101756868407846,0.0703836136123689,0.786328380025844,1.03615620350436,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.103003395115738,0.0749068457283478,0.779309355810436,1.04527733948771,0.169095129279438
4,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.37091312532904,0.0238934497780159,3.7591416465525,4.12824033805289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40934452083559,0.0396369598965125,3.79160326461157,4.42895197827227,0
4,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",0.0366347628973245,0.120691114404811,0.817581162752372,1.31218721603471,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0391246361840022,0.12564729400086,0.813305888221109,1.33093319699954,0.771661534162916
4,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.406621179873485,0.0302697983274117,1.41528459785869,1.5935847992544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419077945044189,0.0386886587582468,1.41039377992326,1.6413608715916,3.64663184385115e-25
4,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.672389337978813,0.0416576589915792,1.8055975615063,2.12588166735016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.692009996878354,0.0495650354155065,1.81411241832953,2.20314897891254,1.33945324185742e-43
4,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.346491468595,0.0264405447691756,3.65041298682377,4.04906236389551,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38426082116998,0.0411278856478234,3.6868632857106,4.33184863648435,3.21379697797846e-301
4,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.620936790192017,0.0211646635614769,1.78509226338679,1.93950746868094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.639165204145109,0.0328440710021752,1.77802220896875,2.02232536585132,1.5876357096657e-80
4,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.38164180835206,0.044043034751571,3.65376907320472,4.34230269098716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42036369218837,0.0549750241277305,3.72011311091748,4.61472468057898,3.34351721675073e-164
4,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.38339824657734,0.0191528396596984,3.84178511407711,4.14132126852092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42216645778857,0.0369232931677964,3.86104698725853,4.46234778410344,0
4,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",0.72357868392734,0.255924669842975,1.26965702267299,3.46236912998577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.744572432020209,0.2641137216837,1.25570492222948,3.53602731847872,0.00494358560934932
4,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.25812772508227,0.0501384934523379,3.19092394849487,3.88393881298825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29352233641382,0.0596280387145475,3.24692521545019,4.10188275836447,8.06481618259452e-112
4,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0558546651102222,0.0203227515512395,0.908702469850511,0.984054662584439,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0558560314334968,0.0288588727515169,0.894087694653489,1.00117397485862,0.0770699980413851
4,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.62757306408616,0.110539231959631,1.50813663015855,2.32607127433199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645990068546136,0.116188778209421,1.5203866488477,2.39747552254506,3.1734857345423e-08
4,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.692312306403051,0.0175269121266933,1.9308879672238,2.06821148483365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.712464813941103,0.0309501123642964,1.92041949213752,2.1681317646139,1.4902742116443e-114
4,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.414339495259312,0.0293589171343141,1.42870656737097,1.60296393837774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.427004224811543,0.037974654539701,1.42361246791418,1.65211377382212,5.76665637819402e-27
4,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.334050621484745,0.0668486988102317,1.22527806296842,1.59234837592221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.34455378979881,0.0722569690566099,1.2257159715461,1.62704787609039,2.98192160722092e-06
4,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.33483166603568,0.0309909162499171,3.57608842136874,4.03800897585381,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3723144396309,0.0442767768163391,3.62059843241686,4.3068255474148,2.33834656856751e-247
4,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.356142127500671,0.0235200120329335,1.3634531621013,1.49513622708453,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.367256728515193,0.0331247674159432,1.35382403203761,1.54153690147882,2.84336798480899e-25
4,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.0098958189962504,0.0426729834004208,0.928694175296407,1.09779017683361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0116654048093029,0.0483268847492675,0.920732985280215,1.11277033596977,0.855045748846139
4,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",0.0022409735969609,0.0266040853588501,0.95129317117446,1.0558573712736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00381085428693138,0.0340371407603286,0.939485065204924,1.07358099318413,0.970086155709066
4,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.367546048956638,0.0225741681432764,1.38166123472864,1.50949579060111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378973686628219,0.0324792831486138,1.37151986734969,1.5577398670764,8.66964195484761e-28
4,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.30946936714676,0.0293480950771438,3.49778466330639,3.92423816178681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34622286244173,0.0429129115753136,3.53678650987938,4.18469604479407,5.99406835286854e-254
4,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.399506875423989,0.200915701217247,1.00897776323805,2.21779349255026,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.411758593913094,0.207647495010525,1.00541431132689,2.26905383093754,0.0489432295812295
4,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.407437448460501,0.0240527597568163,1.43378088372658,1.57554306411252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419928112900042,0.0337747547275165,1.42525430267351,1.6270114431928,6.27649470915775e-32
4,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",-0.015615984144435,0.0394571138769736,0.911134187434198,1.06354104433297,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0145350226303435,0.0452721687750575,0.902316791690976,1.07753285059614,0.723526259380993
4,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",-0.0364505079166522,0.225360597992533,0.619036706623756,1.49751430420808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0359294679652201,0.232328718744123,0.612126586811269,1.52180277150732,0.869231527786569
4,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",-0.00368598036518328,0.0726957461073693,0.863837118415307,1.14865425040392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00228231852259776,0.0773676525855592,0.857746699357146,1.16163579514924,0.952642887512311
4,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.37270686065369,0.0202387616079097,3.79288018393651,4.10604451981193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41118746647896,0.0374428775702128,3.8149724362316,4.41808711339056,0
4,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.38640456278666,0.0154441065802025,3.88130542097382,4.12353716858632,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42524779301896,0.0350677532200907,3.88708190559679,4.45987968844124,0
4,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.786198321327214,0.0462755319954958,2.00468539979948,2.40339877732985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.808880619144751,0.0541429974421785,2.02091027956486,2.49873522375368,1.47710198955794e-50
4,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.47317736000747,0.0408982557380833,4.02877564414519,4.729316722639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51436502826423,0.0528947459834468,4.10374391348403,5.04926809384087,6.39492044684068e-208
4,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.385879077005129,0.0476190761814234,1.33997171047326,1.61496268434373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.39778969489161,0.0539944522080919,1.3398719938857,1.65570755945186,7.56420444073645e-13
4,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",0.0260546457983847,0.0254854009013375,0.976342238725568,1.07891816086571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0282814465963114,0.0332267823003407,0.964274633413439,1.09841414998548,0.479199165833895
4,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.460659098484741,0.0698871060447341,1.38272287029338,1.8184910635646,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474571970790118,0.0755066113397658,1.38711077827901,1.86489263815764,5.67437596125164e-10
4,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.657379341032429,0.0331536232059959,1.80804857015869,2.05897428833803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.676611393470037,0.0421966744556514,1.81231164618688,2.13829997132317,1.42984035505206e-56
4,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.640156796181674,0.0169140065880988,1.83495338150163,1.96073766768764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.658904299165922,0.0302538808585129,1.82270989635166,2.05221024674154,1.8583328032471e-100
4,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.641321508230425,0.0218331495135187,1.81946579762922,1.98204138011489,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.660090421894836,0.033418891599596,1.81360661328655,2.06745237912318,1.41562452711806e-83
4,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.0202839983009793,0.0263923544165843,0.930432008054799,1.0318464346409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0193354269633212,0.0337779093398494,0.918463479952613,1.04849293790491,0.559275720433214
4,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",0.0351350682924164,0.0330411165308661,0.970771283038047,1.10501002854274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0375852341386349,0.0396529145380367,0.961125211652104,1.12275555801983,0.407184425371697
4,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.699130356488296,0.0215422443953566,1.92889530432928,2.09885404764882,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.719465721243323,0.0335576514542577,1.92406158874813,2.19456080798196,4.07914751808685e-100
4,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.642358347067239,0.0452719290528495,1.73987612193921,2.07773138315599,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661168967293604,0.0526931526927453,1.74824166937999,2.14934659251303,1.95315146585832e-35
4,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.374650766783701,0.0232900857160316,1.38957377594008,1.52240682875053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.386264088214134,0.0330434015795696,1.3800324564095,1.57087811523985,4.83859460200025e-28
4,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.355645356366308,0.11026024431552,1.1493803833425,1.77080671802515,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36672876300108,0.11549613838084,1.15138103995353,1.81067312667567,0.00169561864570104
4,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.33538702444162,0.0400045698484124,3.516106271687,4.11306806053194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37286314240499,0.0513440910990831,3.57275663806886,4.36929908631701,1.03901733373183e-176
4,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.34827276182604,0.0252737369924138,3.66525965726718,4.04697791670191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38609493301338,0.0403620132469445,3.69914753493681,4.33325322358268,0
4,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.700730447511127,0.0284856421420565,1.90594198046692,2.13109947001433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.721138897409434,0.0386479304083454,1.90809945177808,2.22021668859443,1.43804681113857e-76
4,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.424476444823937,0.0228554992894923,1.46183425622584,1.59884884428358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.437430921352118,0.0329717375722307,1.45271400061474,1.65314637791214,3.91266776890612e-36
4,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.29294005474003,0.0191900002542432,3.50920924913153,3.78336621220732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32927145169823,0.036209727060047,3.5232337605731,4.06055137773444,0
4,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.650272490526965,0.021814079616869,1.83591284906837,1.99980853615307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.669282843558191,0.0334574779977362,1.83022399154152,2.08671125179544,6.1374438864894e-86
4,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.380561036763198,0.0382252997351065,1.35742494635385,1.57685113308206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.392306981429936,0.0454158843331985,1.35513392998435,1.61919204309467,8.12043012216017e-17
4,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",0.0302538624633298,0.034705141799045,0.962894509178558,1.10321675925785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0325722574210524,0.0411105921050125,0.953587833088534,1.12033395855229,0.491193231273253
4,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.37319414525328,0.0368708770065044,3.67387305024244,4.24515195207386,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41168890293992,0.0490373512133922,3.7311286501697,4.52190633116566,2.94881430139941e-209
5,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",1.29838824123178,0.508683821943361,1.43140053978825,10.5134701296686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64653828149173,0.800801750056869,1.08646222183035,25.0785256293044,0.0461508286712927
5,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.682340782278896,0.40738937411763,0.968339899074767,4.78155058457334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.967884118312959,0.725653432363631,0.638589536202125,10.9793452265275,0.200769073702882
5,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",0.244644639523596,0.205250882128994,0.851795411920271,1.90438622620171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.485691775730169,0.612209804856551,0.492445706364765,5.42732984457893,0.457336412807841
5,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",0.437536929762565,0.238508965940264,0.957701089797441,2.43931778022642,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.698205782162741,0.627183977266192,0.591431943583081,6.91233401816057,0.292890665056032
5,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.509845486018361,0.25232645561637,1.01216637186429,2.72153072113475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.777827956736505,0.633904842748928,0.632094778080199,7.58479353352882,0.245130455777531
5,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.43060628739307,0.395046611796431,2.10465799973942,9.90170778870624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79220693052194,0.71908668212142,1.47513996016496,24.7177317570438,0.0161786129962103
5,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.277624293031709,0.588937830927983,0.267651480882223,2.69264581952575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0896725171576428,0.861911203263165,0.169791812047064,4.98008821685406,0.911288376136956
5,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",-0.115117862026539,0.237398830980975,0.560582817564379,1.42163558128556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.089355858776322,0.625196554120603,0.322972509527124,3.74543359309611,0.90213309538026
5,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",0.516343247605599,0.191890757155485,1.15115293460745,2.44235304660944,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.784982158274884,0.607678064534008,0.670216786750621,7.25651861887699,0.222720287210467
5,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.630674940824439,0.272431449881622,0.310688972222895,0.903886665480325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.478613620976297,0.640953077519429,0.177448094909709,2.18892982402016,0.467759577005503
5,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-1.41840887764037,0.736036288673298,0.057211830357973,1.02451021225669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.34643670325705,0.987760294934314,0.0377539230178945,1.81354468416827,0.179209881173381
5,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.0644977009531429,0.395730515718221,0.476268678949064,2.24669890231013,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.287230899538128,0.716330244436453,0.329252283458374,5.45772456858938,0.707508255639226
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.269786575457577,0.212990604267382,0.868171660486717,2.00078981175344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.513389642868801,0.615482193057811,0.503043481002624,5.61570531959558,0.433813091902038
5,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",-0.181045953733369,0.301568010555959,0.446319831606994,1.45558139706362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0167253562999926,0.657749141108291,0.281778459967797,3.71246150527662,0.990809269714127
5,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.59835615326023,0.337056107765341,0.935862362923949,3.50765878639617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.875356223358397,0.680252975022363,0.636327013782727,9.15682943914379,0.219664714578668
5,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",-0.195224568538663,0.389848834496376,0.399348374414857,1.84090670711171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0011051538803984,0.711796280552296,0.249533741298959,4.06343636586924,0.991661492657646
5,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",0.0241651799448476,0.293364138200034,0.566609182723836,1.78940078254135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.242798251271768,0.653748014732271,0.356046929222345,4.61795697700753,0.731503273471069
5,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",2.03348616183297,1.11762252171584,1.68833106975193,134.927863348719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.45638306429381,1.35858440140877,0.818369780355436,168.192978738214,0.0739794028817057
5,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",2.60090892821452,1.11370671443889,3.01400487878243,237.203831064172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.08148010885127,1.35539811474042,1.53872042422505,312.315581848423,0.0244846316817295
5,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.855311770462785,0.64739902329904,0.128318447460792,1.62339121635481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.72607354891936,0.91033705926651,0.0817126346241126,2.89767606082841,0.430544056780621
5,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",1.78802363853078,1.11988346991509,1.31165940544639,105.758225049051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.18596011616463,1.36053905457472,0.622073118583012,128.83305950275,0.112571267520867
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.70399220147129,0.480236695576239,2.30758415612683,15.1605159335609,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.09339786663672,0.780060915521456,1.76904485326694,37.6458367464699,0.00919202239943957
5,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",-3.33700491963637,1.21618289244465,0.00585779875177685,0.688918673853097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.46007394176668,1.45158278460394,0.00183723895860732,0.543681629406263,0.0181443980195655
5,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.861605129290959,0.401826803400242,1.17327966130184,5.66855980064443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16537301112467,0.722307339997181,0.783141207838046,13.2891842106425,0.121054733344748
5,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.37734944969085,0.284178564168539,2.30927542089299,7.03496915898372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73357686062088,0.652308438564571,1.58559819996701,20.4496106288073,0.0108655221953529
5,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",-1.00379506641366,NA,NA,1537.34939533181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",0.632077533806418,0.622869393616541,0.607582566650164,6.98200382346493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.912510546702345,0.892103469344327,0.43599849233698,14.3947685756088,0.32163793951678
5,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",0.274690182363396,0.41551599697349,0.632614376291575,3.22488901431454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518793974154138,0.730289540875444,0.403853703193611,7.07084370980042,0.499404539822067
5,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-0.568424000438687,1.24598947180677,0.0837755662248944,11.0737239818749,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.410036157161242,1.48500661258371,0.0363413550311148,12.2597314514546,0.779811921376644
5,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.898800900693233,0.291442418334766,0.227966001748637,0.71453343390557,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.7739973689466,0.650345772565337,0.12965531982249,1.65936143026283,0.250274415421769
5,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.34805125360843,0.471924462924456,0.518351271997952,3.29632353206778,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.599640050610733,0.770926177297252,0.404329486470657,8.30161365062857,0.456976818844404
5,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.436779343721671,0.47739872629949,0.235295313575995,1.52875659099676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.265019736920642,0.773311679701946,0.169506288847008,3.5129664801278,0.731560412318255
5,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",-0.521454970624471,0.347445572403116,0.28490875480803,1.11223923096791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.358272375214939,0.683833890680122,0.184007090323768,2.68531652262583,0.606167275613846
5,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",-0.335242388681897,0.370414798080745,0.363379408158133,1.55222834140888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.153154327208124,0.69875719073612,0.219396267559743,3.39465491997141,0.823458296306213
5,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",-0.205392770843005,0.358165856797157,0.425643724171967,1.73296142043558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0100969731186075,0.691271006521655,0.256882993145308,3.85973286579768,0.978994869494922
5,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",-0.381459698893833,0.406629478835948,0.318805173031076,1.56954090831959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.20407377986822,0.722677147980595,0.198955005862657,3.38098059393855,0.776280208914345
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",0.0329878726937826,0.373565748837524,0.520847339905302,2.25252663118359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.252517779036664,0.701672708766489,0.327294240306278,5.12233700400562,0.73779521933568
5,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",0.631023452484997,0.352851183114052,0.992729909054573,3.95845807629613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.911347455065659,0.689985627141007,0.647181776082296,9.67519976614394,0.207033245549479
5,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.598686210338706,0.54715280626811,0.7177920413366,6.13018053603142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.875723219840452,0.829595213019209,0.475032425914279,12.275203676513,0.308241797244268
5,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",1.44870558971835,1.12414512865209,0.922170969835017,75.6065781641029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81215791138878,1.36437594958802,0.424833344977849,89.3174724346329,0.190105330158781
5,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",-1.20619015476878,0.477204596113371,0.104329809632728,0.677334180719581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.11263861921969,0.771514392005782,0.0728743522137525,1.4996958493006,0.159958636931317
5,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",-0.676856124335909,0.890252535480501,0.0724328411381595,2.37412829829325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.529499542063108,1.13249168188366,0.0643541871302547,5.45172754716652,0.639706096447736
5,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",1.19615782608197,0.521689522684874,1.24922310414828,9.65530198106099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53396231694449,0.810679984229973,0.952120250732142,22.845249714756,0.0665204409850861
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",0.331021106252579,0.607239267855024,0.40833591334592,4.41350458217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.580829993531873,0.878356102523307,0.321472041280667,10.0567892194344,0.524548104164344
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.80701484675778,NA,NA,2.64603136110723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",0.992405956774194,0.213647467297699,1.79458875780493,4.14647499286212,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30947131082225,0.617726598981261,1.11031105203297,12.5044424318188,0.0437234223890865
5,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",-1.04261994052408,NA,NA,8.48460996895846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-0.0943465009696228,0.305410009339138,0.489361380465285,1.6201701823405,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.112238649591572,0.660112470501074,0.308590698682701,4.10355575830042,0.880564133307019
5,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",-0.747795639767524,0.392560671643882,0.229206152136461,1.06788077842438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.607640925475268,0.712315265074135,0.135609798109439,2.21278273977682,0.404798708110373
5,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",0.236082461752654,0.344032013042886,0.683076019082713,2.63117782018194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.476259094203814,0.683585986919292,0.424134059820895,6.18360932706986,0.510338613394014
5,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.549226414769611,0.545772481698777,0.171627189336263,1.45784330799671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.388906088041006,0.826163714529699,0.135019153794459,3.44238181878201,0.63975906319267
5,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.741202465533268,0.222916990715294,1.36736085886794,3.27625515232391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03273063550586,0.621011983448461,0.836470205684554,9.54252252410465,0.114487796465584
5,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",-0.176713025979761,0.232732967755632,0.525621367243211,1.308815212504,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0214990056267034,0.622901382499312,0.30314145708854,3.48397130906269,0.984507366740334
5,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",1.21686230463608,0.206887756531881,2.28049770864811,5.13140148433802,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55674591257342,0.615551762777262,1.42790009265935,15.9446519118735,0.0159454044493817
5,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.11927223935912,0.218913873616069,2.00680703390883,4.73353146878937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44923480730668,0.620306442936572,1.27042950846821,14.4531388729024,0.0260103065905128
5,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",1.15516476659566,0.167419094606691,2.29972572989518,4.43292953224787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48876927376666,0.600628545900252,1.37364129297049,14.467224738834,0.0184675263650614
5,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.99572649190174,0.45951842080782,3.25564981183279,19.7207425028478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.41479007651224,0.765428051757179,2.51061969846651,50.4484711910108,0.00218780043413594
5,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",2.02397513484836,0.191320413491425,5.28935045344581,11.1971321850126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.44591062925448,0.611650564434764,3.50101038101258,38.5007515528326,0.000128297871638393
5,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",-0.00832976973260294,0.0714057345461927,0.861871219840181,1.14025955872644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0531545873324188,0.282158803469153,0.549064273699392,1.65947687182824,0.864900451858403
5,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.39287168196508,0.0405715860023667,1.36814108457217,1.60398417045252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459630973147038,0.235986468380119,0.927143121747431,2.33824962226424,0.103366415897267
5,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.795940519924295,0.0272367021722129,2.10155961190041,2.33835023290896,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.868046820472304,0.200847607167098,1.52335018996996,3.3475212100833,0.00187820744652287
5,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.385572965400862,0.0491440563013498,1.33557421294932,1.61931380483112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.452282518243834,0.238400707400358,0.915592574208793,2.33107561769246,0.110881924191713
5,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.33204432750271,0.165577781349332,2.76309876238795,5.28781843193575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41122618116376,0.235144156244694,2.49486179368465,6.27128632550208,1.35621125625456e-05
5,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.359878621101479,0.0964184813599104,1.18705394523463,1.73226198996561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.426226899596878,0.255719536673532,0.860857403480819,2.34568098496997,0.150293626971765
5,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.451466632683258,0.0979552076127086,1.29718866858948,1.90441851053166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519046345369206,0.248752621739565,0.962441028426859,2.55182777131215,0.0797846220720479
5,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.13048305765708,0.0466258794836216,2.82822520066419,3.39539284258596,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20701087713521,0.181698521725142,2.24626863703906,4.57915999128697,1.79860670976133e-05
5,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",1.82206701718962,0.246992631720621,3.91018516829815,10.2962325423316,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.90772670279756,0.286582309574397,3.74569192484841,11.5188908504149,3.3173780795236e-07
5,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.0565541423614532,0.0669998995143247,0.927769654851482,1.20642686441252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.118896178150975,0.274192291457521,0.598590059441485,1.75353849245719,0.687836872784411
5,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.173191785652064,0.0487951698795156,1.08060316338783,1.30838417414023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.237082023904158,0.258145813163925,0.701039459484835,1.92846025634299,0.407569217783159
5,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.403282299047785,0.0611422058048278,1.32797911657603,1.68764044688723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470214512056844,0.239833428881007,0.930434256270131,2.38220351549588,0.100168630851972
5,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.334427151765816,0.0237951003769445,0.68306969205785,0.74984908929593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.277251014025096,0.311705581242183,0.361485709799703,1.22670370527392,0.309756189390566
5,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.692609669659159,0.0580932261466392,1.78465276124136,2.24105139110704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763375764255921,0.215408635425331,1.32746679838689,3.08841742023867,0.00724702235786539
5,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.44549208259342,0.0517748870003416,3.83756776132901,4.70108154443818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52618357412126,0.164593150676493,3.22409636489627,6.14627378090532,6.33882859194263e-08
5,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.534639951057526,0.0287513374943931,1.61343447669686,1.80591663562905,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.603295281413475,0.221799619373683,1.1088681596205,2.64528378480781,0.0312050072271783
5,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.340508021436285,0.0314686794879305,0.668725724058797,0.756519987542396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.283412002973626,0.313254802160894,0.357936371957609,1.22205787449629,0.30066017764214
5,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",-0.145106467275994,0.0189191023204983,0.8334138853855,0.897570705997678,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0854299702264204,0.288119810166427,0.467152129880788,1.44528796850472,0.745357524686115
5,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.0315901727581579,0.044249264059963,0.946265490412947,1.12549374492536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0936037073259583,0.271689214317085,0.585464045057439,1.69834057726421,0.750439447320453
5,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.44446013920627,0.0248362111574034,4.03893170657847,4.45192410869117,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52512574170335,0.157920575818648,3.26314027877588,6.06010598661786,4.2751187193268e-08
5,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.398996765465096,0.0533315004804332,1.34260406711232,1.65477773739692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.465879386801537,0.238189182631452,0.929202327795768,2.36376495079201,0.101399877665603
5,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.125652444763547,0.0275505891243787,1.07425184381146,1.19676344631002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.188923371305601,0.25945926727299,0.664205732500898,1.83656742457215,0.50690117499705
5,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",-0.364256076977517,0.0406058848858629,0.641373688018653,0.75203615974216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.307473475142574,0.317511948334678,0.345625629228435,1.19988399422219,0.2641487983256
5,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.636732779536335,0.0581899830278125,1.68727534626804,2.11957489797872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.706759103535754,0.219750976349522,1.24064431156755,2.93597280819804,0.0129644245837383
5,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.755192847258919,0.0208067022285023,2.04312512723841,2.21674817230048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.826760772183681,0.203118720525612,1.45282023916531,3.22108227568005,0.00301399849760164
5,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.688574933291559,0.0461865574152669,1.81909491442839,2.18013555451314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.759252056944703,0.212609667822843,1.32913052831261,3.05854579843817,0.00709434074537373
5,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.38655955571412,0.0412972120051878,3.69203738482337,4.3408081431363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46647993085815,0.164794638818218,3.03161175149721,5.78389611037204,1.69602665473798e-07
5,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",0.0962408561558705,0.0240645113891223,1.05027148382314,1.15416811535766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.159120999406371,0.262093975219443,0.640048224885045,1.78814317653238,0.577485421982398
5,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",-0.295487590254193,0.119081751595327,0.587983668851465,0.937757195546865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.237796573852145,0.330810552264834,0.363435877618334,1.32923173970974,0.421626168741185
5,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.427681975458437,0.0254311498852038,1.4591801652631,1.61214086109819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.494924662081691,0.23058893005552,0.972545041508029,2.40140289677145,0.0772923413787261
5,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.192163690507234,0.0469246569224141,1.10536953573736,1.32859364851765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.256306769872544,0.255910449113871,0.718700627664982,1.95979552904944,0.369351004003292
5,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.15599819116005,0.0865825954148086,2.68644461782108,3.77204069486402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23286204526212,0.195080169033788,2.24702668074186,4.8274002772384,2.27538796686008e-05
5,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.558659997232575,0.0447210223385317,1.60193032503989,1.90887209506733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.627615893180399,0.222638891613959,1.13562053331607,2.71803079358068,0.0260987361906722
5,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.34079389045396,0.0520900795790383,3.4539688319022,4.23639772836231,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42010114760779,0.170585633945069,2.85812538007341,5.57810630000723,4.88402474067402e-07
5,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",-0.382254422208147,0.0661966540600424,0.598811141104249,0.776217196797161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.325724593808174,0.324679286009067,0.33393559355389,1.19233345772698,0.245552170555458
5,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",-0.115610425694583,0.0361011824365954,0.829870988682124,0.956025214914022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0555440292805242,0.28655735124042,0.48404300058423,1.48840137878427,0.829349418006284
5,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.280592237536383,0.0188121985049805,0.727956783152877,0.783666969037607,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.222705208475484,0.304483999522725,0.389359199183009,1.28441373342042,0.412053405555163
5,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.435607969483314,0.0611313762648384,1.37169340611662,1.74312003490968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.502968184989736,0.237040531192082,0.968407959751325,2.4524314808127,0.0784608464470207
5,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.15510427744916,0.0223198757947135,3.0389055382728,3.3167644208274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23197403292352,0.175149421657493,2.33456118082475,4.63852792824912,9.59101470163564e-06
5,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.204044384352841,0.0240724998910383,0.777786524389403,0.854754729661662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.145146252639094,0.295529579912126,0.431399911741268,1.37401198486896,0.589531602560753
5,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0244631450155809,0.0546415161192826,0.876511677643304,1.08587439412529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0368081744939546,0.279727547770773,0.542091116907194,1.62286102910848,0.908877860244957
5,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.143315450299059,0.105392645545637,0.938508181319569,1.41859631685464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.206802741216515,0.278794178519857,0.651645910879626,1.94371123229419,0.494846869647852
5,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",1.6323442357944,0.251266325340797,3.20376260255351,8.57860942569869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71549830210342,0.295471124609318,3.02558788724811,9.63431246166214,5.2828335987718e-06
5,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",0.135510667857973,0.0313369459713222,1.07686894291823,1.21761773624274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.198910386061342,0.258929532296644,0.672025525324682,1.85433503594431,0.484806890962085
5,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.33748951161835,0.0547918510907062,3.42472479930726,4.24525219327733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41675216460013,0.171664081959295,2.8422989805233,5.57071861594562,5.45588635816429e-07
5,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.4066735885303,0.0179205039013079,3.94181474266071,4.22867327088419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48684680000796,0.159126519124315,3.13023978441462,5.84083696791269,8.71338135124514e-08
5,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.55813509714297,0.0383765001397528,4.40812118348526,5.12372482505828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64033298265161,0.154502502447172,3.69589856575141,6.77244646177008,4.60728393959007e-09
5,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0553358371832052,0.0185619206792073,1.01912147791694,1.09603853988687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117671774008045,0.265873612565427,0.607711461999534,1.72314365913315,0.683035700426243
5,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.298649024772814,0.114553816225484,0.591501928882512,0.926772066709506,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.240994594376169,0.329380306898924,0.363191464176169,1.32091138723849,0.412711993203532
5,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.14534924829697,0.0142088562508203,3.05733813140143,3.23245638434119,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2221003765173,0.17489171627405,2.31210591382952,4.58927330608439,1.08620234339486e-05
5,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.0746909468079021,0.0660557519261275,0.946532273388041,1.22627801558623,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.137272848135181,0.272086008738737,0.613039591430138,1.78110115041692,0.640690317605777
5,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",2.18205430966311,0.240728458399479,5.68447253992228,14.6051843611844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.27246769990054,0.272790470721868,5.57497284990427,16.2420968575548,7.62582381357612e-10
5,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",2.68025622958602,0.234640290846194,9.48490230846748,23.7949730626533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.77722633980889,0.258578280056249,9.55329264649991,26.3243431725152,2.83731673797164e-14
5,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.662826126885751,0.0610819658600358,1.7221829799382,2.18809120279167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733193807350192,0.218570081894539,1.27834190811079,3.01121252878973,0.0100937638072214
5,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.395365499967654,0.033079569028728,1.39178653273299,1.58448229318903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.462174423748352,0.23449956962925,0.932353760856694,2.33772552110959,0.100224870487441
5,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.11762376868799,0.0290677714124072,2.88892119079949,3.23758186182465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19398814381305,0.178630115400114,2.22973424694755,4.49110867439552,1.87434901076156e-05
5,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.0710406311779794,0.023452340354023,0.889539647594951,0.975193159717694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0103856331966585,0.280028122634889,0.514878283100587,1.5432110149228,0.957074314674488
5,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.382869024220606,0.1944216012259,1.00426209231962,2.15194418961239,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.449520447086463,0.308671434620762,0.794730311010041,2.66503538848876,0.189836637842315
5,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.435504155450463,0.0170555878719413,1.49495388472244,1.5983183351047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.502849944948602,0.229061511977391,0.983649395626587,2.41432290395653,0.071949080236679
5,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.703781131014809,0.0162123967619317,1.95824579376173,2.08673469388963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.77466991081775,0.20665947876419,1.36654634630292,3.07214775899279,0.00541014928717001
5,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.12854167301187,0.0173947102087524,2.98775394085515,3.19858308506427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20506277965572,0.176292552352679,2.26564855612715,4.52182269154233,1.45889861448764e-05
5,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.576022827380756,0.0306555536625196,1.67540154068232,1.88932651545374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645224746724653,0.218630301079022,1.16592452601237,2.74705489063769,0.0212456657156187
5,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.25983207409858,0.0273981145278956,3.34130174003123,3.72013184187398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33809049399816,0.169314400388502,2.63381001946979,5.11476639674683,1.58064187070122e-06
5,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.05708865430719,0.0851874218984009,2.43987484649232,3.4071470649763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13264545426147,0.20036308914409,2.00551522568861,4.39870366213608,9.77561930502328e-05
5,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.0474862840815324,0.209455617796332,0.694565858219947,1.57866987536362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.109707738505767,0.345077236096546,0.515098402714393,1.99228174204147,0.762814175622741
5,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",0.140235247261971,0.0301120804268249,1.08457465143278,1.22045662325153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.203698990298934,0.258294265524639,0.676316344396441,1.86153342173657,0.473894521757593
5,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.0757855390365989,0.0577914030597972,0.963279332664796,1.20819352929889,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.138382693206442,0.269899372296589,0.616428492833528,1.77566170726364,0.635698479646881
5,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.251764288227527,0.0171456160873884,1.24379039802549,1.33025821477327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.316683000429124,0.245993140494249,0.781467670847558,2.04970092768148,0.259681223515461
5,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.0805404418849837,0.0357476642087275,1.01047449276315,1.16247143264686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.143205505925581,0.26516614530532,0.625430119407516,1.76847309227117,0.618896690875462
5,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.535572216811115,0.0161312260709525,1.65529830565551,1.76334836536421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.604239498802396,0.220340255031519,1.11316586953566,2.64038837698972,0.0303099254509837
5,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.21510308571911,0.0146865948183084,3.27515909844733,3.46924448082899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2927294412274,0.170452494774987,2.50833719763405,4.89288233411835,3.25241761508242e-06
5,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.0347507393944267,0.0219601662776291,0.991720540876708,1.08087224105624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0968105172888815,0.268338302310212,0.59137973569174,1.69311474886143,0.739339910498019
5,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.51427534938746,0.0436904571905886,1.53544142482988,1.82226705036296,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.582643704451087,0.226107587018681,1.07594253732635,2.61044971402873,0.0388849744833215
5,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.366371678540192,0.0201776977921593,1.38658693791432,1.50071312107212,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.432804564711416,0.235530452909458,0.902068963350651,2.27094967748488,0.122275019435367
5,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.37109782881111,0.0147472912074082,3.82761631821144,4.05540499274748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45080111920051,0.160884203604149,3.00630471478022,5.64836512308541,1.73983937907496e-07
5,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.123243503571891,0.0209835301635029,1.08556846182878,1.17863584306648,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.186487713960215,0.259031276865418,0.663037962773223,1.83026527561569,0.511645895142977
5,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.431229837416202,0.0196599786933053,1.48101017768479,1.59965840213198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.498519245957866,0.229664425384132,0.978012919314369,2.4061683968086,0.074641573389882
5,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.132500624133884,0.0168462803745191,1.10459336774675,1.17999886884284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.195873322998985,0.257756844336809,0.671398765804275,1.84410899380604,0.489668578055022
5,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.454017184121248,0.0157828651878283,1.52669266497432,1.62412861243704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.521607424027325,0.227333576284946,1.00667751061719,2.45416494501462,0.0618040848335882
5,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.075485102801488,0.103554655537395,0.880038290213214,1.32066702339289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.138076432945106,0.284561914765283,0.598622365098121,1.82638369118071,0.651497775306807
5,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.528344611699834,0.0275057552440076,1.60721948106316,1.79019801180771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.596916769251137,0.222159826267872,1.1006946896486,2.62949557997117,0.032966540768946
5,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.686878062510462,0.0382961877305754,1.84420057107057,2.14290885946934,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.757544254826256,0.211069431163503,1.3307456574075,3.04382940816741,0.00697524306022562
5,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.33899093250998,0.0345997046923807,3.56642916805998,4.08447504596249,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41828968861521,0.165951550171508,2.87889034483145,5.51748999594917,3.88615012705283e-07
5,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.43497269582991,0.0250507544032045,0.616192938677376,0.679771885549686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.379124384808612,0.325117888477972,0.314471008797086,1.12476633888729,0.166857833792049
5,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.426548799447663,0.0641348271905936,1.35166303768571,1.73800797766345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.493786872600064,0.238671729195826,0.956016797936136,2.43658188819346,0.0848636803470763
5,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.41205875148077,0.0190950457766471,3.9540398369636,4.26136275136719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49230311435753,0.158955899554487,3.14884214620901,5.8716194940208,7.88094481884405e-08
5,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.575147647393973,0.186270604686875,1.23928541492857,2.57204753608041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644344900635092,0.290036674477096,1.01192969120507,3.15434846420737,0.0559159755705793
5,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.48428810236863,0.0221143415114303,1.55423659973934,1.69498029983601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.552278280559619,0.225274041287431,1.04388760662439,2.52441623597664,0.0482325335493011
5,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.09338482315766,0.0178759365506851,2.88183168391661,3.09101178864268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1694351998136,0.178661800365416,2.17381495326478,4.37902043868919,2.60270848207886e-05
5,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.675929711776525,0.0197309781206313,1.89139335065549,2.04348726698238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.746450762522165,0.209181031550907,1.32034809483879,2.99777391897662,0.0074206612562426
5,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.842136160464786,0.0423549570657839,2.13711867350663,2.52309642769053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.914853022202136,0.200237165316275,1.60115771790795,3.51009185291684,0.00113530324106172
5,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.39171879429847,0.0380298394122857,3.73472382656671,4.33511485636392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47171176694176,0.163668785211047,3.05465274253471,5.80219193747146,1.45980102288693e-07
5,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.23299190727965,0.01801436860748,3.31272034734665,3.55510548960719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31085035011565,0.169662627064336,2.55949214852663,4.97723311117022,2.40234710374054e-06
5,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.372921028732304,0.0209507778195027,1.39358773274502,1.51286781444191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.439440423193697,0.235008454965553,0.909343976349791,2.28458495987354,0.116669945317763
5,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.2319114163832,0.02141836113168,1.20916839506638,1.31507181903349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.296554199455993,0.248271334285404,0.761527185215931,2.01531667017116,0.292181919870887
5,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.74322656260605,0.0418940904807718,1.93751077864237,2.28330935573949,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.814637053829165,0.207472578708633,1.42235144412695,3.20781176876512,0.0037664558110527
5,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.515617054566768,0.0202099046928581,1.60968843625948,1.74239745588796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.584020923279738,0.222394652630336,1.08540362100459,2.59535403701922,0.0365357050448772
5,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.266685770688735,0.0326337799259435,1.22476458952055,1.39190139207698,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.331775414042246,0.246273170123418,0.793659413544895,2.08396478852057,0.239719815011564
5,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.788214197785088,0.0261102023686727,2.08997215337754,2.31521106157364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.860218417069446,0.201268533678837,1.50975362114276,3.32312174963588,0.00205689206248005
5,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.4546515259759,0.0237779581625439,4.08870906099324,4.48813465212563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53545700711699,0.157166313378364,3.30271666011459,6.11549667198084,3.42503952380566e-08
5,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",31.2694856046659,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",-1.05723004973801,NA,NA,5.03986327378513,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",0.796449226081028,0.307051234670937,1.24029896365117,4.13286624784166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481197856328874,0.767946923775127,0.624135706573157,12.6658471401084,0.287508064393445
5,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",1.08641121731436,0.294144105546417,1.70837134791807,5.41170497021835,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.659175821451166,0.838415776995583,0.724648457464343,19.384248940035,0.151906912093108
5,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",1.4375181237066,0.282437575844213,2.49388731784882,7.5456981394031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.874628791375258,0.968916503946678,0.865071749661494,38.5956692900889,0.0598247989493394
5,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.97072395744496,0.270233514165499,4.3719067802409,12.6100631570403,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20188210231338,NA,1.12518559626613,NA,0.0102735962143421
5,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",1.02750285443338,0.310582080569236,1.57949500451608,5.33647094551564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.623025117140812,0.825448553684299,0.699570238044052,17.7859673362983,0.177442007475371
5,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.24860952604422,0.399656313382807,1.62202641867305,7.77023341231913,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.758694287093516,0.918067517171424,0.75295003032454,27.5224524391457,0.121286748104312
5,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.283089157073298,0.329798709235488,0.662487154399755,2.41339163021378,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.166137053192039,0.677018519932712,0.47699937967629,6.7776046516103,0.674121462930008
5,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",3.05908363178943,0.46326127104055,8.65454742352001,53.1987930920149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.86982523098145,NA,1.77084057134672,NA,0.000370448602545825
5,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",0.363758236147755,0.530591765562228,0.502510137456924,4.0218501649175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.215643175585294,0.750483042255228,0.445903818401292,8.45017763996463,0.643540932871591
5,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",2.45306328202734,1.12463634160543,2.51362920901283,206.483614244051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49789742698536,NA,0.852621474713762,NA,0.0624065257250336
5,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",30.8284100405608,NA,0.106756761052816,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",2.77510571771009,1.12035844383291,3.51482951883297,283.926505840299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69554455603064,NA,1.01464092698283,NA,0.0350416273431538
5,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.933964736935982,0.529120099874908,0.131907622748515,1.04965259702803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.580799067013385,0.594169741123009,0.223579323550936,2.29587394266555,0.337408606225934
5,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",0.303708066384893,0.54715734775006,0.449280676329364,3.83707331596759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.178789542805966,0.746815611422838,0.427465896229176,7.98514255432379,0.694460616638698
5,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",-1.53832086132005,0.622674960004875,0.0694527950737232,0.797505160593264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.951700320555028,0.586047011603964,0.148808289218963,1.48018284041163,0.127015504454965
5,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",1.98632169731632,0.600410936237181,2.11670249019879,22.2741557297372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21144103496737,NA,0.981618329363752,NA,0.0323079596408287
5,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",-1.16097588961348,NA,NA,6.15720600192703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",0.338473949898362,0.806013949308719,0.383423428897956,9.03315124254967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.200127813515227,0.8624584533059,0.358001288045845,10.5229261375355,0.717078272859067
5,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",0.957324511361383,0.424714932345652,1.14803153026072,6.06722118338235,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.579923254141125,0.836743114011419,0.642663160151056,17.0788044161755,0.235187821418786
5,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",30.0404697357878,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",32.2104374538449,NA,4.04623395707624e-09,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",31.0565165038041,NA,0.593692451712681,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",-0.545543178303578,1.20762447189379,0.0973957899042504,11.0765321497124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.342405619543694,0.96806373104019,0.148089768898873,6.58506003889383,0.731401057657811
5,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",4.01510646673114,0.392296014560203,26.6188652214247,123.889780438238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.45656316838574,NA,2.82941851104701,NA,1.24831198986183e-06
5,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",0.359569129287211,0.66555152841573,0.38852182390012,5.27779351307009,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.213070569874192,0.802476397385571,0.405024422842747,9.41064753061434,0.674948446071861
5,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-1.87509640546821,0.64412869108387,0.036024949295078,0.449956002723385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.1583857370914,0.574249261521989,0.120927800628256,1.14849701139879,0.0647729941540506
5,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",0.134595947855209,0.350576639376973,0.588134520748397,2.32433875824814,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0750032571738447,0.659384887667599,0.437939567299008,5.80701640386247,0.813928109674145
5,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.254491085668034,0.306757160441501,0.712784505653675,2.37237089459688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.148586003797849,0.667101668689489,0.474722506411785,6.4880735082752,0.696778908930264
5,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.72171464436603,0.295638548273745,3.27424514162841,10.4329510280813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04905899695295,NA,0.98973680920601,NA,0.0260042208652794
5,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",1.46387105122585,1.38526287692947,0.409890938545891,93.5285313232361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.890810436710222,NA,0.388762326776293,NA,0.332741189968894
5,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",-1.00398385415118,NA,NA,84.3757820497565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.52492703197415,0.375301142574794,2.25564065952732,9.82163381137601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.92828052973228,1.05192780288922,0.87290188367003,53.922568275942,0.0571403426522545
5,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",0.0299385491163402,0.792102600659407,0.162444963514502,3.62396640524498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0107789593883245,0.811021401329884,0.306107164560091,7.35459617145148,0.934882703111581
5,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-1.57844147162972,0.565538273663506,0.0598089364812054,0.548959344918395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.97634132174609,0.558232931791514,0.152667903633504,1.36171182270754,0.103690612975952
5,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-2.32546584979709,1.16165974275244,0.00533537682041512,0.506731881402866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.43478980259572,0.828123575464602,0.054914210417004,1.41086309777329,0.100249190849239
5,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",3.035927574536,1.1178761962436,4.59680723982077,367.732639797941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85561699695908,NA,1.16547380940612,NA,0.0211428615452822
5,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",0.837591634811419,0.78257759460768,0.674204029507796,14.4895152490732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.506447245436694,0.948938082065107,0.477660977086233,19.7058368315419,0.406206435338391
5,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",3.66149017857026,1.11354124048515,8.70846183154067,684.916292855964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.23953335534789,NA,1.61406615181211,NA,0.00545423245734742
5,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.581502358903282,0.326568892657532,0.973545019823705,3.50193378614693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.349280018152443,0.728229161350279,0.555802284548002,9.65294650617493,0.430237149291156
5,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-1.3636620484741,0.514059065987804,0.0847786071987067,0.63594860345448,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.844515315079033,0.552714996457821,0.178932182953177,1.56182430208743,0.148738781071922
5,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",1.55203607231147,0.76279123280976,1.45616933173708,28.9594313129896,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.944918658853255,NA,0.707068494926549,NA,0.130389220355496
5,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",0.714839647237786,0.789133816062271,0.585496649896822,12.9106544803692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.431111530104151,0.924039551326275,0.44492125715118,16.6483401220022,0.47541422709172
5,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.10322543443094,0.337649442871591,4.37010740437003,16.4175203944582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28319764513631,NA,1.17436219955186,NA,0.00808190990353675
5,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",-1.00681865236727,NA,NA,93.0240485883204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",-1.02266383508968,NA,NA,14.8755300102428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-1.21055595765533,0.560551420153099,0.0868809777105424,0.782004347241644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.750548666328947,0.583463942695377,0.187727597886609,1.84849780809357,0.215983503052534
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.74547933633364,0.151839856903923,1.56722128418215,2.84199272677634,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.818016353945418,1.14686068364521,0.436648713571617,39.1337397536962,0.335073130095476
5,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",1.55894364717167,0.183502709471659,3.35937276992149,6.89689757852575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62513907945508,1.31382799985457,0.844401024092373,145.617507592328,0.0622172634165357
5,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",30.4095250867867,NA,0.138860974861906,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.16205370691288,0.139263937162266,2.44196618079457,4.2152467428977,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23133305476338,1.22355334043465,0.617797313734312,74.7871526497031,0.151308084972987
5,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.600759318004509,0.140622043775202,1.38866783155101,2.40987089489563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.674390235806228,1.11980117770602,0.388517160998018,31.3157767038133,0.421894830619499
5,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",25.9509527194689,NA,0.133828057853981,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.87550141768573,0.134088610422519,1.8532107078395,3.13471213499536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.946996703744855,1.1679237535008,0.488564563869338,47.5553044731516,0.265501497296009
5,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",30.4370588839035,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.53223378696171,0.123674507368678,3.65468273207128,5.93462858779773,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59863704657245,1.29929530360938,0.839529022448024,136.760301418146,0.0634116801606234
5,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.164134223466061,0.177174818772666,0.829674733153432,1.66161660142328,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.24115491001075,1.05440939405583,0.266861558776675,16.6462274822799,0.756806355312652
5,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",30.5150443101822,NA,0.517009466865293,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",0.322205367949213,0.14882179565424,1.03273431550456,1.85073096867788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.397999103390045,1.07454386406809,0.307423963773839,20.7512617523735,0.624814976999684
5,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",0.676859427471751,0.162891474284974,1.43980290539806,2.72652820186007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.749908146112767,1.13649426151734,0.411131605462256,35.3795416863824,0.376171695865635
5,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",1.32678046930145,0.151072369140865,2.8289228132783,5.11454690059825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39477918891239,1.25873776533341,0.705027140717911,97.9681467457468,0.105925941995653
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",29.7499973062156,NA,0.257788941419863,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",1.50344495983176,0.463022834352571,2.05997375783055,12.6506601869637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57006256516725,1.38375692109273,0.692496550532239,157.083173923915,0.103301949579326
5,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",0.393368980560419,0.170471585389092,1.0667157495245,2.08094240568161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.468609742753819,1.08974726263972,0.323972495353378,23.2111813282113,0.571047199607046
5,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",1.14749465813761,0.316759850245035,1.75496485925162,6.0746515524248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21688294092253,1.25944366776977,0.567504697942279,79.0770115537319,0.176694895755299
5,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",0.760721910664282,0.201017620815648,1.45471452705313,3.1988273008285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.833094755393392,1.15831087355707,0.434941061461994,40.7701600368195,0.331796039901844
5,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",-0.183771921750777,0.460728576078144,0.326067041668502,1.98450708232347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.104053461796602,1.0980678821514,0.165832283803131,12.2750489726374,0.9432098200162
5,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",0.62345994700598,0.369778328205364,0.912188692561019,3.88683810457865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.696907359194984,1.18215268119918,0.354320438670122,36.4667095562316,0.439280173033517
5,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.846257566947337,0.135564329760133,1.77965619977562,3.0277585923813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.917975367418294,1.16274122536345,0.476726665272423,45.4698681895366,0.280020506717574
5,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.29012568864737,0.161832547319693,7.25741137805697,13.6862972874224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35064965997195,1.4949316966675,1.537535703583,539.264142897603,0.00708703657052127
5,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",31.9603616875246,NA,0.0701384440094829,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",1.47650210774248,0.315311100521912,2.43160441724044,8.36911459194131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54334998596987,1.32623294055421,0.745672714869787,134.999233701343,0.0882904122059786
5,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",1.80746816993086,0.461549225158697,2.80207260054698,17.1089047681991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.8717337999749,1.45110289458289,0.892775304525585,263.696408612423,0.0527750162162837
5,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",2.42554035446223,0.459331192864991,5.22835507723105,31.64695393589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.48498799599719,1.6144007110116,1.48799853633756,833.610655280328,0.0103866568694371
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",-0.757687859864566,0.978527271658626,0.0789924892876258,3.65960023976143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.673515654870235,1.36598274683853,0.0524774614914342,11.1026350065739,0.623903063637494
5,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",-1.05797193819221,NA,NA,36.1646856597015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",0.404277110426947,0.178817677548358,1.06483960188472,2.14636689143073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.47943309005914,1.09305587782501,0.325986815689644,23.6603811088939,0.563495343838586
5,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.16444413763322,0.196902617766646,2.18821606724086,4.73475843895693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23370265798219,1.2334012951866,0.608197922691756,76.5228443229127,0.155520622319791
5,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",0.918312724778895,0.347675393072371,1.29031880285697,5.04174281685322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.989479082071167,1.22604744473778,0.460352245258532,56.2752223587039,0.274577486827855
5,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",-3.34975311104863,0.59363996475115,0.0106760040333002,0.109401490118821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.24546022931974,0.875477381200448,0.00849830711935069,0.262874111503257,0.00225440790440979
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",-3.2687692702891,0.566498924993014,0.012464828167127,0.114840695580303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.16511095165292,0.861978058705872,0.00949337866279148,0.278519054068904,0.00252171248233205
5,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.514520949639703,0.160480007999416,1.22104033056025,2.29050724448591,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.588821224052382,1.10816850476805,0.359542161008684,27.6884922433271,0.481765693078379
5,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",-2.21703328418703,0.43194167609023,0.0485170032315226,0.263774501119233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.12153657824112,0.861204849599867,0.0287377161530363,0.840562565705048,0.0315020087126095
5,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",32.7979928735099,NA,13.5646779044897,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",-0.843076361758536,1.16389526949794,0.0234608646775052,2.24782715576974,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.758263136343435,1.50912172035829,0.036333559772274,13.4722900512766,0.616570340615205
5,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",0.0854982833840716,0.180562520363631,0.767053228090452,1.55673859952389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.163129587947093,1.04294879416162,0.249529546102785,14.8813120214784,0.824555649223753
5,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-0.33338786930607,0.445435576088612,0.27258822245177,1.56249266462032,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.252509057183548,1.07108526182142,0.147756215419407,9.83930933077613,0.822951643643427
5,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",-0.593796999181013,1.09818688511782,0.0641860924226215,4.75332686522748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.510879390933332,1.47818710536684,0.0507804668621202,16.6788836783406,0.732435422430588
5,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",1.33227588550604,1.08224188717604,0.45436636328952,31.6095346365123,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40022993673393,1.72648779508833,0.298040431332304,259.091600789364,0.299584753274646
5,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",0.81899844039516,0.172910475458585,1.63187508986193,3.21403232374511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.890925973915348,1.16353667084416,0.461036464169827,44.1106741755218,0.297412459512752
5,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",1.91363068788396,0.298018924415396,3.94547375776525,12.6895872413745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.97707319148377,1.42217857701455,1.0770559202645,284.026885275425,0.0287745698412698
5,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",1.10648915600133,0.167150117004161,2.20188097632046,4.23985216964113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17619903774574,1.21674179889684,0.585601354449233,69.0219248264114,0.172241078199678
5,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.58148178847817,0.109464431907253,3.92270784546605,6.02474334713274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64750270827915,1.30873325017837,0.876454270789,148.156525991377,0.0553780773669907
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",1.11832318662954,0.46590521847463,1.39128834035135,8.64123124845309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18791504778508,1.30788551700756,0.500379055103365,84.3038606820379,0.215241557780408
5,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",26.5698884609292,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",26.7039521583211,NA,0.251757884111255,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-1.23442905404805,0.475365084421334,0.101686307129454,0.655428712289854,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.14655741308187,0.979324923261562,0.0655395369044602,3.04585440911127,0.261300617943057
5,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-1.23806853262547,0.145388160738816,0.218206351449514,0.385812808209906,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.15018303461353,0.859091061050246,0.0823652565609551,2.38925954357304,0.206083118019468
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.850836611807569,0.134474811114523,0.329041016438329,0.557417207870688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.765938990529171,0.904547502688125,0.114996694883033,3.98648210467712,0.406107914776304
5,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",0.771537889392826,0.332625986421515,1.16067731362963,4.27538276133873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.843840030184281,1.19487679828435,0.410988890604282,44.4623109864908,0.345916246390988
5,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.1807178339092,0.172696971705454,0.844691524670001,1.66225632558084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.25760985391324,1.0561554426616,0.271025874905601,17.0220961920497,0.742519307513204
5,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.59188629358278,0.148509636189375,1.34248778459869,2.40288842694223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.665586055009592,1.11944354531056,0.384808538526118,30.9733975384916,0.428352410683891
5,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",-2.72843105416149,0.487158696218848,0.0255733790102406,0.172634894281898,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.62897054254968,0.849892493132097,0.0171172246478038,0.478953061740384,0.00918055593223906
5,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.68562497130233,0.179453345592397,3.82161518128903,7.72233936056818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75084175883524,1.34190508093232,0.937558248775069,180.493518322289,0.0446585360819687
5,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",33.0297234845688,NA,9.23206104688142,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",32.5134006630232,NA,17.9610292744652,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.539120539518335,0.127073267313542,0.456419747475732,0.751094097081873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.456643699819999,0.944166830743871,0.150101329777101,6.07766931540062,0.631011787423193
5,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",32.519284117561,NA,34.8984425422109,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",25.9682339663631,NA,0.428071471301182,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",0.0952536354245986,0.226418008000154,0.70684263277281,1.71702829297103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.172808013035864,1.05442462777883,0.246819639368238,15.3969767566876,0.818154310639933
5,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",1.85597126065957,0.158895696516296,4.74145144343819,8.83925843308103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.91985404990746,1.37930525941523,1.0832646252431,241.472729910328,0.0272729086642198
5,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",0.513449992842254,0.209191907990623,1.11561879193359,2.53305588197837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.587758331485972,1.11725432639039,0.352941621561918,28.1656702366763,0.487396674590619
5,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",1.36928418522521,0.310567711113095,2.22281042273525,7.50954898347382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43695118145242,1.30222711495415,0.684256625703799,112.754652575298,0.111330228369853
5,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.51008148851025,0.185059011742482,3.16858674326334,6.54501481046352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57665623236536,1.30330250165419,0.810928820532315,134.192714160277,0.0703567118622532
5,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",-0.580831843463241,0.896945636136586,0.11776482797049,3.96258527463666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.498050644040006,1.32154053457816,0.0694712574536007,12.3480916639369,0.709397536842726
5,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.216071693296693,0.116372107947832,0.993505613111417,1.5677707620916,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.292691133022114,1.05299032803927,0.28385398434826,17.6079574093451,0.710009697301401
5,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",2.28517956603903,0.372103922315478,4.53722784695925,19.5101880190577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.95637510969275,NA,1.09189254445899,NA,0.0219125827543846
5,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",2.53207154382652,0.252027685741632,7.88898717173017,21.1872192080824,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.18640824873016,NA,1.34016289379561,NA,0.00740673267686381
5,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",0.571594426640035,0.805988664656274,0.483923854688624,11.3997314679697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.359900414477554,NA,0.222064473534557,NA,0.726306242090097
5,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",-1.95773881087301,0.772630926775751,0.042392137255286,0.876222875439373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.99656907206961,0.993326954836533,0.028514898725697,1.39995703478348,0.0647086052598112
5,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",-2.88998363792092,0.807226479674894,0.0152101571636714,0.360046465586481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.865103988902,0.910516667824158,0.011895076660012,0.422117765798406,0.0091566211821238
5,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.188023232670259,0.154838242698662,0.613691668863637,1.12602317735199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.347801362119223,NA,0.218248607714188,NA,0.684862406043765
5,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",-2.57988397562313,0.788819326327271,0.0217860045917687,0.479806411054999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.57622358654667,0.924237458565125,0.0161313852155978,0.604082652563355,0.0179408324221081
5,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",-1.53807192582031,0.761036418201098,0.0666028555411363,1.31547802256567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.60558493753638,1.06951935299647,0.0416382623174731,2.75578698303972,0.135792249153265
5,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.499140866982209,0.199178859781365,1.11359067638359,2.43113061149984,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.292403701941287,NA,0.350378596176142,NA,0.698828015435692
5,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.217626386425784,0.21560453859151,0.810350959051773,1.88677008744188,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0301302531527952,NA,0.28519914447812,NA,0.94930516635609
5,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",0.279552141352942,0.122026398175981,1.04110463718685,1.67970299952088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0878387860484236,NA,0.307502102325043,NA,0.890887901206702
5,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.42273354891981,0.109473443516665,3.36011710587356,5.16086313339655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15290135053051,NA,0.674598727031919,NA,0.140523043987526
5,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-1.48492459743322,0.228025269740121,0.143006418974023,0.349579900644869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.55609773674426,0.73580025474338,0.0800159567085953,1.43154573333159,0.0608378790186686
5,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.229265640818047,0.144973349430706,0.943334537398266,1.66520924229547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0409851424650679,NA,0.294969577173197,NA,0.937679879780463
5,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",2.52688252755369,0.337577346509036,6.27314354410014,23.5601440751456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.18156676740116,NA,1.29599765153948,NA,0.00959688944822172
5,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",0.0596666433122482,0.232496135294364,0.658481618966599,1.63812030951283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.117045636113159,NA,0.252727967795742,NA,0.907415184430872
5,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",1.27677229016386,0.201462301879235,2.42154443181716,5.33411637670216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0169022340641,NA,0.598194516846721,NA,0.201084238252253
5,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",1.56488729030667,0.143341362460485,3.60536674505367,6.32374321528097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28532626932605,NA,0.736588118148553,NA,0.102992946764104
5,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",0.827008005059119,0.11902537671223,1.81913183711231,2.90063673855617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.597863032355311,NA,0.450222281494374,NA,0.437584443493107
5,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.0523513252094986,0.148791451217053,0.79061226905656,1.41666307873986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.123877080782625,NA,0.259833425289172,NA,0.898728567991935
5,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.27357083950593,0.130518856687384,2.78927688174842,4.65251017669289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01387451787614,NA,0.608166587704451,NA,0.195316286788689
5,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",3.20587896584612,0.106325634695797,20.1061921862133,30.5027445820516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.814153808991,NA,2.09454620604246,NA,0.000370829629682953
5,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",-0.00430483120893874,0.20192162211455,0.659027427714085,1.45430495007487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.176659399673498,NA,0.244691191710955,NA,0.848788006978496
5,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.777128857771704,0.177588168951715,0.323289394928205,0.648512132456155,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.89664322112927,1.0099483472424,0.140524373229804,7.36361104381254,0.278613047525886
5,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",0.674821972008954,0.23606381147154,1.23029932135451,3.10374866448391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.456075476844153,NA,0.390488028207654,NA,0.560314419589654
5,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",-0.131869476910521,0.144952024822115,0.659827159187322,1.16465410575061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.295485421892222,NA,0.227995898927515,NA,0.732798899439994
5,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",1.06193406981721,0.212867965803259,1.90573570805312,4.38985073491056,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.816752530840236,NA,0.514953761079663,NA,0.303528189859981
5,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.711414288774401,0.153671446604301,1.4982068116211,2.73641846459549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.49016966222683,NA,0.412282552555846,NA,0.523955043630943
5,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",3.245772579553,0.241754805192122,16.4890932491985,42.5364165770649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.85132415895118,NA,2.09402147511835,NA,0.000472764027354753
5,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",4.13921934748922,0.235489474971444,40.857769222008,102.842508218226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.68370909732532,NA,3.56101822371254,NA,6.26596026916094e-06
5,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",1.44954718444032,0.262368952823823,2.63268212717322,7.36302271304968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17785857440359,NA,0.657677267822095,NA,0.147080981764949
5,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",0.456879930350383,0.320109272200471,0.799910754716419,2.80541134454289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.253027379731018,NA,0.320753528415472,NA,0.745007863786222
5,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",2.0442008740936,0.175005797530385,5.52284322206238,10.9671333689153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7318676024909,NA,1.00093372969511,NA,0.029792018378118
5,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",1.95904128024819,0.268868162169,4.30744180675168,12.3578069920547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65252767351511,NA,0.920716592737468,NA,0.0434625190354128
5,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",0.579447486251642,0.113772596758564,1.42984608509061,2.2334493626932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.367228872869383,NA,0.379948377365453,NA,0.625752066248251
5,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.384058595949678,0.173243015747959,1.03508859497764,2.0413006228966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.185190586986817,NA,0.326122405816678,NA,0.797578767345629
5,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",2.90736768276293,0.302060336207325,9.97106073230146,32.5814051339191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.53604488156917,NA,1.67032163186033,NA,0.00229948459437578
5,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.28605054794832,0.128119254493812,2.81094534138075,4.64475718428671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02550134892056,NA,0.613584646086067,NA,0.190161278269847
5,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.908903436692724,0.181180649018593,1.74537762111124,3.55084650640296,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.674158884698732,NA,0.468598058168051,NA,0.389239825476189
5,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.74462111352123,0.135631911605093,1.62482823316466,2.76507962306298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.521107473480936,NA,0.423827110970083,NA,0.497670424266875
5,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.40856948828537,0.134661947056164,3.16490642105372,5.36549491674144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13970043495505,NA,0.665102059736834,NA,0.146723312168282
5,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",3.05548149289383,0.252466119513178,13.3633804944531,35.9513692206951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.67403535926841,NA,1.85858193362051,NA,0.00107958033980726
5,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.0357381217584342,0.358650885507598,0.460619865532472,1.87893189493205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.20592636312763,NA,0.218532926178494,NA,0.83004075542401
5,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",1.54258403762925,0.284147362055115,2.7241464978382,8.29781609513307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26453479894895,NA,0.694002141093675,NA,0.122809988004952
5,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.514209214525512,0.297937946839609,0.921759795333243,2.9636590659348,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.306438814115318,NA,0.33838620114318,NA,0.695257494441141
5,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.2715354410455,0.245758584713509,2.21665999721702,5.80870414395576,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01201678208417,NA,0.586852291021994,NA,0.209042171965103
5,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",-2.32906282926475,0.789576117961386,0.0279217789442561,0.616765261505957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.34250979279552,0.953826635756635,0.0200898810218203,0.844840594252688,0.0316054236950264
5,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",-2.00587623774024,0.779215281742292,0.0396689287124785,0.841373778061752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.04144556520287,0.991023584377571,0.0270726351127642,1.31720126345976,0.0598457319064467
5,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.0243193830052367,0.165957775796782,0.741343067574189,1.42084355121514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.149996237512179,NA,0.253248788008536,NA,0.873484894751222
5,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",-2.37074052295769,0.785570551059526,0.0270965321343794,0.589211810262198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.3813359203571,0.94522207848827,0.0194918900994823,0.792506691450504,0.0284896190305492
5,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",0.390885556953374,0.136471052663991,1.13665987993306,1.94070387256899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.191556437452681,NA,0.331317933795625,NA,0.789933381751962
5,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",2.03608015331129,0.406293848308123,3.25535777894557,16.0056983545704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72427439513462,NA,0.91076950961681,NA,0.046334173535063
5,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",0.699507125003401,0.130723598946671,1.56650947270247,2.61503366220671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.479078011640172,NA,0.411316678320986,NA,0.531180329200567
5,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",0.719662193274595,0.538598703395129,0.828438855978837,6.84183435228672,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.497847375270756,NA,0.329914664956745,NA,0.578919822960183
5,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",0.87791569270764,0.790811806826323,0.685887505121375,15.2241604383049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.64528729617303,NA,0.286997107595847,NA,0.537038927205723
5,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",1.32251898775386,0.772568176868582,1.12610256910506,23.2702151170338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05950445647805,NA,0.410570070506027,NA,0.311815310640144
5,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.47995322106533,0.163408334084317,3.21083818032688,6.09263654094074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20619715227969,NA,0.692979850452806,NA,0.127141455395396
5,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",0.892075783157957,0.274387321230549,1.4676383201327,4.30265837645305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.65848230549001,NA,0.446683225788381,NA,0.412890829746741
5,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.00283292582550953,0.1470102888984,0.745719442576414,1.32692457014659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.175250239452297,NA,0.249927989383136,NA,0.84820933270862
5,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",1.19197551269442,0.266393645755525,2.01635721954619,5.72897384203868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.93788164344576,NA,0.551252034261104,NA,0.246737554197907
5,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-0.982419958966993,0.191132042564977,0.255891028285665,0.541301011545499,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.08791029855583,0.894519430620713,0.119785407196489,3.99242303906164,0.188201438183793
5,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.667262228507598,0.123934676198503,1.53095208037017,2.48856146888999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.449038210173504,NA,0.402882699377084,NA,0.555637832856382
5,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.166171362615404,0.155999723068914,0.62587674809754,1.15362119735008,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.327443012166853,NA,0.221629224545015,NA,0.703643852700725
5,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",0.191093691345316,0.131253956917613,0.938481062170633,1.56990240465416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00542654096508546,NA,0.288206986487232,NA,0.972938892831954
5,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",0.551690412743361,0.123592221622306,1.36801031959932,2.22071667205358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.341368388872331,NA,0.371882725223597,NA,0.649422235289739
5,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.221137195888658,0.091157583998514,1.04338097034598,1.4915226880608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0333664657132306,NA,0.297069862442134,NA,0.944719432392009
5,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.391480172417206,0.153658122549614,1.09896338034858,2.00711050129044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.192107519490512,NA,0.329861778393047,NA,0.790091502776934
5,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",2.0594836259856,0.127634909639108,6.11150080075447,10.0793827473341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74610630517251,NA,1.02060186967894,NA,0.0269862615281727
5,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",-1.54138359594842,0.762227434535211,0.0661662202946536,1.31296957865688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.60867027783208,1.06971721901188,0.041447450041719,2.74528673752552,0.135304254581247
5,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",1.13212880005324,0.1023428188333,2.54498713589191,3.80114399715988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.882139740805592,NA,0.555864296836169,NA,0.256250563609964
5,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",1.23200196620398,0.528951394063566,1.41768772462234,11.2737672581304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.975175256617115,NA,0.48238216282205,NA,0.284498197027056
5,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",2.1306500626164,0.253419756993602,5.30701517348518,14.3308815299526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81241792444091,NA,1.03536570411011,NA,0.0261877679979154
5,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.212145855394572,0.14606679291497,0.933384988253719,1.65472325684736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.025035602145267,NA,0.291324314742378,NA,0.953523281400895
5,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",1.42528445368511,0.112323847586035,3.35617216495518,5.21272358223054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15527712011258,NA,0.675416194216342,NA,0.139892748376453
5,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.707685018399146,0.146010132519659,1.53279558775774,2.71676667804866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.486695779534161,NA,0.412071517051864,NA,0.526136249971954
5,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",2.15550391549976,0.264758290857622,5.2897634366141,14.933499161746,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83558780123437,NA,1.04819269885636,NA,0.0248906074945115
5,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",3.00375546496558,0.130657377682188,15.611770115935,26.0545556399495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.6258483737655,NA,1.84648400441917,NA,0.000930985362453732
5,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",1.60884366564992,0.523531925881897,2.09591860074981,16.3168671809183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3262930658791,NA,0.632052629466969,NA,0.146684688235589
5,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",0.126948913988326,0.337630821023875,0.569979816307643,2.14113094795047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0543560614863471,NA,0.249898346825151,NA,0.969403979372625
5,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",-0.119974172544786,0.163896489729055,0.638887555043189,1.21462528745061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.284403280834232,NA,0.228491344385509,NA,0.744198985740849
5,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.51652803700168,0.13993941002927,1.2822714688845,2.2192859447417,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.308607974498975,NA,0.361422129974575,NA,0.680086390081953
5,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",4.63172964089321,0.101948906306197,84.4502387806698,125.938644504472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.14255273836263,NA,4.79482198909728,NA,1.68694753144447e-07
5,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.433351753448668,0.130819255414247,1.19406276393774,1.99404180734768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.231120040356969,NA,0.341820713015421,NA,0.751895883811854
5,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.569350381856201,0.0840858383712551,1.49970191205466,2.08522506172318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.357826879657922,NA,0.37937029899955,NA,0.632765678635561
5,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",2.42282117896732,0.25937935244044,6.99232729647593,19.3281353713731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.08462672512697,NA,1.24727249377696,NA,0.0108208890084958
5,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.491705277936278,0.134051135344641,1.25544099792846,2.1232707329535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.28548318808557,NA,0.355757876426959,NA,0.701055743150668
5,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.155009750194683,0.100896026595362,0.701923260737003,1.0424502591418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.317043267234935,NA,0.226907054320989,NA,0.710627830578762
5,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",-0.0924379792569764,0.135102531683548,0.698094730420838,1.18553212466776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.258748844708177,NA,0.235245707934479,NA,0.767121308371462
5,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",0.0100171427678724,0.14644251840001,0.760444476494252,1.35011793052383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.163273282554987,NA,0.25227894337911,NA,0.859901551036628
5,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.615235177206641,0.169687283067374,0.387688466643657,0.753978628152611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.745814324267854,NA,0.158937743697874,NA,0.36902276552886
5,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",3.53742432784128,0.116077263603697,27.4518084584387,43.2694377374094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.12302644300182,NA,2.55202536090126,NA,8.08266433883661e-05
5,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",2.42686812626642,0.518103482528933,4.81556977616679,36.7002183218783,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.08838241703976,NA,1.10712027498077,NA,0.0227036994333324
5,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",0.978532589211201,0.269600756131842,1.51538672783045,4.36006173527558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.739050600898157,NA,0.47532543875948,NA,0.358994758633381
5,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",1.34890191835463,0.122339169286193,3.05216089007539,4.93035286087888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08405554684874,NA,0.64069495331824,NA,0.166139034353959
5,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.13626057078767,0.113699073332238,2.49681972193699,3.89896053624381,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.885996468458954,NA,0.556294770387111,NA,0.255027623968984
5,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.21936884162317,0.0752633266471236,2.92497366768698,3.92871459498566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.963405303135579,NA,0.591800678977165,NA,0.214427384739136
5,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",1.56196954220354,0.763788125154236,1.46663761439013,29.2818209458496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28259035041487,NA,0.494977417363663,NA,0.220047892066697
5,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.42749162120159,0.0644299820937014,3.68272201427556,4.74083388530002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26964124165501,0.6645598471594,0.852566860079404,11.5365826612855,0.082418805880286
5,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.173934330848624,0.109976550363283,0.681019270872849,1.04805438683089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.42739229066779,0.764028496860697,0.123701246543457,2.47205738057813,0.553183031087254
5,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",1.85772700251052,0.199487454823302,4.44072424245513,9.70648223975305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72555919902582,0.672642837379043,1.33529699102655,18.6503554286081,0.0226484667505218
5,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.88483910665158,0.0825104531700216,5.62505450706651,7.77307369665402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75426129427819,0.642588673004494,1.45848934200024,18.1070708143933,0.0165365315143661
5,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.560495982820142,0.0605222857525763,1.5586389818176,1.97596323538646,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350883366549718,0.713102359497115,0.303349017227832,4.96512572523891,0.636193477433718
5,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.752822673056309,0.179628882022469,0.334568732588948,0.676528527345366,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.04084163375906,0.815399109812191,0.0595598016776037,1.45576476693667,0.161295927915077
5,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.85431357243271,0.0465650055980693,2.14746387695221,2.57749764074629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.662213444525644,0.694843305027553,0.43222316585804,6.585843815272,0.366494347595222
5,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",-0.0504752687069109,0.167485217659961,0.693476556909372,1.33708536639193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.296567615445414,0.76843528446842,0.140239530703799,2.85139280742168,0.683452857897373
5,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",2.08671906266166,0.198978570728349,5.58949901488229,12.1931135118887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.96822383303074,0.661150308485612,1.7484081580636,23.344638332458,0.00927568982993024
5,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.117319702859105,0.0449849984972766,1.03037449218193,1.22907305886946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.118766518101373,0.738343940435559,0.178512484560761,3.22572691298013,0.862068748541783
5,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.224238081204899,0.0611529534789607,0.709991307873344,0.902318805266746,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.48069224345219,0.760852863008823,0.117848965484687,2.32596961354443,0.501827565670078
5,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.775115333264597,0.0436158328082694,1.99512989669325,2.36713433516772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.578278506281271,0.699175342215209,0.393345636168154,6.09610722086641,0.430947318452306
5,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.41533835977093,0.0328718870798129,3.86335168779438,4.39466167728521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25676391564665,0.662573206169229,0.844733648839587,11.3419170114175,0.0845743581454843
5,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.35679297965413,0.127797949151895,3.05201777800878,5.0367533287821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19471644184585,0.678769172289589,0.768126623133844,10.9893385212497,0.106745213999079
5,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.595781016572152,0.0470429388971076,1.65651267464624,1.99196089136483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.388279581625083,0.709865032271681,0.31718238618543,5.12608122989938,0.599368258697107
5,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.61135501421735,0.161385454914582,1.36188110317799,2.56378906230285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.404771528433283,0.727995278605953,0.311293092329129,5.40145662426359,0.592903600222548
5,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.459467930780661,0.10266201913948,1.30176143171468,1.94672021405631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243814933815702,0.724529871109349,0.265850718112769,4.55071593235534,0.746467837066529
5,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.27751453990856,0.762176003071855,1.1080994740906,21.9841424154185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11070289370544,1.05515168901076,0.336743375086497,21.066507991323,0.308889992674333
5,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.268345209052509,0.0568562032851527,1.17176246196799,1.46430571371758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0412769594974932,0.730134699604148,0.213717122719431,3.73958048496603,0.962604220809066
5,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",1.48959759554018,0.208876239804137,3.02190346557283,6.85286445814196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33547621038932,0.694517073314037,0.859666374675065,13.082114595193,0.0792238868538723
5,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.89637502138047,0.323489914795621,3.76368792430803,13.3759253088222,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76652930520197,0.72387967550696,1.25898557201996,21.4959056344605,0.0280123743053702
5,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.728803294857377,0.0335331349895149,1.94207708199755,2.21489618846036,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.529198820229743,0.701215923269504,0.372609454148311,5.82111289365353,0.471224800624258
5,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",0.14076864808244,0.0663183642800913,1.01303519347336,1.31378748745674,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0939174250838056,0.738762319031672,0.182964259277221,3.31159725429077,0.889352109487186
5,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.39760069591502,0.206579644374957,7.53146335428104,16.9262671632588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.29768498193991,0.648891323659615,2.50386866975202,31.8629614515135,0.00244884553609159
5,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",0.28631026446454,0.791163136822684,0.378804468449379,8.41964264991117,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0603408128866902,1.1169014641336,0.101949986066127,8.12463146739936,0.961771574813738
5,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",1.08965205639258,0.080364219441625,2.5496866865468,3.4938086157707,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.911612990775647,0.685105100330683,0.568343091525367,8.33557613596329,0.214521991069433
5,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",2.62928885314268,0.198122910596207,9.63616432043135,20.950252020891,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.54318932649185,0.634984606370046,3.30231878225383,39.7941056253075,0.000763546991866512
5,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.82385296730566,0.0792267231401905,5.32464287883096,7.26384056403262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68969137854562,0.645296975731214,1.35836288822017,17.043993930306,0.0209166663655028
5,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.642724140782833,0.100931182425729,1.56901527907762,2.33051943625283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43802073300814,0.713561573950499,0.331316792870627,5.43266436324965,0.555927632249698
5,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.559680031021857,0.114127609072631,0.458995751985943,0.717959357241745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.836187625385243,0.789114144018085,0.0774012891955282,1.70662675041487,0.250312684854842
5,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.640556838912833,0.0513268928679895,1.71828853092159,2.10123754479541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.435731929032021,0.707589578962867,0.334439758497891,5.3569868994611,0.554882534763491
5,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.902570380946837,0.099987330267189,2.03843101750553,3.01657938459613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713397873115663,0.698545701905565,0.452104601782721,6.9894867591121,0.334279595183574
5,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.927333769001423,0.0507819878268323,2.29165975556633,2.79641453538744,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.739600340323747,0.691016169411043,0.471299709157651,7.07432864175227,0.312829631669383
5,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",1.15949287593925,0.210395950096182,2.16495708215689,4.93887467732253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.985633402625053,0.712317321253214,0.581053348268401,9.48128528397503,0.196312744061884
5,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",0.0395094134774111,0.105220818026424,0.8507351451692,1.28505767536544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.201248506760913,0.75009381756949,0.160308666029031,3.03332560003763,0.775869832073492
5,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.6131768132314,0.0498947213527508,4.55807825326091,5.54271699445673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4664273197724,0.653108461161953,1.06559592455471,13.7862582904404,0.0443153147912288
5,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.515172915211896,0.0648428134160503,1.47746714882871,1.90505026424126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.302850896573893,0.716200658502803,0.287056854130356,4.75587172805349,0.684242946487572
5,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.683232258396641,0.130291950124734,1.54803652328336,2.57982722124524,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.480945335494096,0.716676205461723,0.344066039705943,5.71101883911522,0.520211040763916
5,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.24753175731857,0.0591942095030332,3.10641875474544,3.91771107690792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07893052625928,0.673859962809389,0.689180905930354,9.67196056490957,0.140088062559457
5,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.77794541048926,0.0811546690564873,1.86331345147245,2.5612022712344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.581328286823882,0.702857903076869,0.391720211046409,6.15918775686005,0.430827096875182
5,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.773734705712097,0.103190670251498,0.378067571524032,0.56655430405692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.06303247658341,0.801323149836109,0.0598506705841357,1.38434400479286,0.143631690715961
5,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",-0.120204015405852,0.0966079305732375,0.736858454713079,1.07609276175242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.370446741413543,0.758589016134178,0.132544013808401,2.59289183732377,0.605290231977628
5,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.620471292853319,0.0559143570069557,1.66953667360693,2.0786661186432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414444692680736,0.709159752240105,0.326233238298367,5.25779874084051,0.574910413276106
5,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.492901335650971,0.0440400900374052,1.50318577908882,1.78643263389916,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.279249918212805,0.715698665664863,0.280486871633777,4.63788692499195,0.707574896760379
5,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.61057222134645,0.0984358906376316,4.15180106371905,6.1068056660404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46365824359997,0.659521126390379,1.04930899848699,13.9211206813955,0.0463653310944057
5,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.890456881148435,0.08026910526435,2.08907037570501,2.86156386545482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.700506007401053,0.696303563234812,0.448179046069815,6.86816757751085,0.341333114795814
5,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",1.57879591964092,0.200392591603252,3.35347985382368,7.35604992469478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42996251126494,0.687059428473583,0.96057567693144,14.1965781372461,0.0592205611104529
5,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.481645861766109,0.0662812173061579,1.42481356740952,1.84754655569557,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.26732008369702,0.718327981082064,0.27565831535434,4.60526758709034,0.72054513132375
5,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",1.18456004818135,0.0795567844322656,2.80758769796034,3.8350501382702,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01219822168712,0.67973602202861,0.636432396470947,9.13980605941172,0.16775652153414
5,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.90471579639719,0.0786873458809437,5.77879768371193,7.86674495939427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.77532793960244,0.641007263647302,1.4947381265876,18.4424177967115,0.0152102958932702
5,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.093626941587996,0.107795238043868,0.893919385914334,1.36398408069997,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.143896474245707,0.747220482095265,0.17097271007528,3.19887485900403,0.836587691828291
5,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.436432848434782,0.0339240140605138,1.44846922086784,1.65448036482795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.219406971008682,0.718415738573121,0.262427890366816,4.38574280816583,0.769645068516514
5,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.907661909701046,0.055358996658382,2.22700683394901,2.76671787857466,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.718749737630968,0.692537658397632,0.459994451370529,6.94593700466748,0.327053488909013
5,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.798696449272644,0.104270923270554,1.82238544876587,2.7425299601862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.603313877541901,0.705162828635778,0.398811498728801,6.3276004391012,0.415489665849642
5,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.55756425407478,0.0544998093197007,4.27388471405744,5.29180030147269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40748911448589,0.65651100656967,0.996804717947071,13.0694240329272,0.0537453674046661
5,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",3.2052574014375,0.096282493284526,20.5420895559742,29.9609949909983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.15355111392337,0.580227130103551,6.83268415421127,66.4311549072405,1.66715244770487e-05
5,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.0126195508660904,0.0347329828761669,0.946567673929231,1.08462898506978,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.22971822119351,0.744147066875429,0.157523949612016,2.91195631733294,0.74365197895253
5,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.236286278593021,0.052333338925027,1.14464501449216,1.40528127277157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00730362657031443,0.73168208901908,0.205784627551605,3.62268669244819,0.999920389866923
5,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.468825836145339,0.0815939526620081,1.36662561745669,1.88172153084111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.253733026524148,0.720891402751977,0.270488656762479,4.56453778227726,0.735188702318394
5,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",0.759987976764306,0.773030931841529,0.640564050852731,13.2608940805779,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.562264751284263,1.08337656049069,0.181971696011385,12.7159099334562,0.611591465090293
5,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.291080812943207,0.102628654497206,1.09982642130872,1.64452123899972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0653701803765306,0.734487395441087,0.217195254504528,3.86584058442098,0.936674354987915
5,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.999127982597053,0.106707172435282,0.299553966771912,0.455128146796951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.30190586750946,0.816830723168814,0.0454049174617757,1.11603556539965,0.0738754254646175
5,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.232872201360316,0.0479716813191426,1.14995558606486,1.38786813801683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00368569232570975,0.731544707632923,0.205079098282427,3.6083226738981,0.996100310075007
5,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.190163487599044,0.0359985049133525,1.12753090954334,1.29841170549846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0415733272599901,0.73333118542084,0.195111513733436,3.45706998704761,0.946303134402763
5,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.185280811472101,0.0594799099681973,1.07291726800012,1.35464349976509,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0467474967657879,0.735384222529384,0.193299047803078,3.45263035790291,0.940761813065565
5,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",0.112066235971015,0.0676864154423207,0.981888899232873,1.28024153423792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.124334392141845,0.74065498071137,0.176693420707378,3.22191221771189,0.856426740404786
5,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.16523282429207,0.0571322822803322,2.87260898106524,3.59367408338627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.99171682638663,0.678220610174293,0.62512780379244,8.92429002022216,0.175182317595987
5,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",2.32494159082502,0.0967857543388317,8.50741370337002,12.4327133134626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.22067358351741,0.622505333152116,2.4383124300734,27.9797837179228,0.00245757275441899
5,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.759179290353738,0.0655871916270502,1.88318913835421,2.43528491213239,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.561444277130645,0.70205643929266,0.384433861843346,6.02566084159089,0.445862434968891
5,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.126929854509056,0.0629039398855404,0.780014528248213,0.998137915644206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.377625597672007,0.7549209602302,0.132530992513923,2.5556255601223,0.596415832076393
5,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",0.501472202992383,0.085514508537807,1.40164064083132,1.95982297558821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.288329784483922,0.719491994358134,0.281003372702473,4.71603396625418,0.699914962660649
5,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.53149656530191,0.0458034970765927,4.23230489771465,5.06469109155616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37986436647329,0.657154932983138,0.967908809057772,12.7226338500135,0.0584124553795473
5,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",2.53470236543033,0.0965982194527807,10.4987383543086,15.3315554994061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.4429654792017,0.612120188118642,3.11941485724315,34.3675389713405,0.000859817111536247
5,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.282989124629295,0.0613378660748027,1.17897357115025,1.49942877928041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.056795405834525,0.729670059324413,0.217337794114075,3.79601409126768,0.945611800857001
5,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.72931809065158,0.208058024861033,3.84795280684884,8.69817939866291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58948325710972,0.682033250543149,1.14127553346137,16.5381153904039,0.0364737274371074
5,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.715304628970332,0.332215384030389,1.13156210138177,4.16143282611173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.514933617003075,0.786254517931082,0.310748242362867,6.77533539903664,0.52811386642239
5,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.793612469237847,0.0642799070109896,1.95394166875729,2.51386474070135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.59793687431144,0.69993731449477,0.400702056206168,6.22869428569628,0.416406370406076
5,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.44637925575453,0.0631700486840064,3.76184809087053,4.8188359310922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28965763974212,0.663396677108107,0.872131985410998,11.7476436738078,0.0776209873978297
5,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.597664116998861,0.0479044039417832,1.65691690109328,1.99918660397842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.39027514648736,0.709820856852657,0.317857771124761,5.13610686359718,0.597489437419216
5,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-1.35082298463143,0.113440484107842,0.207772796357131,0.324123197900713,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.67456353288281,0.841866516017207,0.0294412325001553,0.798274289977479,0.0218660702721448
5,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",0.316324514666199,0.0826647682955175,1.17090377219284,1.6190116051781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0921215900723439,0.730089951639216,0.225154836579246,3.93902436872865,0.907287926714542
5,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.162800375554062,0.0489229524853815,1.07063537036743,1.29696474901354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0705702357529323,0.735856341671014,0.188465086254032,3.37252373499895,0.914598675844267
5,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",1.03241685996313,0.328785555770845,1.56663660194613,5.68452019663959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.850995763911639,0.768309947617965,0.453720007331852,9.22064191772842,0.29346721658344
5,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",2.70784178756806,0.0963983091439929,12.4871053527432,18.2209306365963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.62645058673618,0.603678335934177,3.82141635111233,40.7312951587371,0.000338398026013531
5,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",0.15137973897379,0.797552513393936,0.325051191906866,7.40811342640374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0826662109262123,1.12760102980445,0.0862266786129637,7.165939399434,0.935599112576267
5,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",1.2631995823849,0.32695326431362,1.98175033835544,7.13929269297408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09553352529399,0.7558794112283,0.596736044883913,11.5503119596015,0.174949061922944
5,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",0.0270636046135932,0.134969076407525,0.795340763504419,1.34997278737183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.214387753285966,0.756310003988211,0.156237793397943,3.02921836912587,0.763812261319673
5,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.480379578105286,0.0585269655334041,1.44375250339555,1.8160560030361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.265978671380868,0.717628927050756,0.275658416925856,4.5926670087357,0.721652556945113
5,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.805192417983703,0.034966326853328,2.0903266890142,2.39740246959204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.610157475061314,0.696884811231127,0.408199049704966,6.26975893256922,0.405334434387384
5,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.386623102941027,0.132111320374264,1.14625641988295,1.92392660631563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.166618127781752,0.734244831609699,0.241024529657264,4.28589879445058,0.828794688095068
5,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.42099656462474,0.042711318613474,3.81287927351284,4.50780307148487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26275960695171,0.662906819677838,0.849356960795964,11.4189156837629,0.083337823060892
5,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.61250776756368,0.0466710122367283,4.58308169276173,5.50313889017678,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46571892329665,0.652871736028641,1.06532160152502,13.7699255372678,0.0443480013322861
5,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.888797254553399,0.084167751635402,2.07027725010018,2.87949248831734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.698745745370509,0.696925212691126,0.44682865491851,6.86417977884773,0.342886259455352
5,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.906485972526331,0.0473284457670779,2.25910396363092,2.71962052224019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717506759899806,0.691922354912114,0.459965582321521,6.92876909816598,0.327476110114161
5,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",1.20352302003869,0.0834387533433862,2.8406612507101,3.93972436509247,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03229352571616,0.67922128082426,0.650273372376837,9.31975242288401,0.159697131349722
5,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.46358338772748,0.0343917542980366,4.04250326513325,4.62592948151427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30789263160559,0.660035612381899,0.89437529520967,11.8895784863338,0.0726356603627931
5,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.331125734772496,0.171342073384977,0.51930495619416,1.01651956524009,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.593983743856661,0.78662479013495,0.0997395665669848,2.17780979705035,0.420327596065225
5,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.36815997755794,0.0996630258148314,3.24983052418644,4.80316334449749,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20676313680533,0.672729916206794,0.786899770724325,10.9945359698002,0.100949049116223
5,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.551236623868156,0.0352619060981199,1.62057789768975,1.86080082205728,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.341073407284687,0.711697804755917,0.301150356767359,4.90207466038078,0.645007842016834
5,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.718217889125857,0.101510206641426,1.69029619243396,2.51636770176224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518026005987772,0.709305717679122,0.362565578384905,5.84670003908732,0.485063271775859
5,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.67948318966328,0.154668276177323,3.98840125783135,7.31318559732168,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54174768265705,0.326303779840127,2.39832383100096,8.6180376040788,2.98644509606264e-05
5,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.880968144618275,0.612691299122662,0.753636699036789,8.32165290222533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717098562549048,0.7044452545724,0.498784139950165,7.89155179314542,0.328481528678524
5,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",1.50891148365058,0.330226045390966,2.43248725714192,8.87622725385628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36558220076724,0.447548502883477,1.58415734211539,9.15601018592039,0.00445192182361561
5,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.59061379944404,0.116713232173351,3.91466100150833,6.18567539776971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44996268912627,0.311071511566732,2.25333154943078,7.62771045081103,4.20824073998443e-05
5,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.740163120206623,0.0794226452152161,1.79384511745121,2.44903109431242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.571703569435467,0.320695620155864,0.914442851170756,3.21447300288275,0.102747959502973
5,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",0.987107804694466,0.595774027440682,0.876141429042918,9.05360952754813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.826709556924429,0.687363647365691,0.575882242756927,8.52125735978836,0.247625012265116
5,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.0691535791524173,0.0603762977008756,0.95153918379898,1.2056228556012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.121273189112863,0.335603530563366,0.442247974920053,1.64815608864491,0.669654437325629
5,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",2.10977258020689,0.310625130984658,4.6369180067964,15.6689032222093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.98610416612708,0.42196414321239,3.10706622348059,16.2443960590667,1.80926946519491e-05
5,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",2.01800280432514,0.0318973035473091,7.06945698692188,8.01102568967379,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.89133187605284,0.277581200615542,3.74922786632359,11.1300452231079,1.31784680780657e-08
5,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.512784581941375,0.0830306665626995,1.4189302589043,1.96477450116969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.336876293890773,0.327995644388924,0.71182176514829,2.57485075038608,0.350584902375991
5,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.117868777664966,0.070178854572067,0.979847820020872,1.29012362847208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.070964247150387,0.336201174243626,0.46467366728766,1.73579318419112,0.784078636135086
5,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",0.0422242099652092,0.663466367782518,0.264363484583109,3.56195689822468,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.149085520170715,0.762772345764297,0.186099180217557,3.70075603216465,0.822853799929589
5,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.249116786451847,0.111998392988135,0.62451956595257,0.968751658658436,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.449949386519661,0.358815121334814,0.303524812827764,1.23891687950269,0.175097795307523
5,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.0940398225829271,0.0590953119441013,0.978020211180276,1.23296818730472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0955728207154978,0.334616366944561,0.454717657009923,1.68808283698296,0.726508932085651
5,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",-0.075581300240503,0.0773911905305141,0.795941959911862,1.07803385981581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.270771017140322,0.343634063101597,0.374523792988039,1.44039996676042,0.386831115939608
5,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.0877327472801858,0.165217507019989,0.786584992587706,1.50318505770997,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.102098173533643,0.371007705941804,0.420635440047783,1.80098677801093,0.739007449841795
5,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",-0.225288286485844,0.736650910379805,0.166322062733108,2.98556579137379,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.425347819502046,0.835198101216628,0.122253106100676,3.22926531113196,0.590002182658177
5,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.0623920897938713,0.102875653731397,0.869179983746664,1.30090489210279,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.128236942715469,0.346715351281569,0.42968326666823,1.67262169372842,0.664744384786376
5,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",1.05763314074252,0.168016757567348,2.08212027743401,4.02288909932712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.899568394051335,0.347705101399144,1.20600657840487,4.71285322553987,0.0177377336644449
5,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.805152526511954,0.0297178967789002,2.11071251943316,2.37148796668397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.638803712826363,0.309653094033184,0.999714157604154,3.36534990301532,0.0602672460873897
5,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.36919068586752,0.0839241826278636,3.33870497637016,4.63928264047864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2212959836115,0.305172555782709,1.81151385854414,5.99195249699822,0.000394100243964319
5,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.99696788164904,0.0747153854919408,2.34135866198617,3.1380773860811,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.836868079868416,0.312460029989919,1.21338725154558,4.12983163937417,0.0152823554478001
5,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.274304579138658,0.22402122282181,0.845750708033231,2.03524544385216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0905894586835803,0.398180748732706,0.484159560625586,2.30596466307784,0.862051171284769
5,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.76533858504251,0.274491023894311,3.48026939198678,10.207214192918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63041669680715,0.400384842702453,2.26741915654188,10.8930175535671,0.00020217235610264
5,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",1.04141525765241,0.0289026808771645,2.67763023547901,2.99884912483567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.882795465096894,0.302963277397667,1.29456922515931,4.24512905021774,0.00875753180859346
5,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.70400991035995,0.026904237545518,5.2147214450795,5.7947268840371,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5670670014733,0.285041260343048,2.66742079780515,8.15354841603338,2.5364789744299e-06
5,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.64926293386437,0.0655106202450364,4.57993580536452,5.92086109942525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51054474696948,0.29306255350311,2.48078297870624,7.82527068167931,8.37753702552664e-06
5,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",1.08235265758568,0.352040450604861,1.50867010630576,5.99665459982467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.925072528167182,0.472338871211335,0.969114692792741,6.17285861925735,0.0646080772796782
5,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.318259740630323,0.0699785337322579,1.19815854930357,1.57632572368092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.135983973966897,0.330294833265996,0.578937339479601,2.11313140541322,0.731493762571678
5,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.0606769123943,0.0593512979713113,2.57216472246222,3.24592596820029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.902687557950906,0.307172014967334,1.30989057056963,4.36682313175528,0.00812047792856275
5,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.458960593430585,0.0537057817976057,1.42414169428603,1.75785112016049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.281296056358869,0.322920770107573,0.67981876722261,2.41065169405065,0.433038142696441
5,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.924054606547932,0.0854374318208768,2.13255363306585,2.98091031586695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.761615870427994,0.317349573453495,1.11417105112899,3.86552746714237,0.0289493083952786
5,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.758958718641256,0.0499437037656366,1.93699694190701,2.355880462247,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.591080133665943,0.313724234167455,0.945304393802073,3.23338024849597,0.0854031300505305
5,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.842082557114292,0.109020693833975,1.87625160421695,2.87665806406144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.676948550635987,0.327169828513518,1.00373762516426,3.61905455483502,0.0581365506083835
5,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",1.15718416956116,0.0818432063181528,2.71225776541544,3.73818756370946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00237124159483,0.310104900838317,1.43964100657049,4.85487160596082,0.0037049327988263
5,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",1.00375365218057,0.106051952857274,2.21907262415273,3.36290568653352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.843912762879192,0.321855812850915,1.19966199433698,4.23630509108419,0.017141902532944
5,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.85021080380484,0.073958874535379,5.51105986570521,7.36449454802831,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71807150593186,0.290173411228059,3.07331835057478,9.58516647241274,4.47177914825478e-07
5,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.539122000846741,0.062984263663525,1.51506898344838,1.93935365163277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.364081978987611,0.322421799232996,0.739581848729172,2.61744828685482,0.30398932029067
5,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.724358416909627,0.051313090057764,1.86606558307062,2.28182569290428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.55534197257315,0.314933594445532,0.909774405939368,3.12663826151026,0.107119488790177
5,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.45858313771425,0.0510389504438475,3.89226752840159,4.75435437830659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31362192819688,0.294918749758854,2.0279669092456,6.44364274891707,9.7061489972111e-05
5,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.42249956492765,0.0446872946099709,3.80099898788686,4.5286998964904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27635756259936,0.294765410754736,1.95401047528407,6.20492351657577,0.000146653214382472
5,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",1.0027092056627,0.322601651469217,1.45798009105071,5.16356491003044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.842823558464672,0.450720888508149,0.930816756030492,5.44719376819319,0.0784926405831342
5,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.998670187117332,0.323078206372492,1.45094004532303,5.14824021703686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.838652405542551,0.451162794509584,0.926118471357485,5.42909548714869,0.0802468685968535
5,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.58689692706518,0.457680266353023,2.07786188978441,12.4960563732732,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44612168389984,0.5538345429516,1.39462087033788,12.2266025653322,0.0131876575695789
5,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.937810630446997,0.111237401231192,2.05579982485755,3.17944795191877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775809287370611,0.325449669661824,1.11239550189441,3.98387539309769,0.0295950577846522
5,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.46518545271753,0.100049834885339,3.56486756676422,5.27677465922754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32043120366982,0.307916314215921,1.99056927390003,6.65541252627022,0.000153798307074957
5,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.573764260584982,0.144980943640221,1.33713467669415,2.36043017393333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.39986062143696,0.348736446230766,0.728140508459703,2.85696681009858,0.29259272778736
5,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.428155884410472,0.0548391327913476,1.37784606934989,1.70827981991672,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.249481351717839,0.324015387484915,0.656989259599117,2.33971557196901,0.491578618884116
5,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.794767823767092,0.136722991173531,1.6969336640139,2.90016366745844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.628064735138777,0.339363665202251,0.933034125361072,3.52883440686149,0.0886162323009578
5,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.904333049700599,0.172893922817768,1.76734946930614,3.48062777634524,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.741243458696187,0.353947740173662,1.01600901348121,4.06873388769341,0.0534352604122581
5,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.06668779287744,0.0558803459538626,2.60500684172376,3.24294618378449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.908895056966607,0.306309886341785,1.32032370284838,4.38675435443433,0.00756724958583485
5,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.298314956870433,0.0966405392083264,1.11474778209732,1.62816258009384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.115385679752967,0.33799975741742,0.558551586178148,2.10123738780353,0.782581133771148
5,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.07151600197042,0.0832093646193681,2.4834785602412,3.44125055346881,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.913910876659153,0.312763213788576,1.31026702669683,4.46487055578885,0.00834325174030446
5,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.84197396901752,0.0771070517500082,5.43274900178239,7.34999296767295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70956240121107,0.291253998584081,3.04071563856342,9.52373963328378,5.41020662513567e-07
5,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.503182425643224,0.0308687937424913,1.55699887519242,1.75727377807454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.326978796406454,0.31840960341947,0.718105289075996,2.50178288462301,0.352241930163285
5,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",-0.141360192632156,0.190028629498642,0.59396520478198,1.25102598237583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.338662066420628,0.389604370229147,0.319619480622312,1.47196310274954,0.346185942945715
5,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.470524329840211,0.0876911599536152,0.525004215204019,0.74036945273559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.678600982121837,0.358255079261219,0.241363570073716,0.983028872455184,0.0394810339498162
5,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.674976167769518,0.228952229742153,0.319621890817172,0.78416146932624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.889746657130818,0.425473015710333,0.171021428601095,0.9065194050052,0.0241431541982415
5,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",0.816884460168008,0.146151260409319,1.70092895776286,3.01643889252497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.65089261215451,0.342989475305988,0.947951153638646,3.63657292341968,0.0805748885273763
5,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.569808667169076,0.0915527480424697,1.47780030650096,2.11580399654521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.395765809886893,0.328826842776035,0.754026212810806,2.73641697531,0.271396295419464
5,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.433672704733587,0.150967857266524,1.14594508940012,2.07096116052713,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.255176268110865,0.355113945474894,0.621681590307366,2.5010080161626,0.518326868510008
5,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.129658646466249,0.0913663901180557,0.950888392015371,1.36041674938761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0588177241513603,0.341277751781062,0.465742014779322,1.7747521687139,0.815035631684562
5,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.763986641797119,0.138626620114339,1.63643611023052,2.81771744110812,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.596269440677829,0.340985179837715,0.900806980972162,3.42867219684778,0.107385135279563
5,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.44884172363481,0.0436717325658671,3.91023449522135,4.64033884886537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30356389481245,0.293906438241538,2.01155918664646,6.36619655204348,0.000104182552777582
5,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.727886867715031,0.339168900087605,1.0665999083861,4.03091578059808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.558991983239965,0.468710764028453,0.675456019200386,4.24161970040398,0.261758997893568
5,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",0.575043094753665,0.182879830373866,1.24421962000575,2.54819249975641,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401169804784988,0.367316291181499,0.703035169888056,2.96686263659809,0.314439487878892
5,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.801596379830985,0.0581780929623606,1.98901801887237,2.49851109606728,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.635107816950143,0.314053312178141,0.987471518378793,3.38197120896071,0.0650305865301322
5,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.76356659243583,0.172732778569294,4.18934570871923,8.24531051405346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62857777087782,0.33402822577779,2.5776265942514,9.54708273950106,1.62088845367795e-05
5,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.560634608013401,0.0586656007055114,1.56138084115909,1.965085023537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.386301661567742,0.320934362399921,0.758509603590019,2.66882890658693,0.272541445736337
5,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.9496805516514,0.0537287980319376,2.32703344223044,2.87257050068751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.788059993974479,0.30909871852991,1.16288345910385,3.90613101295168,0.0208892732829536
5,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",-0.574179313032705,0.866370040475247,0.0814889090385677,2.4322574060823,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.785677350149161,0.963781448747827,0.0660865967566397,2.88973421893088,0.397227029321082
5,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.66882670511714,0.0473627014227003,4.83818063313572,5.8252220902875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53070347060128,0.288788198644629,2.55296572998184,7.91915613664358,5.10288992750255e-06
5,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.346697764806675,0.0820094417237325,0.60100990424484,0.828885906956574,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.550716826393038,0.352988432942959,0.277379675432618,1.10663202292234,0.0909772300240238
5,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",1.05552409945734,0.0364225750156444,2.67593387638252,3.08660660876904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.897365960589992,0.303458096568385,1.31243665421357,4.31207544961327,0.00783132582180584
5,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.62870068050477,0.118784490760174,1.485803900685,2.36690364170765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.456581641350824,0.336459565808897,0.789687250799335,2.95287409488098,0.212778009479207
5,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.38384968687291,0.0876501961528067,1.23515779030911,1.74155985973079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.203719910150305,0.332920248298077,0.616584899857823,2.27382660104475,0.590517129172911
5,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",1.31790149583103,0.034941987140441,3.48909907105174,4.00127727838933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16833264668871,0.296142663410257,1.74823660467905,5.58154452440774,0.000495455900423171
5,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.912908887693064,0.0763818364149032,2.14594569434894,2.89501888771743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.750112654753129,0.31516671830317,1.10607268107216,3.80473540524715,0.0303880684453336
5,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.72482511080665,0.555456981922431,2.04775340770674,18.0671369989925,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58856254250287,0.640942954935622,1.35659310676035,16.7337343669069,0.0176244310890098
5,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.56130570538958,0.0674073766346627,4.17935500480512,5.44331902956837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41970458314549,0.295767656505369,2.25234492435684,7.18043359995445,2.93310532458775e-05
5,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.50121662318849,0.123750526229229,3.53376065161989,5.73998038586764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35765664046097,0.316136614555456,2.03337386715938,7.02116511053052,0.000142925236104095
5,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.880968144618275,0.612691299122662,0.753636699036789,8.32165290222533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717098562549048,0.7044452545724,0.498784139950165,7.89155179314542,0.328481528678524
5,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.827997625629879,0.0914410881730682,1.91415039251666,2.73933816055274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.662408937391816,0.321728276108952,0.999758533655992,3.52863168961633,0.0597819489176643
5,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.226631165550273,0.0640389005889618,1.10591851184565,1.42148784273827,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0413565505123729,0.331675988840737,0.524927490297931,1.92639589590438,0.951228606630396
5,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",1.15835316874205,0.0863970492849579,2.6909215113353,3.77557962574456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00356257263267,0.311395800265342,1.43774453271356,4.87307276412545,0.00378563039859141
5,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.385501751142412,0.120887734116246,1.15953452932944,1.86244449009268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.205424822337261,0.343862892803669,0.604526893975295,2.32706694040546,0.598535434360816
5,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.858902073623605,0.359152304020769,1.18567595214019,4.84605124672364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.694285495053704,0.482025120281882,0.753971884808119,4.98834180569203,0.173492946605735
5,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.0560980828147812,0.177582519062343,0.743338204975031,1.49108871426164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.134726670381425,0.377929360817384,0.401541546532508,1.76652015822315,0.678266772348909
5,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.138306984785779,0.11486065175365,0.914798393192987,1.43504170005864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0498434309395895,0.34856792412084,0.463277183339313,1.81653605116105,0.838938957701574
5,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.446240610177898,0.0997478394107655,1.28456751985006,1.89918803879696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.268152038542621,0.33480697906254,0.655449572990976,2.43509393710589,0.471371741458482
5,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.7607457246839,0.202976183549981,1.44070514084911,3.19243737943482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.59294721696825,0.374038456394538,0.841452225709765,3.64580709793406,0.141202597991867
5,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.82412421385112,0.0930524007238185,5.17644629123522,7.45494436088096,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69111959674702,0.296637947730344,2.95357782434292,9.44812817614365,9.85628797333923e-07
5,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.34834471827346,0.126950253689331,1.10353631272139,1.81512748179369,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.167051993978057,0.347216403326281,0.577818814770249,2.25368884865793,0.678647958978868
5,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.445944643090049,0.104265416426717,1.27200492639029,1.91421431661946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.267846099428073,0.336288864873172,0.653345911377088,2.44141933193567,0.47375894125175
5,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.669810536807674,0.0390488380030917,1.81001460724857,2.10940000197496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.499015450815391,0.314589586368817,0.860238364187679,2.95241286952889,0.147268693859619
5,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.694283730272918,0.0975340629225517,1.65333560729544,2.423278386712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.524314638514894,0.327250932622853,0.860767364290903,3.10455094013705,0.141716437022777
5,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.380714727995593,0.0659559951393089,1.28545400931832,1.66471630356588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.20048417344445,0.327597063038279,0.62099985147396,2.24281652614124,0.591344799866264
5,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.10707970897134,0.0713128916019801,0.967146753920739,1.27907398304935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0821087907471724,0.336775677889293,0.458974033003743,1.71836757449874,0.75884405968195
5,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",1.16647396342033,0.18718203847272,2.2362689469491,4.65782656215616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01194585743603,0.355525071547828,1.32975253231104,5.35818624483517,0.00915099780104097
5,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",0.232705245353818,0.154722487054615,0.931112847357974,1.70766374659736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.047629341838311,0.36219427824926,0.497567681296908,2.05803530592996,0.941571204888398
5,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",2.00415906521986,0.356720083883814,3.92998840155762,15.9100901497883,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70680182876672,0.544588407885745,1.96752227410234,16.6352236507733,0.000923834523602101
5,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-0.404996558313173,0.97564668597363,0.0878480834016534,4.02416908474742,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.912887792600761,1.10982079102815,0.0468157224637255,3.62872510926855,0.403701234889944
5,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.663199632302277,0.260937960789803,1.18235262679952,3.28827863238316,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.248646975693576,0.447546117458104,0.549989526663905,3.17876418411273,0.593233467157129
5,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",1.2451944011423,0.173970145157644,2.49848944658409,4.94134106833421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.881510115633198,0.407464304594645,1.12330060673154,5.54835809794063,0.023411862778024
5,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.24123781533976,0.16197414574511,6.94212146418517,13.0989804438198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.96459620964531,0.426244178658841,3.21484257866888,17.0922453001134,2.14456276876518e-07
5,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.327537360350959,0.117491365987508,1.10444871266621,1.75050444305329,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.116340416243628,0.360723184184378,0.4519609410974,1.85864807564104,0.711211075740343
5,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.41666006828338,0.16373188865594,3.02412629803072,5.74562923339982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06793266750244,0.406484566023706,1.35728792230089,6.67840210643622,0.00520661940224304
5,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",2.09506521178367,0.155874390769573,6.06101025590507,11.1662169824427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80564795035083,0.419749561827203,2.77522845787948,14.3840667514053,1.56643448348278e-06
5,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.484352005563376,0.104799980238217,1.32445488323173,1.99732610709955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0541796713885716,0.359741128079126,0.537387534967002,2.20146606464086,0.911962803135746
5,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",1.26550747770772,0.240600614534613,2.26078823520835,5.80576045986878,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.903598228223374,0.446347839799546,1.06423678671924,6.12212520055621,0.0356155543736555
5,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.472513920903676,0.196452149667396,1.09911222325581,2.37401130990632,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0413012234764088,0.402478244265078,0.487872848373149,2.36312586794221,0.947617369319622
5,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",0.750645083432649,0.187699431428286,1.47981296808906,3.08849512560915,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.343739228496108,0.403522068597808,0.659616549145676,3.20810635944516,0.399471137827834
5,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.44875153467436,0.159674653102271,3.14658302923365,5.88396144435091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10282647457885,0.405339077808847,1.40887259653231,6.90116194805425,0.00370198829487774
5,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.401847298861029,0.201450432229363,1.01388523225553,2.23325664540858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0355353358537592,0.403922834391696,0.450372770080941,2.19387361356055,0.898168805246309
5,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.477434588709135,0.196368288778483,1.10489612198285,2.38571977370131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0466519315223773,0.40254918875916,0.490417722818195,2.37611325937033,0.936824278967711
5,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.79417114320353,0.0958225678060727,5.00618214609627,7.28845173559909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4784613798832,0.389710217825108,2.11869235684832,9.76139253738469,2.61618742984135e-05
5,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",1.39829734854526,0.223083475824973,2.66708284798425,6.39461650413956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04798922401751,0.438343794758327,1.24980815985633,6.96756750281262,0.0120285187438043
5,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.26054494352735,0.0938243456037598,2.94441875010476,4.25330405562537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.898199489600156,0.375273939655522,1.21669118403897,5.29721834444754,0.0110303988838585
5,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",1.27733151115712,0.25859021444268,2.21668564618684,6.10841996949142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.916455741111306,0.458385299683321,1.0529414507102,6.34981060252202,0.0383535031528837
5,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.3447466344222,0.0902560280530953,3.22559105461809,4.59474534820896,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.989762274689937,0.376376044815119,1.33099609892273,5.81996701053382,0.00488660630185246
5,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.749515808304075,0.177176750422321,1.50741138672874,3.01896472322684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.34250930421201,0.397806655159123,0.666221820756531,3.1684446923086,0.394076260269776
5,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",1.1229879403088,0.180641905410517,2.18243768560132,4.43064740244798,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.748623618375287,0.408077047098219,0.981765923765997,4.8609323670344,0.0573321986339639
5,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.621210319581889,0.300512169332852,1.05268120377094,3.41892609507368,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.202999406464255,0.47533297532639,0.497513796725479,3.20636864631678,0.687118490671906
5,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.758076758014795,0.106649609015404,1.73682967980234,2.63826159493142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.351824506676888,0.366933982847317,0.714423506255529,3.01040745196571,0.338719743324865
5,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",1.10425126922697,0.101920650804475,2.47954265985562,3.69727381581296,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.728234996548641,0.373846234218765,1.02861981041663,4.45340166569082,0.0416825953497856
5,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",1.68665714941668,0.36390116700638,2.81226186429134,11.7101437808433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36157203463367,0.54413804331473,1.39197742129881,11.7482850468611,0.00915642263370117
5,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.938625063338156,0.180951502944323,1.81073181242555,3.68049751471768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.548147831174498,0.404047460565518,0.809083405049378,3.94316488334279,0.167438768375121
5,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.449985392437721,0.188155240048552,1.09156234126764,2.28225730351679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0168016027835683,0.397271344326217,0.480894177136554,2.28226190525351,0.997052480940585
5,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.7114089464609,0.277819380340769,1.20487228783135,3.58015299478844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.301078439235651,0.460371361095944,0.565336870869271,3.43593497952877,0.524456884790142
5,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.703305734044273,0.109970111762858,1.63395880281443,2.51451690724384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.292267148909634,0.366780919001574,0.673151059197117,2.83479398144402,0.432655425997527
5,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.630825128419371,0.182208819011055,1.3250374067742,2.70658078797614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.213445669833447,0.397885167222487,0.58515212507775,2.78374675192374,0.608424852138829
5,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.3781812449526,0.166020321764668,2.89735375659556,5.55437288876952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02609136145938,0.406664743306963,1.30095938560108,6.40576574552576,0.00748389131204972
5,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.842580137323709,0.0652884434082993,2.0457010452093,2.64234435275653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.443712869054453,0.35735893456342,0.798320029862302,3.24000722777392,0.207085701195669
5,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",1.07277584396008,0.0631985269406426,2.58642981372731,3.31352357659617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.694026422563662,0.362742450209701,1.01572563659645,4.21027323122908,0.0453241513636338
5,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.585117466630438,0.068065882120706,1.57251223467056,2.05338129184358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.163751876897266,0.351576996530135,0.609552026603637,2.41844682860433,0.662686186779561
5,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.0992683445266794,0.820667326388902,0.231095625254119,5.7663143410539,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.364556111121967,0.953620940053204,0.110235033672098,4.63198208192315,0.689878792946154
5,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.61787850617021,0.0598211305196081,4.49230463045203,5.67948394277796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28676421230547,0.376328133544854,1.79394047211489,7.84278309257544,0.00017134540127642
5,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.277490552903037,0.204666172173541,0.888241856046872,1.98132426126485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.170759494121569,0.403273956796658,0.393700142860357,1.91293582724213,0.641454080245894
5,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",1.16568002521048,0.517547365930231,1.28003860676702,9.73413357705331,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.795047460683381,0.668356732239794,0.617672952751614,8.48342350683111,0.232775315997774
5,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.0919658306923595,0.395158086892542,0.511329962390076,2.40668686970585,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.372495386072224,0.543346497780538,0.244343032274129,2.0558655727028,0.475054128185633
5,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",1.23942332246978,0.515909306591428,1.38310603946006,10.4505963489396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.875250580499206,0.667906309315207,0.670072286873455,9.18686678725537,0.187150039208125
5,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.82914544229028,0.488958286990939,2.67210557497271,18.1659330819324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5164938372063,0.652501376271297,1.31531475729094,16.9765739509807,0.01663130540072
5,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.549354146095305,0.56882720613754,0.604937445945857,5.62449661536669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.124864882587191,0.708258179047977,0.291410189462986,4.67999773904446,0.876056190158469
5,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.117672965173957,0.211015412664701,0.746639708165767,1.7074357598684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.344549636285603,0.403925514548595,0.330249380860087,1.60874072016663,0.372509887299925
5,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",2.37699633788196,0.351403075934623,5.77863244055315,22.911564852735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.11221850908975,0.547999445376852,2.9376055135756,25.1715188581476,3.43833432430911e-05
5,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.194309859056319,0.107775675987086,0.984353391098857,1.50185735317912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.261218204006371,0.354029000112104,0.395949263828498,1.58613300533395,0.432141805646624
5,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.96203524899074,0.345144102645917,10.5280776191886,40.7308491016028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.74838505745863,0.555814706323111,5.48476689107579,48.4594907379713,4.91989666865424e-08
5,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.996351637746667,0.266287616815765,1.64463131992903,4.67086609803755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.610919303063863,0.457856606029152,0.775492942400692,4.66696290551908,0.176418224402605
5,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.81573690909697,0.247243823979482,3.89662257387368,10.2706278047251,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50190046185429,0.462644853120514,1.88032429176111,11.5303046589194,0.00050214910814138
5,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.199983993984838,0.111043383620701,0.983708373709951,1.52022183942565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.255046869702278,0.355357780130879,0.397374544877535,1.60015563484151,0.444032006719423
5,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",1.54908637203286,0.652856030218854,1.56808483714719,20.267196406186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21196034726706,0.801455798063562,0.723410890292954,16.7411723179539,0.126804116055966
5,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.987327586683983,0.105757327645754,2.18945652898351,3.31419400829722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.60108033721792,0.372217207104895,0.908205093439668,3.90703818164163,0.0955065147995759
5,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.708050783336159,0.277586035784101,1.20153084306829,3.56696006927486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.297426813988786,0.460139658967404,0.563523578070202,3.42180508571007,0.529614576261444
5,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.58506625795142,0.168902004050164,3.54814740970078,6.87924770360579,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25106726901225,0.413046663305633,1.61061350347178,8.13136114858429,0.00112678646638301
5,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.116261727303007,0.811354839760624,0.242432684227955,5.83235772583066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.346077707592558,0.944263373989342,0.114376989066475,4.63292790483441,0.701399691100612
5,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.72575317266687,0.646448055917876,1.90301232669266,23.9859413288475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4040650042867,0.797542346891816,0.884184797393725,20.1503037101024,0.0740469210106433
5,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.46768505142429,0.247287537176039,2.74192382387038,7.22833799045893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12341371733601,0.455000893458491,1.30493393550961,7.76575081074544,0.00949955614886429
5,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",1.14774069868287,0.168024492073684,2.28979622739435,4.42427638337342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.77553923401268,0.402204523741395,1.02033709021737,4.93694053879666,0.0448657491300075
5,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",1.06377399502244,0.690636182279013,0.87017422735295,13.0420957592189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.684236010784045,0.832542049422397,0.400593145763263,10.4719043966766,0.415306461092381
5,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.279142633882245,0.377811609567329,0.643102498287161,2.82792473734438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.168962769255365,0.53139160957868,0.306836501416016,2.46348395769737,0.727111738090651
5,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.779901639313534,0.346034197541091,1.1441594176565,4.44197618239193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.375574074118483,0.5135166020287,0.548989843808568,4.1093824173444,0.472895932466404
5,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.59421598599027,0.170774792224215,3.56886373062551,6.97039675813392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26101789570816,0.414182734576963,1.62317963271999,8.23137808673654,0.00105859740440214
5,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",2.07075517868113,1.17474642926622,1.46877268174173,146.840729460068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.77920466403732,1.33674076032793,0.448261482637264,84.5674079515925,0.181417967953555
5,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",1.29511539395204,0.240551890307784,2.32902856177008,5.97986108161366,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.935793722517464,0.446952029030129,1.09791707269631,6.33085041497543,0.0294341102876615
5,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.24320345340948,0.175707373166271,2.48596229966631,4.9501608666407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.879345189595303,0.408302162264816,1.11902201565293,5.54540784104809,0.0241057305074437
5,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.59423854502128,0.0993976036560764,4.06998115436792,6.00906892570775,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26105721627896,0.385524392678436,1.71699428203148,7.78192005406822,0.000360214153319437
5,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.284817941948038,0.236792377519721,0.471812648112225,1.19367377735516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.78221933353074,0.412967121200936,0.209112171490077,1.05539689862559,0.0576589029661206
5,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.99069179684965,0.244662474680254,4.66898027331967,12.1824935761032,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69215060795613,0.464983085754999,2.2660702441343,14.0236804904058,8.10876585636642e-05
5,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.34730420092617,0.323336711205949,2.12846239364053,7.55988860887034,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.992542829969485,0.506175946237138,1.03496670903854,7.5273459029381,0.0433101312647189
5,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.822282975884665,0.171506389228224,1.6393946156382,3.21111981680432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421635577826854,0.396482511805786,0.723192262398721,3.42158097688021,0.286027446439475
5,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",-0.151933394731702,0.316705682307055,0.463823714245975,1.60514281976742,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.637689287518618,0.47442082291375,0.214314717141674,1.37628212253751,0.172179354874242
5,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.715308439682798,0.100666699997433,1.68299981714917,2.49723474936006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.305318813735253,0.36388673724956,0.685909147179334,2.8559361859731,0.40688218719678
5,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.13188130956913,0.26149385313431,1.9042853641841,5.30762183683578,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.75829393476246,0.457327532129821,0.900142015239914,5.40588541010667,0.0892168626149604
5,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.360577490835508,0.284576450318977,0.8330380238499,2.54172553779544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0804115654809539,0.45872255780061,0.386687772284263,2.33502286374087,0.832859963043275
5,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",1.14806833637316,0.261722081093762,1.93420820315959,5.39584790435722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775895675396248,0.457814925005104,0.915323171545605,5.50756965036126,0.0820054181431842
5,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.711972244789634,0.268714293059218,1.22713055969376,3.51844538034332,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.301684541393553,0.453918522533557,0.572882436048688,3.39482820086105,0.517387926557805
5,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.48722336005502,0.62048055484071,4.36844041944279,49.7318286281253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.23208081530407,0.78338950303509,2.08942823064339,45.0476526980359,0.00319968252155525
5,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.57397042753533,0.178313813618831,1.26002224216881,2.53477956993165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.15162039063604,0.394543060363962,0.553552426270746,2.59914245013454,0.72304090598591
5,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",1.5984864053829,0.219006895027477,3.28765176388457,7.75753643129784,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26567330468853,0.440413043625813,1.54903355866957,8.70605389429655,0.00221300311539102
5,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",1.27408260503004,0.674300180779988,1.12290438776093,15.7860504998696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.91291354968007,0.818948785074937,0.517643216014795,12.8295512532521,0.264798161981681
5,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.44971446663041,0.621152091606416,4.20004316508101,47.9407685117388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.19129451004234,0.783467810086788,2.00517328052318,43.2444050869487,0.00383878810258515
5,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",2.60406358965082,1.14682369098837,2.73029425711025,244.661507150808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35912876595266,1.31240824761227,0.84222912201859,144.436882283587,0.0693416550194394
5,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.390998804648008,0.113513793362137,1.1860976799906,1.85083067444903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.047332113847226,0.360682777168249,0.484422038810125,1.99182585864059,0.859498519862208
5,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",2.04602483275912,0.226701251981199,5.09102904309454,12.380622614593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7523236843285,0.455336300675447,2.45326894315343,14.6187784588717,2.66462189417609e-05
5,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.821981841416535,0.185406723353744,1.59718927525037,3.30364492609573,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421310495477149,0.403838301756095,0.712610821981125,3.47014789722025,0.295982263714485
5,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",1.04619742310619,0.232218523137292,1.83735202249737,4.56585276058357,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.665118326107898,0.436332925151651,0.854158196770558,4.7244671254525,0.119306830130748
5,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",0.512767022815871,0.738556303560836,0.442147519351545,7.99627503539728,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0850780780305285,0.874323960825266,0.202229215066999,6.22724145873467,0.936066130700031
5,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.82591234624802,0.639965081916073,2.14084908328186,26.3065916817791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51297663672209,0.792625110031501,0.996001074501758,22.2652328141414,0.0520969824756261
5,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.90613928317284,0.260676316672073,4.16974244569075,11.5847161361676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60020902810013,0.473324288316401,2.03257484114908,12.9967652580056,0.000283043996731629
5,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.962387234382564,0.284732033471783,1.53587102289531,4.68903462052605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.573964651770419,0.470189867065113,0.729413325956456,4.60708658343314,0.21850713186114
5,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",1.07268231424758,0.280179708511386,1.73324811583563,5.19803904395109,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.693921765425537,0.469107838256037,0.824530643038029,5.18581992708637,0.132107586456207
5,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.709706580865512,0.716680138849034,0.57089346781487,9.47618551230116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.299227576434872,0.854474070259379,0.260687148817909,7.42640990382237,0.737549983671021
5,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.697941825182303,0.0979195636695971,1.66264629819695,2.44061028525829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.286434605187551,0.362575650425406,0.674755406245344,2.79509310721179,0.436905522572982
5,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",0.214577116963477,0.190596267147409,0.856589016808289,1.80819046601042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.239171060671598,0.393698055913545,0.374527867858615,1.75273768234248,0.515468104056436
5,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.00536369159732721,0.20818424348583,0.662639024843892,1.49861649292982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.478344908948709,0.399722242310332,0.291136360948304,1.39503411511389,0.219227751505097
5,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",3.28058084469841,1.127921134169,5.69260588988374,473.682715593101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.0947657626566,1.2995072095532,1.81031586365576,295.147726002491,0.0153710937110333
5,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",2.30223607465091,0.209961735648085,6.78023945372196,15.4413241046112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.03091541764906,0.451938008203486,3.26778564920797,19.2147271231769,5.66912421997919e-07
5,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",0.0442461578873198,0.216397850146895,0.686219427154425,1.60272634936873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.424394637305791,0.405840715295378,0.303672380185966,1.49042380949005,0.279861663617598
5,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.480505330133816,0.101595073267506,1.32754370189826,1.97699054813647,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0499969082234314,0.358557750580353,0.536375956082884,2.18715278949227,0.921168691218652
5,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",2.07075517868113,1.17474642926622,1.46877268174173,146.840729460068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.77920466403732,1.33674076032793,0.448261482637264,84.5674079515925,0.181417967953555
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.429944105177557,0.0847912492198437,1.30396484207103,1.818087439056,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419258855414569,0.0820534141205815,1.29559538975663,1.78713507856718,1.50943824485884e-07
6,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",0.0897162970017953,0.109290050482777,0.882415613106521,1.35434373465752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0924671008796213,0.10516526816692,0.892751013070646,1.3482301311145,0.336471180602761
6,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.161754759722229,0.08692884849922,0.991062574707145,1.39344238409181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.161660828411567,0.0837729264278854,0.997719659510054,1.38555515454118,0.0416388155707406
6,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.0734092828009782,0.0610580709963055,0.824119893353542,1.0469738780253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0642165084083687,0.0588383138948882,0.835762051398835,1.05256560625447,0.341487930217986
6,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.555420943105378,0.458063342145156,0.703210536705947,4.2353939986686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.539779499789904,0.440948957348535,0.724272540701263,4.07919893977483,0.212761937910988
6,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.768356498438482,0.0607677441720929,1.91504270604686,2.43013084890755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.744307449618664,0.0604822905026483,1.87227109144553,2.3731979783911,4.7158140935148e-38
6,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",0.118995566939284,0.136622487064791,0.862353705140787,1.47323482828937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.120590039705581,0.131415555375859,0.87217936796399,1.45991663105174,0.325518436234791
6,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.221183376289102,0.12582964977921,0.973858470700583,1.59480882532445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.218742250728571,0.121114937304892,0.981836691864617,1.578431360701,0.0601593485789968
6,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.60046771129149,0.0928779231581173,4.14289055063457,5.96237274567642,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54357718469687,0.10545636009535,3.87057018680738,5.851998148302,8.6946581448175e-68
6,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.028262582973055,0.0428041044457717,0.893704639430839,1.05697289883999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0208526619103652,0.0414127506639155,0.903136387715111,1.06231798730704,0.762532833605418
6,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",1.11872360741857,0.208546858547004,2.05690135223224,4.65848047248633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08086675605191,0.2032084338766,1.98826444481985,4.40977886154421,5.3918470195682e-08
6,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.508707170133176,0.0809274348248955,1.41972816558247,1.94973825592435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.494911482536775,0.0785255558041742,1.40729703215986,1.91455532348903,9.45711977982368e-11
6,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.62302069317926,0.0490540892896971,1.6939933763716,2.05315407262754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.604721522756464,0.0488064824238298,1.66523854924111,2.01634462696137,1.02966102111751e-38
6,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.843566679691924,0.112779975869255,1.86701211552499,2.90498647812141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.816573489263223,0.109959166839076,1.82730494753262,2.81193874037577,2.62315617865246e-14
6,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.127282460715576,0.0897218084868731,0.952297389518597,1.35367770919843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.128549853410596,0.0864301727460498,0.960176598333678,1.34738004129302,0.111950844897768
6,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.415841064871098,0.0532189858995451,1.36561668917416,1.68239892235595,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405722585732056,0.0519900973137301,1.35570922877207,1.6621669955244,5.4147641949504e-16
6,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",-0.0492595752530326,0.0984662015599335,0.784228944615092,1.15364458737061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0410231194426036,0.0947155849001769,0.797300831179293,1.15575643695609,0.730402175541078
6,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.0735505982482729,0.13925070392599,0.818789605835031,1.41329606252051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0769397844276798,0.133912257495576,0.830835178523706,1.40438931722181,0.523297477461385
6,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.56762143793382,0.0996893372173819,3.95738601172893,5.84951487488476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51201645699375,0.109918464983159,3.71218584752373,5.71156659286096,8.88136882652308e-57
6,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0385905236644335,0.0335106352733906,0.900869438229872,1.02733116436894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0307730530012386,0.0325537978311437,0.909879208713336,1.03372120974289,0.487586915304356
6,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.80057365214129,0.204117037993251,1.50141276032889,3.34187020290527,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775246546006331,0.197209542143784,1.47782762666804,3.20150300843976,6.40880922752504e-05
6,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.61653235294925,0.195232249833527,3.48157654023066,7.48410603540102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55901635803262,0.200315043708,3.27676469645099,7.18558621576152,6.34858880833128e-17
6,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.24369434405833,0.122138339750765,1.0035748238581,1.61986359235423,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.240364218094311,0.117592501319273,1.01026427165972,1.60186101325006,0.0339438769320634
6,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.589592245624308,0.107534454749502,1.46208057484057,2.22863165468094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.572601920440079,0.104099967489192,1.44691469161564,2.17602074981223,1.85108873568609e-08
6,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.0722960576545547,0.0439296724827607,0.853402971594425,1.0137716936925,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0631476370230748,0.0424523547380166,0.863958422625967,1.02038452280107,0.194707793044516
6,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.0596741768454815,0.0718855228894267,0.921675796094545,1.22167677805202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0636124351500724,0.0692886413330057,0.93052260554185,1.22091133267371,0.296776805678666
6,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.33268581032202,0.0958614809524525,3.15008850640354,4.58688273228313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28635735616425,0.0994743251023323,3.00051153174301,4.43139739730127,6.491987216791e-45
6,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.0743170836488592,0.0453429519628894,0.84924292912597,1.01443429024257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0650888132129398,0.0437989776637135,0.860006413668751,1.0210927787795,0.193282223312826
6,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.577891374516949,0.0909945690301344,1.49274902838694,2.13253531736849,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.561363229901538,0.0882852687281633,1.47572334499441,2.08594119760708,7.0638747270852e-11
6,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",-0.0124836178370903,0.0364656613127917,0.91931326785788,1.06057841098499,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0056995447204539,0.0353895074139531,0.92782291901848,1.06588979169369,0.937803887051394
6,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.876568268644127,0.0922071483509815,2.00879467300721,2.88342913230178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.848253076328556,0.0906330400192246,1.95925856193501,2.79502515185623,3.93629879687627e-22
6,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.0300616943933234,0.0454657188929031,0.887446851682128,1.06057975604095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.022580717291098,0.0439496319816352,0.897101807514201,1.06576565533755,0.745908845130565
6,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.49663301107783,0.0777900451979756,3.8428563640248,5.21295726913028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44382204519171,0.0882805851687408,3.60624532898289,5.09734946020539,3.79565705269175e-84
6,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",0.00763864562331952,0.0347822138294415,0.94117346932024,1.07865615146499,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0136311576456847,0.0338116957691661,0.948868140109613,1.08334554049334,0.509042981999015
6,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.784317425590462,0.0492536714281924,1.98982581774714,2.41359647972785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.759641306273245,0.0499613387147732,1.94091955338391,2.36081454662894,2.8401699181081e-59
6,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.55612348915116,0.0440475451805853,4.35144502669213,5.17154345355015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50096095148101,0.0653826200418946,4.00161468897096,5.17062263154696,9.2240099795568e-279
6,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",0.238144077458653,0.209066891160703,0.84103283436752,1.90866219723204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.235006693566359,0.201031142195965,0.85331870970075,1.87649453932582,0.225358522525822
6,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.388225668302175,0.0516352602744579,1.33249591749894,1.63143551974747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.379200766620618,0.0504257433793376,1.32422923177845,1.61364542749623,5.47510207083795e-15
6,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",-0.00846278181144327,0.0717464723708959,0.861308220861254,1.14103773843455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00182982269325034,0.0691125513577153,0.871846133718227,1.14313432807287,0.923757422419039
6,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.34312509636696,0.043760710487509,3.51806085297366,4.17639643053076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29638473224265,0.0554541915531976,3.30362242062624,4.10578110484228,1.42791141012006e-211
6,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",0.0182109892584034,0.0444631296004115,0.933226471110639,1.11091599088439,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.023767660618283,0.0430366785988799,0.941382262889501,1.11437609108853,0.450648907408499
6,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",-0.0597182126800505,0.0557287630986837,0.844267057032743,1.05039503896797,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0510661154468481,0.0537453790138053,0.855326907279383,1.05591372166619,0.4257289304368
6,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",-0.110715482809329,0.139012148275741,0.680816815623553,1.17404565121266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.100049272085563,0.133615853649328,0.696413584341289,1.17580492671725,0.492603786987056
6,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",-0.0462337300470429,0.058046679073697,0.851865028653162,1.06952178539891,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0381140899375742,0.0559713886383396,0.862708281811508,1.07436000351134,0.594441478504187
6,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.247539015668363,0.250039348333181,0.780813230783528,2.08072613475468,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.244044276140075,0.240401144416736,0.797151073443448,2.04550377575639,0.293117713337456
6,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.450751069146494,0.0309939918492937,1.47704830752133,1.66785759409985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.439245428642654,0.0313479310986847,1.45987762995445,1.65075745959409,4.15401826813367e-51
6,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.781097682128553,0.0292187555608452,2.06253957095888,2.3128336061227,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.756544713888954,0.0322044324954627,2.00339618586847,2.27295986863307,1.35886276494817e-163
6,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.47538405298904,0.030069032709095,4.123070311318,4.63885027203739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4234107075502,0.0523976809402284,3.78677575970249,4.65019925408942,0
6,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.421464093297491,0.0324151556508467,1.43043393622297,1.62424472870514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.41111445171331,0.0325293009387125,1.41603702494742,1.60861676743867,2.19589991838957e-41
6,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.743602242083946,0.0304827522522176,1.9818646829077,2.23340729356457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.720530059580479,0.0328846764652737,1.92967364849183,2.19516333838958,8.00444386937385e-137
6,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.43987080080972,0.0274305378186259,4.00038650131772,4.45450843239863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38929814488408,0.049077581799849,3.67969894714413,4.46027992067276,0
6,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.408355773560336,0.0383892992508037,1.39536084650813,1.62196169742353,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.398522941817383,0.0380219630239188,1.38332161755421,1.60565365057131,2.54670043824547e-28
6,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.674958530281714,0.0361258561223256,1.82995246156412,2.10833965223695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.654596982273857,0.0372690562544938,1.7906844438391,2.07236389426146,2.1722906870261e-81
6,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.38369424859427,0.0322529025076259,3.74637947887203,4.25127507648587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33534086350172,0.0491449767588484,3.48076517723684,4.22026075772815,0
6,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.391216797087366,0.0299948768499902,1.3943333170688,1.56830300904106,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.382063294401207,0.0301866274321076,1.38176314006187,1.55533308703503,7.51907624095308e-42
6,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.695711755088331,0.02817124482627,1.8975439158622,2.11909608890395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.674531829926229,0.030446111422694,1.85144596103157,2.08613588958279,1.46040384168601e-140
6,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.37498598421097,0.0289317831220623,3.73643867642157,4.18515373515786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32697819235116,0.0467509042182954,3.46722623256448,4.16457860286858,0
6,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.707190171810048,0.0774598070186096,1.74389421434648,2.36258776935983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.685555887643592,0.0758522551520914,1.71269104957506,2.30573897873073,1.08227930372693e-20
6,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.42057597064106,0.0687269455960447,3.62223217199454,4.74217140994554,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37077025370595,0.0779771992062653,3.41203216194429,4.63192736877221,6.21340563631423e-97
6,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.459446891538258,0.0398775570860916,1.46424286017574,1.71198829598659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.447596313494153,0.0395854735124677,1.44856315963374,1.69171760230367,1.10343745783003e-32
6,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.730527294482513,0.0375623655230614,1.92918775883743,2.23522262406957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.707952347759815,0.0389751284288356,1.88285172849564,2.19365082763102,9.68710907642533e-88
6,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.475510364009,0.0338241213786653,4.09432049900505,4.67481172241433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42353308604565,0.0545479706123819,3.77142157896171,4.67054666021564,0
6,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.449724125921247,0.0650278374903157,1.38048095639271,1.78128746273166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.438259548387042,0.063264471470617,1.37001174708628,1.75560141616164,8.57714771010308e-13
6,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.45888239062386,0.0546600745503392,3.86839064436109,4.79273927376063,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40755238481516,0.068095583180574,3.61291077479167,4.71827627696651,3.27681388409503e-160
6,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.428853527629206,0.0398272187224161,1.42025827359515,1.66023401693314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.418211148774393,0.039431287955925,1.40697663438209,1.64215758830793,6.94363052581394e-29
6,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.712200512756423,0.0374914504721225,1.89432346707733,2.19421763099284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.690355289076392,0.0387683952801846,1.85064117647272,2.15437676574352,6.97324024596693e-84
6,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.40220227149236,0.033205759473824,3.80910861820476,4.33863329089441,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35311841872205,0.0505685369365521,3.53496809068975,4.30996289453443,0
6,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.548830484640926,0.121923033054758,1.3649139253599,2.20124008300017,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.533449905902078,0.117775831539726,1.3544490595313,2.14913954337733,3.70682637932893e-06
6,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.800571961026312,0.119550340221962,1.76585100950229,2.82147967529797,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775272183851017,0.116220614854989,1.7316511420772,2.73095621420306,8.80795079089994e-12
6,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.50886815583428,0.0993755993665206,3.73409749524423,5.51268249731924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45558283872907,0.107432506198459,3.51694755901852,5.35869850036773,4.27827356044286e-53
6,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.395241367321526,0.384247435456563,0.690550420319791,3.11414918627431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385924568452983,0.369560283849134,0.713567036894815,3.03791310615604,0.285292648936881
6,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.21346501484846,0.380622484557147,1.65435442993893,7.35531795623664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17183693887146,0.370821369655929,1.57622031566761,6.74379507735348,0.00124493427613884
6,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.344251431496047,0.0529932731248218,1.27130129608749,1.56482004782627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.336961277113948,0.0516154800949677,1.26643362004114,1.5504322158892,1.15766744575076e-11
6,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.643547742110759,0.0467924343150724,1.7368098680135,2.08646864483648,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.624441273447608,0.0468121668732499,1.70514591051017,2.04858847519291,4.98146436741726e-45
6,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.34561377112804,0.0416499915437924,3.5411163974785,4.16912845642849,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2987854699011,0.0539866928636348,3.32123429222738,4.10399313832457,3.45840310623174e-234
6,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.611375198200748,0.114349217042182,1.47421550346241,2.30796614586685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.593524606394774,0.110664334419435,1.45871138662917,2.25094393242331,4.23845617324982e-08
6,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.805944491791969,0.109157220014362,1.81084690208182,2.77786619523458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.780418325827328,0.106343451008073,1.77463707654021,2.69245820192055,5.32200042021367e-14
6,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.357087280782163,0.0405932187282084,1.31990581312514,1.54756522576124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.349279084556768,0.0399344653221116,1.31183462123632,1.53413523771165,4.54317324911516e-20
6,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.67505977028511,0.0379178956690953,1.82392229577576,2.11620567569534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.654688306045386,0.0388836391518416,1.78518388408059,2.07911535026227,4.50322102042421e-74
6,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.40750637458211,0.0340341669285814,3.82347336975782,4.36915991474954,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35821356625009,0.0513324778486252,3.54818077225482,4.33904652491923,0
6,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.772932296486832,0.0758313742809516,1.86828790029454,2.51500797651214,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.748701663634475,0.0746182616745371,1.82919215666518,2.45069739699319,2.61497055868356e-25
6,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.47936890516028,0.067658853471319,3.85073010964417,5.02025435761311,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42724212756763,0.0792194707801516,3.60802358219989,4.92190060369155,3.79977526805157e-108
6,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.493849326983071,0.0792562818698254,1.40357684224539,1.91497157999711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.480640479307836,0.0769001394280501,1.39174286581429,1.88136923715794,1.32343387562215e-10
6,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.739895132821902,0.0751868224869939,1.80995309147233,2.43033195981897,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71696927255168,0.0738499808794462,1.77449842548554,2.37027127677052,9.70064891352558e-24
6,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.38136625899628,0.0672132510139187,3.49409702099324,4.5473565302041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33310958477799,0.0754629299330862,3.29872646523518,4.43419338354911,6.55791934156314e-96
6,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.430176026138885,0.0635046695524043,1.35789237743732,1.74171020256627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419483928914617,0.0617735615414956,1.34842188254414,1.71786603703663,2.29436701208516e-12
6,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.737015464321919,0.0593955704748019,1.86105714555177,2.34895615952199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.714204646196618,0.0590225695009252,1.82173462016233,2.29596527952218,9.04666490511563e-37
6,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.468853978655,0.0531361939051828,3.9178198218926,4.82507068226861,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41713993132132,0.0673626102385976,3.65404950945884,4.75831011425187,1.10071334997239e-171
6,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.615846887148795,0.210093868400754,1.23492709994798,2.81388128586515,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.597809039572981,0.202473430729184,1.22393298582643,2.70675553084744,0.00266230509370764
6,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.841670408103366,0.181424041105426,1.63699635114401,3.33353146610049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.814719642179114,0.175578854175815,1.60413794244562,3.19262341522765,2.31549851029896e-06
6,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.3230612549454,0.170677564739953,2.71391636360751,5.29856751588866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27710484853432,0.169356318510925,2.59389223456697,5.03807523129151,4.44735506413645e-15
6,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.394317214568099,0.0381663563740666,1.37649692797392,1.59863666503196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385038805772393,0.037768980889674,1.36544446240509,1.58333229513343,7.11092849733142e-27
6,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.687158039430351,0.0359102021196975,1.85320992666445,2.13333106136033,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.666314705450212,0.0371648914954695,1.81222830199649,2.09644046899954,3.2396944320506e-85
6,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.38348953338361,0.0319995224525844,3.74730882407241,4.24810821729201,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33514393481565,0.0489788026202566,3.48119411114974,4.2180323376039,0
6,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.53103309496341,0.123544075191986,1.33715593222274,2.17022054389041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5163553706111,0.119294706869853,1.32748447446016,2.11893252677405,9.76075338574899e-06
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.8525395598863,0.293658123812436,3.64231854861848,11.5160203016831,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28934157025633,NA,2.27085273157883,NA,4.52292079836059e-08
6,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.815841662624145,0.359850672948081,1.11144945202892,4.55512828427425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446332007030776,NA,0.880514429704578,NA,0.113606453885861
6,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",-0.266145662641226,0.513340708634217,0.26775911623695,2.00288988228415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.433580597060759,0.417461652761159,0.285995248065434,1.4690846580139,0.317975717756974
6,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.627712693673556,0.395630860048978,0.858781505638198,4.04954174529597,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.293347215318106,0.322286570569357,0.713718214072622,2.52457590279521,0.33525553507627
6,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",1.67973821480958,0.404290633485128,2.52102402422838,12.2982298776794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14884198443561,NA,1.65599721129587,NA,0.000392473154786387
6,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.573516524831868,0.46448308222323,0.719541976074348,4.44419971631486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.249227076374742,0.378596335585591,0.611964074611554,2.6992897019411,0.481391856935788
6,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.895250674205543,0.48291702867333,0.967310508907791,6.42222247534064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.510874016595297,NA,0.771958719824587,NA,0.179135772927004
6,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.97906159883157,0.310680145516727,4.09045314590519,13.8252903553935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39227201938905,NA,2.44719416197052,NA,2.45116446020135e-08
6,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.319124999605072,0.41116248738379,0.605091155220912,3.03239025514971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0423940778138463,0.33443302318771,0.54173932129151,2.0096950841013,0.859777142548318
6,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.755281999226949,0.366295312070525,1.034934706814,4.3500597396175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.397083399725026,0.298903195607048,0.829635490057005,2.67757130252654,0.164826200715099
6,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",1.01171530688618,0.341073267256264,1.40694938933949,5.35701248070563,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.605624299200156,NA,1.06391252419477,NA,0.0248593959983461
6,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.54706238639132,0.280985132837477,2.74041684855646,8.24454297938952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04094769278779,NA,1.80929524298588,NA,3.68116654211957e-06
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",3.17221920977299,0.50846765726377,9.57647946242693,70.2785497126666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.36254713426896,NA,4.13285093560347,NA,8.71496914069138e-09
6,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.223901238939062,0.349881967662463,0.385719385000113,1.52023808149505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0406812528071645,0.310613492341247,0.522325306189023,1.76494198989858,0.841295124896472
6,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.536541092879349,0.235743426989716,1.08039836813638,2.7221638183307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.634419539587992,0.209282757855384,1.25136326674647,2.84228102151214,0.0034056473606063
6,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.63438494768948,0.307530792969503,2.90000606010886,9.68144709496991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60903718705187,0.273012001287389,2.92689905787559,8.53462057700459,6.07108733843532e-09
6,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",1.10943519831927,0.489757347004493,1.22894478395133,8.38101831602703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1430104802471,0.434784661762257,1.33756115236614,7.35347121808049,0.0098973975008508
6,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.63272548303407,0.579677096754926,1.73516534192535,16.8339077602579,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60756402163408,0.514611367623227,1.8201956651417,13.6834010598741,0.00205611997472083
6,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",-0.217597435131955,0.537720604109701,0.260447435907695,2.14356818335582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0350760102340237,0.477365861811171,0.378820579889311,2.46094938220984,0.905618926422539
6,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.625819622850493,0.426935053875841,0.779383816042991,4.1549608577263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713677889835242,0.379018519744874,0.971228319933026,4.29105059534708,0.0678227623039196
6,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.43141186121421,0.35288451137965,2.08175055290811,8.30195490459587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42884684221678,0.313275325798937,2.25880933386977,7.71259373384765,7.04671940940549e-06
6,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",-0.217783219703238,0.536140460076573,0.261259030009296,2.13697028907039,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0352409797161544,0.475963090951308,0.379800881384615,2.45378780254105,0.905067536883458
6,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.312657066765212,0.267183045830971,0.807629660912919,2.30178895755333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43566601312481,0.237187592689962,0.971219893830851,2.46097079295588,0.0808128070279809
6,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.77633094988483,0.612168755942734,5.73924342280457,63.2430235542844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.62280546813204,0.543455862038882,4.74765844149524,39.9632135766732,1.69677881507134e-06
6,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",1.18977273822877,0.383111793174356,1.60808331901813,7.21970156868114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2143305243095,0.340109646083821,1.72931846550341,6.55962013187268,0.000453005652305183
6,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.48494149156239,0.316942399013215,2.43728885918504,8.44249324150142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47636802835381,0.281367634104019,2.5216079231206,7.59763960904069,2.33341471948376e-07
6,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.431893325594716,0.410663040051377,0.667851870840536,3.34036691682048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5415189390359,0.36457283409901,0.841104426438986,3.51155792332195,0.153777271446657
6,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.76714490398292,0.323777295479169,1.13056297051087,4.02248306157487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.839139625842606,0.287435148868315,1.31755475924593,4.06536139419996,0.0044480321943475
6,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.971174754144852,0.320941470687939,1.39981099532139,4.92539597079195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02026908689304,0.284917685477842,1.58699151644335,4.84863343886564,0.00045598535197563
6,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.208903298994681,0.259021810961407,0.48479344433028,1.3381853431548,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0273800892145488,0.229955349266266,0.619978907763402,1.52705124351931,0.831658909978238
6,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.5825181405989,0.267768943757455,2.89636949147594,8.27379279736884,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56299216143132,0.237713224872257,2.99541513347618,7.60572725443879,8.90009207699097e-11
6,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",-0.0113077878650713,0.244075467907045,0.611004286296225,1.59059307303776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.148065033942463,0.216673430237255,0.758360996544755,1.77313378548758,0.55923703728997
6,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.242744553343249,0.218889545031191,0.50782633160198,1.19771490182454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.057372169722698,0.194314835754894,0.645175393051304,1.38191067344294,0.684630196826499
6,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.307516566693664,0.224999780016171,0.877028166705818,2.11862387151655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.431102221284019,0.199744674512039,1.04040478433658,2.276398501411,0.0403173427120734
6,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.218499513351791,0.191491921372038,0.853056939186381,1.80706784471765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.352076759736791,0.169997906456036,1.01906647295971,1.98430064832799,0.051844591195431
6,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.12799677252817,0.19455065589041,2.13045220935306,4.56746716073446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15948858440509,0.172714230730374,2.27271036023276,4.47273668131048,4.43666832781049e-11
6,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.570400328376562,0.177936683515181,1.24904919299297,2.50899330429875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.664477107334255,0.157964178720955,1.4259995496716,2.6487324597029,4.69686417568637e-05
6,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.27904970363293,0.152040649244748,2.6831536291846,4.869451115442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29358651456597,0.134974841806786,2.79838002096021,4.74994169543644,4.32627150294522e-21
6,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.758531391510701,0.233151166627767,1.3615088419024,3.39576581307347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.618711689461582,0.265639552661931,1.16768645719617,3.30789592930761,0.00158071467458639
6,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",1.20179220753537,0.243662629340241,2.09088057593891,5.43427034936393,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.99687898928089,0.302159445408197,1.63578460679841,5.34716135504313,1.32631806982427e-06
6,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.608074670146865,0.332837834630762,0.983297246980713,3.62500809048363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.490348935397837,0.331275714563815,0.897636169469342,3.28900961217521,0.0771638526258433
6,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.80354177148384,0.195704842195718,4.19216712791148,9.02832357090398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51026278744001,0.34076380626937,2.72883792359658,10.3775562842081,1.28720712530261e-19
6,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",1.02456440139858,0.197587928840321,1.90935450586723,4.14248429245989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.845650180224698,0.25994976390822,1.50523204874316,4.17006415934551,4.21210451779363e-07
6,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.555166341633241,0.477293810930207,0.696242904652912,4.52175720443032,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.445218233030613,0.445070831275859,0.686898357521139,3.93171866973564,0.261356441224941
6,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.459051631568995,0.105418185381263,1.28775925777186,1.94669953387594,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.363209360253211,0.173376850688487,1.06773345701499,2.10678460963803,4.36709805404403e-05
6,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.990920346835387,0.233809906295239,1.71860594672119,4.29749140055351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.817003158684066,0.280302260522374,1.40304317960066,4.20977098388155,3.47350493599935e-05
6,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.89822292919938,0.0950527665610446,2.04052368264717,2.96182751125809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.737888386011552,0.199251611044739,1.5080150695051,3.29315550637843,2.13284191106853e-19
6,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.613757600214399,0.228726104621507,1.18323342082851,2.90037701268421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.495199313401183,0.255017749468848,1.0460909608464,2.84257841039318,0.00959558817317485
6,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",2.14806117446453,0.218947535751021,5.6797864980694,13.3988946240279,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80418997394908,0.415507896209941,3.44101296511443,17.5407530333501,3.83401286067031e-22
6,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.96523450217307,0.0536474975661849,6.43061584485274,7.93564500420124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64821300011687,0.320370096566421,3.35286692478793,11.77105415675,1.74681354959382e-245
6,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",1.14960407758673,0.0604611676727067,2.80611421996615,3.55659671493586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.952354461185793,0.211234201695589,1.85683234724484,4.24989744493902,8.08471784472963e-69
6,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.269450163801696,0.155924998840677,0.963991830167016,1.77631732873062,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.201462598955887,0.191061411681379,0.871661987758414,1.84336630285707,0.11114862408356
6,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",0.981663474333147,0.123162522320583,2.10036395839249,3.40382180018694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.809076523546762,0.217431137403028,1.57118733232135,3.68454112585549,1.43722630278888e-14
6,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.671868232112386,0.085761084241286,1.65612506359541,2.31789129406237,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.544771338487236,0.178892808052183,1.27809514524033,2.5769788475808,1.71783840331295e-13
6,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.61486909127366,0.21243134911811,3.35335406855793,7.71122181409668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34929586688284,0.324243923835237,2.33015929942613,8.30576174356834,7.8377912875771e-14
6,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.36818246745295,0.0797575124256557,3.36208320195297,4.5960833085426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1388368809714,0.238961953217953,2.16102649308564,5.51403676998198,1.23369392348664e-59
6,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.830437324547353,0.21514829419551,1.52007119354141,3.53291386353301,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.680062307186922,0.257878934230294,1.26530558415971,3.47703704906625,0.000174409421860858
6,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.546626553754577,0.121557434185457,1.36152637062962,2.19263230514069,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43792279824106,0.186330729404934,1.12580585717413,2.33707964362569,1.93546964233902e-05
6,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.94510280658512,0.202918403504035,4.78047744638689,10.5905908476183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63103577317449,0.367105158976788,3.00952697229952,12.689929099792,3.84745264420714e-21
6,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.0667977251297331,0.16038040236268,0.77930197096299,1.46129489338629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0285665969887374,0.185426564237926,0.737004957495408,1.5245482171807,0.765432228570718
6,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",1.02254643618825,0.113963514840409,2.22807970102895,3.48291247948706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.843955833301865,0.216867005762182,1.63311095637134,3.82129663961092,5.45491504181363e-18
6,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",1.28729981992621,0.360033578313505,1.86875728036584,7.66434723893416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06986052461819,0.390390320881197,1.49752958051118,6.91794487234244,0.000435949194687868
6,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.71658351804612,0.0983919251836741,4.60171956455627,6.7674158735745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43608765291111,0.288757374940825,2.75705237563876,8.55118816106238,1.63072818049762e-63
6,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.59094664309125,0.0856040322225596,4.15987067967421,5.81851821648619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32888777503135,0.267689120841777,2.53469378955932,7.23836178844515,1.31614485791137e-70
6,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.746379170250135,0.246167286956493,1.31149379000139,3.44224824840949,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.608343861755298,0.273910103201875,1.13653852338548,3.32574974132451,0.00323320779150515
6,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.584818428857506,0.164249785223325,1.30120573877534,2.47722418479706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470510559072744,0.211948800130851,1.10829786643399,2.54377554994729,0.000635229923488866
6,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.978901330152103,0.149307096370643,1.99418639915399,3.58052418552949,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.806719954897463,0.229678811160114,1.53042351053192,3.76545572770529,2.00902929991951e-10
6,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.787950405467593,0.394060655224781,1.02850049269386,4.82008370011872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.643819908550097,0.386920481692332,0.948612167079378,4.32298086230847,0.0512362438652387
6,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.873575837754642,0.270388632968348,1.41794688561023,4.09232772894897,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.716849563866952,0.297936065251953,1.21782472870252,3.91554361108922,0.00162393768269279
6,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.721544089818046,0.126873288188977,1.60578958131525,2.64045100419549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.58715445209372,0.20002835376024,1.28275788337608,2.80978816678655,4.86257943599496e-08
6,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",1.34299402889817,0.250636761212507,2.37569485236189,6.34564032721105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11736386099388,0.318584568947772,1.81087471883083,6.31317399854413,1.41402769527407e-07
6,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.44490015690219,0.102542292301743,3.47839768235853,5.19933197639202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20430460059515,0.254581423509855,2.25637963817094,6.12085896989848,4.78055118940973e-42
6,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.270869136762232,0.390269899842703,0.605077713116237,2.79388057939268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.20266166922774,0.365146711523789,0.621949556072291,2.60244794198135,0.518515709119291
6,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.25329033010313,0.367597951471122,1.74941685883786,7.3908296869243,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04084034843175,0.393524838161089,1.4414229828745,6.74107783185167,0.000799821672488979
6,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.687450150764278,0.0657923760018054,1.74841364866721,2.26281647484391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.55804783729401,0.173410917341657,1.31005625093357,2.58526594039967,6.55735015123509e-22
6,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.77432211888673,0.17931101676945,4.19382204963135,8.46973119157948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48533380113561,0.328481386039041,2.71073985906211,9.8241631721679,2.57944232932683e-22
6,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.57038650486548,0.112595677583753,3.87134656701353,6.01929018205918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31132313323909,0.273262779790064,2.45798159283082,7.17434118013606,1.26592565682162e-41
6,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.355498768423613,0.0919115616959318,1.19154644807104,1.70836829416662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.274861980397697,0.161352072791267,0.996897709732453,1.87644943100491,0.000368701903511288
6,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.636521679697518,0.287712870169257,1.08784292169989,3.36023358671402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.514618680832068,0.298344821342837,0.98161322158215,3.16113864488558,0.0322272571088871
6,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.64195782378862,0.284218975631303,3.04454908197983,9.27637381166579,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37241074379467,0.3708270522945,2.19176867347974,9.37760280001975,1.23922011374039e-08
6,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.588146463269468,0.0879383081416404,1.51635445551353,2.14046030828792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473344505836342,0.17401081491611,1.19684014811104,2.36740574726256,3.48081413994832e-10
6,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",2.10374660403371,0.0717925448780225,7.13449668728968,9.45329456253875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76639159423747,0.351916930497009,3.67341321322161,14.593996993796,4.56875507394127e-169
6,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.558029470032251,0.130819138593045,1.35247828870675,2.25858899353444,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.447652137279159,0.191727617022643,1.125468356714,2.38633260971553,4.81009967840094e-05
6,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.70328672853036,0.127180852915215,4.30364586070913,7.0851590414128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42472122891436,0.296309530540533,2.6819515416128,8.56819192378556,6.82234378115461e-39
6,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.233602694414816,0.957432708732471,0.188342125112926,8.03311278975922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.170867823423003,0.845921556104682,0.238352095662683,6.56626555639673,0.822269763958209
6,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.0974320960388242,0.264067570284587,0.661198408769089,1.86157803671427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0546995879294585,0.260578933590566,0.653895494519264,1.81601204947086,0.765771822527205
6,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.53819837562623,0.210723272813228,3.12072370593386,7.12838700831369,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28388418867869,0.31433998689921,2.2026441438756,7.5522733863174,7.43856891592542e-13
6,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.695655908956688,0.142690507453223,1.52007843156749,2.65939444422686,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565068682388935,0.206408434217407,1.23768243934518,2.77971060863561,2.76153957985293e-06
6,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.0803273938444257,0.0781902076728616,0.929027669450391,1.26223407393809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0400951831182623,0.140917879885965,0.813553197064237,1.41346477449553,0.44717526307756
6,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.932605604426029,0.134599556696817,1.95707208159485,3.31703093910634,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.767222773442274,0.218859517341297,1.4980052338411,3.53264867448047,2.10673739591281e-11
6,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.404673010223078,0.196135231852171,0.452022427597336,0.975127057838012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.373702458349792,0.196040581518318,0.477910796711948,1.03059239419288,0.0320828541760057
6,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.0572292242185488,0.194863137842825,0.721961152433972,1.54970643643144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0203945933731135,0.208425757174489,0.698735989235009,1.58174971541476,0.843398723714036
6,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.101312857010568,0.186791680513241,0.766397380925622,1.59385476574156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.058004661569368,0.204384939939701,0.732130549101275,1.63130092072637,0.659739029655203
6,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.0782597578920721,0.144951871268302,0.81245196222203,1.43404970650293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.038364924779145,0.176110488818235,0.758122479243081,1.51199520505002,0.683613552130262
6,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.648005066443635,0.161069873319218,1.39824267526468,2.6289867810436,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.524414916107389,0.213704399171182,1.16899075036731,2.70160656858164,0.00010848400863963
6,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",-0.146714499411607,0.106635351108257,0.699497661812452,1.06248453643204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.153600302839139,0.144643088448422,0.661818761634596,1.16675565595262,0.129586671680933
6,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.86605524142007,0.136747553922499,4.97606481371845,8.50521871818564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56359193886818,0.324708991165707,2.998509074894,10.7075708397116,1.51936991572374e-40
6,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.405982366602653,0.541916844482572,0.216169819971607,1.80865598365009,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.374794921938487,0.477704350099264,0.275564014531269,1.79253590355907,0.433871884673445
6,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.0506902321260262,0.149892334901734,0.706483886074755,1.27139188237915,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0716757211927867,0.1742661923733,0.679385285566835,1.34520180148328,0.648146863459406
6,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.844699137435067,0.0886911585243141,1.95939088012384,2.77401742219401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.692223596799649,0.192718777807778,1.4546446077377,3.09629223441361,1.72595126412126e-19
6,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.257632578987725,0.156452346127193,0.950579460745783,1.75522737293725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.191380067987584,0.190855984035198,0.862938481145654,1.82344913107037,0.13027300032864
6,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",1.34203821771669,0.0818741160909299,3.26729602925345,4.50371845132472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11653169426083,0.236641281865887,2.11754395777659,5.35415923533958,8.87012338556367e-55
6,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.358081575857652,0.308330165513884,0.792330208296823,2.65343491530477,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.277067478227475,0.302908715913925,0.758423643970103,2.48647786032769,0.271984771181628
6,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.770247389192261,0.340083131017291,0.233888978869785,0.887091319819605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.685564159570997,0.304230300772011,0.281630382660664,0.928115676550215,0.0206594556001569
6,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.532979523024095,0.251797610695928,1.04509697714279,2.80425576379384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.426282851735222,0.267470336213289,0.949708370039556,2.70977100521542,0.0418312095804112
6,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.0622232826833793,0.10595266300737,0.864144995933481,1.30906363897804,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0246513836088643,0.153112470276722,0.781857842503701,1.42490837386453,0.686317321025636
6,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",-0.0297190760189177,0.264995153574592,0.574194333292718,1.62251032619728,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0537596688691046,0.257678358957517,0.588027356405575,1.61461864980172,0.856188699772253
6,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.573766132967828,0.454984613693811,0.222393697599317,1.32339559968094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.517939608878308,0.402342181450576,0.275757554388728,1.33498378374869,0.193570079339112
6,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",-0.0705540622461927,0.110465019400042,0.749525595581876,1.15569293446319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0886317071631022,0.149810151306136,0.700343112256158,1.25993495736855,0.429675000382167
6,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.280073374354649,0.325182197427745,0.695065031506965,2.48666119082186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.210514586015094,0.313474206333274,0.693270351169386,2.36898376073537,0.422242947251389
6,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",-0.0908243722817661,0.280251144407739,0.526843507576021,1.5804546759353,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.105917462701063,0.267947464270599,0.546277696361358,1.56159374053425,0.69744990194613
6,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.908653213980774,0.160626434584151,1.8175659640806,3.41146656694576,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.746787742767298,0.23041841630675,1.43306217299106,3.53614492379665,4.05906421729698e-08
6,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.206508131126041,0.0956196236261073,1.01918742651577,1.48264507608847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.147751203143037,0.154981509947906,0.884627350663721,1.62405735817409,0.0556063099959009
6,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.34211767007405,0.0763261853867839,3.30017818509576,4.45118169947256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11660009125348,0.235146850334119,2.12380988360201,5.3386366221908,3.98250640882624e-62
6,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.0707382807186651,0.372340940503408,0.517391216437697,2.22686258211765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0319199141119568,0.345372457217999,0.541484345526209,2.09676154367879,0.88858167822266
6,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.514784326461239,0.318694657815647,0.904758085449894,3.15558034262472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410758279750507,0.316641001786036,0.849310472683032,2.93844183201126,0.120318465434334
6,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.30356530295243,0.23678479887671,2.3535212659245,5.95417094695236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08370838837994,0.30633019178814,1.78585236767745,5.93393818500248,6.55810170754909e-08
6,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.355781729374841,0.249818985726341,0.874997047139431,2.32969570894065,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.27510891515583,0.258721344928417,0.824805244032692,2.27404696426897,0.178708324146541
6,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.424297219681303,0.556091616502905,0.212243553685748,1.87726936454091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.390420260906807,0.489440128685352,0.26506988333418,1.80544711916364,0.426278365889553
6,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.109382981431723,0.115923720539918,0.888314285486249,1.39931518155706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0648882338140818,0.160545462616123,0.803237944602149,1.507152878133,0.441420562315777
6,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",2.28297550085735,0.20327715984086,6.62372583202412,14.6947435832727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33088954016804,0.151262766267989,2.79590183554473,5.05862072950449,6.07561416620255e-28
6,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.533484396007706,0.240775408654039,1.06139600530772,2.7275595903136,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.200192308089712,0.187658649728517,0.835400833657156,1.74327366231411,0.0470969643244004
6,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",2.12146612930929,0.193280290730403,5.75734989790344,12.2818443053216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22650817469727,0.146886185947665,2.53945391976473,4.51647731213143,1.14276221475223e-26
6,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",1.16042551458594,0.196186913084205,2.17570960579663,4.69450856239725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.605387675720854,0.157142037287469,1.33345931271536,2.46887361325653,1.77824153281851e-08
6,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",2.54212285012543,0.403897877278942,5.91159772613168,28.7939911143657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49838142971537,0.270940567452191,2.61587685786704,7.56601771890912,7.4273539750805e-10
6,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",2.51955017101314,0.140532390586509,9.48463135300129,16.4536869819428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48379269125021,0.115581969734599,3.49568100788739,5.49919217748895,7.86980897835762e-69
6,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",3.07465221104983,0.594220555623413,7.86085311011069,80.7369964551238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.84255629718897,0.389890898168167,2.9259473946746,13.4901873808508,3.75535584579355e-07
6,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",1.7418745611508,0.184802356313328,3.98514441267352,8.22341420233468,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.981177101867144,0.145462771865069,1.99049259667615,3.52043912065837,7.13407324725268e-20
6,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.977429829914863,0.314039140833977,1.44362802150058,4.94397773144352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487112051413606,0.224901876181254,1.03661691664521,2.50317919190109,0.00332581652699539
6,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",2.14218949019576,0.373497964064605,4.20350808648924,18.1742280815143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23990380399526,0.253698733965967,2.08754167126565,5.64329380385772,2.30975869803437e-08
6,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",3.10533188387355,0.459000113758305,9.94533019547738,60.1204769195267,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.86238447783449,0.303829332684678,3.53334563665099,11.6258875103135,3.03963535437787e-11
6,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.835624897992399,0.425648790189966,1.01153683319526,5.3654668449487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.395468199636264,0.292933192282218,0.827229503239057,2.60805283851637,0.0668136423525726
6,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",1.05658911111242,0.216622106899806,1.88796384779974,4.41338502632834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.53827813721695,0.169068931219289,1.21763054699716,2.36232151393599,3.80740719164079e-06
6,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",2.20064242581633,0.703866155551859,2.44867041125705,38.6539828004434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27769225702748,0.462039131338015,1.44103564412654,8.81559371280902,0.00230570375309659
6,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",2.51907115489617,0.314691357532888,6.9334092569013,23.8055584687154,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48348250998401,0.215836183849341,2.87110517510215,6.69097315636759,4.92883567226705e-15
6,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",1.19263465427497,0.356250482233878,1.64435199616497,6.64472038725229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.626200288706433,0.248456382488143,1.13846520583562,3.01503719712272,0.00141235376461698
6,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",1.56634216050351,0.321521170144497,2.58629219999395,9.12086909002016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.867712546197526,0.225149531110957,1.51917439725367,3.67200183255191,2.6115268476117e-06
6,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",2.12376525347361,0.210248001796514,5.58297769910137,12.7289546808697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22799492735172,0.156338649890422,2.49655883648391,4.60779559931721,7.75856257602184e-23
6,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.879017064047747,0.288800509874713,1.36118404335855,4.2225201309744,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423506736222166,0.211059006375444,0.99909860810392,2.28515602393183,0.00434850339563479
6,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",1.19665942416189,0.260995014163968,1.98373842369992,5.51827224990515,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.628832448050838,0.192402865344433,1.27405279211792,2.70853627099483,1.2279653853493e-05
6,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",2.20123750141046,0.220176277579575,5.91555989828203,14.0224735889545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27806498563875,0.161431004818279,2.59917450971975,4.89391114630471,1.92248627425222e-22
6,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.93223396375498,0.383303490803037,3.35830953753506,15.0889065428769,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10422432721171,0.260733495045034,1.79669284725998,4.99283651233397,9.76285005536657e-07
6,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",2.48080322732932,0.477501660492171,4.98218213482367,32.3832103364033,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4587505288802,0.317370856338958,2.29515511728055,7.96352170121805,3.78883693136985e-07
6,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",2.04450090366678,0.388759839981999,3.7367612650858,17.1522581303853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1767471502794,0.263576160375195,1.92174487252538,5.4001845243007,3.11389589912498e-07
6,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.659985779343546,0.28419588919729,1.10418087121623,3.36400147918661,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.281950435087169,0.210437622529875,0.867470719885904,1.97926745153691,0.0334029052993774
6,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",-0.330733683926639,0.301272434058022,0.391475704705899,1.27524002800961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.35835132827833,0.231015442761206,0.436832361990505,1.08042893775952,0.199906964750485
6,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.0890121085706641,0.370486420492792,0.517488005778803,2.21114648056967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0870687665947511,0.265823275607408,0.536511072423196,1.52095741371918,0.927802516428568
6,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.243489131051837,0.414434956782437,0.554481982656185,2.81463956567475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0127705659600544,0.290555676478604,0.565237409438658,1.76552461834171,0.650014123857066
6,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.230790714385912,0.250073416273929,0.765706373766525,2.04074160158141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00456337881532947,0.196187713354139,0.674566368407854,1.45551020140489,0.483185983862664
6,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.0686150024073203,0.345649808483372,0.532276297476008,2.06334774669849,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.10025148533916,0.251542259694674,0.544463480746026,1.45946967143137,0.969600116620821
6,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.8717562967216,0.0873118969802495,2.01909780912135,2.84313446807962,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.805975966333633,0.160573110324742,1.758132219395,3.29922315373746,9.85059143115636e-19
6,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.569766352647724,0.109475992701419,1.42975861959824,2.19601342775973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.491904291136559,0.14306511881608,1.2742359932284,2.23256631714476,1.50247777680208e-05
6,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.483405753502617,0.0685829916886268,1.41857124488128,1.85612426794737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.402091573995028,0.102650442622733,1.25179483956654,1.87191268467312,2.05364246346544e-08
6,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.787762952379869,0.0651730970356624,1.93675886013557,2.50049754773165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71862225488785,0.132091118762551,1.673710571874,2.809006134213,9.93580485830142e-26
6,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.50769100155612,0.0602363894170066,4.01905775371561,5.08945011935924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46736139609298,NA,3.08443638023631,NA,1.69766291485629e-117
6,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.207145169556647,0.17855259831998,0.86814432402172,1.74807646031803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.114777741801737,0.194944188168909,0.77534102224341,1.66481641801189,0.524156605595677
6,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.572519646901494,0.161776483375712,1.29344354959648,2.4386881274172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.494770609614761,0.192709850461087,1.16198070794217,2.47325423754888,0.00312483059247776
6,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.35704783074184,0.162270294721768,2.85576265385748,5.39475294029941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31068207892002,NA,2.45972303918296,NA,7.96259509782934e-15
6,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",0.246597125295715,0.368693467706982,0.622203545443041,2.63996019603176,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.155809051047108,0.394742907741811,0.550532499773867,2.5869885492269,0.67746008491506
6,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.328298824640206,0.189591947316129,0.960978960100604,2.02057881609613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.240777196576963,0.20952086300242,0.858999695837824,1.95290885172632,0.215791181955536
6,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.35465490029966,0.708254174692,1.04316478337325,16.7527848129912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30819426018899,NA,0.871748399714218,NA,0.0749328501810407
6,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.45842377755475,0.426606596075053,5.52151204679732,29.39777149698,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.45611930173073,NA,4.32864305528753,NA,2.98651025641299e-08
6,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.607220439193501,0.0684948104782581,1.60605763943134,2.10071387674166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.530856167293305,0.112783903314393,1.4090281032757,2.19241780485724,1.40586138925989e-13
6,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.790303037136574,0.0669627379879341,1.93507920987679,2.51591705304313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.721263968879476,0.133580151082006,1.6740597760641,2.82603946827266,1.15392997352695e-24
6,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.196655786832503,0.215148192895972,0.537182406664668,1.24850627142745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.305169252405423,0.226951016650369,0.474683873230388,1.15549105703593,0.178606321918431
6,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",1.08256707756238,0.38557972948267,1.46473573971414,6.64005077077347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02523446449589,NA,1.26056527959909,NA,0.0103234623881009
6,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.355810015440489,0.0972575971399995,1.18083080898159,1.72885794198814,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.269388577225855,0.119719171914197,1.05339152030915,1.6842249853136,0.00734511660944112
6,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.36591937317938,0.0840786861276821,3.33265746919247,4.63368486104388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31990980591807,NA,2.71149070462934,NA,8.49028271076969e-51
6,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.534321979169752,0.086716973739951,1.44131885659017,2.0248241510938,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.455050005995491,0.120829506633356,1.27850547551283,2.05306697612921,4.63774465314551e-07
6,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.177632683086638,0.133539558193677,0.920313787401618,1.55336703457639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0840859580378065,0.148718847987472,0.82191751530496,1.47233847547217,0.528660585565174
6,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.845063746602125,0.082481440858345,1.98304147643906,2.73998671617018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.778215508088942,0.152502033779166,1.72647562078414,3.13892098244837,1.81609546591992e-19
6,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.43709276531592,0.0769902648170093,3.62717008667022,4.90497034041244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39393184648636,NA,2.88774373601782,NA,1.04768132142863e-66
6,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.862884476056875,0.271461389504561,1.40988138806348,4.08619685089574,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.796752075755183,0.340441589170933,1.26174656417087,4.79226629684604,0.00461457060964011
6,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.60751545196673,0.283374839973651,2.96233866983967,8.99607173789442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57118030241666,NA,2.55934745260156,NA,9.32871095778546e-08
6,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",1.28808280733906,0.48486441434537,1.52108325205571,10.1762474758489,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2389757055789,NA,1.27673995513002,NA,0.0137510683861739
6,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.525694025506762,0.181110453126077,1.19357892021434,2.42758326261796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446069708768247,0.209215620303131,1.0681461150656,2.42549276215105,0.0171662144309314
6,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.07634136960606,0.0755273580327653,0.931010151222722,1.2517927264114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0212760678260963,0.0899139325183207,0.827638523054299,1.17736318916123,0.825792805162677
6,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.987090414467245,0.699797429359067,0.786170927802687,12.2138978478655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.925920505812181,NA,0.605755059256573,NA,0.201524282447067
6,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",0.944968797967069,0.645604020938926,0.803443414522661,10.0933090962482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.88210495931422,NA,0.647380056761176,NA,0.18711353786541
6,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.0767681924711307,0.149875857511355,0.805019214848357,1.44862297569951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0208187672611163,0.163070598585407,0.717825189147983,1.36028711522019,0.913140162347886
6,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.34204465787272,0.459310994369088,1.66632273978219,10.0853639567516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29508299050697,NA,1.4194668666998,NA,0.00656531041712488
6,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.464704804187265,0.294145479000972,0.907598180907566,2.87506579655933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.382653210302865,0.323774767402196,0.802188933370084,2.85411737680563,0.206916129545678
6,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.0567327522694157,0.445241257972704,0.389597927536159,2.23149917062928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.159660383383171,0.469202785743596,0.343844743351308,2.1633892129636,0.73645409602911
6,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.642951775194187,0.28016782684601,1.11443796395611,3.34206176054039,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.56802915607342,0.320353336427385,0.991004057525048,3.4789320105462,0.0499259684964777
6,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.48716130323349,0.0615454544440029,3.9276617091724,4.99930054730133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44600954387704,NA,3.03373551652476,NA,1.29894475843247e-109
6,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.25165421539626,0.215699079411775,2.32838690748603,5.42327874863592,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20107287855481,NA,2.05336083307487,NA,8.19374670898249e-08
6,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.843064951944066,0.71124865781984,0.604816373051555,9.82778053791306,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.77610898452488,NA,0.50959027243174,NA,0.291793924006083
6,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.466962126703822,0.12378172271063,1.25385041952313,2.03691129483616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385005074869073,0.149850599888131,1.12188268992554,2.01861534760139,0.0026459723574662
6,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.837666944421756,0.115983447638601,1.8467545625864,2.9097773562473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.770534697998401,0.177303525543957,1.63330097508531,3.27271577964434,1.70314993396929e-10
6,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",0.120707052306332,0.133829058520278,0.868216047132135,1.46709693866283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.024882086578792,0.147715941434174,0.775010627286423,1.38286483291734,0.837582413496796
6,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.47172822998701,0.106478581335572,3.55126643807333,5.39079382840701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42993321075942,NA,2.89642397572997,NA,6.82630500662534e-38
6,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.405876128527045,0.119639615867812,1.18841661454845,1.89951866821847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.321481438154914,0.142905028486065,1.0633956490859,1.86198784080237,0.00929240274417969
6,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.642848663459099,0.0911073486514888,1.59348256480626,2.27744945688112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.567915628180024,0.133434163655806,1.40987822871227,2.37870363519415,2.18745369493809e-09
6,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.529511042849334,0.136474672679529,1.30295925108237,2.22467071411258,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450044916038231,0.165454483374413,1.16672839851541,2.23172147250844,0.00144585379122618
6,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.749601127804299,0.129776055094731,1.64653062112205,2.73842574167164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.678941522654777,0.177638745322372,1.46711093572495,2.94357904523564,4.71965457521015e-07
6,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.31236035288875,0.129670401427516,2.89703836104865,4.8162113579602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26420688014481,NA,2.46980335054413,NA,7.71673250827393e-21
6,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.649940658391921,0.0899175217982003,1.60825109314419,2.28786145689139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.575292268827317,0.133146651822546,1.42212606838962,2.39666519162423,8.28988356957541e-10
6,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.51254935310544,0.0806685357384145,3.88459195623283,5.32936874696476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47240690521336,NA,3.05670870585334,NA,6.98903531145303e-68
6,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.466494258948875,0.16086342113705,1.16783580061414,2.19399770666021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.384505443962243,0.185911040237895,1.04590414031055,2.16764126945947,0.0206383301374884
6,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.723741718739633,0.145035260661838,1.55895438217796,2.75259224842717,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.652042489981434,0.188923095176071,1.39291047996858,2.92110027939513,1.46838607019191e-05
6,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.45693185908786,0.133248703704203,3.32956649464399,5.61346083646738,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41456141265106,NA,2.78248465199784,NA,2.09316791581646e-24
6,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.810559196668209,0.0988020152538105,1.85748273581096,2.73606015568904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.742332092250372,0.159214908913639,1.63432157231466,3.05060140241814,5.61411547468289e-13
6,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.4590062319898,0.0922914206305578,3.60177714310419,5.17170848660009,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41672591639469,NA,2.90345712526132,NA,8.7359658737689e-49
6,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.183065393260787,0.251698673755031,0.503444019277327,1.35034202857929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.291071190133446,0.265027676649342,0.447046996066758,1.26338907102484,0.272962344476232
6,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.249292948652999,0.241303586313544,0.804019948014269,2.0704406890547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.158609553631626,0.260701186555328,0.714283080810316,1.98467257171682,0.518126752455267
6,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.608170675343705,0.113686724913861,1.4734518851907,2.30078792866426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.531825302882082,0.149736909355118,1.31364295025868,2.3625984577843,6.61369110350585e-06
6,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.882351859072491,0.109293386131965,1.95657272027266,3.00301424225048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.817007071074179,0.179269250828662,1.72120616289138,3.47553301502647,7.02410346326575e-13
6,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.6095978716232,0.098831102846865,4.137478426463,6.09517412367246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57335162823569,NA,3.25210686195657,NA,2.06562428018526e-52
6,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.477793461024029,0.125910335421369,1.26241662527363,2.06801102116189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.396266853357657,0.152448770473773,1.12967751445084,2.05344815259258,0.0023547861326099
6,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.881265415649559,0.260649583972912,1.46679626936556,4.07474516350091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.815868486814048,0.331935504385853,1.31272547642284,4.82238567948107,0.00252364806002767
6,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",1.49450200075179,0.270046786442195,2.7119920308268,7.81658206342442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45365083998834,NA,2.35520642314702,NA,2.16862154260497e-07
6,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.17875418322853,0.168945193997672,2.35725572686397,4.57108733743415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12523705215783,NA,2.07051734860831,NA,1.45500530402788e-10
6,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.339634563860448,0.126972475829121,1.09679041891195,1.80418880100622,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.252576421769545,0.147202717010335,0.981242480664499,1.74732906699416,0.0532658288921592
6,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.559357014763914,0.116651843382947,1.39471835281882,2.20330679565286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481051336926767,0.148805716836886,1.24561557854393,2.23208815499954,7.00609437478119e-05
6,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.24752718737337,0.10363366408489,2.85205019265104,4.28137662780303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19677434953301,NA,2.40849941964931,NA,1.81045726464971e-28
6,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.144241113071445,0.315816555401689,0.630709879938468,2.17508740125604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.049365804921226,0.336336414475089,0.551158307872473,2.05994918936301,0.871615129071643
6,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.12244776611102,0.0966917938885092,0.934814375883681,1.36563233352535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0266898339975962,0.111156326454791,0.833860493430197,1.28921773612524,0.763728357218896
6,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.352678789517896,0.267503688492431,0.409565772373399,1.16875305797157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.467426756749066,0.280357313898103,0.363015931284905,1.08944884137498,0.0958992791339932
6,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.222562675615294,0.0996440988874069,1.02725141881596,1.51813772098057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.130810052232969,0.116859470638476,0.917640764343953,1.45082363341696,0.19720920633568
6,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.209669249544482,0.075392422255855,1.06413460261259,1.43002904290662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117414902062831,0.0940115332779313,0.946305593179292,1.36797112812265,0.126849742187827
6,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.00905819189284874,0.130328253372534,0.767069214553,1.27851484185719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.110070477002499,0.141829445567645,0.683140555207741,1.1911349128025,0.434705516019225
6,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",0.112927498005372,0.136644303501028,0.856723437996919,1.46374131890204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0167905552745044,0.150381510905208,0.764635449356629,1.37868286136321,0.885442065521825
6,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.699211155471553,0.120519205835332,1.59317882764941,2.55526998871814,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.626546902180226,0.16394293272242,1.41910843688362,2.69843857558336,5.59729021877722e-07
6,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.120601683719542,0.151763659866989,0.657499033388426,1.19195001011362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.226083599815463,0.162214923458083,0.583566716965766,1.10216267846423,0.160225100845124
6,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.41214060630723,0.110331834354466,3.32159893754842,5.11889767517394,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36797019755172,NA,2.74797325231292,NA,1.38874104426578e-32
6,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",-0.200955767658796,0.197631314288025,0.55269519826696,1.19931661669588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.309652472793043,0.208762169029024,0.489629170669863,1.10985091591834,0.137388096894499
6,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",1.35989639546442,0.219570741291569,2.58447950810856,6.11182626871292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31364774819365,NA,2.25900009352517,NA,8.37247458259643e-09
6,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",-0.0221462018408301,0.10671263607717,0.793287601096858,1.20530952176114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.123689078786235,0.117926071805347,0.705965192166925,1.12083322720124,0.282807377000003
6,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.58412711117475,0.218441818736857,3.2400926546496,7.62839997440314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54684680517145,NA,2.77469113877278,NA,9.39554766719101e-12
6,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.43465846912136,0.22031849730921,7.5982756810189,18.021292530882,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.43141082866714,NA,5.33827525694741,NA,2.60658341610271e-26
6,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.131974582850536,0.119186321570447,0.903804243880377,1.44204076616688,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0366102314093626,0.133369256079593,0.806619357139923,1.36055741361429,0.745926757619954
6,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.0571002011965459,0.182826877487978,0.660312296744786,1.35205520863492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.160071588608272,0.194870954317395,0.585458361044306,1.25673851990246,0.412102233587567
6,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",-0.194417620919222,0.642170007527448,0.234110798504412,2.90170761252507,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.302853407115408,0.675758986802185,0.199508879636272,2.82082675788006,0.654328579455122
6,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.634353479032361,0.294140393896487,0.292698889208723,0.927185409282091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.760387088702688,0.306988852496225,0.256615343944045,0.854872586864954,0.0134590473557475
6,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.619609485683679,0.112043571767164,1.49455935022157,2.31876367540659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.543726912351946,0.149211311183505,1.33209580860383,2.39085511325188,2.97348581644178e-06
6,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.28371068853816,0.10117943180686,2.97151716829803,4.41800721503739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2344010784388,NA,2.49091417454233,NA,1.48116721918557e-31
6,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
